infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test
home management of gestational diabetes, includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately); per diem (do not use this code with any home infusion per diem code)
injection, oritavancin (kimyrsa), 10 mg
hospice general inpatient care; per diem
bundled payments for care improvement advanced (bpci advanced) model home visit for patient assessment performed by clinical staff for an individual not considered homebound, including, but not necessarily limited to patient assessment of clinical status, safety/fall prevention, functional status/ambulation, medication reconciliation/management, compliance with orders/plan of care, performance of activities of daily living, and ensuring beneficiary connections to community and other services; for use only for a bpci advanced model episode of care; may not be billed for a 30-day period covered by a transitional care management code
services performed by dietary counselor in the hospice setting, each 15 minutes
lumbar orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg
addition to upper extremity joint, wrist or elbow, concentric adjustable torsion style mechanism for custom fabricated orthotics only, each
eye pad, non-sterile, each
pessary, rubber, any type
injection, cytarabine liposome, 10 mg
injection, factor xiii (antihemophilic factor, human), 1 i.u.
metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams
patient whose mode of vascular access is a catheter at the time maintenance hemodialysis is initiated terminated december 31, 2020.
ultraviolet light therapy system panel, includes bulbs/lamps, timer and eye protection, 6 foot panel
stroke following isolated cabg surgery terminated december 31, 2020.
magnetic resonance cholangiopancreatography (mrcp)
metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
injection, methylergonovine maleate, up to 0.2 mg
bupropion hcl sustained release tablet, 150 mg, per bottle of 60 tablets
commode chair, extra wide and/or heavy duty, stationary or mobile, with or without arms, any type, each
injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)
preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no cover, sach foot, thermoplastic or equal, molded to model
paraffin, per pound
transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography
injection, pemetrexed (pemfexy), 10 mg
stationary compressed gaseous oxygen system, rental; includes container, contents, regulator, flowmeter, humidifier, nebulizer, cannula or mask, and tubing
i intend to report the cataract measures group terminated december 31, 2016.
transportation of portable ekg to facility or location, per patient
nasal vaccine inhalation
simultaneous pancreas kidney transplantation
porcine implant, permacol, per square centimeter
within the past 2 years, calcium and/or vitamin d optimization has not been ordered or performed terminated december 31, 2020.
gastric suction pump, home model, portable or stationary, electric
addition to lower extremity, thoracic control, lateral support uprights
i intend to report the hypertension (htn) measures group terminated december 31, 2014.
arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
automatic blood pressure monitor
injection, cemiplimab-rwlc, 1 mg terminated september 30, 2019.
incontinence product, disposable, penile wrap, each
disposable pack (water reservoir bag, speculum, valving mechanism and collection bag/box) for use with the electronic bowel irrigation/evacuation system
hand restoration (casts, shading and measurements included), partial hand, with glove, multiple fingers remaining
power wheelchair accessory, head control interface, mechanical, proportional, including all related electronics, mechanical direction change switch, and fixed mounting hardware
patient whose mode of vascular access is not a catheter at the time maintenance hemodialysis is initiated terminated december 31, 2020.
i intend to report the perioperative care measures group terminated december 31, 2014.
clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy
patients 81 years and older with a diagnosis of frailty terminated december 31, 2020.
injection, immune globulin (hizentra), 100 mg
patient with transient or reversible cause of af (e.g., pneumonia, hyperthyroidism, pregnancy, cardiac surgery)
radiation treatment delivery, single treatment area,single port or parallel opposed ports, simple blocks or no blocks: 20 mev or greater
hospice services for patient occurred any time during the measurement period
current perception threshold/sensory nerve conduction test, (snct) per limb, any nerve
oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; post r0 resection (with or without neoadjuvant therapy) with no evidence of disease recurrence, progression, or metastases (for use in a medicare-approved demonstration project)
replacement lens shield cartridge for use with laser skin piercing device, each
chore services; per 15 minutes
sealant, pulmonary, liquid
wheelchair with fixed arm, elevating legrests
lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
injection, oliceridine, 0.1 mg
infusion, albumin (human), 25%, 20 ml
topographic brain mapping
targeted case management; per month
bifocal vision prescription lens (safety, athletic, or sunglass), per lens
wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, adjustable rancho type
loxapine, inhalation powder, 10 mg terminated december 31, 2018.
incontinence product, disposable underpad, small size, each
hearing aid, contralateral routing device, monaural, in the ear (ite)
plastazote sandal, each
clinician did not attempt to achieve the diagnosis of breast cancer preoperatively by a minimally invasive biopsy method, reason not given
home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 24 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
injection, sculptra, 0.5 mg
injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units)
annual gynecological examination, new patient
documentation of medical reason for not receiving at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively (e.g., intolerance or other medical reason)
percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch
acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
documentation of patient death in the hospital following endovascular aaa repair terminated december 31, 2020.
antithrombotic therapy prescribed at discharge terminated december 31, 2017.
truss, single with standard pad
injection, heparin sodium, (heparin lock flush), per 10 units
disposable drug delivery system, flow rate of 50 ml or greater per hour
collagen dressing, sterile, size 16 sq. in. or less, each
all lower extremity prostheses, shoulder harness
azathioprine, oral, 50 mg
truss, addition to standard pad, water pad
oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage i (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
patient discharged to home no later than post-operative day #2 following cea
physical or manipulative therapy performed for maintenance rather than restoration
replace quadrilateral socket brim, molded to patient model
school-based individualized education program (iep) services, bundled
lso, corset front
stat laboratory request (situations other than s3601)
injection, siltuximab, 10 mg
injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg
prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity
artificial cornea
percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; each additional coronary artery, coronary artery branch, or bypass graft (list separately in addition to code for primary procedure)
diabetic indicator; retinal eye exam, dilated, bilateral
sildenafil citrate, 25 mg
cervical traction equipment not requiring additional stand or frame
fluoroestradiol f 18, diagnostic, 1 millicurie
crutches underarm, wood, adjustable or fixed, pair, with pads, tips and handgrips
injection, tobramycin sulfate, up to 80 mg
patient lift, electric with seat or sling
bed pan, fracture, metal or plastic
injection, onabotulinumtoxina, 1 unit
voice amplifier
disposable liner/shield/guard/pad/undergarment, for incontinence, each
injection, fosphenytoin sodium, 750 mg
all lower extremity prosthesis, combination single axis ankle and flexible keel foot
services of a qualified nursing aide, up to 15 minutes
monitoring feature/device, stand-alone or integrated, any type, includes all accessories, components and electronics, not otherwise classified
documentation of reasons for patient initiating maintenance hemodialysis with a catheter as the mode of vascular access (e.g., patient has a maturing arteriovenous fistula (avf)/arteriovenous graft (avg), time-limited trial of hemodialysis, other medical reasons, patient declined avf/avg, other patient reasons, patient followed by reporting nephrologist for fewer than 90 days, other system reasons) terminated december 31, 2020.
health-related quality of life assessed with tool during at least two visits and quality of life score remained the same or improved terminated december 31, 2021.
preparatory, elbow disarticulation or above elbow, single wall plastic socket, friction wrist, locking elbow, figure of eight harness, fair lead cable control, usmc or equal pylon, no cover, molded to patient model
granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
injection, chloramphenicol sodium succinate, up to 1 gm
mental health clubhouse services, per diem
contact layer, sterile, more than 48 sq. in., each dressing
non-pneumatic compression controller without calibrated gradient pressure
gradient compression stocking, full length/chap style, 30-40 mmhg, each
injection, fentanyl citrate, 0.1 mg
adult sized disposable incontinence product, brief/diaper, medium, each
noc for enteral supplies
adult sized disposable incontinence product, protective underwear/pull-on, medium size, each
non-segmental pneumatic appliance for use with pneumatic compressor, half arm
documentation of medical reason(s) for not prescribing a beta-lactam antibiotic (e.g., allergy, intolerance to beta-lactam antibiotics) terminated december 31, 2020.
incontinence product, protective underwear/pull-on, reusable, any size, each
cast supplies, long leg cylinder cast, adult (11 years +), plaster
patient documented not to have experienced a wrong site, wrong side, wrong patient, wrong procedure or wrong implant event
injection, velaglucerase alfa, 100 units
injection, pentostatin, 10 mg
chlamydia, gonorrhea and syphilis screening results documented (report when results are present for all of the 3 screenings)
professional services, initial visit, for the administration of anti-infective, pain management, chelation, pulmonary hypertension, inotropic, or other intravenous infusion drug or biological (excluding chemotherapy or other highly complex drug or biological) for each infusion drug administration calendar day in the individual's home, each 15 minutes
i intend to report the optimizing patient exposure to ionizing radiation measures group terminated december 31, 2016.
other scoliosis procedure, body jacket molded to patient model
ostomy pouch, urinary, for use on faceplate, heavy plastic, each
injection, pantoprazole sodium, 40 mg
replacement battery for external infusion pump owned by patient, lithium, 1.5 volt, each
chemodenervation of adductor muscle(s) of vocal cord
intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each
meprobamate terminated december 31, 2015.
colpopexy, vaginal; minimally invasive extra-peritoneal approach (sacrospinous)
drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed
i intend to report the total knee replacement measures group terminated december 31, 2016.
injection, ertapenem sodium, 500 mg
gradient compression stocking/sleeve, not otherwise specified
each additional 30 minutes of counseling in a week of medication assisted treatment, (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure
portable gaseous oxygen system, purchase; includes regulator, flowmeter, humidifier, cannula or mask, and tubing
patient admitted to the icu in the last 30 days of life
all endoskeletal lower extremity prosthesis, axial rotation unit, with or without adjustability
power operated vehicle (three or four wheel nonhighway) specify brand name and model number
drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed
addition to lower extremity, endoskeletal system, above knee, hydracadence system
walker, enclosed, four sided framed, rigid or folding, wheeled with posterior seat
temporary, absorbable lacrimal duct implant, each
wheelchair accessory, power seating system, combination tilt and recline, with mechanical shear reduction
initial, below knee 'ptb' type socket, non-alignable system, pylon, no cover, sach foot, plaster socket, direct formed
blood pressure reading not documented, reason not given
pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%
implantable wireless pulmonary artery pressure sensor with delivery catheter, including all system components
patient immunocompromised terminated december 31, 2020.
injection, margetuximab-cmkb, 5 mg
infusion pump used for uninterrupted parenteral administration of medication, (e.g., epoprostenol or treprostinol)
enteral formula, nutritionally complete, for special metabolic needs, excludes inherited disease of metabolism, includes altered composition of proteins, fats, carbohydrates, vitamins and/or minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit
spherocylinder, single vision, plus or minus 4.25 to 7.00d sphere, over 6.00d cylinder, per lens
development testing, with interpretation and report, per standardized instrument form
prosthetic sheath, below knee, each
12-lead electrocardiogram (ecg) performed terminated december 31, 2014.
spoken language comprehension functional limitation, discharge status, at discharge from therapy or to end reporting terminated december 31, 2019.
ocular implant, aqueous drainage assist device
application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children
power wheelchair, group 1 standard, portable, sling/solid seat and back, patient weight capacity up to and including 300 pounds
injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg
gradient compression stocking, waist length, 30-40 mmhg, each
moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate)
patients age 66 and older in institutional special needs plans (snp) or residing in long-term care with a pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period
addition to lower extremity, below knee/above knee, custom fabricated socket insert for other than congenital or atypical traumatic amputee, silicone gel, elastomeric or equal, for use with or without locking mechanism, initial only (for other than initial, use code l5673 or l5679)
azithromycin dihydrate, oral, capsules/powder, 1 gram
home injectable therapy; hormonal therapy (e.g.; leuprolide, goserelin), including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
patient has not been treated with a systemic or biologic medication for psoriasis for at least six months terminated december 31, 2016.
heavy duty wheelchair
risk-adjusted functional status change residual score for the hip impairment not measured because the patient did not complete the lepf prom at initial evaluation and/or near discharge, reason not given
splint, prefabricated, wrist or ankle
all quality actions for the applicable measures in the inflammatory bowel disease (ibd) measures group have been performed for this patient terminated december 31, 2016.
gauze, impregnated, water or normal saline, sterile, pad size more than 48 sq. in., without adhesive border, each dressing
injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg
initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment
injection, omadacycline, 1 mg
pressure support ventilator with volume control mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube) terminated december 31, 2015.
injection, ampicillin sodium, 500 mg
injection, incobotulinumtoxin a, 1 unit
aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
patient receiving hospice services any time during the measurement period
percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; each additional branch subtended by the bypass graft (list separately in addition to code for primary procedure)
conforming bandage, non-elastic, knitted/woven, non-sterile, width greater than or equal to three inches and less than five inches, per yard
patients not receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills
addition to lower extremity, above knee, pelvic control belt, padded and lined
aminolevulinic acid hcl for topical administration, 10% gel, 10 mg
addition to lower extremity, above knee, wood socket
patient has been treated with a systemic or biologic medication for psoriasis for at least six months terminated december 31, 2016.
sphere, single vision, plus or minus 7.12 to plus or minus 20.00d, per lens
injection, temsirolimus, 1 mg
knee disarticulation (or through knee), molded socket, single axis knee, pylon, sach foot, endoskeletal system
spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere, over 6.00d cylinder, per lens
injection, hydroxyzine hcl, up to 25 mg
nursing care, in the home, by licensed practical nurse, per diem
patient received adjuvant treatment course including both chemotherapy and her2-targeted therapy
wheelchair accessory, addition to power seating system, center mount power elevating leg rest/platform, complete system, any type, each
safety vest, wheelchair
clinician has documented reason for not performing fasting lipid profile (e.g., patient declined, other patient reasons) terminated december 31, 2016.
addition to halo procedure, magnetic resonance image compatible systems, rings and pins, any material
amantadine hydrochloride, oral brand, per 100 mg (for use in a medicare-approved demonstration project) terminated december 31, 2019.
patient had a prior influenza virus vaccine adverse reaction any time before or during the measurement period terminated december 31, 2020.
injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
injection, peramivir, 1 mg terminated december 31, 2015.
doxepin terminated december 31, 2015.
female external urinary collection device; pouch, each
lower extremity neurological exam performed and documented
electromyography (emg), biofeedback device
breast pump, manual, any type
injection, oxacillin sodium, up to 250 mg
assistive listening device, television amplifier, any type
childbirth preparation/lamaze classes, non-physician provider, per session
injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg
ostomy pouch, drainable, high output, for use on a barrier with flange (2 piece system), with filter, each
controlled dose inhalation drug delivery system
documentation of patient stroke following cea terminated december 31, 2020.
injection, aprepitant, 1 mg
hearing aid, contralateral routing system, binaural, ite/itc
catheter, balloon tissue dissector, non-vascular (insertable)
power wheelchair, group 3 very heavy duty, captains chair, patient weight capacity 451 to 600 pounds
cardioverter-defibrillator, other than single or dual chamber (implantable)
addition to lower extremity, prosthetic type, (bk) socket, molded to patient model, (used for 'ptb' 'afo' orthoses)
power wheelchair, group 3 very heavy duty, single power option, sling/solid seat/back, patient weight capacity 451 to 600 pounds
patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy
oral magnetic resonance contrast agent, per 100 ml
cord blood harvesting for transplantation, allogeneic
manual wheelchair accessory, gear reduction drive wheel, each
ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf
contraceptive supply, condom, male, each
most current ldl-c >=100mg/dl terminated december 31, 2014.
patient receiving first-time biologic disease modifying anti-rheumatic drug therapy
tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams
child sitting services for children of the individual receiving alcohol and/or substance abuse services
addition, endoskeletal system, below knee, alignable system
skilled services of a licensed nurse (lpn or rn), in the training and/or education of a patient or family member, in the home health or hospice setting, each 15 minutes terminated december 31, 2016.
evaluation by ocularist
extensive (75 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)
vision item or service, miscellaneous
p2y inhibitor prescribed at discharge terminated december 31, 2016.
tlso, triplanar control, one piece rigid plastic shell with interface liner, multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, anterior or posterior opening, restricts gross trunk motion in sagittal, coronal, and transverse planes, prefabricated, includes fitting and adjustment
upper extremity addition, excursion amplifier, lever type
injection, thiotepa, 15 mg
injection, mogamulizumab-kpkc, 1 mg terminated september 30, 2019.
injection, acetylcysteine, 100 mg
tag, per square centimeter
cygnus, per square centimeter
injection, mitoxantrone hydrochloride, per 5 mg
injection, ganciclovir sodium, 500 mg
tracheostomy, inner cannula
aniseikonic, per lens, bifocal
transperineal implantation of permanent adjustable balloon continence device, with cystourethroscopy, when performed and/or fluoroscopy, when performed terminated june 30, 2019.
contact lens, hydrophilic, spherical, per lens
hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose
shingrix vaccine documented as administered or previously received terminated december 31, 2020.
documentation of patient pain brought to a comfortable level within 48 hours from initial assessment
services performed by an occupational therapist assistant in the home health setting in the delivery of a safe and effective occupational therapy maintenance program, each 15 minutes
gasket or seal, for use with prosthetic socket insert, any type, each
surgical stockings full length, each
fully-reclining wheelchair, detachable arms (desk or full length) swing away detachable footrest
continent device; catheter for continent stoma
injection/implantation of bulking or spacer material (any type) with or without image guidance (not to be used if a more specific code applies) terminated june 30, 2016.
skin te, per square centimeter
foam dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing
evaluation for wheelchair requiring face to face visit with physician
patients who are currently statin therapy users or received an order (prescription) for statin therapy
addition to lower extremity, below knee suction socket
injection, von willebrand factor complex (humate-p), per iu vwf:rco
transcarpal/metacarpal or partial hand disarticulation prosthesis, external power, self-suspended, inner socket with removable forearm section, electrodes and cables, two batteries, charger, myoelectric control of terminal device terminated december 31, 2014.
medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)
injection, sirolimus protein-bound particles, 1 mg terminated june 30, 2022.
documentation of medical reason for not performing foot exam (e.g., patient with bilateral foot/leg amputation) terminated december 31, 2014.
assessment by chaplain services
brachytherapy source, non-stranded, palladium-103, per source
heel wedge
injection, chloroprocaine hydrochloride, per 30 ml
power wheelchair, group 2 extra heavy duty, captains chair, patient weight 601 pounds or more
salicylate terminated december 31, 2015.
patient was a permanent nursing home resident at any time during the performance period
documentation of medical reason(s) for not prescribing/administering androgen deprivation therapy in combination with external beam radiotherapy to the prostate (e.g., salvage therapy)
colistimethate sodium, inhalation solution administered through dme, concentrated form, per mg
addition of joint to upper extremity orthosis, any material; per joint
provider who referred the patient to another provider did not receive a report from the provider to whom the patient was referred
injection, prednisolone acetate, up to 1 ml
segmental gradient pressure pneumatic appliance, full leg
addition to lower extremity, pelvic control, hip joint, adjustable flexion, extension, abduction control, each
wheelchair accessory, seat upholstery, replacement only, each
injection, dexamethasone 9%, intraocular, 1 mcg terminated december 31, 2018.
all necessary data elements not included, reason not given terminated december 31, 2016.
injection, sotrovimab, 500 mg
most recent tobacco status is not tobacco free
heel, pad and depression for spur
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc
power wheelchair accessory, expandable controller, including all related electronics and mounting hardware, replacement only
single energy x-ray absorptiometry (sexa) bone density study, one or more sites; appendicular skeleton (peripheral) (e.g., radius, wrist, heel)
addition, endoskeletal knee-shin system, single axis, fluid swing phase control
cryo-cord, per square centimeter
deluxe item, patient aware (list in addition to code for basic item)
additions to lower extremity, below knee, knee joints, polycentric, pair
rehabilitation services (occupational, physical or speech) not indicated at or prior to discharge terminated december 31, 2014.
documentation in the patient record of a discussion between the physician/clinician and the patient that includes all of the following: treatment choices appropriate to genotype, risks and benefits, evidence of effectiveness, and patient preferences toward the outcome of the treatment terminated december 31, 2021.
community psychiatric supportive treatment program, per diem
patients with clinical ascvd diagnosis
oxygen concentrator, dual delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate, each
knee orthosis, adjustable knee joints (unicentric or polycentric), positional orthosis, rigid support, prefabricated, off-the shelf
water pressure pad for mattress, standard mattress length and width
rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c terminated december 31, 2016.
positron emission tomography radiopharmaceutical, diagnostic, for non-tumor identification, not otherwise classified
lumbar-sacral orthosis, sagittal-coronal control, with rigid posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf
injection, pegaspargase, per single dose vial
patients 81 years of age and older with at least one claim/encounter for frailty during the six months prior to the measurement period through december 31 of the measurement period
assistive listening device, telephone amplifier, any type
back pain was not measured by the visual analog scale (vas) within three months preoperatively and at three months ( 6 - 20 weeks) postoperatively
injection, eptifibatide, 5 mg
injection, succinylcholine chloride, up to 20 mg
material for vocal cord medialization, synthetic (implantable)
injection, cetirizine hydrochloride, 1 mg terminated june 30, 2020.
gauze, non-impregnated, non-sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing
magnetic resonance angiography without contrast followed by with contrast, chest (excluding myocardium)
injection, carboplatin, 50 mg
clinical decision support mechanism curbside clinical augmented workflow, as defined by the medicare appropriate use criteria program
gauze, non-impregnated, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing
gradient compression stocking, thigh length, 30-40 mmhg, each
wheelchair, detachable arms, desk or full length swing away detachable elevating legrests
addition, exoskeletal knee-shin system, single axis, manual lock
within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered and documented, no review of systems and no medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed terminated december 31, 2019.
shoulder disarticulation, molded socket, endoskeletal system, including soft prosthetic tissue shaping
injection, tetracycline, up to 250 mg
sacroiliac orthosis, provides pelvic-sacral support, with rigid or semi-rigid panels over the sacrum and abdomen, reduces motion about the sacroiliac joint, includes straps, closures, may include pendulous abdomen design, prefabricated, off-the-shelf
iodine i-131 iobenguane, diagnostic, 1 millicurie terminated december 31, 2019.
injection, granisetron hydrochloride, 100 mcg
patient died prior to the end of the performance period
injection, fosnetupitant 235 mg and palonosetron 0.25 mg terminated december 31, 2018.
foot, insert/plate, removable, addition to lower extremity orthosis, high strength, lightweight material, all hybrid lamination/prepreg composite, each
manual wheelchair accessory, pneumatic propulsion tire, any size, each
electrical stimulation of auricular acupuncture points; each 15 minutes of personal one-on-one contact with the patient
antiretroviral thereapy not prescribed terminated december 31, 2016.
documentation of medical reason(s) for not prescribing an fda-approved anticoagulant to a patient with a cha2ds2-vasc score of 0 or 1 for men; or 0, 1, or 2 for women (e.g., present or planned atrial appendage occlusion or ligation)
binaural, behind the ear
home injectable therapy, palivizumab, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
underarm pad, crutch, replacement, each
durable medical equipment, miscellaneous
wrist hand orthosis, includes one or more nontorsion joint(s), elastic bands, turnbuckles, may include soft interface, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); diagnostic, including collection of specimen(s) by brushing or washing when performed terminated december 31, 2015.
psychosocial rehabilitation services, per 15 minutes
pre-operative pulmonary surgery services for preparation for lvrs, 1 to 9 days of services
ambulance waiting time (als or bls), one half (1/2) hour increments
filter, disposable, used with aerosol compressor or ultrasonic generator
celera dual layer or celera dual membrane, per square centimeter
ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, without built-in convexity, 4 x 4 inches or smaller, each
dynamic knee, extension/flexion device with active resistance control
home infusion therapy, anti-spasmotic therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
catheter, suprapubic/cystoscopic
patient did not have one tetanus, diphtheria toxoids and acellular pertussis vaccine (tdap) on or between the patient's 10th and 13th birthdays
injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u.
documentation of medical reason(s) for not currently being a statin therapy user or receive an order (prescription) for statin therapy (e.g., patient with adverse effect, allergy or intolerance to statin medication therapy, patients who have an active diagnosis of pregnancy or who are breastfeeding, patients who are receiving palliative care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease (esrd), and patients with diabetes who have a fasting or direct ldl-c laboratory test result < 70 mg/dl and are not taking statin therapy) terminated december 31, 2016.
injection, somatropin, 1 mg
injection, interferon alfacon-1, recombinant, 1 microgram
embolization protective system
adjuvant chemotherapy not prescribed or previously received, reason not given terminated december 31, 2016.
back school, per visit
injection, immune globulin (bivigam), 500 mg
gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing
trifocal seg width over 28 mm
mucus trap
symphony, per square centimeter
injection, durvalumab, 10 mg
immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain terminated december 31, 2014.
medical home program, comprehensive care coordination and planning, maintenance of plan
injection, romidepsin, non-lyophilized, 0.1 mg
granulocytes, pheresis, each unit
injection, triptorelin extended release, 3.75 mg terminated december 31, 2018.
injection, ocrelizumab, 1 mg terminated december 31, 2017.
factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram
respite care services, up to 15 minutes
brachytherapy source, stranded, cesium-131, per source
sensor; invasive (e.g., subcutaneous), disposable, for use with artificial pancreas device system
office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of up to 56 mg of esketamine nasal self-administration, includes 2 hours post-administration observation
tamoxifen citrate, oral, 10 mg
patient was not admitted to hospice terminated december 31, 2020.
autologous platelet rich plasma for non-diabetic chronic wounds/ulcers, including phlebotomy, centrifugation, and all other preparatory procedures, administration and dressings, per treatment
supply, not otherwise specified
biodfence, per square centimeter
injection, epirubicin hcl, 2 mg
oncology; disease status; non-hodgkin's lymphoma, transformed from original cellular diagnosis to a second cellular classification (for use in a medicare-approved demonstration project)
miscellaneous component, supply or accessory for use with total artificial heart system
power wheelchair accessory, 22nf sealed lead acid battery, each, (e.g., gel cell, absorbed glassmat)
surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, 21-40 specimens terminated december 31, 2014.
buprenorphine/naloxone, oral, greater than 10 mg buprenorphine
immediate post surgical or early fitting, each additional cast change and realignment
wheelchair accessory, crutch and cane holder, each
risk-adjusted functional status change residual score for the low back impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate
light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard
ultraviolet light therapy system panel, includes bulbs/lamps, timer and eye protection, 4 foot panel
fracture frame, attachments for complex pelvic traction
psychiatric symptoms assessed terminated december 31, 2019.
injection, cabotegravir, 1 mg
upper extremity addition, flexion/extension and rotation wrist unit
home infusion therapy, total parenteral nutrition (tpn); one liter per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem
patient did not receive at least one td vaccine or one tdap vaccine between nine years prior to the start of the measurement period and the end of the measurement period; or have history of at least one of the following contraindications any time during or before the measurement period: anaphylaxis due to tdap vaccine, anaphylaxis due to td vaccine or its components; encephalopathy due to tdap or td vaccination (post tetanus vaccination encephalitis, post diphtheria vaccination encephalitis or post pertussis vaccination encephalitis.) terminated december 31, 2020.
corrugated tubing, disposable, used with large volume nebulizer, 100 feet
language screening
seat lift mechanism, non-electric, any type
injection, fosphenytoin, 50 mg phenytoin equivalent
risk-adjusted functional status change residual score for the hip impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)
riboflavin 5'-phosphate, ophthalmic solution, up to 3 ml
hospital bed, institutional type includes: oscillating, circulating and stryker frame, with mattress
high osmolar contrast material, up to 149 mg/ml iodine concentration, per ml
iris prosthesis
pathology report includes the pt category, thickness, ulceration and mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors
dialysis procedure at a medicare certified esrd facility for acute kidney injury without esrd
aniseikonic lens, single vision
non-coring needle or stylet with or without catheter
injection, avalglucosidase alfa-ngpt, 4 mg
patient education, not otherwise classified, non-physician provider, group, per session
whirlpool, portable (overtub type)
home infusion therapy, uninterrupted, long-term, controlled rate intravenous or subcutaneous infusion therapy (e.g., epoprostenol); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
upper extremity addition, disconnect locking wrist unit
presbyopia correcting function of intraocular lens
functional status measured by the oxford knee score (oks) at one year (9 to 15 months) postoperatively was greater than or equal to 37 or knee injury and osteoarthritis outcome score joint replacement (koos, jr.) was greater than or equal to 71
health-related quality of life not assessed with tool for documented reason(s) (e.g., patient has a cognitive or neuropsychiatric impairment that impairs his/her ability to complete the hrqol survey, patient has the inability to read and/or write in order to complete the hrqol questionnaire) terminated december 31, 2021.
addition to lower extremity, molded inner boot
adenoma(s) or colorectal cancer detected during screening colonoscopy terminated december 31, 2020.
adhesive skin support attachment for use with external breast prosthesis, each
addition to tlso, (low profile), lateral thoracic extension
cast supplies, long leg cylinder cast, pediatric (0-10 years), plaster
graftjacket xpress, injectable, 1 cc
contact layer, sterile, 16 sq. in. or less, each dressing
alcohol and/or drug services; sub-acute detoxification (residential addiction program outpatient)
grafix prime, grafixpl prime, stravix and stravixpl, per square centimeter
brachytherapy needle
insertion of non-biodegradable drug delivery implants, 4 or more (services for subdermal rod implant)
injection fluconazole, 200 mg
documentation of medical reason(s) for patient having a hemoglobin level < 10 g/dl (e.g., patients who have non-renal etiologies of anemia [e.g., sickle cell anemia or other hemoglobinopathies, hypersplenism, primary bone marrow disease, anemia related to chemotherapy for diagnosis of malignancy, postoperative bleeding, active bloodstream or peritoneal infection], other medical reasons) terminated december 31, 2020.
other manual wheelchair/base
specialty absorptive dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing
compression burn garment, bodysuit (head to foot), custom fabricated
documentation of patient survival and absence of stroke following cas terminated december 31, 2020.
plumbing and/or electrical work for home hemodialysis equipment
ostomy pouch, drainable, high output, with extended wear barrier (one-piece system), with or without filter, each
derma-gide, per square centimeter
more than one ct scan of the paranasal sinuses ordered or received within 90 days after diagnosis
injection, pertuzumab, 1 mg
knee orthosis, single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
non-contact wound warming device (temperature control unit, ac adapter and power cord) for use with warming card and wound cover
cast supplies, short leg cast, pediatric (0-10 years), plaster
walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated, off-the-shelf
injection, morphine sulfate, up to 10 mg
injection, cyclophosphamide, (auromedics), 5 mg
face-to-face home health nursing visit by a rural health clinic (rhc) or federally qualified health center (fqhc) in an area with a shortage of home health agencies; (services limited to rn or lpn only)
replacement, socket, hip disarticulation, including hip joint, molded to patient model
interferential current stimulator, 4 channel
aortic aneurysm 6.0 cm or greater maximum diameter on centerline formatted ct or minor diameter on axial formatted ct
injection, melphalan flufenamide, 1mg
lvf testing documented as being performed prior to discharge or in the previous 12 months terminated december 31, 2014.
injection, thiethylperazine maleate, up to 10 mg
injection, pentazocine, 30 mg
spoken language comprehension functional limitation, current status at therapy episode outset and at reporting intervals terminated december 31, 2019.
wheelchair, detachable arms, desk or full length, swing away detachable footrests
services performed by a qualified physical therapist assistant in the home health or hospice setting, each 15 minutes
endometrial sampling or hysteroscopy with biopsy and results documented during the 12 months prior to the index date (exclusive of the index date) of the endometrial ablation
addition, endoskeletal system, below knee, flexible protective outer surface covering system
episodes where the patient had a comorbid condition during the 12 months prior to or on the episode date (e.g., tuberculosis, neutropenia, cystic fibrosis, chronic bronchitis, pulmonary edema, respiratory failure, rheumatoid lung disease)
documentation of medical reason(s) for not providing tobacco cessation intervention on the date of the encounter or within the previous 12 months (e.g., limited life expectancy, other medical reason)
patient transferred to practice after initiation of chemotherapy terminated december 31, 2020.
cast supplies, short leg cast, pediatric (0-10 years), fiberglass
lightweight wheelchair, fixed full length arms, swing away detachable elevating legrests
addition, exoskeletal knee-shin system, polycentric, mechanical stance phase lock
transcutaneous electrical nerve stimulation (tens) device, four or more leads, for multiple nerve stimulation
immediate post surgical or early fitting, application of initial rigid dressing, including fitting, alignment and suspension and one cast change 'ak' or knee disarticulation
flutemetamol f18, diagnostic, per study dose, up to 5 millicuries terminated june 30, 2016.
filter holder and integrated filter without adhesive, for use in a tracheostoma heat and moisture exchange system, each
isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
knee ankle foot orthosis, full plastic, with or without free motion knee, multi-axis ankle, custom fabricated
skin protection wheelchair seat cushion, width 22 inches or greater, any depth
alcohol and/or other drug treatment program, per hour
cast supplies, shoulder cast, adult (11 years +), fiberglass
documentation of patient reason(s) for not prescribing beta-blocker therapy (eg, patient declined, other patient reasons)
wheelchair accessory, adjustable height, detachable armrest, complete assembly, each
addition to lower extremity, below knee, molded distal cushion
home therapy; intermittent anticoagulant injection therapy (e.g., heparin); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code for flushing of infusion devices with heparin to maintain patency)
sphere, bifocal, plus or minus 4.12 to plus or minus 7.00d, per lens
amniotext patch, per square centimeter
injection, reslizumab, 1 mg terminated december 31, 2016.
brief face-to-face behavioral counseling for alcohol misuse, 15 minutes
other scoliosis procedure, post-operative body jacket
frames, purchases
financial management, self-directed, waiver; per 15 minutes
medical foods for inborn errors of metabolism
skilled nursing facility mips specialty set
specimen site other than anatomic location of lung or is not classified as primary non-small cell lung cancer
cardiac stress imaging test primarily performed on low chd risk patient for initial detection and risk assessment
levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg
patient lift, hydraulic or mechanical, includes any seat, sling, strap(s) or pad(s)
indwelling catheter; foley type, two-way latex with coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each
risk-adjusted functional status change residual score for the elbow, wrist or hand impairment not measured because the patient did not complete the elbow/wrist/hand fs prom at initial evaluation and/or near discharge, reason not given
custom shaped protective cover, below knee
non-elastic binder for extremity
radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 11-19 mev
segmental pneumatic appliance for use with pneumatic compressor, chest
services performed by a qualified physical therapist in the home health or hospice setting, each 15 minutes
all quality actions for the applicable measures in the chronic kidney disease (ckd) measures group have been performed for this patient terminated december 31, 2016.
fitting/orientation/checking of hearing aid
take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure
addition, exoskeletal system, above knee, ultra-light material (titanium, carbon fiber or equal)
no implantable/insertable device used with device-intensive procedures
hospital bed, variable height, hi-lo, with any type side rails, without mattress
speech generating device, digitized speech, using pre-recorded messages, greater than 8 minutes but less than or equal to 20 minutes recording time
newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total)
cervical, collar, semi-rigid thermoplastic foam, two-piece, prefabricated, off-the-shelf
integral lens service, miscellaneous services reported separately
power wheelchair accessory, electronic connection between wheelchair controller and one power seating system motor, including all related electronics, indicator feature, mechanical function selection switch, and fixed mounting hardware
magnetic resonance angiography without contrast, pelvis
ostomy deodorant, with or without lubricant, for use in ostomy pouch, per fluid ounce
for diabetics only, not otherwise specified modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe, per shoe
rear wheel assembly, complete, with pneumatic tire, spokes or molded, replacement only, each
hospice or home health care provided in patient's home/residence
pcp prophylaxis was not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3, reason not given terminated december 31, 2016.
trapeze bar, heavy duty, for patient weight capacity greater than 250 pounds, attached to bed, with grab bar
in vitro fertilization procedure cancelled before aspiration, case rate
cast supplies, long leg cylinder cast, pediatric (0-10 years), fiberglass
ultrafiltration monitor
dna analysis for apoe epsilon 4 allele for susceptibility to alzheimer's disease
medical records copying fee, per page
treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg
injectable bulking agent, dextranomer/hyaluronic acid copolymer implant, anal canal, 1 ml, includes shipping and necessary supplies
genetic testing for alpha-thalassemia
iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries
spherocylinder, single vision, plano to plus or minus 4.00d sphere, 4.25 to 6.00d cylinder, per lens
knee ankle foot orthosis, fracture orthosis, femoral fracture cast orthosis, thermoplastic type casting material, custom fabricated
injection, moxetumomab pasudotox-tdfk, 0.01 mg terminated september 30, 2019.
genetic testing, sodium channel, voltage-gated, type v, alpha subunit (scn5a) and variants for suspected brugada syndrome
objective measurement of adherence to positive airway pressure therapy not performed, reason not given
arthroscopy, knee, surgical, for removal of loose body, foreign body, debridement/shaving of articular cartilage (chondroplasty) at the time of other surgical knee arthroscopy in a different compartment of the same knee
hospitalist services (list separately in addition to code for appropriate evaluation and management service)
antithrombotic therapy was not prescribed at discharge, reason not given terminated december 31, 2017.
injection, calcium glycerophosphate and calcium lactate, per 10 ml
safety concerns screening positive screen is without provision of mitigation recommendations, including but not limited to referral to other resources
elbow orthosis (eo), with adjustable position locking joint(s), prefabricated, off-the-shelf
patients 66 years of age or older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period terminated december 31, 2020.
injection, eptinezumab-jjmr, 1 mg terminated september 30, 2020.
patient receiving >5 mg daily prednisone (or equivalent) for longer than 6 months, and improvement or no change in disease activity
electronic salivary reflex stimulator (intra-oral/non-invasive)
clinical decision support mechanism agilemd, as defined by the medicare appropriate use criteria program
injection, bezlotoxumab, 10 mg
mapcp demonstration - state provided services
injection, penicillin g benzathine, 100,000 units
injection, naltrexone, depot form, 1 mg
patients 81 years of age and older with at least one claim/encounter for frailty during the measurement period
custom fabricated wheelchair seat cushion, any size
parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, 52 to 73 grams of protein - premix
colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk
bicarbonate concentrate, solution, for hemodialysis, per gallon
power wheelchair accessory, group 27 non-sealed lead acid battery, each
addition to lower extremity, thigh/weight bearing, gluteal/ ischial weight bearing, ring
iodine i-123 iobenguane, diagnostic, per study dose, up to 15 millicuries
mesh (implantable)
unskilled respite care, not hospice; per diem
semi-reclining wheelchair, detachable arms (desk or full length) elevating leg rest
manual wheelchair accessory, solid seat support base (replaces sling seat), includes any type mounting hardware
injection, depo-estradiol cypionate, up to 5 mg
oxygen accessory, battery pack/cartridge for portable concentrator, any type, replacement only, each
injection, sulfur hexafluoride lipid microspheres, per ml
unlisted ambulance service
all lower extremity prostheses, foot, multiaxial ankle/foot
lidocaine 70 mg/tetracaine 70 mg, per patch
injection, codeine phosphate, per 30 mg
replacement socket, above elbow/elbow disarticulation, molded to patient model, for use with or without external power
injection, glucagon hydrochloride, per 1 mg
documentation of medical reason(s) for not completely infusing the prophylactic antibiotic prior to the inflation of the proximal tourniquet (e.g., a tourniquet was not used) terminated december 31, 2020.
elder maltreatment screen documented as negative, no follow-up required
filter holder and integrated filter housing, and adhesive, for use as a tracheostoma heat and moisture exchange system, each
injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg
trastuzumab administered within 12 months of diagnosis terminated december 31, 2020.
stent, non-coronary, temporary, without delivery system
cane, includes canes of all materials, adjustable or fixed, with tip
services performed by a physical therapist assistant in the home health setting in the delivery of a safe and effective physical therapy maintenance program, each 15 minutes
wheelchair seat cushion, powered
foot exam was not performed, reason not given
injection, arbutamine hcl, 1 mg
injection, paclitaxel, 30 mg terminated december 31, 2014.
addition to upper extremity prosthesis, external powered, additional switch, any type
human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml
patients who did not receive cervical cytology or an hpv test
documentation of medical reason(s) for not performing a 12-lead electrocardiogram (ecg) terminated december 31, 2014.
benesch boot, pair, infant
unspecified maxillofacial prosthesis, by report, provided by a non-physician
depression, anxiety, apathy, and psychosis assessed
tlso, flexible, provides trunk support, thoracic region, rigid posterior panel and soft anterior apron, extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, restricts gross trunk motion in the sagittal plane, produces intracavitary pressure to reduce load on the intervertebral disks, includes straps and closures, prefabricated, off-the-shelf
brachytherapy source, non-stranded, ytterbium-169, per source
injection, droperidol and fentanyl citrate, up to 2 ml ampule
large size footplate, each
take-home supply of injectable naloxone (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure
health club membership, annual
ostomy faceplate equivalent, silicone ring, each
contact lens, pmma, bifocal, per lens
injection, hydroxyprogesterone caproate, (makena), 10 mg
uri episodes when the patient had competing diagnoses on or three days after the episode date (e.g., intestinal infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, acute pharyngitis, acute tonsillitis, chronic sinusitis, infection of the pharynx/larynx/tonsils/adenoids, prostatitis, cellulitis, mastoiditis, or bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia/gonococcal infections, venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis or uti, and acne)
documentation of medical reason(s) for not counting previous ct and cardiac nuclear medicine (myocardial perfusion) studies (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) terminated december 31, 2015.
injection, calcitonin salmon, up to 400 units
shoulder orthosis, shoulder joint design, without joints, may include soft interface, straps, prefabricated, off-the-shelf
replace pretibial shell
injection, bupivacaine liposome, 1 mg
nurse practitioner visit at member's home, outside of a capitation arrangement
netupitant 300 mg and palonosetron 0.5 mg terminated december 31, 2015.
comprehensive care management services for a single high-risk disease, e.g., principal care management, at least 30 minutes of physician or other qualified health care professional time per calendar month with the following elements: one complex chronic condition lasting at least 3 months, which is the focus of the care plan, the condition is of sufficient severity to place patient at risk of hospitalization or have been the cause of a recent hospitalization, the condition requires development or revision of disease-specific care plan, the condition requires frequent adjustments in the medication regimen, and/or the management of the condition is unusually complex due to comorbidities terminated december 31, 2021.
hemi-wheelchair, fixed full length arms, swing away detachable elevating leg rest
wheelchair accessory, addition to mobile arm support, offset or lateral rocker arm with elastic balance control
specimen site other than anatomic location of prostate
patient did not have one dose of meningococcal vaccine (serogroups a, c, w, y) on or between the patient's 11th and 13th birthdays
phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml
adhesion barrier
injection, midazolam hydrochloride, per 1 mg
injection, aripiprazole lauroxil, 1 mg terminated september 30, 2019.
ultrasound, abdominal, with contrast terminated december 31, 2018.
pediatric patient with minor blunt head trauma not classified as low risk according to the pecarn prediction rules
coordinated care fee, maintenance rate
current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given
enteral formula, manufactured blenderized natural foods with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit
visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)
injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u.
addition to lower extremity, socket insert, multi-durometer symes
filters for use with electric or electric/pneumatic ventricular assist device, replacement only
pain assessment using a standardized tool is documented as negative, no follow-up plan required terminated december 31, 2020.
eosinophil count, blood, direct
adjustable chair, for esrd patients
surgical boot/shoe, each
hospice services for patient provided any time during the measurement period
oncology; disease status; limited to multiple myeloma, systemic disease; smoldering, stage i (for use in a medicare-approved demonstration project)
terminal device, hand, mechanical, voluntary closing, any material, any size, pediatric
smoking cessation counseling, individual, in the absence of or in addition to any other evaluation and management service, per session (6-10 minutes) [demo project code only]
no documentation of blood pressure measurement, reason not given
each additional cervical vertebral body (list separately in addition to code for primary procedure) terminated december 31, 2015.
generator, neurostimulator (implantable), non-rechargeable, with transvenous sensing and stimulation leads
patient survey results not available
power wheelchair, group 3 standard, single power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds
lutetium lu 177, dotatate, therapeutic, 1 mci terminated december 31, 2018.
injection, calcium gluconate, per 10 ml
addition to lower extremity, pelvic control, hip joint, adjustable flexion, each
home infusion therapy, catheter care / maintenance, complex (more than one lumen), includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
home infusion therapy, hydration therapy; more than one liter but no more than two liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
diabetic management program, nurse visit
ct studies not reported to a radiation dose index registry due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) terminated december 31, 2015.
insertion of levonorgestrel-releasing intrauterine system
compression burn garment, glove to axilla, custom fabricated
hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given terminated december 31, 2016.
receipt and analysis of remote, asynchronous images for dermatologic and/or ophthalmologic evaluation, for use only in a medicare-approved cmmi model, more than 20 minutes
statin not prescribed for documented reasons (e.g., allergy, medical intolerance) terminated december 31, 2016.
patient care survey was not completed by patient
current smoker (e.g., cigarette, cigar, pipe, e-cigarette or marijuana)
catheter, intracardiac echocardiography
injection, etidronate disodium, per 300 mg
screening for hcv infection not received within the 12 month reporting period, reason not given
injection, dimenhydrinate, up to 50 mg
documentation of reason(s) for not measuring an apnea hypopnea index (ahi) or a respiratory disturbance index (rdi) at the time of initial diagnosis (e.g., psychiatric disease, dementia, patient declined, financial, insurance coverage, test ordered but not yet completed)
above knee, short prosthesis, no knee joint ('stubbies'), with articulated ankle/foot, dynamically aligned, each
custom shaped protective cover, hip disarticulation
clinician documented that patient received vascular access other than autogenous av fistula, reason not given terminated december 31, 2015.
nebulizer, ultrasonic, large volume
cardioverter-defibrillator, single chamber (implantable)
injection, reteplase, 18.1 mg
sacroiliac orthosis, flexible, provides pelvic-sacral support, reduces motion about the sacroiliac joint, includes straps, closures, may include pendulous abdomen design, prefabricated, off-the-shelf
clinician documented reason that patient's biopsy results were not reviewed
transducer protectors/fluid barriers, for hemodialysis, any size, per 10
lumbar orthosis, sagittal control, with rigid posterior panel(s), posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf
parenteral nutrition solution; amino acid, 3.5%, (500 ml = 1 unit) - home mix
services provided outside of the united states of america (list in addition to code(s) for service(s))
injection, kanamycin sulfate, up to 75 mg
patient safety and support of positive experiences with anesthesia mips value pathways
injection, kanamycin sulfate, up to 500 mg
rehabilitation services were not ordered, reason not otherwise specified terminated december 31, 2014.
aspirin not prescribed at discharge terminated december 31, 2016.
injection, ferric pyrophosphate citrate solution, 0.1 mg of iron terminated december 31, 2015.
injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg
alginate or other fiber gelling dressing, wound filler, sterile, per 6 inches
addition to knee joint, disc or dial lock for adjustable knee flexion, each joint
tracheostoma filter, any type, any size, each
alcohol wipes, per box
emergency power supply cable for use with electric ventricular assist device, replacement only
irrigation supply; sleeve, reusable, per month
emergency power supply cable for use with electric/pneumatic ventricular assist device, replacement only
community-based wrap-around services, per diem
destruction of intraosseous basivertebral nerve, each additional vertebral body, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum (list separately in addition to code for primary procedure) terminated december 31, 2021.
injection, rituximab-arrx, biosimilar, (riabni), 10 mg
injection, rasburicase, 0.5 mg
genetic testing for sickle cell anemia
hospice continuous home care; per hour
addition to lower extremity orthosis, soft interface for molded plastic, below knee section
anti-lipid treatment at discharge terminated december 31, 2014.
knee orthosis, double upright with adjustable joint, with inflatable air support chamber(s), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
tissue marker, implantable, any type, each
repair or nonroutine service for durable medical equipment other than oxygen equipment requiring the skill of a technician, labor component, per 15 minutes
implantable radiation dosimeter, each
lithium ion battery for use with cochlear implant device speech processor, other than ear level, replacement, each
day care services, adult; per 15 minutes
lenticular lens, per lens, single
skin piercing device for collection of capillary blood, laser, each
ostomy skin barrier, with flange (solid, flexible or accordion), without built-in convexity, larger than 4 x 4 inches, each
power wheelchair accessory, u-1 non-sealed lead acid battery, each
gloves, sterile, per pair
spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere,.12 to 2.00d cylinder, per lens
low (or very low) risk of recurrence, prostate cancer
computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure)
hearing aid, contralateral routing system, binaural, itc/itc
powered upper extremity range of motion assist device, elbow, wrist, hand, finger, single or double upright(s), includes microprocessor, sensors, all components and accessories, custom fabricated
hip knee ankle foot orthosis, torsion control, unilateral rotation straps, pelvic band/belt, custom fabricated
incontinence supply, rectal insert, any type, each
injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)
cochlear implant, external speech processor and controller, integrated system, replacement
services performed by a qualified physical therapist, in the home health setting, in the establishment or delivery of a safe and effective physical therapy maintenance program, each 15 minutes
cervical, semi-rigid, adjustable molded chin cup (plastic collar with mandibular/occipital piece)
injection, hydromorphone, up to 4 mg
other speech language pathology functional limitation, discharge status at discharge from therapy or to end reporting terminated december 31, 2019.
all lower extremity prostheses, flex-walk system or equal
pediatric patient with minor blunt head trauma and pecarn prediction criteria are not assessed
lumbar orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf
rectal control system for vaginal insertion, for long term use, includes pump and all supplies and accessories, any type each
electrophysiology cardiac specialist mips specialty set
prosthesis, penile, non-inflatable
patient does not have verification and documentation of sudden or rapidly progressive hearing loss
cardiac stress imaging performed primarily for monitoring of asymptomatic patient who had pci within 2 years
commode chair with integrated seat lift mechanism, non-electric, any type
behavioral health; long-term residential (non-medical, non-acute care in a residential treatment program where stay is typically longer than 30 days), without room and board, per diem
cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10 years), plaster
ostomy pouch, drainable; for use on barrier with flange (2 piece system), each
surgical boot, each, junior
creation of arteriovenous fistula, percutaneous; direct, any site, including all imaging and radiologic supervision and interpretation, when performed and secondary procedures to redirect blood flow (e.g., transluminal balloon angioplasty, coil embolization, when performed) terminated june 30, 2020.
transcutaneous electrical joint stimulation device system, includes all accessories
injection, agalsidase beta, 1 mg
blood collection tube, vacuum, for dialysis, per 50
injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg
hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
power wheelchair, group 2 standard, portable, sling/solid seat/back, patient weight capacity up to and including 300 pounds
misoprostol, oral, 200 mcg
injection, pembrolizumab, 1 mg terminated december 31, 2015.
injection, bamlanivimab and etesevimab, 2100 mg
patient not referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not given
one way chest drain valve
injection, gonadorelin hydrochloride, per 100 mcg
clinician documented that patient was not an eligible candidate for footwear evaluation measure
functional status was measured by the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively terminated december 31, 2019.
home infusion therapy, sympathomimetic/inotropic agent infusion therapy (e.g., dobutamine); administrative services, professional pharmacy services, care coordination, all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
injection, oxymorphone hcl, up to 1 mg
six volt battery, each
injection, menotropins, 75 iu
repair, congenital cystic adenomatoid malformation in the fetus, procedure performed in utero
injection, urea, up to 40 gm
injection, hydralazine hcl, up to 20 mg
elbow wrist hand finger orthosis, rigid, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment
special wheelchair seat depth, by upholstery
injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg
factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram
upper extremity addition, frame type socket, above elbow or elbow disarticulation
ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, with built-in convexity, each
patient had a head ct for trauma ordered by someone other than an emergency care provider or was ordered for a reason other than trauma terminated december 31, 2020.
pulse generator system for tympanic treatment of inner ear endolymphatic fluid
amputee wheelchair, detachable arms (desk or full length) swing away detachable elevating legrests
foot, shoe molded to patient model, silicone shoe, each
radiolabeled product provided during a hospital inpatient stay
genetic testing for von hippel-lindau disease
syringe, sterile, 20 cc or greater, each
gradient pressure aid (sleeve and glove combination), custom made
wide heavy duty wheelchair, detachable arms desk or full length arms, swing away detachable footrests
electromagnetic therapy, to one or more areas, for wound care other than described in g0329 or for other uses
risk-adjusted functional status change residual score for the knee impairment not measured because the patient did not complete the lepf prom at initial evaluation and/or near discharge, reason not given
fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
intrapulmonary percussive ventilation system and related accessories
oncology; primary focus of visit; supervising, coordinating or managing care of patient with terminal cancer or for whom other medical illness prevents further cancer treatment; includes symptom management, end-of-life care planning, management of palliative therapies (for use in a medicare-approved demonstration project)
iv chelation therapy (chemical endarterectomy)
platelets, leukocytes reduced, cmv-negative, apheresis/pheresis, each unit
pediatric sized disposable incontinence product, brief/diaper, small/medium size, each
patient does not achieve refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit terminated december 31, 2015.
injection, sebelipase alfa, 1 mg terminated december 31, 2016.
patient did not receive follow-up on or within 7 days after discharge
patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the measurement period
oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage iii a (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin
complete cycle, gamete intrafallopian transfer (gift), case rate
addition, endoskeletal knee-shin system, single axis, pneumatic/ swing phase control
patient in hospice at any time during the measurement period
portable oxygen contents, liquid, 1 month's supply = 1 unit, prescribed amount at rest or nighttime exceeds 4 liters per minute (lpm)
alcohol and/or drug prevention alternatives service (services for populations that exclude alcohol and other drug use e.g., alcohol free social events)
injection, vestronidase alfa-vjbk, 1 mg
patient not ambulatory, bed ridden, immobile, confined to chair, wheelchair bound, dependent on helper pushing wheelchair, independent in wheelchair or minimal help in wheelchair
documentation rh-immunoglobulin (rhogam) was not ordered, reason not given terminated december 31, 2020.
medicaid certified community behavioral health clinic services, per month
hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c terminated december 31, 2016.
injection, dmso, dimethyl sulfoxide, 50%, 50 ml
minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using venous graft only, single coronary venous graft
talymed, per square centimeter
zanamivir, inhalation powder, administered through inhaler, brand, per 10 mg (for use in a medicare-approved demonstration project) terminated december 31, 2019.
camisole, post-mastectomy
genetic analysis for a specific gene mutation for hypertrophic cardiomyopathy (hcm) in an individual with a known hcm mutation in the family
flutemetamol f18, diagnostic, per study dose, up to 5 millicuries
alcohol and/or drug services, brief intervention, per 15 minutes
her2-targeted therapies administered during the initial course of treatment terminated december 31, 2020.
methotrexate sodium, 5 mg
gallium ga-68 gozetotide, diagnostic, (locametz), 1 millicurie
placement of interstitial device(s) for radiation therapy/surgery guidance (e.g., fiducial markers, dosimeter), for other than the following sites (any approach): abdomen, pelvis, prostate, retroperitoneum, thorax, single or multiple
muromonab-cd3, parenteral, 5 mg
patient education, not otherwise classified, non-physician provider, individual, per session
patients receiving high doses of immunosuppressive therapy terminated december 31, 2020.
artificial larynx, any type
addition to lower extremity, socket insert, below knee (kemblo, pelite, aliplast, plastazote or equal)
operative report does not identify the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant, reason not given terminated december 31, 2020.
addition to lower extremity fracture orthosis, plastic shoe insert with ankle joints
binaural, body
partial hospitalization services, less than 24 hours, per diem
diaper service, reusable diaper, each diaper
home modifications; per service
activity therapy, such as music, dance, art or play therapies not for recreation, related to the care and treatment of patient's disabling mental health problems, per session (45 minutes or more)
prosthetic sheath, upper limb, each
patient documented not to have received a burn prior to discharge
direct admission of patient for hospital observation care
axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
power wheelchair accessory, group 34 sealed lead acid battery, each (e.g., gel cell, absorbed glassmat)
injection, elotuzumab, 1 mg terminated december 31, 2016.
mediskin, per square centimeter
parenteral nutrition administration kit, per day
electrical stimulation or electromagnetic wound treatment device, not otherwise classified
memory functional limitation, current status at therapy episode outset and at reporting intervals terminated december 31, 2019.
skilled services of a licensed practical nurse (lpn), in the training and/or education of a patient or family member, in the home health or hospice setting, each 15 minutes
microsurgical epididymal sperm aspiration (mesa)
improvement in visual function not achieved within 90 days following cataract surgery
injection, cephalothin sodium, up to 1 gram
mapcp demonstration - community health teams
transport chair, adult size, patient weight capacity up to and including 300 pounds
transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report
female external urinary collection device; meatal cup, each
injection, aripiprazole lauroxil, 1 mg terminated december 31, 2016.
hip disarticulation, canadian type, molded socket, endoskeletal system, hip joint, single axis knee, sach foot
peritoneal dialysis catheter anchoring device, belt, each
collagen dressing, sterile, size more than 16 sq. in. but less than or equal to 48 sq. in., each
intensive, extended multidisciplinary services provided in a clinic setting to children with complex medical, physical, medical and psychosocial impairments, per hour
powered pressure-reducing air mattress
manual wheelchair accessory, nonstandard seat frame depth, 22 to 25 inches
gradient compression stocking, waist length, 18-30 mmhg, each
injection, guselkumab, 1 mg
surveillance colonoscopy - personal history of colonic polyps, colon cancer, or other malignant neoplasm of rectum, rectosigmoid junction, and anus terminated december 31, 2020.
oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)
receiver (monitor); external, for use with artificial pancreas device system
patient not screened for unhealthy alcohol use using a systematic screening method or patient did not receive brief counseling if identified as an unhealthy alcohol user, reason not given
addition to ctlso or scoliosis orthosis, outrigger, bilateral with vertical extensions
injection, haloperidol, up to 5 mg
finger orthosis, nontorsion joint, may include soft interface, custom fabricated, includes fitting and adjustment
patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic not initiated on time
excised tissue not evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesion terminated december 31, 2020.
dentistry mips specialty set
pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg
hyaluronan or derivative, durolane, for intra-articular injection, 1 mg
buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine
pediculosis (lice infestation) treatment, topical, for administration by patient/caretaker
frontier extended stay clinic demonstration; for a patient stay in a clinic approved for the cms demonstration project; the following measures should be present: the stay must be equal to or greater than 4 hours; weather or other conditions must prevent transfer or the case falls into a category of monitoring and observation cases that are permitted by the rules of the demonstration; there is a maximum frontier extended stay clinic (fesc) visit of 48 hours, except in the case when weather or other conditions prevent transfer; payment is made on each period up to 4 hours, after the first 4 hours
contraceptive supply, hormone containing patch, each
wrist hand finger orthosis, dynamic flexor hinge, reciprocal wrist extension/ flexion, finger flexion/extension, cable driven, custom fabricated
self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting terminated december 31, 2019.
terminal device, hand, mechanical, voluntary closing, any material, any size
tacrine hydrochloride, 10 mg
home infusion therapy, continuous anticoagulant infusion therapy (e.g., heparin), administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
bed board
minoxidil, 10 mg
water collection device, used with large volume nebulizer
relese, per square centimeter
osteogenesis stimulator, low intensity ultrasound, non-invasive
indium in-111 labeled autologous white blood cells, diagnostic, per study dose
documentation of medical reason(s) for not recommending at least a 10 year follow-up interval (e.g., inadequate prep, familial or personal history of colonic polyps, patient had no adenoma and age is = 66 years old, or life expectancy < 10 years old, other medical reasons)
insulin cartridge for use in insulin delivery device other than pump; 300 units
coordinated care fee, risk adjusted maintenance, level 5
ostomy pouch, closed; for use on barrier with non-locking flange, with filter (2 piece), each
collagen skin test
injection, amiodarone hydrochloride, 30 mg
hearing aid, digital, monaural, cic
replacement electrodes for use with automated external defibrillator, garment type only, each
functional outcome assessment using a standardized tool not documented, reason not given
insulin delivery device, reusable pen; 1.5 ml size
duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure or general or neuraxial anesthesia less than 60 minutes, as documented in the anesthesia record terminated december 31, 2015.
lift, elevation, heel and sole, neoprene, per inch
injection, testosterone undecanoate, 1 mg terminated december 31, 2014.
open treatment of iliac spine(s), tuberosity avulsion, or iliac wing fracture(s), unilateral or bilateral for pelvic bone fracture patterns which do not disrupt the pelvic ring includes internal fixation, when performed
hearing aid, contralateral routing system, binaural, glasses
injection, rimabotulinumtoxinb, 100 units
below elbow, molded socket, endoskeletal system, including soft prosthetic tissue shaping
instillation, ciprofloxacin otic suspension, 6 mg
irrigation tubing set for continuous bladder irrigation through a three-way indwelling foley catheter, each
addition to lower extremity, offset knee joint, each joint
alcohol and/or drug services; case management
humidifier, durable, glass or autoclavable plastic bottle type, for use with regulator or flowmeter
medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)
benesch boot, pair, child
commode seat, wheelchair
nephrology mips specialty set
smoking and tobacco cessation counseling visit for the asymptomatic patient; intermediate, greater than 3 minutes, up to 10 minutes terminated september 30, 2016.
power wheelchair, group 2 standard, sling/solid seat/back, patient weight capacity up to and including 300 pounds
injection, docetaxel, 1 mg
home uterine monitor with or without associated nursing services
cycler dialysis machine for peritoneal dialysis
home sleep study test (hst) with type ii portable monitor, unattended; minimum of 7 channels: eeg, eog, emg, ecg/heart rate, airflow, respiratory effort and oxygen saturation
dna analysis of the connexin 26 gene (gjb2) for susceptibility to congenital, profound deafness
magnetic resonance angiography without contrast, upper extremity
trapeze bars, a/k/a patient helper, attached to bed, with grab bar
clinical decision support mechanism, qualified tool not otherwise specified, as defined by the medicare appropriate use criteria program
prednisolone oral, per 5 mg
hospital bed, total electric (head, foot and height adjustments), with any type side rails, with mattress
coordinated care fee, risk adjusted low, initial
physical exam for college, new or established patient (list separately in addition to appropriate evaluation and management code)
documentation of planned hybrid or staged procedure terminated december 31, 2021.
tension based scoliosis orthosis and accessory pads, includes fitting and adjustment
infection control supplies, not otherwise specified
documentation of patient reason(s) for not receiving one-time screening for hcv infection (e.g., patient declined, other patient reasons)
absorptive wound dressing for use with suction pump, home model, portable, pad size 16 square inches or less
injection, lincomycin hcl, up to 300 mg
implantable neurostimulator pulse generator, dual array, non-rechargeable, includes extension
patient is currently on a daily aspirin or other antiplatelet
documentation of reason(s) for not objectively measuring adherence to positive airway pressure therapy (e.g., patient didn't bring data from continous positive airway pressure [cpap], therapy not yet initiated, not available on machine)
injection, irinotecan, 20 mg
skills training and development, per 15 minutes
oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i, or stage iia-iib; or t3, n1, m0; and er and pr negative; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
packing strips, non-impregnated, sterile, up to 2 inches in width, per linear yard
exhalation port with or without swivel used with accessories for positive airway devices, replacement only
corecyte, for topical use only, per 0.5 cc
prophylactic parenteral antibiotics were not ordered to be given or given within one hour (if fluoroquinolone or vancomycin, two hours) prior to the surgical incision (or start of procedure when no incision is required), reason not given terminated december 31, 2014.
cogenex flowable amnion, per 0.5 cc
addition, endoskeletal ankle-foot or ankle system, power assist, includes any type motor(s)
assistive listening device, personal fm/dm, ear level receiver
urinal; female, jug-type, any material
percutaneous skeletal fixation of posterior pelvic bone fracture and/or dislocation, for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, (includes ilium, sacroiliac joint and/or sacrum)
clinician documented that patient is not an eligible candidate for quantitative rna testing at week 12; patient not receiving antiviral treatment for hepatitis c terminated december 31, 2016.
bmi is documented within normal parameters and no follow-up plan is required
injection, romiplostim, 10 micrograms
wheelchair van, mileage, per mile
transportation of portable x-ray equipment and personnel to home or nursing home, per trip to facility or location, one patient seen
injection, amobarbital, up to 125 mg
detachable, adjustable height armrest, upper portion, replacement only, each
assertive community treatment, face-to-face, per 15 minutes
injection, epoetin alfa, 1000 units (for esrd on dialysis) terminated december 31, 2015.
brachytherapy source, non-stranded, iodine-125, per source
contact lens, gas permeable, spherical, per lens
halo procedure, cervical halo incorporated into plaster body jacket
battery for use in hearing device
repair device, urinary, incontinence, with sling graft
injection, cefazolin sodium, 500 mg
decompression procedure, percutaneous, of nucleus pulposus of intervertebral disc, using radiofrequency energy, single or multiple levels, lumbar
sterile water/saline, 500 ml
ostomy pouch, drainable, with extended wear barrier attached, with built in convexity, with filter, (1 piece), each
composite dressing, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing
injection, c-1 esterase inhibitor (recombinant), ruconest, 10 units terminated december 31, 2015.
telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth
injection, sacituzumab govitecan-hziy, 2.5 mg terminated december 31, 2020.
fabrication and fitting of ocular conformer
patient does not have a caregiver
influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)
battery, lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only
most favored nation (mfn) model drug add-on amount, per dose, (do not bill with line items that have the jw modifier) terminated february 27, 2022.
contact lens, hydrophilic, bifocal, per lens
slab off prism, glass or plastic, per lens
clinician treating major depressive disorder communicates to clinician treating comorbid condition terminated december 31, 2020.
gallium ga-68 psma-11, diagnostic, (ucsf), 1 millicurie
power wheelchair, group 4 standard, captains chair, patient weight capacity up to and including 300 pounds
wrist disarticulation, external power, self-suspended inner socket, removable forearm shell, otto bock or equal, switch, cables, two batteries and one charger, switch control of terminal device
medication assisted treatment, medication not otherwise specified; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)
injection, pegfilgrastim-bmez, biosimilar, (ziextenzo) 0.5 mg terminated june 30, 2020.
brachytherapy source, stranded, palladium-103, per source
immunization counseling by a physician or other qualify ed health care professional when the vaccine(s) is not administered on the same date of service for ages under 21, 5 to 15 mins time (this code is used for medicaid billing purposes)
adhesive remover, wipes, any type, each
all quality actions for the applicable measures in the preventive care measures group have been performed for this patient terminated december 31, 2016.
injection, oprelvekin, 5 mg
documentation of medical reason(s) for ordering an advanced brain imaging study (i.e., patient has an abnormal neurological examination; patient has the coexistence of seizures, or both; recent onset of severe headache; change in the type of headache; signs of increased intracranial pressure (e.g., papilledema, absent venous pulsations on funduscopic examination, altered mental status, focal neurologic deficits, signs of meningeal irritation); hiv-positive patients with a new type of headache; immunocompromised patient with unexplained headache symptoms; patient on coagulopathy/anti-coagulation or anti-platelet therapy; very young patients with unexplained headache symptoms) terminated december 31, 2018.
specialty absorptive dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing
injection, teprotumumab-trbw, 10 mg
injection, olaratumab, 10 mg terminated december 31, 2017.
radiofrequency transmitter (external) for use with implantable neurostimulator radiofrequency receiver
chromium cr-51 sodium chromate, diagnostic, per study dose, up to 250 microcuries
at least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) achieved within the 30 minutes immediately before or the 15 minutes immediately after anesthesia end time
remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: a detailed history; a detailed examination; medical decision making of low complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate severity. typically, 30 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology
pulmonary rehabilitation program, non-physician provider, per diem
electrical stimulator supplies, 2 lead, per month, (e.g., tens, nmes)
telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth
patients with documented shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure
lift, elevation, metal extension (skate)
infusion, plasma protein fraction (human), 5%, 50 ml
canister, disposable, used with suction pump, each
humidifier, non-heated, used with positive airway pressure device
u-v lens, per lens
elective delivery (without medical indication) by cesarean birth or induction of labor performed (<39 weeks of gestation)
injection, infliximab, biosimilar, 10 mg terminated march 31, 2018.
brachytherapy planar source, palladium-103, per square millimeter
addition to upper extremity prosthesis, below elbow/wrist disarticulation, ultralight material (titanium, carbon fiber or equal)
buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine
for diabetics only, deluxe feature of off-the-shelf depth-inlay shoe or custom-molded shoe, per shoe
power wheelchair, group 4 standard, single power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds
injection, dihydroergotamine mesylate, per 1 mg
injection, emapalumab-lzsg, 1 mg terminated september 30, 2019.
injection, estrone, per 1 mg
hyperbaric oxygen under pressure, full body chamber, per 30 minute interval terminated december 31, 2014.
power wheelchair accessory, chin cup for chin control interface
injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram terminated september 30, 2022.
platelets, pheresis, leukocytes reduced, cmv-negative, irradiated, each unit
lead, left ventricular coronary venous system
adults who are not ambulatory
restrata, per square centimeter
tlso, triplanar control, one piece rigid plastic shell without interface liner, with multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, anterior or posterior opening, restricts gross trunk motion in sagittal, coronal, and transverse planes, includes a carved plaster or cad-cam model, custom fabricated
technetium tc-99m pyrophosphate, diagnostic, per study dose, up to 25 millicuries
als routine disposable supplies
patient not referred, reason not otherwise specified
individual did not have a pdc of 0.8 or greater
orthopedic footwear, custom molded shoe, removable inner mold, prosthetic shoe, each
i intend to report the sleep apnea measures group terminated december 31, 2016.
hearing aid, contralateral routing device, monaural, in the canal (itc)
injection, lurbinectedin, 0.1 mg
hearing aid, not otherwise classified
injection, c-1 esterase inhibitor (human), cinryze, 10 units
albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
addition to lower extremity, thigh/weight bearing, lacer, molded to patient model
anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); with biopsy(ies) terminated december 31, 2015.
frozen embryo transfer procedure cancelled before transfer, case rate
corplex, per square centimeter
electronic elbow, hosmer or equal, switch controlled
patient did not receive combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively
technetium tc-99m exametazime labeled autologous white blood cells, diagnostic, per study dose
tlso, sagittal-coronal control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, extends from sacrococcygeal junction over scapulae, lateral strength provided by pelvic, thoracic, and lateral frame pieces, restricts gross trunk motion in sagittal and coronal planes, produces intracavitary pressure to reduce load on intervertebral disks, prefabricated, off-the-shelf
catheter, drainage
contact lens, pmma, color vision deficiency, per lens
injection, trastuzumab-pkrb, biosimilar, (herzuma), 10 mg
hearing aid, contralateral routing device, monaural, behind the ear (bte)
multisystemic therapy for juveniles, per 15 minutes
coordinated care fee, initial rate
general use wheelchair back cushion, width less than 22 inches, any height, including any type mounting hardware
documentation of sexual activity
footrest, upper hanger bracket, replacement only, each
catheter, guiding (may include infusion/perfusion capability)
documentation that the patient declined change in medication or alternative therapies were unavailable, has documented contraindications, or has not been treated with a systemic medication for at least six consecutive months (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi
speech screening
clozapine, 25 mg
orthopedic shoe addition, march bar
risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment successfully calculated and the score was less than zero (< 0) terminated december 31, 2020.
stationary compressed gas system, purchase; includes regulator, flowmeter, humidifier, nebulizer, cannula or mask, and tubing
coretext or protext, per cc
catheter, transluminal atherectomy, rotational
hospital outpatient clinic visit for assessment and management of a patient
cobalt co-57/58, cyanocobalamin, diagnostic, per study dose, up to 1 microcurie
surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, 41-60 specimens terminated december 31, 2014.
alcohol and/or drug assessment
portable liquid oxygen system, rental; home liquefier used to fill portable liquid oxygen containers, includes portable containers, regulator, flowmeter, humidifier, cannula or mask and tubing, with or without supply reservoir and contents gauge
lead, neurostimulator test kit (implantable)
injection, romosozumab-aqqg, 1 mg
injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u. terminated december 31, 2016.
lead, cardioverter-defibrillator, other than endocardial single or dual coil (implantable)
pneumococcal vaccine not administered or previously received, reason not given
addition to lower limb prosthesis, vacuum pump, residual limb volume management and moisture evacuation system, heavy duty
beta-blocker contraindicated terminated december 31, 2014.
pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period
gradient compression stocking, full length/chap style, 40-50 mmhg, each
memory functional limitation, discharge status at discharge from therapy or to end reporting terminated december 31, 2019.
slings
immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service, 5 to 15 mins time (this code is used for medicaid billing purposes)
amnio wound, per square centimeter
documentation of system reason(s) for an interval of less than 3 years since the last colonoscopy (e.g., unable to locate previous colonoscopy report, previous colonoscopy report was incomplete)
injection, bendamustine hcl (treanda), 1 mg
level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)
noc drugs, other than inhalation drugs, administered through dme
epifix, injectable, 1 mg
signature apatch, per square centimeter
episodes where the patient is taking antibiotics (table 1) in the 30 days prior to the episode date, or had an active prescription on the episode date
ostomy pouch, drainable; for use on barrier with non-locking flange, with filter (2 piece system), each
idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose terminated december 31, 2021.
ostomy skin barrier, powder, per oz
specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source
auditory osseointegrated device, transducer/actuator, replacement only, each
prosthetic sock, multiple ply, above knee, each
terminal device, hook or hand, heavy duty, mechanical, voluntary opening, any material, any size, lined or unlined
hospice services provided to patient any time during the measurement period
cardiac rehabilitation program, non-physician provider, per diem
hip knee ankle foot orthosis, torsion control, bilateral torsion cables, hip joint, pelvic band/belt, custom fabricated
injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg
neox cord 1k, neox cord rt, or clarix cord 1k, per square centimeter
injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg
breast prosthesis, silicone or equal, with integral adhesive
chlamydia, gonorrhea, and syphilis not screened, reason not given
injection, asparaginase (erwinaze), 1,000 iu
power wheelchair, group 4 heavy duty, single power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds
patient received at least one td vaccine or one tdap vaccine between nine years prior to the start of the measurement period and the end of the measurement period terminated december 31, 2020.
supplies for maintenance of insulin infusion pump with dosage rate adjustment using therapeutic continuous glucose sensing, per week
mental health assessment, by non-physician
patient did not start or is not receiving antiviral treatment for hepatitis c during the measurement period terminated december 31, 2016.
red blood cells, washed, each unit
residential care, not otherwise specified (nos), waiver; per diem
hip orthosis, bilateral thigh cuffs with adjustable abductor spreader bar, adult size, prefabricated, includes fitting and adjustment, any type
above elbow, external power, molded inner socket, removable humeral shell, internal locking elbow, forearm, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device
oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n0, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
injection, lefamulin, 1 mg
patient had prior pneumococcal vaccine adverse reaction any time during or before the measurement period terminated december 31, 2020.
injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg
auditory osseointegrated device, external sound processor, used without osseointegration, body worn, includes headband or other means of external attachment
injection, loncastuximab tesirine-lpyl, 0.075 mg
bupivacaine, collagen-matrix implant, 1 mg
below elbow, molded socket, (muenster or northwestern suspension types)
injection, tezepelumab-ekko, 1 mg
injection, pasireotide long acting, 1 mg terminated december 31, 2015.
application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children
skin protection wheelchair seat cushion, width less than 22 inches, any depth
repair, congenital malformation of fetus, procedure performed in utero, not otherwise classified
bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service terminated december 31, 2017.
shoulder disarticulation, molded socket, shoulder bulkhead, humeral section, internal locking elbow, forearm
manual wheelchair accessory, wheel lock brake extension (handle), each
transfer bench for tub or toilet with or without commode opening
specialty absorptive dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing
injection, ceftriaxone sodium, per 250 mg
battery charger; replacement for patient-owned ventilator
technetium tc-99m pentetate, diagnostic, aerosol, per study dose, up to 75 millicuries
patient has documented immunity to hepatitis b and initiating anti-tnf therapy
addition to lower extremity, above knee, air, fluid, gel or equal, cushion socket
chlamydia, gonorrhea, and syphilis screening results not documented (patient refusal is the only allowed exception)
injection, belantamab mafodotin-blmf, 0.5 mg
most recent blood pressure under control terminated december 31, 2014.
positioning seat for persons with special orthopedic needs
spoken language expression functional limitation, current status at therapy episode outset and at reporting intervals terminated december 31, 2019.
compression burn garment, trunk, including arms down to leg openings (leotard), custom fabricated
upper extremity addition, test socket, elbow disarticulation or above elbow
prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99354, 99355, 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes)
external defibrillator with integrated electrocardiogram analysis
foot, insert, removable, formed to patient foot, each
acute bronchitis/bronchiolitis episodes when the patient had a new or refill prescription of antibiotics (table 1) in the 30 days prior to the episode date
amputee wheelchair, fixed full length arms, swing away detachable elevating legrests
injection, dobutamine hydrochloride, per 250 mg
enteral formula, for adults, used to replace fluids and electrolytes (e.g., clear liquids), 500 ml = 1 unit
injection, c1 esterase inhibitor (recombinant), ruconest, 10 units
supported employment, per diem
percutaneous islet cell transplant, includes portal vein catheterization and infusion
follow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth
functional status measured by the oswestry disability index (odi version 2.1a) at three months (6-20 weeks) postoperatively was less than or equal to 22 or functional status measured by the odi version 2.1a within three months preoperatively and at three months (6-20 weeks) postoperatively demonstrated an improvement of 30 points or greater
hearing aid, cros, in the ear terminated december 31, 2018.
power operated vehicle, group 2 standard, patient weight capacity up to and including 300 pounds
tobacco screening not performed or tobacco cessation intervention not provided on the date of the encounter or within the previous 12 months, reason not otherwise specified
human health factor 10 amniotic patch (hhf10-p), per square centimeter
vabra aspirator
transfer bench, heavy duty, for tub or toilet with or without commode opening
duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure 60 minutes or longer, as documented in the anesthesia record terminated december 31, 2015.
patient identified as tobacco user did not receive tobacco cessation intervention on the date of the encounter or within the previous 12 months (counseling and/or pharmacotherapy), reason not given
documentation of medical reason(s) for not screening for tobacco use (e.g., limited life expectancy, other medical reason)
injection, anidulafungin, 1 mg
sterile saline or water, metered dose dispenser, 10 ml
diabetes outpatient self-management training services, group session (2 or more), per 30 minutes
centrifuge, for dialysis
oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t4, n0, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
care management services for behavioral health conditions, at least 20 minutes of clinical staff time, directed by a physician or other qualified health care professional, per calendar month, with the following required elements: initial assessment or follow-up monitoring, including the use of applicable validated rating scales; behavioral health care planning in relation to behavioral/psychiatric health problems, including revision for patients who are not progressing or whose status changes; facilitating and coordinating treatment such as psychotherapy, pharmacotherapy, counseling and/or psychiatric consultation; and continuity of care with a designated member of the care team terminated december 31, 2017.
stationary oxygen contents, liquid, 1 month's supply = 1 unit
spherocylinder, bifocal, sphere over plus or minus 12.00d, per lens
power wheelchair accessory, battery charger, dual mode, for use with either battery type, sealed or non-sealed, each
pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15% for medical reason (i.e., patient's cd4+ cell count above threshold within 3 months after cd4+ cell count below threshold, indicating that the patient's cd4+ levels are within an acceptable range and the patient does not require pcp prophylaxis) terminated december 31, 2014.
spherocylinder, trifocal, sphere over plus or minus 12.00d, per lens
placement of occlusive device into either a venous or arterial access site, post surgical or interventional procedure (e.g., angioseal plug, vascular plug)
oral device/appliance used to reduce upper airway collapsibility, without fixed mechanical hinge, custom fabricated, includes fitting and adjustment
above elbow, external power, molded inner socket, removable humeral shell, internal locking elbow, forearm, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device
upper extremity prosthesis, not otherwise specified
for diabetics only, multiple density insert, made by direct carving with cam technology from a rectified cad model created from a digitized scan of the patient, total contact with patient's foot, including arch, base layer minimum of 3/16 inch material of shore a 35 durometer (or higher), includes arch filler and other shaping material, custom fabricated, each
peripheral nerve block (pnb)
pressure support ventilator with volume control mode, may include pressure control mode, used with non-invasive interface (e.g., mask) terminated december 31, 2015.
this code is for onsite acute care treatment of a resident with copd or asthma; may only be billed once per day per beneficiary
collagen based wound filler, dry form, sterile, per gram of collagen
metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams
voice functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting terminated december 31, 2019.
pacemaker, dual chamber, non rate-responsive (implantable)
unite biomatrix, per square centimeter terminated december 31, 2016.
addition to lower extremity, thoracic control, thoracic band
amniowrap2, per square centimeter
oxygen accessory, wheeled cart for portable cylinder or portable concentrator, any type, replacement only, each
manual wheelchair accessory, solid (rubber/plastic) caster tire (removable), any size, replacement only, each
home infusion therapy, all supplies (including catheter) necessary for a peripherally inserted central venous catheter (picc) line insertion
isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram
immediate post surgical or early fitting, application of non-weight bearing rigid dressing, below knee
face-to-face educational services related to the care of chronic kidney disease; group, per session, per one hour
injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram
whole blood or red blood cells, leukocytes reduced, cmv-negative, each unit
gauze, non-impregnated, sterile, pad size more than 48 sq. in., without adhesive border, each dressing
injection, daratumumab, 10 mg
ostomy pouch, urinary, with barrier attached, with built-in convexity, with faucet-type tap with valve (1 piece), each
wheelchair with detachable arms, footrests
functional outcome assessment not documented as being performed, documentation the patient is not eligible for a functional outcome assessment using a standardized tool at the time of the encounter
lenticular, (myodisc), per lens, single vision
power wheelchair, group 2 standard, multiple power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds
physician management of patient home care, episodic care monthly case rate (per 30 days)
excellagen, 0.1 cc
rehabilitation program, per 1/2 day
vision supply, accessory and/or service component of another hcpcs vision code
payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only
custom manual wheelchair/base
compounded drug, not otherwise classified terminated december 31, 2015.
documentation of medical reason(s) for not performing urine protein test (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not cllinically appropriate) terminated december 31, 2014.
her2-targeted therapies not administered during the initial course of treatment terminated december 31, 2020.
lead, neurostimulator (implantable)
injection, floxuridine, 500 mg
dialysate concentrate, solution, additive for peritoneal dialysis, per 10 ml
patient did not have a medical visit in the last 6 months terminated december 31, 2014.
most recent diastolic blood pressure < 90 mmhg
tourniquet for dialysis, each
final report documented that dicom format image data available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study terminated december 31, 2020.
meals, per diem, not otherwise specified
prescription drug, brand name
orthopedic shoe addition, insole, rubber
becaplermin gel 0.01%, 0.5 gm
pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up not documented, documentation the patient is not eligible terminated december 31, 2015.
spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens
non-emergency transportation: mini-bus, mountain area transports, or other transportation systems
iodine i-131 tositumomab, therapeutic, per treatment dose terminated december 31, 2016.
portable oxygen concentrator, rental
rural health clinic or federally qualified health center (rhc/fqhc) only, psychiatric collaborative care model (psychiatric cocm), 60 minutes or more of clinical staff time for psychiatric cocm services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm) and including services furnished by a behavioral health care manager and consultation with a psychiatric consultant, per calendar month
urinary catheter anchoring device, adhesive skin attachment, each
replace metal bands kafo, proximal thigh
probe, image-guided, robotic, waterjet ablation
oncology; disease status; non-hodgkin's lymphoma, any cellular classification; stage iii, iv, not relapsed, not refractory (for use in a medicare-approved demonstration project)
fresh frozen plasma (single donor), frozen within 8 hours of collection, each unit
induced abortion, 17 to 24 weeks
injection, triptorelin, extended-release, 3.75 mg
ankle foot orthosis, spiral, (institute of rehabilitative medicine type), plastic, custom fabricated
arm pad, replacement only, each
lumbar-sacral orthosis, sagittal-coronal control, with rigid posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, custom fabricated
indium in-111 pentetate, diagnostic, per 0.5 millicurie
strattice tm, per square centimeter
adjunctive continuous glucose monitor or receiver
power wheelchair accessory, group 24 non-sealed lead acid battery, each
budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram
amnioband, 1 mg
screening for depression documented as positive, a follow-up plan not completed, documented reason terminated december 31, 2016.
methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg
nutritional counseling, dietitian visit
upper extremity addition, stainless steel, any wrist
skin substitute, synthetic, resorbable, per square centimeter
influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)
retinal prosthesis, includes all internal and external components
monitor, cardiac, including intracardiac lead and all system components (implantable)
custom fabricated wheelchair back cushion, any size, including any type mounting hardware
anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)
patient refused to participate at admission and/or discharge; patient unable to complete the neck fs prom at admission or discharge due to cognitive deficit, visual deficit, motor deficit, language barrier, or low reading level, and a suitable proxy/recorder is not available; patient self-discharged early; medical reason terminated december 31, 2020.
orthopedic shoe, oxford with supinator or pronator, junior
lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, custom fabricated
influenza virus vaccine, not otherwise specified
non-emergency transportation: ancillary: meals-recipient
injection, gadoteridol, (prohance multipack), per ml
home infusion therapy, anti-hemophilic agent infusion therapy (e.g., factor viii); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
removal with reinsertion, non-biodegradable drug delivery implants, 4 or more (services for subdermal implants)
services performed by other qualified therapist in the hospice setting, each 15 minutes
injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes
technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries
percutaneous transluminal revascularization of acute total/subtotal occlusion during acute myocardial infarction, coronary artery or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including aspiration thrombectomy when performed, single vessel
continuous noninvasive glucose monitoring device, rental, including sensor, sensor replacement, and download to monitor (for physician interpretation of data, use cpt code)
radiation exposure indices, or exposure time and number of fluorographic images not documented in final report for procedure using fluoroscopy, reason not given
limited (30 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)
injection, plazomicin, 5 mg terminated september 30, 2019.
breast pump, electric (ac and/or dc), any type
exercise equipment
home management of postpartum hypertension, includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code with any home infusion per diem code)
above elbow, molded socket, endoskeletal system, including soft prosthetic tissue shaping
indium in-111 capromab pendetide, diagnostic, per study dose, up to 10 millicuries
risk-adjusted functional status change residual score for the neck impairment successfully calculated and the score was less than zero (< 0)
belt, strap, sleeve, garment, or covering, any type
incontinence supply; miscellaneous
cervical, multiple post collar, occipital/mandibular supports, adjustable
oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive without current clinical, radiologic, or biochemical evidence of disease (for use in a medicare-approved demonstration project)
transplantation of small intestine and liver allografts
injection, ramucirumab, 5 mg
special casting material (e.g., fiberglass)
hospital bed, semi-electric (head and foot adjustment), without side rails, with mattress
patient was referred to another provider or specialist during the performance period
orthopedic shoe addition, convert firm shoe counter to soft counter
levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg
ostomy pouch, closed; without barrier attached (1 piece), each
injection, corticorelin ovine triflutate, 1 microgram
patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g., history of dvt, pe, mi, arrhythmia and stroke)
hospice care provided in long term care facility
power wheelchair accessory, expandable controller, including all related electronics and mounting hardware, upgrade provided at initial issue
separate seat lift mechanism for use with patient owned furniture-electric terminated december 31, 2016.
moderate (45 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)
eye patch, occlusive, each
aspirin or another antiplatelet therapy not used, reason not given
nitrogen n-13 ammonia, diagnostic, per study dose, up to 40 millicuries
patients who have received dose of corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days terminated december 31, 2014.
injection, etoposide, 10 mg
injection, conivaptan hydrochloride, 1 mg
synthetic resorbable wound dressing, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing
contact lens, hydrophilic, dual focus, per lens
ostomy pouch, closed, with barrier attached, with built-in convexity, with filter (1 piece), each
alloderm, per square centimeter
catheter, intravascular ultrasound
cast supplies, short leg splint, adult (11 years +), plaster
hydrocollator unit, portable
contraceptive pills for birth control
payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only
insulin for administration through dme (i.e., insulin pump) per 50 units
bellacell hd or surederm, per square centimeter
home therapy, intermittent anti-emetic injection therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
wheelchair, pediatric size, tilt-in-space, rigid, adjustable, without seating system
most recent assessment of adequacy of volume management documented
addition to lower extremity, limited ankle motion, each joint
injection, alglucerase, per 10 units
injection, quinupristin/dalfopristin, 500 mg (150/350)
patient starting antiviral treatment for hepatitis c during the measurement period terminated december 31, 2016.
patient not receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills
home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation
injection, vedolizumab, 1 mg
stoma plug or seal, any type
death occurring during the index acute care hospitalization terminated december 31, 2020.
tension ring, for vacuum erection device, any type, replacement only, each
patients with clinical indications for imaging of the head: abnormal neurologic exam
wound suction, disposable, includes dressing, all accessories and components, any type, each
surgraft, per square centimeter
injection, granisetron extended release, 0.1 mg terminated december 31, 2017.
injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units
patients receiving a first course of anti-tnf therapy terminated december 31, 2016.
injection, trabectedin, 0.1 mg terminated december 31, 2016.
prenatal care, at-risk enhanced service; antepartum management
injection, testosterone cypionate, 1 cc, 200 mg terminated december 31, 2014.
preparatory, above knee- knee disarticulation, ischial level socket, non-alignable system, pylon, no cover, sach foot, plaster socket, molded to model
procedure-related bp's not taken during an outpatient visit. examples include same day surgery, ambulatory service center, g.i. lab, dialysis, infusion center, chemotherapy
addition to tlso, (low profile), lumbar derotation pad
ambulance service, outside state per mile, transport (medicaid only)
functional status performed once in the last 12 months
power operated vehicle, group 1 heavy duty, patient weight capacity 301 to 450 pounds
alprostadil urethral suppository (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
commode chair, mobile or stationary, with fixed arms
patient not screened for future fall risk, reason not given
ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each
ambulatory infusion pump, mechanical, reusable, for infusion 8 hours or greater
pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg
gold terminated december 31, 2015.
electric hand, switch or myoelectric controlled, adult
non-emergency transportation; taxi
parenteral infusion pump, stationary, single or multi-channel
patient did not sustain a bowel injury at the time of surgery nor discovered subsequently up to 30 days post-surgery
breast reconstruction with deep inferior epigastric perforator (diep) flap or superficial inferior epigastric artery (siea) flap, including harvesting of the flap, microvascular transfer, closure of donor site and shaping the flap into a breast, unilateral
nipple prosthesis, prefabricated, reusable, any type, each
orthopedic footwear, man's shoe, oxford, used as an integral part of a brace (orthosis)
adapter for breast pump, replacement
positioning wheelchair back cushion, posterior, width less than 22 inches, any height, including any type mounting hardware
sphere, trifocal, plus or minus 7.12 to plus or minus 20.00, per lens
auditory osseointegrated device, external sound processor, excludes transducer/actuator, replacement only, each
tlso, triplanar control, hyperextension, rigid anterior and lateral frame extends from symphysis pubis to sternal notch with two anterior components (one pubic and one sternal), posterior and lateral pads with straps and closures, limits spinal flexion, restricts gross trunk motion in sagittal, coronal, and transverse planes, includes fitting and shaping the frame, prefabricated, includes fitting and adjustment
prism, per lens
injection, naxitamab-gqgk, 1 mg
partial foot, molded socket, ankle height, with toe filler
specialized childcare, waiver; per diem
bath conductivity meter for hemodialysis, each
walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf
wrist hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, prefabricated, includes fitting and adjustment
composite dressing, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing
scheduled interdisciplinary team conference (minimum of three exclusive of patient care nursing staff) with patient present
cast supplies, short leg cast, adult (11 years +), plaster
hand restoration (casts, shading and measurements included), partial hand, with glove, no fingers remaining
assistive listening device, not otherwise specified
parenteral nutrition solution; amino acid, 7% through 8.5%, (500 ml = 1 unit) - home mix
specimen site other than anatomic cutaneous location
injection, belinostat, 10 mg
injection, obinutuzumab, 10 mg
power wheelchair, group 2 heavy duty, single power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds
non-emergency transportation; encounter/trip
elbow orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment
creation of subcutaneous pocket with insertion of 180 day implantable interstitial glucose sensor, including system activation and patient training
individual filled at least two prescriptions for any antipsychotic medication and had a pdc of 0.8 or greater terminated december 31, 2015.
breast prosthesis, mastectomy bra, with integrated breast prosthesis form, bilateral, any size, any type
injection, evinacumab-dgnb, 5mg
truss, addition to standard pad, scrotal pad
injection, tinzaparin sodium, 1000 iu
improving care for lower extremity joint repair mips value pathways
i intend to report the inflammatory bowel disease (ibd) measures group terminated december 31, 2016.
protective body sock, prefabricated, off-the-shelf, each
injection, ceftolozane 50 mg and tazobactam 25 mg
injection, bendamustine hcl (bendeka), 1 mg
injection, cephapirin sodium, up to 1 gm
patient did not receive anti-egfr monoclonal antibody therapy
vessel mapping of vessels for hemodialysis access (services for preoperative vessel mapping prior to creation of hemodialysis access using an autogenous hemodialysis conduit, including arterial inflow and venous outflow) terminated december 31, 2019.
documentation of patient reason(s) for not having records of negative or managed positive tb screen (e.g., patient does not return for mantoux (ppd) skin test evaluation)
alcohol and/or substance abuse services, skills development
upper extremity addition, harness, chest or shoulder, saddle type
plasma, cryoprecipitate reduced, pathogen reduced, each unit
cast supplies, short leg splint, pediatric (0-10 years), fiberglass
nonpowered advanced pressure reducing mattress
addition to lower extremity prosthesis, endoskeletal knee shin system, microprocessor control feature, stance phase only, includes electronic sensor(s), any type
professional services, initial visit, for the administration of subcutaneous immunotherapy or other subcutaneous infusion drug or biological for each infusion drug administration calendar day in the individual's home, each 15 minutes
prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
electronic elbow, child, variety village or equal, myoelectronically controlled
injection, plerixafor, 1 mg
injection, trilaciclib, 1mg
injection, phenytoin sodium, per 50 mg
revitalon, per square centimeter
ostomy pouch, urinary, for use on faceplate, rubber, each
reservoir bottle, non-disposable, used with large volume ultrasonic nebulizer
external ambulatory insulin delivery system, disposable, each, includes all supplies and accessories
colonoscopy through stoma; with transendoscopic stent placement (includes predilation) terminated december 31, 2015.
patients who are breastfeeding at any time during the measurement period
left ventricular ejection fraction (lvef) not performed or assessed, reason not given terminated december 31, 2014.
magnetic resonance angiography without contrast followed by with contrast, spinal canal and contents
oncology; practice guidelines; management differs from guidelines for other reason(s) not listed (for use in a medicare-approved demonstration project)
dispensing fee, contralateral, monaural
injection, daunorubicin, 10 mg
preparatory, above knee - knee disarticulation ischial level socket, non-alignable system, pylon, no cover, sach foot, thermoplastic or equal, molded to model
transmitting coil and cable, integrated, for use with cochlear implant device, replacement
foot, insert, removable, molded to patient model, spenco, each
injection, c-1 esterase inhibitor (human), haegarda, 10 units terminated december 31, 2018.
posterior chamber intraocular lens
power wheelchair accessory, pneumatic caster tire, any size, replacement only, each
replace leather cuff kafo-afo, calf or distal thigh
implantable access total catheter, port/reservoir (e.g., venous, arterial, epidural, subarachnoid, peritoneal, etc.)
nasal endoscopy for post-operative debridement following functional endoscopic sinus surgery, nasal and/or sinus cavity(s), unilateral or bilateral
heel, sach cushion type
injection, papaverine hcl, up to 60 mg
death occurring after discharge from the hospital but within 30 days post procedure terminated december 31, 2020.
injection, potassium chloride, per 2 meq
patient screened for future fall risk
home care training, family; per 15 minutes
non-emergency transportation and bus, intra or inter state carrier
tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
injection, paclitaxel, 1 mg
ostomy pouch, closed; for use on barrier with flange (2 piece), each
upper extremity fracture orthosis, radius/ulnar, prefabricated, includes fitting and adjustment
mometasone furoate sinus implant, 10 micrograms terminated march 31, 2021.
implantable cardiac event recorder with memory, activator and programmer
wrist disarticulation, molded socket, flexible elbow hinges, triceps pad
hearing aid, contralateral routing system, binaural, itc/bte
lower extremity neurological exam not performed
mifepristone, oral, 200 mg
radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 6-10 mev
patient transfer to practice after initiation of chemotherapy terminated december 31, 2020.
antithrombotic therapy not prescribed for documented reasons (e.g., patient had stroke during hospital stay, patient expired during inpatient stay, other medical reason(s)); (e.g., patient left against medical advice, other patient reason(s)) terminated december 31, 2017.
cardioverter-defibrillator, dual chamber (implantable)
implanted pleural catheter, each terminated december 31, 2014.
injection, peramivir, 1 mg
adult sized disposable incontinence product, brief/diaper, large, each
patient is not eligible for the "referral for otologic evaluation for sudden or rapidly progressive hearing loss" measure
electrical stimulation, (unattended), to one or more areas, for wound care other than described in g0281
interventional radiology mips specialty set
for diabetics only, modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe with roller or rigid rocker bottom, per shoe
qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 5-10 minutes terminated december 31, 2020.
patient prescribed at least a 135 day treatment within the 180-day measurement interval with beta-blockers post-discharge for ami terminated december 31, 2020.
multiple vitamins, with or without minerals and trace elements, oral, per dose, not otherwise specified
knee ankle foot orthosis, full plastic, static (pediatric size), without free motion ankle, prefabricated, includes fitting and adjustment
injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)
disposable contact lens, per lens
addition to lower extremity prosthesis, endoskeletal knee-shin system, microprocessor control feature, swing phase only, includes electronic sensor(s), any type
lens, intraocular (telescopic)
habilitation, residential, waiver; per diem
injection, acetaminophen, 10 mg
family stabilization services, per 15 minutes
ostomy irrigation supply; cone/catheter, with or without brush
injection, penicillin g benzathine and penicillin g procaine, 100,000 units
isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
helmet, protective, soft, prefabricated, includes all components and accessories
power wheelchair, group 3 heavy duty, single power option, captains chair, patient weight capacity 301 to 450 pounds
gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing
injection, nesiritide, 0.1 mg
addition to lower extremity, knee disarticulation, leather socket
habilitation, educational; waiver, per diem
manual wheelchair accessory, anti-tipping device, each
hospitalists mips specialty set
intravertebral body fracture augmentation with implant (e.g., metal, polymer)
addition, endoskeletal system, above knee, flexible protective outer surface covering system
power wheelchair accessory, head control interface, contact switch mechanism, nonproportional, including all related electronics, mechanical stop switch, mechanical direction change switch, head array, and fixed mounting hardware
immunosuppressive drug, not otherwise classified
transmitting coil for use with cochlear implant device, replacement
documentation of patient with pain not brought to a comfortable level within 48 hours from initial assessment
drug confirmation, each procedure terminated december 31, 2015.
fda approved nerve stimulator, with replaceable batteries, for treatment of nausea and vomiting
venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admission terminated december 31, 2014.
injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
telemonitoring of patient in their home, including all necessary equipment; computer system, connections, and software; maintenance; patient education and support; per month
wrist hand orthosis, includes one or more nontorsion joint(s), elastic bands, turnbuckles, may include soft interface, straps, prefabricated, off-the-shelf
patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase terminated december 31, 2014.
skilled services by a registered nurse (rn) for management and evaluation of the plan of care; each 15 minutes (the patient's underlying condition or complication requires an rn to ensure that essential non-skilled care achieves its purpose in the home health or hospice setting)
hearing aid, analog, monaural, itc (in the canal)
addition to lower extremity, symes type, expandable wall socket
contact lens, pmma, toric or prism ballast, per lens
pneumococcal vaccine administered or previously received
documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family
enteral feeding supply kit; gravity fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape
antibiotic not prescribed or dispensed
hearing aid, digitally programmable analog, monaural, ite (in the ear)
pneumococcal screening performed and documentation of vaccination received prior to discharge
extra ambulance attendant, ground (als or bls) or air (fixed or rotary winged); (requires medical review)
imaging of the head (ct or mri) was obtained
elder maltreatment screen documented as positive and a follow-up plan is documented
whirlpool tub, walk-in, portable
prosthetic eye, plastic, custom
urinary drainage bag, leg or abdomen, latex, with or without tube, with straps, each
home management of gestational hypertension, includes administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately); per diem (do not use this code with any home infusion per diem code)
wheelchair accessory, power seat elevation system, any type
histrelin implant (vantas), 50 mg
transfer of an orthosis from one shoe to another, solid stirrup, new
ankle foot orthosis, fracture orthosis, tibial fracture orthosis, soft, prefabricated, includes fitting and adjustment
tlso, triplanar control, two piece rigid plastic shell without interface liner, with multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, lateral strength is enhanced by overlapping plastic, restricts gross trunk motion in the sagittal, coronal, and transverse planes, includes a carved plaster or cad-cam model, custom fabricated
injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg
anesthesiology mips specialty set
insertion tray with drainage bag with indwelling catheter, foley type, two-way, all silicone
injection, diethylstilbestrol diphosphate, 250 mg
oxygen probe for use with oximeter device, replacement
florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
injection, ziv-aflibercept, 1 mg
for diabetics only, modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe with wedge(s), per shoe
ambulatory traction device, all types, each
hypertonic saline solution, 1 ml
saliva test, hormone level; during menopause
florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries terminated june 30, 2016.
insulin delivery device, disposable pen (including insulin); 1.5 ml size
low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
tlso, flexible, provides trunk support, thoracic region, rigid posterior panel and soft anterior apron, extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, restricts gross trunk motion in the sagittal plane, produces intracavitary pressure to reduce load on the intervertebral disks, includes straps and closures, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)
preparatory, below knee 'ptb' type socket, non-alignable system, no cover, sach foot, prefabricated, adjustable open end socket
patient documented to have experienced a hospital transfer or hospital admission upon discharge from asc
clinical decision support mechanism ehealthline clinical decision support mechanism, as defined by the medicare appropriate use criteria program
catheterization for collection of specimen, single patient, all places of service
dome and mouthpiece, used with small volume ultrasonic nebulizer
dispensing fee, unspecified hearing aid
injection, promazine hcl, up to 25 mg
sphygmomanometer/blood pressure apparatus with cuff and stethoscope
technetium tc-99m labeled red blood cells, diagnostic, per study dose, up to 30 millicuries
foot, arch support, non-removable attached to shoe, longitudinal/metatarsal, each
developmental delay prevention activities, dependent child of client, per 15 minutes
fabric wrapping of abdominal aneurysm
upper facial prosthesis, provided by a non-physician
complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count
patients with clinical indications for imaging of the head terminated december 31, 2019.
brachytherapy source, non-stranded, non-high dose rate iridium-192, per source
door to puncture time of greater than 90 minutes, no reason given
patient documented not to have experienced a fall within ambulatory surgical center
elbow disarticulation, external power, molded inner socket, removable humeral shell, outside locking hinges, forearm, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device
injection, brentuximab vedotin, 1 mg
injection, ranibizumab, 0.1 mg
drug or biological, not otherwise classified, part b drug competitive acquisition program (cap)
addition to ctlso or scoliosis orthosis, trapezius sling
interactive group psychotherapy, in a partial hospitalization setting, approximately 45 to 50 minutes
injection, melphalan flufenamide hydrochloride, 1 mg terminated september 30, 2021.
not otherwise classified, antineoplastic drugs
bed cradle, any type
shock absorber for manual wheelchair, each
addition to upper extremity prosthesis, shoulder disarticulation/interscapular thoracic, ultralight material (titanium, carbon fiber or equal)
addition to lower extremity, quick change self-aligning unit, above knee or below knee, each
injection, darbepoetin alfa, 1 microgram (non-esrd use)
manual adult size wheelchair, includes tilt in space
screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed, reason not otherwise specified
injection, deferoxamine mesylate, 500 mg
contact layer, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing
enteral formula, nutritionally complete, hydrolyzed proteins (amino acids and peptide chain), includes fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit
most recent blood pressure has a systolic measurement of < 140 mmhg and a diastolic measurement of < 90 mmhg
narrowing device, wheelchair
patient refused to participate
a model participant (ambulance supplier/provider), the beneficiary refuses services covered under the model (transport to an alternate destination/treatment in place)
addition, endoskeletal knee-shin system, single axis, pneumatic swing, friction stance phase control
nipple prosthesis, custom fabricated, reusable, any material, any type, each
flex hd, or allopatch hd, per square centimeter
home infusion therapy, all supplies necessary for restoration of catheter patency or declotting
hepatitis b virus (hbv) status assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy
periodic assessment; assessing periodically by qualified personnel to determine the most appropriate combination of services and treatment (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure
tacrolimus, parenteral, 5 mg
addition, exoskeletal knee-shin system, single axis, external joints fluid swing phase control
addition to lower extremity, extended steel shank
injection, human fibrinogen concentrate (fibryga), 1 mg
patient who have received or are receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills within the last twelve months terminated december 31, 2016.
hearing aid, monaural, in the ear
polycarbonate lens (list this code in addition to the basic code for the lens)
heel, counter, plastic reinforced
injection, fosaprepitant, 1 mg
orthopedic shoe addition, toe tap standard
mild obstructive sleep apnea (apnea hypopnea index (ahi) or respiratory disturbance index (rdi) of less than 15) terminated december 31, 2016.
injection, aminocaproic acid, 5 grams
corplex p, per cc
injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iu
injection, testosterone enanthate, up to 100 mg terminated december 31, 2014.
unskilled respite care, not hospice; per 15 minutes
back pain was not measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively
genesis amniotic membrane, per square centimeter
wheelchair, pediatric size, not otherwise specified
phenothiazine terminated december 31, 2015.
endoscope, single-use (i.e. disposable), upper gi, imaging/illumination device (insertable)
prehensile actuator, switch controlled
revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram
parenteral nutrition; additives (vitamins, trace elements, heparin, electrolytes), home mix, per day
dexamethasone, lacrimal ophthalmic insert, 0.1 mg terminated september 30, 2019.
two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 7-9 under the mdpp expanded model (em). a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary did not achieve at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 7-9
hospice long term care, room and board only; per diem
cellular therapy
bmi is documented below normal parameters and a follow-up plan is documented
replacement soft interface material/cuffs for bi-directional static progressive stretch device
cryoprecipitate, each unit
tracheostomy speaking valve
foster care, therapeutic, child; per diem
addition to upper extremity prosthesis, below elbow/above elbow, lock mechanism, excludes socket insert
epifix, per square centimeter
resource-intensive services for patients for whom the use of specialized mobility-assistive technology (such as adjustable height chairs or tables, patient lift, and adjustable padded leg supports) is medically necessary and used during the provision of an office/outpatient, evaluation and management visit (list separately in addition to primary service)
contracts, repair and maintenance, for hemodialysis equipment
laser in situ keratomileusis (lasik)
mometasone furoate sinus implant, 10 micrograms (sinuva) terminated march 31, 2021.
adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5. either phq- 9 or phq-9m score was not assessed or is greater than or equal to 5
cast supplies, long leg splint, pediatric (0-10 years), plaster
seat lift mechanism placed over or on top of toilet, any type
thallium tl-201 thallous chloride, diagnostic, per millicurie
orthopedic shoe, modification, addition or transfer, not otherwise specified
ankle foot orthosis, fracture orthosis, tibial fracture cast orthosis, thermoplastic type casting material, custom fabricated
immediate post surgical or early fitting, application of initial rigid dressing, including fitting, alignment, suspension, and one cast change, below knee
antisperm antibodies test (immunobead)
levamisole hydrochloride, oral, 50 mg
hydrogel dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing
stent, coated/covered, with delivery system
injection, irinotecan liposome, 1 mg terminated december 31, 2016.
addition to lower limb prosthesis, vertical shock reducing pylon feature
supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each
patients with clinical indications for imaging of the head: new or change in headache above 50 years of age
addition to cervical-thoracic-lumbar-sacral orthosis (ctlso) or scoliosis orthosis, axilla sling
addition, endoskeletal knee-shin system, polycentric, mechanical stance phase lock
hyaluronan or derivative, gel-one, for intra-articular injection, per dose
patient is currently on a statin therapy
hand orthosis, metacarpal fracture orthosis, prefabricated, off-the-shelf
birthing classes, non-physician provider, per session
patient had one dose of meningococcal vaccine (serogroups a, c, w, y) on or between the patient's 11th and 13th birthdays
patient documented to have experienced a wrong site, wrong side, wrong patient, wrong procedure or wrong implant event
apnea monitor, with recording feature
stomach tube - levine type
addition to lower extremity, polycentric knee joint, for custom fabricated knee ankle foot orthosis, each joint
patient receiving <=5 mg daily prednisone (or equivalent), or ra activity is worsening, or glucocorticoid use is for less than 6 months
orthopedic shoe addition, insole, felt covered with leather
referral to a physician for an otologic evaluation not performed, reason not given
intraoperative near-infrared fluorescence lymphatic mapping of lymph node(s) (sentinel or tumor draining) with administration of indocyanine green (icg) (list separately in addition to code for primary procedure)
gradient compression stocking, full length/chap style, 18-30 mmhg, each
ostomy pouch, urinary, with faceplate attached, plastic, each
patients with an active diagnosis or history of cancer (except basal cell and squamous cell skin carcinoma), patients who are heavy tobacco smokers, lung cancer screening patients
electronic wrist rotator, for utah arm terminated december 31, 2014.
paramedic intercept (pi), rural area, transport furnished by a volunteer ambulance company which is prohibited by state law from billing third party payers
injection, tirofiban hcl, 0.25 mg
fully-reclining wheelchair, fixed full length arms, swing away detachable elevating leg rests
patient did not receive chemotherapy in the last 14 days of life
patient lift, bathroom or toilet, not otherwise classified
keroxx (2.5g/cc), 1cc
electrodes, (e.g., apnea monitor), per pair
documentation of reason for not detecting adenoma(s) or other neoplasm. (e.g., neoplasm detected is only diagnosed as traditional serrated adenoma, sessile serrated polyp, or sessile serrated adenoma terminated december 31, 2017.
documentation patient unable to communicate and informant not available
other physical or occupational therapy subsequent functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting terminated december 31, 2019.
gastrointestinal fat absorption study
elbow disarticulation, molded socket, endoskeletal system, including soft prosthetic tissue shaping
final reports for ct, cta, mri or mra studies of the chest or neck without an incidentally found thyroid nodule < 1.0 cm noted or no nodule found
press-on lens, fresnell prism, per lens
legg perthes orthosis, (scottish rite type), custom fabricated
skin barrier; solid, 8 x 8 or equivalent, each
death did not occur after discharge from the hospital within 30 days post procedure terminated december 31, 2020.
spoken language expression functional limitation, discharge status at discharge from therapy or to end reporting terminated december 31, 2019.
preparatory, shoulder disarticulation or interscapular thoracic, single wall plastic socket, shoulder joint, locking elbow, friction wrist, chest strap, fair lead cable control, usmc or equal pylon, no cover, molded to patient model
hallux implant
implantable neurostimulator pulse generator, dual array, rechargeable, includes extension
injection, desmopressin acetate, per 1 mcg
swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting terminated december 31, 2019.
injection, fluorouracil, 500 mg
injection, pralatrexate, 1 mg
home administration of aerosolized drug therapy (e.g., pentamidine); administrative services, professional pharmacy services, care coordination, all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
catheter, occlusion
wet mounts, including preparations of vaginal, cervical or skin specimens
injection, basiliximab, 20 mg
automated eeg monitoring terminated december 31, 2015.
patient sustained bowel injury at the time of surgery or discovered subsequently up to 30 days post-surgery
prosthetic sheath/sock, including a gel cushion layer, below knee or above knee, each
replacement cushions for jaw motion rehabilitation system, pkg. of 6
medical records copying fee, administrative
hearing aid, disposable, any type, monaural
injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
lenticular, (myodisc), per lens, trifocal
surgicord, per square centimeter
all quality actions for the applicable measures in the diabetes mellitus (dm) measures group have been performed for this patient terminated december 31, 2016.
parenteral nutrition infusion pump, stationary
addition to lower extremity, pelvic control, hip joint, clevis type two position joint, each
supplies for self-administered injections
antiretroviral therapy prescribed terminated december 31, 2016.
compression burn garment, not otherwise classified
patient exhibits 2 or more risk factors for post-operative vomiting
supra sdrm, per square centimeter
electronic elbow, child, variety village or equal, switch controlled
spherocylinder, trifocal, plus or minus 7.25 to plus or minus 12.00d sphere, 4.25 to 6.00d cylinder, per lens
oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; clinical or pathologic m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)
static progressive stretch toe device, extension and/or flexion, with or without range of motion adjustment, includes all components and accessories
desipramine terminated december 31, 2015.
injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg
lubricant, per ounce
home ventilator, multi-function respiratory device, also performs any or all of the additional functions of oxygen concentration, drug nebulization, aspiration, and cough stimulation, includes all accessories, components and supplies for all functions
oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; blast phase not in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)
ostomy pouch, drainable, with faceplate attached, rubber, each
patient spent greater than or equal to three days in hospice care
contact lens, scleral, gas impermeable, per lens (for contact lens modification, see 92325)
injection, necitumumab, 1 mg
coll-e-derm, per square centimeter
special wheelchair seat height from floor
novachor, per square centimeter
risk-adjusted functional status change residual score for the shoulder impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate terminated december 31, 2019.
performance measurement, evaluation of patient self assessment, depression
primary non-small cell lung cancer lung biopsy and cytology specimen report does not document classification into specific histologic type or histologic type does not follow iaslc guidance or is classified as nsclc-nos but without an explanation
compensator-based beam modulation treatment delivery of inverse planned treatment using 3 or more high resolution (milled or cast) compensator, convergent beam modulated fields, per treatment session
injection, elosulfase alfa, 1 mg
face-to-face behavioral counseling for obesity, group (2-10), 30 minutes
shoulder disarticulation, external power, molded inner socket, removable shoulder shell, shoulder bulkhead, humeral section, mechanical elbow, forearm, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device
axolotl graft or axolotl dualgraft, per square centimeter
specimen site other than anatomic location of lung or is not classified as non small cell lung cancer
immediate post surgical or early fitting, application of initial rigid dressing including fitting alignment and suspension of components, and one cast change, elbow disarticulation or above elbow
documentation of medical reason(s) for recommending follow up imaging (e.g., patient has multiple endocrine neoplasia, patient has cervical lymphadenopathy, other medical reason(s))
external ambulatory infusion pump, insulin
injection, edaravone, 1 mg terminated december 31, 2018.
magnetic resonance angiography with contrast, spinal canal and contents
segmental pneumatic appliance for use with pneumatic compressor, full arm
otolaryngology mips specialty set
power wheelchair accessory, solid (rubber/plastic) caster tire (removable), any size, replacement only, each
risk-adjusted functional status change residual score for the lower leg, foot or ankle impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate terminated december 31, 2019.
injection, hyaluronidase, up to 150 units
trapeze bar, heavy duty, for patient weight capacity greater than 250 pounds, free standing, complete with grab bar
two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 13-15 under the mdpp expanded model (em). an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 13-15
ambulatory setting substance abuse treatment or detoxification services, per diem
injection, reslizumab, 1 mg
foot, arch support, non-removable attached to shoe, metatarsal, each
patient did not have at least two hpv vaccines (with at least 146 days between the two) or three hpv vaccines on or between the patient's 9th and 13th birthdays
injection, haloperidol decanoate, per 50 mg
department of veterans affairs whole health partner services
all quality actions for the applicable measures in the diabetic retinopathy measures group have been performed for this patient terminated december 31, 2016.
lenticular (myodisc), per lens, bifocal
copper cu-64, dotatate, diagnostic, 1 millicurie terminated march 31, 2021.
dna analysis, fecal, for colorectal cancer screening terminated december 31, 2015.
injection, dexrazoxane hydrochloride, per 250 mg
injection, plasminogen, human-tvmh, 1 mg
addition to upper extremity prosthesis, below elbow/above elbow, custom fabricated from existing mold or prefabricated, socket insert, silicone gel, elastomeric or equal, not for use with locking mechanism
prenatal care, at-risk enhanced service; education
ratchet assembly, replacement only
injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg
gel pressure mattress
patient with an initial phq-9 score greater than nine who achieves remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score of less than five
injection, immune globulin (xembify), 100 mg
routine venipuncture for collection of specimen(s), single home bound, nursing home, or skilled nursing facility patient
transmitter; external, for use with artificial pancreas device system
oral cushion for combination oral/nasal mask, replacement only, each
injection, isatuximab-irfc, 10 mg
hand orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment
traction stand, free standing, cervical traction
kafo, fracture orthosis, femoral fracture cast orthosis, rigid, prefabricated, includes fitting and adjustment
patient had a medical visit in the last 6 months terminated december 31, 2014.
bmi documented outside normal parameters, no follow-up plan documented, no reason given
orthopedic shoe addition, insole, leather
emergent cases
power wheelchair, group 2 very heavy duty, sling/solid seat/back, patient weight capacity 451 to 600 pounds
revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy and atherectomy, includes angioplasty within the same vessel(s), when performed
positioning wheelchair back cushion, posterior, width 22 inches or greater, any height, including any type mounting hardware
addition to ctlso or scoliosis orthosis, thoracic pad
arm rest, each
addition to lower extremity fracture orthosis, hip joint, pelvic band, thigh flange, and pelvic belt
dimethadione terminated december 31, 2015.
injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
injection, gemtuzumab ozogamicin, 0.1 mg
lift, elevation, heel, tapered to metatarsals, per inch
pharmacy dispensing fee for inhalation drug(s); per 30 days
injection, olanzapine, long-acting, 1 mg
oseltamivir phosphate, oral, per 75 mg (for use in a medicare-approved demonstration project) terminated december 31, 2019.
patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter as the mode of vascular access terminated december 31, 2020.
platelets, pheresis, leukocytes reduced, irradiated, each unit
injection, fosnetupitant 235 mg and palonosetron 0.25 mg
affinity, per square centimeter
injection, interferon, alfa-2a, recombinant, 3 million units
ringers lactate infusion, up to 1000 cc
total number of emergency department visits and inpatient hospitalizations equal to or greater than two in the past 12 months or patient not screened, reason not given
injection, pasireotide long acting, 1 mg
day habilitation, waiver; per diem
phototherapy (bilirubin) light with photometer
scleral cover shell
case management, each 15 minutes
spherocylinder, bifocal, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens
traction stand, free standing, extremity traction
injection, ravulizumab-cwvz, 10 mg terminated september 30, 2019.
patients who had a follow-up evaluation conducted at least every three months during opioid therapy terminated december 31, 2021.
screening performed and documentation that vaccination not indicated/patient refusal
oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)
documented medical reason for not reporting bladder injury (e.g., gynecologic or other pelvic malignancy documented, concurrent surgery involving bladder pathology, injury that occurs during urinary incontinence procedure, patient death from non-medical causes not related to surgery, patient died during procedure without evidence of bladder injury)
orthopedic/device/drug matrix for opposing bone-to-bone or soft tissue-to bone (implantable)
therapeutic camping, day, waiver; each session
patient screened for tobacco use and received tobacco cessation intervention on the date of the encounter or within the previous 12 months (counseling, pharmacotherapy, or both), if identified as a tobacco user
ostomy pouch, urinary; for use on barrier with non-locking flange, with faucet-type tap with valve (2 piece), each
behavioral health; short-term residential (non-hospital residential treatment program), without room and board, per diem
history of injection drug use terminated december 31, 2021.
psychoeducational service, per 15 minutes
neopatch or therion, per square centimeter
injection, porfimer sodium, 75 mg
cast supplies, long leg cylinder cast, adult (11 years +), fiberglass
injection, levocarnitine, per 1 gm
compression burn mask, face and/or neck, plastic or equal, custom fabricated
terminal device, hand, mechanical, voluntary opening, any material, any size
transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for monitoring purposes, including probe placement, real time 2-dimensional image acquisition and interpretation leading to ongoing (continuous) assessment of (dynamically changing) cardiac pumping function and to therapeutic measures on an immediate time basis
red blood cells, deglycerolized, each unit
back pain measured by the visual analog scale (vas) pain at one year (9 to 15 months) postoperatively was greater than 3.0 and back pain measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated a change of less than 5.0
indwelling catheter, foley type, two-way, all silicone, each
injection, dexamethasone acetate, 1 mg
zinc paste impregnated bandage, non-elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard
y set tubing for peritoneal dialysis
self care functional limitation, current status, at therapy episode outset and at reporting intervals terminated december 31, 2019.
nasal endoscopy, surgical; balloon dilation of eustachian tube terminated december 31, 2020.
documentation of medical reason for not receiving combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively (e.g., intolerance or other medical reason)
matristem micromatrix, 1 mg
hearing aid, monaural, body worn, bone conduction
dispensing fee, bilateral
injection, clonidine hydrochloride, 1 mg
florbetapir f18, diagnostic, per study dose, up to 10 millicuries
injection, dexamethasone 9 percent, intraocular, 1 microgram
patient received at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively
addition to upper extremity prosthesis, below elbow/wrist disarticulation, acrylic material
documented re-assessment for the appropriateness of filter removal within 3 months of placement
heel, pad, removable for spur
coordinated care fee, risk adjusted maintenance
injection, asparaginase, not otherwise specified, 10,000 units
radiation treatment delivery, single treatment area,single port or parallel opposed ports, simple blocks or no blocks: up to 5 mev
kafo, fracture orthosis, femoral fracture cast orthosis, semi-rigid, prefabricated, includes fitting and adjustment
image-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment
catheter, transluminal angioplasty, drug-coated, non-laser
wheelchair with fixed arm, footrests
foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed)
prosthetic donning sleeve, any material, each
injection, gadobenate dimeglumine (multihance multipack), per ml
iodine i-131 iobenguane, therapeutic, 1 millicurie terminated december 31, 2019.
injection, aldesleukin, per single use vial
unipuncture control system for hemodialysis
high osmolar contrast material, 150-199 mg/ml iodine concentration, per ml
chest shell (cuirass)
transfer tub rail attachment
patients who died from cancer
remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: an expanded problem focused history; an expanded problem focused examination; straightforward medical decision making, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of low to moderate severity. typically, 20 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology
injection, magnesium sulfate, per 500 mg
service assessment/plan of care development, waiver
professional services, initial visit, for the administration of intravenous chemotherapy or other highly complex infusion drug or biological for each infusion drug administration calendar day in the individual's home, each 15 minutes
alcohol or peroxide, per pint
documented medical reasons for not reporting bowel injury (e.g., gynecologic or other pelvic malignancy documented, planned (e.g., not due to an unexpected bowel injury) resection and/or re-anastomosis of bowel, or patient death from non-medical causes not related to surgery, patient died during procedure without evidence of bowel injury)
documentation of an order for anti-platelet agents
functional status measurement with score was obtained utilizing the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at three months (6 to 20 weeks) postoperatively terminated december 31, 2019.
parenteral nutrition solution: amino acid, greater than 8.5% (500 ml = 1 unit) - home mix
embolization endpoints are documented separately for each embolized vessel and ovarian artery angiography or embolization performed in the presence of variant uterine artery anatomy
nine total medicare diabetes prevention program (mdpp) core sessions were attended by an mdpp beneficiary under the mdpp expanded model (em). a core session is an mdpp service that: (1) is furnished by an mdpp supplier during months 1 through 6 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for core sessions
injection, voretigene neparvovec-rzyl, 1 billion vector genomes
saliva test, hormone level; to assess preterm labor risk
wheelchair accessory, medial thigh support, any type, including fixed mounting hardware, each
clinician documented that patient was not an eligible candidate for lower extremity neurological exam measure terminated december 31, 2014.
magnetic resonance angiography without contrast, abdomen
continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure)
injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco
cocaine or metabolite terminated december 31, 2015.
restorigin, 1 cc
ez-derm, per square centimeter
artacent cord, per square centimeter
vascular graft material, synthetic, implant
transparent film, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing
combination sit to stand frame/table system, any size including pediatric, with seat lift feature, with or without wheels
patient admitted for performance of elective carotid intervention
oncology; disease status; non-hodgkin's lymphoma, any cellular classification; stage i, ii at diagnosis, not relapsed, not refractory (for use in a medicare-approved demonstration project)
power wheelchair accessory, group 27 sealed lead acid battery, (e.g., gel cell, absorbed glassmat), each
hydrocolloid dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing
ocular implant
services performed by a qualified occupational therapist in the home health or hospice setting, each 15 minutes
shunt accessory, for hemodialysis, any type, each
brachytherapy linear source, non-stranded, palladium-103, per 1 mm
two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 19-21 under the mdpp expanded model (em). an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 19-21
injection, amitriptyline hcl, up to 20 mg
factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u. terminated december 31, 2014.
patients in whom mrs score could not be obtained at 90 day follow-up terminated december 31, 2021.
standing frame/table system, multi-position (e.g., three-way stander), any size including pediatric, with or without wheels
injection, calcitriol, 0.1 mcg
self care functional limitation, discharge status, at discharge from therapy or to end reporting terminated december 31, 2019.
physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequently than once a week; billing units of service include 4 tests
patient not eligible (e.g., documentation the patient is not eligible due to active diagnosis of hypertension, patient refuses, urgent or emergent situation) terminated december 31, 2016.
sinusitis caused by, or presumed to be caused by, bacterial infection
hydrogel dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing
addition to terminal device, precision pinch device
brief office visit for the sole purpose of monitoring or changing drug prescriptions used in the treatment of mental psychoneurotic and personality disorders terminated december 31, 2014.
annual gynecological examination, established patient
blinded procedure for transcatheter implantation of coronary sinus reduction device or placebo control, including vascular access and closure, right heart catherization, venous and coronary sinus angiography, imaging guidance and supervision and interpretation when performed in an approved investigational device exemption (ide) study
replacement battery, alkaline, j cell, for use with medically necessary home blood glucose monitor owned by patient, each
upper extremity additions, single pivot hinge, pair
conforming bandage, non-elastic, knitted/woven, non-sterile, width less than three inches, per yard
elective surgery
above knee, short prosthesis, no knee joint ('stubbies'), with foot blocks, no ankle joints, each
parenteral nutrition solution compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, renal-aminosyn-rf, nephramine, renamine-premix
all quality actions for the applicable measures in the cardiovascular prevention measures group have been performed for this patient terminated december 31, 2016.
documentation of patient pregnancy anytime during the measurement period prior to and including the current encounter
traction frame, attached to footboard, extremity traction, (e.g., buck's)
laminotomy (hemilaminectomy), with decompression of nerve root(s), including partial facetectomy, foraminotomy and excision of herniated intervertebral disc, and repair of annular defect with implantation of bone anchored annular closure device, including annular defect measurement, alignment and sizing assessment, and image guidance; 1 interspace, lumbar
sitz type bath or equipment, portable, used with or without commode, with faucet attachment/s
repair/modification of a hearing aid
oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n1-2, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence or metastases (for use in a medicare-approved demonstration project)
injection, voretigene neparvovec-rzyl, 1 billion vector genome terminated december 31, 2018.
spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d cylinder, per lens
oral aspirin or other antithrombotic therapy was not prescribed, reason not given terminated december 31, 2014.
health care practitioners rendering treatment in place (tip)
receiver and/or transmitter, neurostimulator (implantable)
lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panels, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
addition to lower extremity, symes type, 'ptb' brim design socket
plasma, cryoprecipitate reduced, each unit
injection, gemtuzumab ozogamicin, 5 mg terminated december 31, 2017.
childbirth refresher classes, non-physician provider, per session
wheelchair accessory, addition to power seating system, power leg elevation system, including leg rest, pair
addition, endoskeletal knee-shin system, single axis, manual lock
ostomy filter, any type, each
pillow for use on nasal cannula type interface, replacement only, pair
injection, hydrocortisone sodium phosphate, up to 50 mg
multimodal pain management was not used
plastic surgery mips specialty set
special height arms for wheelchair
preparatory, wrist disarticulation or below elbow, single wall socket, friction wrist, flexible elbow hinges, figure of eight harness, humeral cuff, bowden cable control, usmc or equal pylon, no cover, direct formed
home infusion therapy, catheter care / maintenance, implanted access device, includes administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment, (drugs and nursing visits coded separately), per diem (use this code for interim maintenance of vascular access not currently in use)
patient not treated with a beta-lactam antibiotic as definitive therapy, reason not given terminated december 31, 2020.
injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco
sales tax
services of clinical social worker in home health or hospice settings, each 15 minutes
magnetic resonance imaging with contrast, breast; unilateral
foster care, adult; per month
testosterone pellet, 75 mg
wound pouch, each
gelatin capsules or equivalent, for use with tracheoesophageal voice prosthesis, replacement only, per 10
patients who did not have a follow-up evaluation conducted at least every three months during opioid therapy terminated december 31, 2021.
lpn/lvn services, up to 15 minutes
patient transferred directly from anesthetizing location to pacu or other non-icu location
medication training and support, per 15 minutes
positive airway pressure therapy prescribed
home management of preterm labor, including administrative services, professional pharmacy services, care coordination, and all necessary supplies or equipment (drugs and nursing visits coded separately), per diem (do not use this code with any home infusion per diem code)
heel loop/holder, any type, with or without ankle strap, each
hiv antigen/antibody, combination assay, screening
jaw motion rehabilitation system
laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band) terminated june 30, 2015.
low-dose computed tomography for lung cancer screening terminated september 30, 2016.
patient refused to participate terminated december 31, 2020.
hip orthosis, abduction control of hip joints, static, adjustable, (ilfled type), prefabricated, includes fitting and adjustment
injection, theophylline, per 40 mg
screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system, under physician supervision
wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, friction arm support (friction dampening to proximal and distal joints)
vacuum drainage collection unit and tubing kit, including all supplies needed for collection unit change, for use with implanted catheter, each
cms innovation center models, home visit for patient assessment performed by clinical staff for an individual not considered homebound, including, but not necessarily limited to patient assessment of clinical status, safety/fall prevention, functional status/ambulation, medication reconciliation/management, compliance with orders/plan of care, performance of activities of daily living, and ensuring beneficiary connections to community and other services. (for use only in medicare-approved cms innovation center models); may not be billed for a 30 day period covered by a transitional care management code
antenna (external) for use with implantable diaphragmatic/phrenic nerve stimulation device, replacement, each
patient's highest fasting or direct ldl-c laboratory test result in the measurement period or two years prior to the beginning of the measurement period is 70-189 mg/dl terminated december 31, 2021.
bedside drainage bottle with or without tubing, rigid or expandable, each
portable peak flow meter
injection, fludarabine phosphate, 50 mg
vendaje, per square centimeter
spherocylinder, bifocal, plus or minus 7.25 to plus or minus 12.00d sphere, 4.25 to 6.00d cylinder, per lens
episodes where the patient had a competing diagnosis on or within three days after the episode date (e.g., intestinal infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, chronic sinusitis, infection of the adenoids, prostatitis, cellulitis, mastoiditis, or bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia/gonococcal infections, venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis or uti)
intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session
cast supplies, long arm splint, adult (11 years +), plaster
habilitation, prevocational, waiver; per diem
oasis wound matrix, per square centimeter
tlso, sagittal control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, restricts gross trunk motion in sagittal plane, produces intracavitary pressure to reduce load on intervertebral disks, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
hip orthosis, abduction control of hip joints, static, pelvic band or spreader bar, thigh cuffs, custom fabricated
upper extremity addition, heavy duty control cable
dialysate solution test kit, for peritoneal dialysis, any type, each
injection, cetuximab, 10 mg
patient spent less than three days in hospice care
injection, dipyridamole, per 10 mg
knee ankle foot orthosis, any material, single or double upright, stance control, automatic lock and swing phase release, any type activation, includes ankle joint, any type, custom fabricated
patient did not receive an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period; or did not have a prior influenza virus vaccine adverse reaction any time before or during the measurement period terminated december 31, 2020.
injection, aripiprazole, extended release, 1 mg
dihydrocodeinone terminated december 31, 2015.
injection, eteplirsen, 10 mg terminated december 31, 2017.
prophylactic antibiotic not completely infused prior to the inflation of the proximal tourniquet, reason not given terminated december 31, 2020.
nebulizer, with compressor
pad for water circulating heat unit, for replacement only
porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold putty, integra os osteoconductive scaffold putty), per 0.5 cc
brachytherapy source, stranded, iodine-125, per source
humidifier, heated, used with positive airway pressure device
injection, alemtuzumab, 10 mg terminated december 31, 2015.
injection, imiglucerase, 10 units
finger splint, static
manual wheelchair accessory, push-rim activated power assist system
gel or gel-like pressure pad for mattress, standard mattress length and width
specialty absorptive dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing
enema bag with tubing, reusable
knee orthosis, derotation, medial-lateral, anterior cruciate ligament, custom fabricated
pathogen(s) test for platelets
dna analysis for germline mutations of the ret proto-oncogene for susceptibility to multiple endocrine neoplasia type 2
traction frame, attached to headboard, cervical traction
genetic testing for myotonic muscular dystrophy
gene expression profiling panel for use in the management of breast cancer treatment
replacement socket, shoulder disarticulation/interscapular thoracic, molded to patient model, for use with or without external power
patient receiving antiviral treatment for hepatitis c during the measurement period terminated december 31, 2016.
laparoscopic esophagomyotomy (heller type)
more than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis for documented reasons (eg, patients with complications, second ct obtained prior to surgery, other medical reasons)
injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.
skin protection and positioning wheelchair seat cushion, adjustable, width 22 inches or greater, any depth
development of deep sternal wound infection/mediastinitis within 30 days postoperatively terminated december 31, 2020.
foster care, child, non-therapeutic, per month
methotrexate sodium, 50 mg
antiplatelet medication at discharge terminated december 31, 2014.
addition, exoskeletal system, hip disarticulation, ultra-light material (titanium, carbon fiber or equal)
addition to ctlso or scoliosis orthosis, lumbar sling
home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 3 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
form fitting conductive garment for delivery of tens or nmes (with conductive fibers separated from the patient's skin by layers of fabric)
revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies), with intravascular lithotripsy, includes angioplasty within the same vessel (s), when performed
platelets, each unit
risk-adjusted functional status change residual scores for the hip impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate terminated december 31, 2019.
medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes
hemipelvectomy, canadian type; molded socket, hip joint, single axis constant friction knee, shin, sach foot
injection, alglucosidase alfa, 10 mg, not otherwise specified
injection, aripiprazole lauroxil (aristada initio), 1 mg terminated september 30, 2019.
diabetic management program, dietitian visit
antiplatelet medication contraindicated terminated december 31, 2014.
water seal drainage container and tubing for use with implanted chest tube
physician service or other qualified health care professional for the evaluation and management of a beneficiary's acute change in condition in a nursing facility. this service is for a demonstration project
cervical-thoracic-lumbar-sacral-orthoses (ctlso), anterior-posterior-lateral control, molded to patient model, (minerva type)
type, anatomic location, and activity all documented terminated december 31, 2014.
elbow disarticulation, molded socket, outside locking hinge, forearm
upper extremity addition, additional disconnect insert for locking wrist unit, each
placement of endorectal intracavitary applicator for high intensity brachytherapy
inpatient telehealth pharmacologic management, including prescription, use, and review of medication with no more than minimal medical psychotherapy
hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress
onsite nursing facility conference, that is separate and distinct from an evaluation and management visit, including qualified practitioner and at least one member of the nursing facility interdisciplinary care team terminated december 31, 2018.
sitz bath chair
home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 12 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
manual wheelchair accessory, handrim without projections (includes ergonomic or contoured), any type, replacement only, each
orthopedic footwear, custom shoe, depth inlay, each
injection, gadobenate dimeglumine (multihance), per ml
long-acting inhaled bronchodilator prescribed
injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml
i intend to report the ischemic vascular disease (ivd) measures group terminated december 31, 2014.
ct scan of the paranasal sinuses ordered at the time of diagnosis for documented reasons terminated december 31, 2021.
dihydrotestosterone terminated december 31, 2015.
architect, architect px, or architect fx, extracellular matrix, per square centimeter
injection, teprotumumab-trbw, 10 mg terminated september 30, 2020.
injection, fremanezumab-vfrm, 1mg terminated september 30, 2019.
insertion tray without drainage bag with indwelling catheter, foley type, three-way, for continuous irrigation
segmental gradient pressure pneumatic appliance, full arm
addition to lower extremity, abduction bar (bilateral hip involvement), jointed, adjustable
patients 66 years of age or older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period terminated december 31, 2020.
injection, streptomycin, up to 1 gm
replacement battery for automated external defibrillator, garment type only, each
injection, chloroquine hydrochloride, up to 250 mg
documentation of patient reason(s) for not prescribing a long-acting inhaled bronchodilator
endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy terminated december 31, 2015.
amniomatrix or biodmatrix, injectable, 1 cc
cabergoline, oral, 0.25 mg
surgical procedures that included the use of silicone oil
midfacial prosthesis, provided by a non-physician
megestrol acetate, oral, 20 mg
donor egg cycle, incomplete, case rate
addition to tlso, (low profile), anterior asis pad
pediatric sized disposable incontinence product, brief/diaper, large size, each
compression burn garment, glove to wrist, custom fabricated
nebulizer, durable, glass or autoclavable plastic, bottle type, for use with regulator or flowmeter
patient has been treated with a systemic medication for psoriasis vulgaris
documentation amoxicillin, with or without clavulanate, prescribed as a first line antibiotic at the time of diagnosis
injection, natalizumab, 1 mg
repair, extralobar pulmonary sequestration in the fetus, procedure performed in utero
laryngoscopy, flexible fiberoptic, with injection into vocal cord(s), therapeutic, including diagnostic laryngoscopy, if performed terminated december 31, 2016.
replacement bulb/lamp for ultraviolet light therapy system, each
skin protection wheelchair seat cushion, adjustable, width 22 inches or greater, any depth
compression burn garment, foot to thigh length, custom fabricated
patients with mechanical prosthetic heart valve
spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens
injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu
referral to physical, occupational, speech, or recreational therapy
nushield, per square centimeter
injection, sincalide, 5 micrograms
indium in-111 labeled autologous platelets, diagnostic, per study dose
iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation (list separately in addition to primary procedure)
injection, follitropin alfa, 75 iu
within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered or documented
addition to lower extremity, above knee or knee disarticulation, pelvic band
final reports without documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)
admission to medicare care choice model program (mccm)
rocking bed with or without side rails
performance of trans-abdominal or trans-vaginal ultrasound and pregnancy location documented
cannula, nasal
replace proximal and distal upright for kafo
splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies)
home management of preterm premature rupture of membranes (pprom), including administrative services, professional pharmacy services, care coordination, and all necessary supplies or equipment (drugs and nursing visits coded separately), per diem (do not use this code with any home infusion per diem code)
patient lift, fixed system, includes all components/accessories
electric hand, switch or myoelectric controlled, independently articulating digits, any grasp pattern or combination of grasp patterns, includes motor(s)
patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period
documentation of medical or patient reason(s) for not ordering or performing screening for hcc. medical reason: comorbid medical conditions with expected survival < 5 years, hepatic decompensation and not a candidate for liver transplantation, or other medical reasons; patient reasons: patient declined or other patient reasons (e.g., cost of tests, time related to accessing testing equipment)
injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)
air fluidized bed
ablation of prostate, transrectal, high intensity focused ultrasound (hifu), including imaging guidance terminated december 31, 2020.
biovance, per square centimeter
patients who had an endometrial ablation procedure during the 12 months prior to the index date (exclusive of the index date)
pharmacy compounding and dispensing services
levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
clinical decision support mechanism speed of care, as defined by the medicare appropriate use criteria program
intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency
addition to lower extremity prosthesis, user adjustable heel height
all lower extremity prostheses, foot, external keel, sach foot
technetium tc-99m pentetate, diagnostic, per study dose, up to 25 millicuries
pediatric crib, hospital grade, fully enclosed, with or without top enclosure
adrenal tissue transplant to brain
injection, sargramostim (gm-csf), 50 mcg
housing, reusable without adhesive, for use in a heat and moisture exchange system and/or with a tracheostoma valve, each
injection, inotuzumab ozogamicin, 0.1 mg
injection, apomorphine hydrochloride, 1 mg
continent device, stoma absorptive cover for continent stoma
risk-adjusted functional status change residual score for the shoulder impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)
high strength lightweight wheelchair, fixed full length arms, swing away detachable elevating leg rests
comprehensive gene sequence analysis for hypertrophic cardiomyopathy
one high-risk medication not ordered terminated december 31, 2020.
injection, morphine sulfate, 500 mg (loading dose for infusion pump)
targeted case management, each 15 minutes
level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)
clinician documented that patient was not an eligible candidate for lower extremity neurological exam measure, for example patient bilateral amputee; patient has condition that would not allow them to accurately respond to a neurological exam (dementia, alzheimer's, etc.); patient has previously documented diabetic peripheral neuropathy with loss of protective sensation
patient with documented results of a central dual-energy x-ray absorptiometry (dxa) ever being performed
supports brokerage, self-directed, waiver; per diem
addition to ctlso or scoliosis orthosis, sternal pad
locking ring for breast pump, replacement
documentation of negative or managed positive tb screen with further evidence that tb is not active prior to treatment with a biologic immune response modifier
infusion pump, programmable (implantable)
power wheelchair accessory, attendant control, proportional, including all related electronics and fixed mounting hardware
bmi is documented as being outside of normal parameters, follow-up plan is not documented, documentation the patient is not eligible terminated december 31, 2021.
injection, azacitidine, 1 mg
injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u.
hearing aid, contralateral routing system, binaural, ite/ite
elevating leg rests, pair (for use with capped rental wheelchair base)
pacemaker, other than single or dual chamber (implantable)
clinician documented that patient was not an eligible candidate for ordering prophylactic parenteral antibiotics to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required) terminated december 31, 2014.
replace non-molded calf lacer, for custom fabricated orthosis only
static progressive stretch elbow device, extension and/or flexion, with or without range of motion adjustment, includes all components and accessories
walker, heavy duty, multiple braking system, variable wheel resistance
oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage ia-b (grade 1) without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
pharmacotherapy for oud initiated after june 30th of performance period terminated december 31, 2020.
oncology; disease status; limited to non-small cell lung cancer; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)
power wheelchair accessory, u-1 sealed lead acid battery, each (e.g., gel cell, absorbed glassmat)
aerosol compressor, adjustable pressure, light duty for intermittent use
addition to tlso, (low profile), abdominal pad
non-radioactive contrast imaging material, not otherwise classified, per study
addition to lower extremity, below knee, removable medial brim suspension
electric heat pad, moist
lipid profile not performed, reason not given terminated december 31, 2014.
no unplanned hospital readmission within 30 days of principal procedure
cases in which an inhalational anesthetic is used only for induction
zenith amniotic membrane, per square centimeter
injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg
patient did not undergo abdominal imaging and did not have a documented reason for not undergoing abdominal imaging in the submission period
injection, guselkumab, 1 mg terminated december 31, 2018.
back pain was measured by the visual analog scale (vas) within three months preoperatively and at three months (6 - 20 weeks) postoperatively terminated december 31, 2019.
transportation ancillary: parking fees, tolls, other
male external catheter, with or without adhesive, disposable, each
transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, follow-up or limited study
internal medicine mips specialty set
gait trainer, pediatric size, upright support, includes all accessories and components
injection, melphalan hydrochloride, not otherwise specified, 50 mg
unplanned hospital readmission within 30 days of principal procedure
revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy, and transluminal stent placement(s), includes angioplasty within the same vessel(s), when performed
heat lamp, with stand, includes bulb, or infrared element
wheelchair, fixed full length arms, swing away detachable elevating legrests
non-pneumatic sequential compression garment, full arm
irrigation supply; sleeve, disposable, per month
catheter, ureteral
community-based wrap-around services, per 15 minutes
technetium tc-99m arcitumomab, diagnostic, per study dose, up to 45 millicuries
therapeutic procedures to improve respiratory function, other than described by g0237, one on one, face to face, per 15 minutes (includes monitoring)
enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape
injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography
replacement battery, silver oxide, for use with medically necessary home blood glucose monitor owned by patient, each
detachable, adjustable height armrest, base, replacement only, each
power mobility device, not coded by dme pdac or does not meet criteria
patients with 90 day mrs score greater than 2
iodine i-131 iobenguane sulfate, diagnostic, per 0.5 millicurie
all quality actions for the applicable measures in the hiv/aids measures group have been performed for this patient terminated december 31, 2016.
replacement bulb for therapeutic light box, tabletop model
dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
patient not discharged to home by post-operative day #7
injection, dolasetron mesylate, 10 mg
laetrile, amygdalin, vitamin b17
all lower extremity prostheses, foot, single axis ankle/foot
patient did not receive at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period; or have prior adverse reaction caused by zoster vaccine or its components any time during or before the measurement period terminated december 31, 2020.
brachytherapy source, stranded, not otherwise specified, per source
drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes
injection, mepolizumab, 1 mg terminated december 31, 2016.
injection, ixabepilone, 1 mg
spherocylinder, single vision, plus or minus 4.25 to plus or minus 7.00d sphere, 4.25 to 6.00d cylinder, per lens
porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold strip), per 0.5 cc
hearing aid, digital, monaural, bte
ongoing care not indicated, patient seen only 1-2 visits (e.g., home program only, referred to another provider or facility, consultation only) terminated december 31, 2020.
power wheelchair accessory, nonstandard seat frame depth, 20 or 21 inches
breast prosthesis, mastectomy bra, with integrated breast prosthesis form, unilateral, any size, any type
pt category, pn category and histologic grade were not documented in the pathology report, reason not given
hand restoration (casts, shading and measurements included), partial hand, with glove, thumb or one finger remaining
patient did not achieve an improvement in visual acuity, from their preoperative level, within 90 days of surgery, reason not given
chemicals/antiseptics solution used to clean/sterilize dialysis equipment, per 8 oz
compression burn garment, chin strap, custom fabricated
lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf
dermacyte amniotic membrane allograft, per square centimeter
interferential current stimulator, 2 channel
cast supplies, long arm cast, adult (11 years +), fiberglass
remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved cms innovation center demonstration project, which requires at least 2 of the following 3 key components: a detailed history; a detailed examination; medical decision making of moderate complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 25 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology
bio-connekt wound matrix, per square centimeter
interim labor facility global (labor occurring but not resulting in delivery)
repair, congenital diaphragmatic hernia in the fetus using temporary tracheal occlusion, procedure performed in utero
injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml
injectable anesthetic, for dialysis, per 10 ml
heel, thomas extended to ball
injection, immune globulin (asceniv), 500 mg
asthma kit (including but not limited to portable peak expiratory flow meter, instructional video, brochure, and/or spacer)
heavy duty wheelchair, detachable arms (desk or full length) swing away detachable footrest
prior thyroid disease diagnosis
injection, tedizolid phosphate, 1 mg
injection, pentastarch, 10% solution, 100 ml
pharmacologic therapy (other than minierals/vitamins) for osteoporosis prescribed
hip disarticulation, canadian type; molded socket, hip joint, single axis constant friction knee, shin, sach foot
injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg
preparatory, shoulder disarticulation or interscapular thoracic, single wall socket, shoulder joint, locking elbow, friction wrist, chest strap, fair lead cable control, usmc or equal pylon, no cover, direct formed
patients with a medication dispensing event indicator of a history of asthma any time during the patient's history through the end of the measure period terminated december 31, 2020.
electrical stimulation device used for cancer treatment, includes all accessories, any type
addition to lower extremity, anterior swing band
skilled services of a registered nurse (rn), in the training and/or education of a patient or family member, in the home health or hospice setting, each 15 minutes
i intend to report the dementia measures group terminated december 31, 2016.
other physical or occupational therapy subsequent functional limitation, discharge status, at discharge from therapy or to end reporting terminated december 31, 2019.
documentation of medical reason(s) for not using multimodal pain management (e.g., allergy to multiple classes of analgesics, intubated patient, hepatic failure, patient reports no pain during pacu stay, other medical reason(s))
addition, endoskeletal knee-shin system, single axis, hydraulic swing phase control, with miniature high activity frame
electric heat pad, standard
mometasone furoate sinus implant, (sinuva), 10 micrograms
injection, alefacept, 0.5 mg
stent, non-coronary, temporary, with delivery system (propel)
non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation
injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine terminated december 31, 2018.
bmi is documented above normal parameters and a follow-up plan is documented
addition to upper extremity prosthesis, glove for terminal device, any material, prefabricated, includes fitting and adjustment
shoulder disarticulation, passive restoration (complete prosthesis)
injection, sulfur hexafluoride lipid microsphere, per ml terminated december 31, 2015.
technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries
no documentation of negative or managed positive tb screen
hemi-wheelchair, fixed full length arms, swing away detachable foot rests
physical therapy; in the home, per diem
injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency
pre-operative pulmonary surgery services for preparation for lvrs, 10 to 15 days of services
kafo, fracture orthosis, femoral fracture cast orthosis, soft, prefabricated, includes fitting and adjustment
patient discharge to home no later than post-operative day #2 following evar
injection, inotuzumab ozogamicin, 0.1 mg terminated december 31, 2018.
hip orthosis, abduction control of hip joints, dynamic, pelvic control, adjustable hip motion control, thigh cuffs (rancho hip action type), custom fabricated
apligraf, per square centimeter
injection, propofol, 10 mg terminated december 31, 2014.
percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; single vessel
dermatology mips specialty set
spherocylinder, trifocal, plano to plus or minus 4.00d sphere, 2.25-4.00d cylinder, per lens
one or more neuropsychiatric symptoms terminated december 31, 2017.
uri episodes when the patient had an active prescription of antibiotics (table 1) in the 30 days prior to the episode date
hospitalizations in which the patient was transferred directly to a non-acute care facility for any diagnosis terminated december 31, 2020.
smoking cessation classes, non-physician provider, per session
personal care services, per 15 minutes, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant)
syringe with needle, sterile 2 cc, each
negative pressure wound therapy, (e.g. vacuum assisted drainage collection) using a mechanically-powered device, not durable medical equipment, including provision of cartridge and dressing(s), topical application(s), wound assessment, and instructions for ongoing care, per session; total wounds(s) surface area greater than 50 square centimeters terminated december 31, 2014.
changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting terminated december 31, 2019.
injection, talimogene laherparepvec, 1 million plaque forming units (pfu) terminated december 31, 2016.
cyclosporine, oral, 100 mg
documentation of medical reason(s) for not reporting pt category and a statement on thickness and ulceration and for pt1, mitotic rate (e.g., negative skin biopsies in a patient with a history of melanoma or other documented medical reasons)
alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting)
knee ankle foot orthosis, single upright, free ankle, solid stirrup, thigh and calf bands/cuffs (single bar 'ak' orthosis), without knee joint, custom fabricated
therapeutic behavioral services, per diem
revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy and transluminal stent placement(s), and atherectomy, includes angioplasty within the same vessel(s), when performed
national committee for quality assurance - level 2 medical home
ct studies performed not reported to a radiation dose index registry that is capable of collecting at a minimum all necessary data elements, reason not given terminated december 31, 2020.
supply allowance for therapeutic continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service
repair of orthotic device, labor component, per 15 minutes
for diabetics only, modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe with metatarsal bar, per shoe
injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg
anti-inhibitor, per i.u.
interscapular-thoracic, external power, molded inner socket, removable shoulder shell, shoulder bulkhead, humeral section, mechanical elbow, forearm, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device
left ventricular ejection fraction (lvef) >= 40% or documentation as normal or mildly depressed left ventricular systolic function terminated december 31, 2014.
shingrix vaccine was not administered for reasons documented by clinician (e.g. patient administered vaccine other than shingrix, patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) terminated december 31, 2020.
walker, with trunk support, adjustable or fixed height, any type
gastrostomy/jejunostomy tube, low-profile, any material, any type, each
small volume nonfiltered pneumatic nebulizer, disposable
pain assessment documented as positive using a standardized tool and a follow-up plan is documented terminated december 31, 2020.
chemotherapy administration by other than infusion technique only (e.g., subcutaneous, intramuscular, push), per visit
patient unable to complete the general orthopedic fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available terminated december 31, 2020.
risk-adjusted functional status change residual score for the knee impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)
terminal device, hook, mechanical, voluntary opening, any material, any size, lined or unlined
molecular pathology procedure; physician interpretation and report
re-exploration not required due to mediastinal bleeding with or without tamponade, graft occlusion, valve dysfunction or other cardiac reason
injection, tafasitamab-cxix, 2 mg terminated march 31, 2021.
twelve volt battery, each
shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure, not documented, reason not given
blinded procedure for nyha class iii/iv heart failure; transcatheter implantation of interatrial shunt or placebo control, including right heart catheterization, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study
non-emergency transportation: ancillary: lodging escort
prescription drug, generic
breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type
special base curve, glass or plastic, per lens
injection, nusinersen, 0.1 mg
ostomy pouch, closed; without barrier attached, with filter (1 piece), each
contact lens, other type
memory functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting terminated december 31, 2019.
noc drugs, inhalation solution administered through dme
dihydromorphinone terminated december 31, 2015.
finasteride, 5 mg
contraceptive supply, spermicide (e.g., foam, gel), each
injection, metaraminol bitartrate, per 10 mg
screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed
home therapy; enteral nutrition via pump; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem
index event date phq-9 or phq-9m score greater than 9 documented during the twelve month denominator identification period
replacement battery for external infusion pump owned by patient, silver oxide, 1.5 volt, each
patient did not die within 30 days of the procedure or during the index hospitalization
injection, prochlorperazine, up to 10 mg
amniocore, per square centimeter
static progressive stretch ankle device, flexion and/or extension, with or without range of motion adjustment, includes all components and accessories
iodine i-131 sodium iodide capsule(s), therapeutic, per millicurie
ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
patients who use palliative care services any time during the measurement period
parenteral nutrition solution: carbohydrates (dextrose), 50% or less (500 ml = 1 unit) - home mix
injection, viltolarsen, 10 mg
destruction of intraosseous basivertebral nerve, first two vertebral bodies, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum terminated december 31, 2021.
infusion set for external insulin pump, non needle cannula type
artificial saliva, 30 ml
wheelchair accessory, foot box, any type, includes attachment and mounting hardware, each foot
upper extremity addition, suction socket
spherocylinder, single vision, plano to plus or minus 4.00d sphere, over 6.00d cylinder, per lens
platform attachment, forearm crutch, each
two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 10-12 under the mdpp expanded model (em). a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary achieved at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 10-12
hospice services received by patient any time during the measurement period
complete in vitro fertilization cycle, not otherwise specified, case rate
electrical stimulation, (unattended), to one or more areas, for chronic stage iii and stage iv pressure ulcers, arterial ulcers, diabetic ulcers, and venous stasis ulcers not demonstrating measurable signs of healing after 30 days of conventional care, as part of a therapy plan of care
syringe with needle for external insulin pump, sterile, 3 cc
replace metal bands kafo-afo, calf or distal thigh
intravenous infusion, sotrovimab, includes infusion and post administration monitoring
bmi not documented, documentation the patient is not eligible for bmi calculation terminated december 31, 2021.
alcohol and/or drug services; acute detoxification (residential addiction program outpatient)
replacement battery, lithium, for use with medically necessary home blood glucose monitor owned by patient, each
initial psychiatric collaborative care management, first 70 minutes in the first calendar month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: outreach to and engagement in treatment of a patient directed by the treating physician or other qualified health care professional; initial assessment of the patient, including administration of validated rating scales, with the development of an individualized treatment plan; review by the psychiatric consultant with modifications of the plan if recommended; entering patient in a registry and tracking patient follow-up and progress using the registry, with appropriate documentation, and participation in weekly caseload consultation with the psychiatric consultant; and provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies terminated december 31, 2017.
tracheo-esophageal voice prosthesis, patient inserted, any type, each
spoken language expression functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting terminated december 31, 2019.
metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
arthroflex, per square centimeter
gradient compression stocking, below knee, 18-30 mmhg, each
standard size footplate, replacement only, each
patient with central dual-energy x-ray absorptiometry (dxa) results not documented, reason not given
immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service, 16-30 mins time (this code is used for medicaid billing purposes)
addition, endoskeletal knee-shin system, 4 bar linkage or multiaxial, fluid swing and stance phase control
lifestyle modification program for management of coronary artery disease, including all supportive services; first quarter / stage
mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting terminated december 31, 2019.
hydrocolloid dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing
injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u.
specimen site other than anatomic location of lung, or classified as nsclc-nos
power wheelchair, group 2 very heavy duty, captains chair, patient weight capacity 451 to 600 pounds
specialty care transport (sct)
prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity terminated june 30, 2021.
hospice evaluation and counseling services, pre-election
foster care, therapeutic, child; per month
ostomy skin barrier, solid 4 x 4 or equivalent, standard wear, with built-in convexity, each
functional status was not measured by the oswestry disability index (odi version 2.1a) at three months (6 - 20 weeks) postoperatively
non-standard size or length
hospital bed, fixed height, without side rails, with mattress
bath tub rail, floor base
patient not screened for tobacco use, reason not given
injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u. terminated december 31, 2016.
lightweight wheelchair, detachable arms (desk or full length) swing away detachable footrest
administration set, with small volume nonfiltered pneumatic nebulizer, disposable
seat lift mechanism, electric, any type
daily wear specialty contact lens, per lens
palingen or promatrx, 0.36 mg per 0.25 cc
partial hand, no finger remaining
documentation that the patient is not on daily aspirin or anti-platelet regimen
habilitation, supported employment, waiver; per 15 minutes
hip orthosis, abduction control of hip joints, flexible, (pavlik harness), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
injection, epoetin beta, 1 microgram, (non-esrd use) terminated december 31, 2014.
walker, rigid, wheeled, adjustable or fixed height
ongoing support to maintain employment, per diem
removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing
footwear evaluation was not performed
amniply, for topical use only, per square centimeter
rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month
documentation of patient death following cas terminated december 31, 2020.
specimen site other than anatomic location of lung, is not classified as non small cell lung cancer or classified as nsclc-nos
partial foot, molded socket, tibial tubercle height, with toe filler
hand finger orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment
injection, dostarlimab-gxly, 10 mg
enverse, per square centimeter
injection, belimumab, 10 mg
magnetic source imaging
home health aide or certified nurse assistant, per visit
sleep apnea symptoms assessed, including presence or absence of snoring and daytime sleepiness
home care training to home care client, per session
knee ankle foot orthosis, full plastic, single upright, with or without free motion knee, medial lateral rotation control, with or without free motion ankle, custom fabricated
insulin delivery device, disposable pen (including insulin); 3 ml size
addition to lower extremity, below knee, acrylic socket
uri episodes where the patient had a comorbid condition during the 12 months prior to or on the episode date (e.g., tuberculosis, neutropenia, cystic fibrosis, chronic bronchitis, pulmonary edema, respiratory failure, rheumatoid lung disease)
interscapular thoracic, passive restoration (shoulder cap only)
platelets, pheresis, pathogen-reduced, each unit terminated december 31, 2017.
spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, over 6.00d cylinder, per lens
clinician documented patient not an eligible candidate to receive pharmacologic therapy for osteoporosis terminated december 31, 2016.
paraffin bath unit, portable (see medical supply code a4265 for paraffin)
injection, aflibercept, 1 mg
patient had a bone mineral density test in the past two years or received osteoporosis medication or therapy in the past 12 months
transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; complete
all lower extremity prostheses, flex foot system
addition to ctlso or scoliosis orthosis, outrigger
injection, eribulin mesylate, 0.1 mg
xcm biologic tissue matrix, per square centimeter
addition to lower extremity, below knee, molded supracondylar suspension ('pts' or similar)
wheelchair, pediatric size, tilt-in-space, folding, adjustable, without seating system
tablo hemodialysis system for the billable dialysis service
intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency
upper extremity addition, harness, (e.g., figure of eight type), dual cable design
brachytherapy source, non-stranded, gold-198, per source
portable liquid oxygen system, rental; includes portable container, supply reservoir, humidifier, flowmeter, refill adaptor, contents gauge, cannula or mask, and tubing
injection, elotuzumab, 1 mg
pathogen(s) test for platelets terminated december 31, 2017.
behavioral health hotline service
injection, icatibant, 1 mg
surgical dressing holder, non-reusable, each
administration of pneumococcal vaccine
stoma cap
rn services, up to 15 minutes
wheelchair accessory, manual swingaway, retractable or removable mounting hardware for joystick, other control interface or positioning accessory
catheter, brachytherapy seed administration
clinical decision support mechanism intermountain clinical decision support mechanism, as defined by the medicare appropriate use criteria program
oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation agreement terminated june 30, 2022.
patient with minor blunt head trauma did not have an appropriate indication(s) for a head ct
risk-adjusted functional status change residual score for the elbow, wrist or hand impairment successfully calculated and the score was less than zero (< 0)
addition to lower extremity, torsion control, ankle joint and half solid stirrup
reciprocating peritoneal dialysis system
bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, each
i intend to report the preventive care measures group terminated december 31, 2016.
colorectal cancer screening; alternative to g0104, screening sigmoidoscopy, barium enema
red blood cells, leukocytes reduced, irradiated, each unit
injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg
solid organ(s), complete or segmental, single organ or combination of organs; deceased or living donor(s), procurement, transplantation, and related complications; including: drugs; supplies; hospitalization with outpatient follow-up; medical/surgical, diagnostic, emergency, and rehabilitative services, and the number of days of pre- and post-transplant care in the global definition
injection, triflupromazine hcl, up to 20 mg
ostomy pouch, drainable, with extended wear barrier attached, with built-in convexity (1 piece), each
injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu
biopsy results not reviewed, communicated, tracked or documented
dextroamphetamine sulfate, 5 mg
injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) terminated december 31, 2014.
casting supplies, body cast adult, with or without head, plaster
bundled payments for care improvement initiative home visit for patient assessment performed by a qualified health care professional for individuals not considered homebound including, but not limited to, assessment of safety, falls, clinical status, fluid status, medication reconciliation/management, patient compliance with orders/plan of care, performance of activities of daily living, appropriateness of care setting; (for use only in the meidcare-approved bundled payments for care improvement initiative); may not be billed for a 30-day period covered by a transitional care management code
documentation of patient discharged alive following endovascular aaa repair terminated december 31, 2020.
mannitol, administered through an inhaler, 5 mg
lumbar-sacral orthosis, sagittal control, with rigid posterior panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf
injection, fluocinolone acetonide intravitreal implant, 0.01 mg terminated december 31, 2015.
ostomy pouch, urinary; for use on barrier with locking flange, with faucet-type tap with valve (2 piece), each
bed accessory: board, table, or support device, any type
addition to lower extremity, thigh/weight bearing, high roll cuff
injection, pegfilgrastim-cbqv, biosimilar, (udenyca), 0.5 mg
counseling, individual, by chaplain services
woundex flow, bioskin flow, 0.5 cc
medical nutrition therapy, reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition, or treatment regimen (including additional hours needed for renal disease), group (2 or more individuals), each 30 minutes
seat attachment, walker
colorectal cancer screening; stool-based dna and fecal occult hemoglobin (e.g., kras, ndrg4 and bmp3) terminated december 31, 2015.
variable sphericity lens, other type
prenatal care, at-risk enhanced service; follow-up home visit
patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 days during the measurement period terminated december 31, 2020.
addition to lower extremity orthosis, high strength, lightweight material, all hybrid lamination/prepreg composite, per segment, for custom fabricated orthosis only
oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)
documentation of medical reason for not conducting a search for dicom format images for prior patient ct imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure, authorized, media-free, shared archive (e.g., trauma, acute myocardial infarction, stroke, aortic aneurysm where time is of the essence)
power wheelchair, group 3 standard, captains chair, patient weight capacity up to and including 300 pounds
allowrap ds or dry, per square centimeter
patient received at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period terminated december 31, 2020.
standard wheelchair, fixed full length arms, fixed or swing away detachable footrests
this code is for the onsite acute care treatment a nursing facility resident with a skin infection; may only be billed once per day per beneficiary
leg strap, each
microprocessor control unit for use with electric/pneumatic combination ventricular assist device, replacement only
brachytherapy source, non-stranded, high dose rate iridium-192, per source
documentation of medical reason for not performing foot exam (i.e., patients who have had either a bilateral amputation above or below the knee, or both a left and right amputation above or below the knee before or during the measurement period)
creation of arteriovenous fistula, percutaneous using magnetic-guided arterial and venous catheters and radiofrequency energy, including flow-directing procedures (e.g., vascular coil embolization with radiologic supervision and interpretation, when performed) and fistulogram(s), angiography, venography, and/or ultrasound, with radiologic supervision and interpretation, when performed terminated june 30, 2020.
dynamic adjustable shoulder flexion / abduction / rotation device, includes soft interface material
percutaneous catheter/tube anchoring device, adhesive skin attachment
tlso, sagittal-coronal control, modular segmented spinal system, three rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the xiphoid, soft liner, restricts gross trunk motion in the sagittal and coronal planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment
noncovered surgical procedure(s) using conscious sedation, regional, general or spinal anesthesia in a medicare qualifying clinical trial, per day
oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)
injection, baclofen, 10 mg
filter, non disposable, used with positive airway pressure device
pneumatic compressor, segmental home model without calibrated gradient pressure
addition to lower extremity, above knee or knee disarticulation, silesian bandage
power wheelchair accessory, insert for pneumatic drive wheel tire (removable), any type, any size, replacement only, each
patient was not referred to hospice care, reason not given terminated december 31, 2020.
spoke protectors, each
gradient pressure aid (sleeve), custom made, heavy weight
red blood cells, leukocytes reduced, each unit
antiemetic drug, oral, not otherwise specified
betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
dialysis equipment, not otherwise specified
injection, viltolarsen, 10 mg terminated march 31, 2021.
surgigraft-dual, per square centimeter
at least two orders for high-risk medications from the same drug class
injection, urokinase, 5000 iu vial
skills training and development, per diem
surgical pathology, gross and microscopic examination, for prostate needle biopsy, any method, >60 specimens terminated december 31, 2014.
monitor/display module for use with electric or electric/pneumatic ventricular assist device, replacement only
addition, endoskeletal system, above knee or hip disarticulation, alignable system
mental health service plan development by non-physician
enteral nutrition infusion pump, any type
interscapular thoracic, passive restoration (complete prosthesis)
remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of moderate complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 45 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology
catheter, electrophysiology, diagnostic/ablation, other than 3d or vector mapping, other than cool-tip
kidney, dialysate delivery syst kidney machine, pump recirculating, air removal syst, flowrate meter, power off, heater and temperature control with alarm, i.v. poles, pressure gauge, concentrate container
speech generating device, digitized speech, using pre-recorded messages, greater than 40 minutes recording time
orthopedic shoe, oxford with supinator or pronator, child
trifocal vision prescription lens (safety, athletic, or sunglass), per lens
documentation of medical reason(s) for a colonoscopy performed on a patient greater than or equal to 86 years of age (e.g., iron deficiency anemia, lower gastrointestinal bleeding, crohn's disease (i.e., regional enteritis), familial history of adenomatous polyposis, lynch syndrome (i.e., hereditary non-polyposis colorectal cancer), inflammatory bowel disease, ulcerative colitis, abnormal finding of gastrointestinal tract, or changes in bowel habits)
tubing, used with suction pump, each
puraply, per square centimeter
lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf
replace girdle for spinal orthosis (ctlso or so)
adapter/extension, pacing lead or neurostimulator lead (implantable)
risk-adjusted functional status change residual score for the neck impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)
injection, testosterone propionate, up to 100 mg terminated december 31, 2014.
glasses, air conduction
surgical mask, per 20
injection, lefamulin (xenleta), 1 mg terminated june 30, 2020.
ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)
budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg
replacement, tip, cane, crutch, walker, each.
home infusion therapy, total parenteral nutrition (tpn); more than three liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem
adjunctive blue light cystoscopy with fluorescent imaging agent (list separately in addition to code for primary procedure)
truskin, per square centimeter
cold or hot fluid bottle, ice cap or collar, heat and/or cold wrap, any type
knee ankle foot orthosis, full plastic, double upright, with or without free motion knee, with or without free motion ankle, custom fabricated
positron emission tomography radiopharmaceutical, diagnostic, for tumor identification, not otherwise classified
fluorine-18 fluorodeoxyglucose (f-18 fdg) imaging using dual-head coincidence detection system (non-dedicated pet scan)
home infusion therapy, continuous (twenty-four hours or more) chemotherapy infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
home infusion therapy, pain management infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment, (drugs and nursing visits coded separately), per diem (do not use this code with s9326, s9327 or s9328)
binaural, glasses
sterile dilutant for epoprostenol, 50 ml
implantation of auditory brain stem implant
hearing service, miscellaneous
plan of care for moderate to severe pain not documented on or before the date of the second visit with a clinician, reason not given terminated december 31, 2019.
fasting lipid profile performed (triglycerides, ldl-c, hdl-c and total cholesterol) terminated december 31, 2016.
apnea monitor, without recording feature
syringe, with or without needle, each
wheel attachment, rigid pick-up walker, per pair
patient did not receive follow-up on the date of discharge or within 30 days after discharge
islet cell tissue transplant from pancreas; allogeneic
swivel adapter
injection, ferric pyrophosphate citrate solution (triferic), 0.1 mg of iron
injection, amphotericin b liposome, 10 mg
power wheelchair accessory, group 24 sealed lead acid battery, each (e.g., gel cell, absorbed glassmat)
the mdpp beneficiary achieved at least 9% weight loss (wl) from his/her baseline weight in months 1-24 under the mdpp expanded model (em). this is a one-time payment available when a beneficiary first achieves at least 9% weight loss from baseline as measured by an in-person weight measurement at a core session, core maintenance session, or ongoing maintenance session
patient receiving maintenance hemodialysis in an outpatient dialysis facility
diagnostic colonoscopy terminated december 31, 2020.
psychosocial rehabilitation services, per diem
for diabetics only, modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe with off-set heel(s), per shoe
hemi-wheelchair, detachable arms desk or full length arms, swing away detachable elevating leg rests
catheter, thrombectomy/embolectomy
patient has metastatic disease at diagnosis terminated december 31, 2020.
heavy duty wheelchair, detachable arms (desk or full length) elevating legrests
injection, chlorpromazine hcl, up to 50 mg
imatinib, 100 mg
brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose terminated march 31, 2021.
upper extremity addition, latex suspension sleeve, each
hospital bed, total electric (head, foot and height adjustments), without side rails, without mattress
hand finger orthosis, without joints, may include soft interface, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
power wheelchair component, integrated drive wheel motor and gear box combination, replacement only
non-emergency transport; commercial carrier, multi-pass
services by a journal-listed christian science nurse, per hour
pacemaker, dual chamber, rate-responsive (implantable)
patients who use hospice services any time during the measurement period
didanosine (ddi), 25 mg
crutch underarm, wood, adjustable or fixed, each, with pad, tip and handgrip
preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no cover, sach foot, laminated socket, molded to model
back, planar, for pediatric size wheelchair including fixed attaching hardware
implantable programmable infusion pump, replacement (excludes implantable intraspinal catheter)
iodine i-131 iodinated serum albumin, diagnostic, per 5 microcuries
hip knee ankle foot orthosis, torsion control, bilateral torsion cables, ball bearing hip joint, pelvic band/ belt, custom fabricated
knee orthosis (ko), single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf
oncology; disease status; limited to non-small cell lung cancer; stage iii b- iv at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)
magnetic resonance angiography with contrast, chest (excluding myocardium)
patient already receiving physical/occupational/speech/recreational therapy during the measurement period
insertion tray without drainage bag and without catheter (accessories only)
infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r
orthopedic footwear, woman's shoe, oxford, used as an integral part of a brace (orthosis)
knee ankle foot orthosis, fracture orthosis, femoral fracture cast orthosis, custom fabricated
home delivered meals, including preparation; per meal
oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate
non-emergency transportation; per diem
hip orthosis, abduction control of hip joint, postoperative hip abduction type, prefabricated, includes fitting and adjustment
endoscopic ultrasound-guided direct measurement of hepatic portosystemic pressure gradient by any method (list separately in addition to code for primary procedure)
electronic wrist rotator, any type
radium ra-223 dichloride, therapeutic, per microcurie
oxygen tent, excluding croup or pediatric tents
barbiturates, not elsewhere specified terminated december 31, 2015.
oncology; practice guidelines; management differs from guidelines as a result of patient enrollment in an institutional review board approved clinical trial (for use in a medicare-approved demonstration project)
gradient compression stocking, below knee, 40-50 mmhg, each
travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled
injection, itraconazole, 50 mg
ct scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after date of diagnosis terminated december 31, 2021.
mitomycin, ophthalmic, 0.2 mg
ear impression, each
irrigation tray with bulb or piston syringe, any purpose
temporary replacement for patient owned equipment being repaired, any type
interfyl, 1 mg
color contact lens, per lens
injection, aurothioglucose, up to 50 mg
adenoma(s) or colorectal cancer not detected during screening colonoscopy terminated december 31, 2020.
ostomy pouch, drainable; with barrier attached, (1 piece), each
light compression bandage, elastic, knitted/woven, width less than three inches, per yard
sphere, bifocal, plano to plus or minus 4.00d, per lens
injection, methylprednisolone sodium succinate, up to 125 mg
commode chair with integrated seat lift mechanism, electric, any type
injection, obinutuzumab, 10 mg terminated december 31, 2014.
protamine sulfate, for hemodialysis, per 50 mg
bilateral hip, knee, ankle, foot device, powered, includes pelvic component, single or double upright(s), knee joints any type, with or without ankle joints any type, includes all components and accessories, motors, microprocessors, sensors
microlyte matrix, per square centimeter
injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg terminated december 31, 2014.
variable asphericity lens, bifocal, full field, glass or plastic, per lens
extra heavy duty wheelchair
supply of injectable contrast material for use in echocardiography, per study
high intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes
documentation of patient without one or more complications and without mortality within 30 days terminated december 31, 2021.
aqueous shunt
front caster assembly, complete, with solid tire, replacement only, each
injection, omacetaxine mepesuccinate, 0.01 mg
cane, quad or three prong, includes canes of all materials, adjustable or fixed, with tips
injection, cisplatin, powder or solution, 10 mg
gauze, impregnated, hydrogel, for direct wound contact, sterile, pad size more than 48 sq. in., each dressing
walker, rigid (pickup), adjustable or fixed height
nonpowered advanced pressure reducing overlay for mattress, standard mattress length and width
clinical decision support mechanism reliant medical group, as defined by the medicare appropriate use criteria program
power wheelchair, group 3 heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds
histrelin implant (supprelin la), 50 mg
patient screened for unhealthy alcohol use using a systematic screening method and not identified as an unhealthy alcohol user
non-emergency transportation, per mile - vehicle provided by volunteer (individual or organization), with no vested interest
injection, taliglucerase alfa, 10 units
rubidium rb-82, diagnostic, per study dose, up to 60 millicuries
ambulance service, conventional air services, transport, one way (rotary wing)
procurement of donor sperm from sperm bank
comprehensive care management for a single high-risk disease services, e.g. principal care management, at least 30 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month with the following elements: one complex chronic condition lasting at least 3 months, which is the focus of the care plan, the condition is of sufficient severity to place patient at risk of hospitalization or have been cause of a recent hospitalization, the condition requires development or revision of disease-specific care plan, the condition requires frequent adjustments in the medication regimen, and/or the management of the condition is unusually complex due to comorbidities terminated december 31, 2021.
patients who have had a hysterectomy
ostomy irrigation set
technetium tc-99m apcitide, diagnostic, per study dose, up to 20 millicuries
iodine i-131 sodium iodide, diagnostic, per microcurie (up to 100 microcuries)
injection, sotalol hydrochloride, 1 mg
disposable collection and storage bag for breast milk, any size, any type, each
prolonged postoperative intubation (> 24 hrs) not required
drug test(s), presumptive, any number of drug classes; any number of devices or procedures, (e.g., immunoassay) capable of being read by direct optical observation only (e.g., dipsticks, cups, cards, cartridges), includes sample validation when performed, per date of service terminated december 31, 2016.
sleeve for intermittent limb compression device, replacement only, each
patient had hospice services any time during the measurement period
hyperbaric oxygen under pressure, full body chamber, per 30 minute interval
drug test(s), presumptive, any number of drug classes; any number of devices or procedures, (e.g., immunoassay) read by instrument-assisted direct optical observation (e.g., dipsticks, cups, cards, cartridges), includes sample validation when performed, per date of service terminated december 31, 2016.
rollabout chair, any and all types with casters 5" or greater
pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period
chlorhexidine containing antiseptic, 1 ml
injection, ferric carboxymaltose, 1 mg
oncology; disease status; pancreatic cancer, limited to adenocarcinoma; post r1 or r2 resection with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)
iodine i-131, iobenguane, 1 millicurie
addition to lower extremity fracture orthosis, adjustable motion knee joint, lerman type
documentation of medical reason(s) for not including the pt category, the pn category or the histologic grade in the pathology report (e.g., re-excision without residual tumor; non-carcinomasanal canal)
supported housing, per diem
patient identified as an unhealthy alcohol user received brief counseling
repair, myelomeningocele in the fetus, procedure performed in utero
functional status was not measured by the oxford knee score (oks) or the knee injury and osteoarthritis outcome score joint replacement (koos, jr.) at one year (9 to 15 months) postoperatively
wheelchair with detachable arms, elevating legrests
oropharyngeal suction catheter, each
patient unable to complete the shoulder fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available
patients who have a diagnosis of pregnancy at any time during the measurement period
provider who referred the patient to another provider received a report from the provider to whom the patient was referred
choline c 11, diagnostic, per study dose terminated december 31, 2016.
aspirin or another antiplatelet therapy used
retinal prosthesis, includes all internal and external components; add-on to c1841
lens, polycarbonate or equal, any index, per lens
injection, golodirsen, 10 mg
tensix, per square centimeter
transcutaneous electrical nerve stimulation (tens) device, two lead, localized stimulation
documentation of post-surgical anatomy (e.g., right hemicolectomy, ileocecal resection, etc.)
lightweight wheelchair
clinical decision support mechanism inveniqa semantic answers in medicine, as defined by the medicare appropriate use criteria program
home infusion therapy, total parenteral nutrition (tpn); more than one liter but no more than two liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem
magnetic resonance angiography without contrast followed by with contrast, upper extremity
injection, metoclopramide hcl, up to 10 mg
diabetic management program, follow-up visit to md provider
chlorpromazine hydrochloride, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
heparin infusion pump for hemodialysis
speech therapy, in the home, per diem
gelatin capsule, application device for use with tracheoesophageal voice prosthesis, each
wound cleansers, any type, any size
thoracic-lumbar-sacral-orthosis (tlso), inclusive of furnishing initial orthosis only
hip knee ankle foot orthosis, torsion control, unilateral torsion cable, hip joint, pelvic band/belt, custom fabricated
annual alcohol misuse screening, 15 minutes
walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
immediate post surgical or early fitting, application of non-weight bearing rigid dressing, above knee
repair of sacrococcygeal teratoma in the fetus, procedure performed in utero
shower cover for use with electric or electric/pneumatic ventricular assist device, replacement only
injection, corticotropin, up to 40 units
breast pump, hospital grade, electric (ac and / or dc), any type
preparatory, elbow disarticulation or above elbow, single wall socket, friction wrist, locking elbow, figure of eight harness, fair lead cable control, usmc or equal pylon, no cover, direct formed
hmatrix, per square centimeter
unclassified biologics
mechanical allergen particle barrier/inhalation filter, cream, nasal, topical
power wheelchair, group 1 standard, sling/solid seat and back, patient weight capacity up to and including 300 pounds
back pain measured by the visual analog scale (vas) at three months (6 - 20 weeks) postoperatively was greater than 3.0 and back pain measured by the visual analog scale (vas) within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated a change of less than an improvement of 5.0 points
the number of adult patient-months in the denominator who were on maintenance hemodialysis under the care of the same practitioner or group partner as of the last hemodialysis session of the reporting month using a catheter continuously for less than three months
cast supplies, short arm cast, adult (11 years +), plaster
injection, valrubicin, intravesical, 200 mg
dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity
annual gynecological examination; clinical breast examination without pelvic evaluation
for diabetics only, multiple density insert, custom molded from model of patient's foot, total contact with patient's foot, including arch, base layer minimum of 3/16 inch material of shore a 35 durometer (or higher), includes arch filler and other shaping material, custom fabricated, each
addition to lens; tint, any color, solid, gradient or equal, excludes photochromatic, any lens material, per lens
unclassified drugs or biologicals
intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose
patient achieves final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery
specialty occupational multifocal lens, per lens
hemipelvectomy, canadian type, molded socket, endoskeletal system, hip joint, single axis knee, sach foot
this code is for onsite acute care treatment of a nursing facility resident with chf; may only be billed once per day per beneficiary
wheelchair, pediatric size, folding, adjustable, without seating system
addition to lower extremity, endoskeletal system, above knee-knee disarticulation, 4 bar linkage, with hydraulic swing phase control
holding chamber or spacer for use with an inhaler or nebulizer; with mask
foam dressing, wound filler, sterile, per gram
self-adherent bandage, elastic, non-knitted/non-woven, width less than three inches, per yard
urology mips specialty set
flutter device
bicarbonate concentrate, powder, for hemodialysis, per packet
injection, alemtuzumab, 1 mg terminated december 31, 2015.
magnetic resonance angiography without contrast, lower extremity
patient was referred to hospice care terminated december 31, 2020.
stage of breast cancer is greater than t1n0m0 or t2n0m0
aortic aneurysm 5.5 - 5.9 cm maximum diameter on centerline formatted ct or minor diameter on axial formatted ct
pneumatic compressor, non-segmental home model
knee ankle foot device, any material, single or double upright, swing and stance phase microprocessor control with adjustability, includes all components (e.g., sensors, batteries, charger), any type activation, with or without ankle joint(s), custom fabricated
audiometry for hearing aid evaluation to determine the level and degree of hearing loss
more than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis, reason not given
patients with a normal neurological examination terminated december 31, 2018.
injection, avalglucosidase alfa-ngpt, 4 mg terminated march 31, 2022.
patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method
children who were screened for risk of developmental, behavioral and social delays using a standardized tool with interpretation and report terminated december 31, 2020.
tlso, corset front
genetic testing for hemoglobin e beta-thalassemia
orthopedic shoe addition, toe tap, horseshoe
dialysate solution, any concentration of dextrose, fluid volume greater than 999 cc but less than or equal to 1999 cc, for peritoneal dialysis
power wheelchair, group 2 heavy duty, sling/solid seat/back, patient weight capacity 301 to 450 pounds
angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed, reason not given
diagnostic mammography, including computer-aided detection (cad) when performed; unilateral terminated december 31, 2017.
hydrogel dressing, wound filler, gel, per fluid ounce
semen analysis; presence and/or motility of sperm excluding huhner
oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i or stage iia-iib; or t3, n1, m0; and er and/or pr positive; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
services provided in an urgent care center (list in addition to code for service)
lightweight wheelchair, detachable arms, (desk or full length) swing away detachable, elevating legrest
patients under hospice care in the current reporting month
scintimammography (radioimmunoscintigraphy of the breast), unilateral, including supply of radiopharmaceutical
injection, olaratumab, 10 mg
upper extremity fracture orthosis, humeral, prefabricated, includes fitting and adjustment
ankle foot orthosis, plastic or other material, prefabricated, includes fitting and adjustment
injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg
injection, alprostadil, 1.25 mcg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
customized durable medical equipment, other than wheelchair
lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, custom fabricated
high mount flip-up footrest, each
initial, above knee - knee disarticulation, ischial level socket, non-alignable system, pylon, no cover, sach foot, plaster socket, direct formed
linear accelerator based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, maximum five sessions per course of treatment terminated december 31, 2014.
patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period terminated december 31, 2020.
upper extremity additions, shoulder abduction joint, pair
hospitalized patients with newly diagnosed cva considered for endovascular stroke treatment
manual wheelchair accessory, caster wheel excludes tire, any size, replacement only, each
pulmonology mips specialty set
non-prescription lens (safety, athletic, or sunglass), per lens
positive airway pressure therapy not prescribed, reason not given
cough stimulating device, alternating positive and negative airway pressure
adhesive disc for use in a heat and moisture exchange system and/or with tracheostoma valve, any type each
infrared heating pad system
elevating legrest, lower extension tube, replacement only, each
additions exoskeletal knee-shin system, single axis, manual lock, ultra-light material
door to puncture time of 90 minutes or less
antithrombin iii (human), per i.u.
replacement diaphragm/faceplate for tracheostoma valve, each
terminal device, hand, mechanical, voluntary opening, any material, any size, pediatric
injection, lumasiran, 0.5 mg terminated june 30, 2021.
services performed by a qualified speech-language pathologist, in the home health setting, in the establishment or delivery of a safe and effective speech-language pathology maintenance program, each 15 minutes
angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) or angiotensin receptor-neprilysin inhibitor (arni) therapy prescribed or currently being taken
activity therapy, per 15 minutes
spirometer, electronic, includes all accessories
sole wedge, between sole
wheelchair, pediatric size, rigid, adjustable, without seating system
services, supplies and accessories used in the home under the medicare intravenous immune globulin (ivig) demonstration
enuresis alarm, using auditory buzzer and/or vibration device
oncology; disease status; small cell lung cancer, limited to small cell and combined small cell/non-small cell; extensive stage at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)
patients not assessed for risk of bone loss, reason not given
injection, immune globulin (cuvitru), 100 mg
search conducted for prior patient ct studies completed at non-affiliated external healthcare facilities or entities within the past 12-months and are available through a secure, authorized, media-free, shared archive prior to an imaging study being performed
cochlear implant, external speech processor, component, replacement
patient not prescribed or dispensed antibiotic
hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg terminated december 31, 2016.
injection, carfilzomib, 1 mg
beta-blocker at discharge terminated december 31, 2014.
epicord, per square centimeter
addition to lower extremity, ischial containment/narrow m-l socket
ballistocardiogram
preadmission screening and resident review (pasrr) level ii evaluation, per evaluation
injection, pegfilgrastim, 6 mg terminated december 31, 2021.
injection, hyaluronidase, ovine, preservative free, per 1000 usp units
manual wheelchair accessory, manual standing system
injection, inclisiran, 1 mg
injection, infliximab, excludes biosimilar, 10 mg
high frequency chest wall oscillation system vest, replacement for use with patient owned equipment, each
i intend to report the chronic kidney disease (ckd) measures group terminated december 31, 2016.
tracheostoma stent/stud/button, each
enteral formula, for pediatrics, hydrolyzed/amino acids and peptide chain proteins, includes fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit
injection, micafungin sodium, 1 mg
blood glucose monitor with integrated voice synthesizer
injection, oxytocin, up to 10 units
cryoprecipitated fibrinogen complex, pathogen reduced, each unit
injection, polatuzumab vedotin-piiq, 1 mg
power wheelchair, group 3 extra heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 601 pounds or more
skilled services of a licensed nurse (lpn or rn) for the observation and assessment of the patient's condition, each 15 minutes (the change in the patient's condition requires skilled nursing personnel to identify and evaluate the patient's need for possible modification of treatment in the home health or hospice setting) terminated december 31, 2016.
laser-assisted uvulopalatoplasty (laup)
injection, treprostinil, 1 mg
injection, gadoterate meglumine, 0.1 ml
knee orthosis (ko), double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf terminated december 31, 2016.
within the past 2 years, calcium and/or vitamin d optimization has been ordered or performed terminated december 31, 2020.
injection, irinotecan liposome, 1 mg
mycophenolic acid, oral, 180 mg
miscellaneous external component, supply or accessory for use with the argus ii retinal prosthesis system
peak expiratory flow rate meter, hand held
platform attachment, walker, each
injection, nivolumab, 1 mg
addition, endoskeletal knee-shin system, polycentric, friction swing, and stance phase control
home therapy; professional pharmacy services for provision of infusion, specialty drug administration, and/or disease state management, not otherwise classified, per hour (do not use this code with any per diem code)
hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result
depression, anxiety, apathy, and psychosis not assessed
adhesive or non-adhesive; disk or foam pad
injection, omalizumab, 5 mg
patient did not have the retina attached after 6 months following only one surgery terminated december 31, 2015.
alcohol and/or drug screening
phakic intraocular lens for correction of refractive error
flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram
power wheelchair accessory, head control interface, proximity switch mechanism, nonproportional, including all related electronics, mechanical stop switch, mechanical direction change switch, head array, and fixed mounting hardware
injection, cimetidine hydrochloride, 300 mg
all quality actions for the applicable measures in the aoe measures group have been performed for this patient terminated december 31, 2016.
positive airway pressure therapy not prescribed terminated december 31, 2016.
lenticular lens, per lens, trifocal
shoulder orthosis, shoulder joint design, without joints, may include soft interface, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
radiopharmaceutical, diagnostic, not otherwise classified
all quality actions for the applicable measures in the hypertension (htn) measures group have been performed for this patient terminated december 31, 2014.
documentation of medical reason(s) for not prescribing beta-blocker therapy (eg, allergy, intolerance, other medical reasons)
injection, rituximab 10 mg and hyaluronidase
enteral formula, for pediatrics, special metabolic needs for inherited disease of metabolism, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit
clinical decision support mechanism national imaging associates, as defined by the medicare appropriate use criteria program terminated december 31, 2020.
injection, romidepsin, 1 mg terminated september 30, 2021.
angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed
injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.
injection, erythromycin lactobionate, per 500 mg
injection, torsemide, 10 mg/ml
covid-19 vaccine administration inside a patient's home; reported only once per individual home per date of service when only covid-19 vaccine administration is performed at the patient's home
addition to lower extremity prosthesis, endoskeletal knee-shin system, microprocessor control feature, swing and stance phase, includes electronic sensor(s), any type
home infusion therapy, hydration therapy; one liter per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
upper extremity fracture orthosis, humeral, prefabricated, includes shoulder cap design, with or without joints, forearm section, may include soft interface, straps, includes fitting and adjustments
oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage iiia-iiib; and not t3, n1, m0; and er and/or pr positive; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
aniseikonic lens, trifocal
insulin cartridge for use in insulin delivery device other than pump; 150 units
revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy, includes angioplasty within the same vessel(s), when performed
chemotherapy administration by infusion technique only, per visit
human breast milk processing, storage and distribution only
crutch substitute, lower leg platform, with or without wheels, each
glaucoma screening for high risk patients furnished by an optometrist or ophthalmologist
tracheostomy care kit for new tracheostomy
generator, cardiac contractility modulation (implantable)
drain bag/bottle, for dialysis, each
cast supplies, body cast adult, with or without head, fiberglass
technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries
bed pan, standard, metal or plastic
ankle orthosis, ankle gauntlet or similar, with or without joints, prefabricated, off-the-shelf
atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
contracted home health agency services, all services provided under contract, per day
mycophenolate mofetil, oral, 250 mg
injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram
full face mask used with positive airway pressure device, each
addition to lower extremity, below knee / above knee suspension locking mechanism (shuttle, lanyard or equal), excludes socket insert
bionextpatch, per square centimeter terminated september 30, 2021.
hand restoration (shading, and measurements included), replacement glove for above
foster care, adult; per diem
initial physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) which must include: (1) the diagnosis of lops, (2) a patient history, (3) a physical examination that consists of at least the following elements: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of a protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear and (4) patient education
patient has documentation of ventricular shunt, brain tumor, multisystem trauma, or is currently taking an antiplatelet medication including: abciximab, anagrelide, cangrelor, cilostazol, clopidogrel, dipyridamole, eptifibatide, prasugrel, ticlopidine, ticagrelor, tirofiban, or vorapaxar
previously diagnosed or have an active diagnosis of clinical ascvd, including ascvd procedure
improvement in visual function achieved within 90 days following cataract surgery
injection, ado-trastuzumab emtansine, 1 mg
contact lens, gas permeable, extended wear, per lens
acellular pericardial tissue matrix of non-human origin (veritas), per square centimeter
factor ix, complex, per i.u.
injection, ceftizoxime sodium, per 500 mg
spirometer, non-electronic, includes all accessories
catheterization for collection of specimen(s) (multiple patients)
injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 600 mg
motor speech functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting terminated december 31, 2019.
hospital bed, extra heavy duty, extra wide, with weight capacity greater than 600 pounds, with any type side rails, with mattress
injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg
injection, gemcitabine hydrochloride, (infugem), 100 mg
obstetrics/gynecology mips specialty set
patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis
introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away
hyalomatrix, per square centimeter
injection, dalbavancin, 5 mg
services of home health/hospice aide in home health or hospice settings, each 15 minutes
documentation of patient discharged to home no later than post operative day 2 following cas
injection, argatroban, 1 mg (for non-esrd use)
tracheostomy/laryngectomy tube, non-cuffed, polyvinylchloride (pvc), silicone or equal, each
documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care
metacarpal phalangeal joint replacement, two or more pieces, metal (e.g., stainless steel or cobalt chrome), ceramic-like material (e.g., pyrocarbon), for surgical implantation (all sizes, includes entire system)
infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening
addition to lower extremity, above knee or knee disarticulation, acrylic socket
injection, rituximab, 10 mg
oncology; disease status; pancreatic cancer, limited to adenocarcinoma; unresectable at diagnosis, m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)
injection, blinatumomab, 1 microgram
injection, givosiran, 0.5 mg
patients who are receiving comfort care only
glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
documentation of medical reason(s) for not achieving at least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) within the 30 minutes immediately before or the 15 minutes immediately after anesthesia end time (e.g., emergency cases, intentional hypothermia, etc.)
stress management classes, non-physician provider, per session
all quality actions for the applicable measures in the asthma measures group have been performed for this patient terminated december 31, 2016.
addition to lower extremity, below knee, leather socket
injection, emapalumab-lzsg, 1 mg
a transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is not used
intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump
hepatitis c antibody screening, for individual at high risk and other covered indication(s)
subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation; participation in weekly caseload consultation with the psychiatric consultant; ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers; additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant; provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies; monitoring of patient outcomes using validated rating scales; and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment terminated december 31, 2017.
injection, moxifloxacin, 100 mg
delivery and/or installation charges for hemodialysis equipment
allogen, per cc
breast shield and splash protector for use with breast pump, replacement
infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening
clubfoot wedge
limited (30 minutes) care management home care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)
adult sized disposable incontinence product, protective brief/diaper, above extra large, each
portable liquid oxygen system, purchase; includes portable container, supply reservoir, flowmeter, humidifier, contents gauge, cannula or mask, tubing and refill adaptor
standing frame/table system, mobile (dynamic stander), any size including pediatric
addition to lower extremity, above knee, leather socket
injection, bezlotoxumab, 10 mg terminated december 31, 2017.
tlso, sagittal-coronal control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, extends from sacrococcygeal junction over scapulae, lateral strength provided by pelvic, thoracic, and lateral frame pieces, restricts gross trunk motion in sagittal, and coronal planes, produces intracavitary pressure to reduce load on intervertebral disks, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
prosthetic eye, other type
receipt and analysis of remote, asynchronous images for dermatologic and/or ophthalmologic evaluation, for use only in a medicare-approved cmmi model, less than 10 minutes
heel, new rubber, standard
vbac (vaginal birth after cesarean) classes, non-physician provider, per session
no documentation in the patient record of a discussion between the physician or other qualified healthcare professional and the patient that includes all of the following: treatment choices appropriate to genotype, risks and benefits, evidence of effectiveness, and patient preferences toward treatment terminated december 31, 2021.
voice functional limitation, current status at therapy episode outset and at reporting intervals terminated december 31, 2019.
coordinating stroke care to promote prevention and cultivate positive outcomes mips value pathways
percutaneous vertebroplasty, one vertebral body, unilateral or bilateral injection; cervical terminated december 31, 2015.
levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg
positioning wheelchair seat cushion, width 22 inches or greater, any depth
sacroiliac orthosis, flexible, provides pelvic-sacral support, reduces motion about the sacroiliac joint, includes straps, closures, may include pendulous abdomen design, custom fabricated
injection, rilonacept, 1 mg
cast supplies, long leg splint, adult (11 years +), plaster
addition to lower extremity, below knee, total contact
injection, pemetrexed, not otherwise specified, 10 mg
injection, ethanolamine oleate, 100 mg
advancing rheumatology patient care mips value pathways
hospice care, in the home, per diem
fetoscopic laser therapy for treatment of twin-to-twin transfusion syndrome
for diabetics only, multiple density insert, made by direct carving with cam technology from a rectified cad model created from a digitized scan of the patient, total contact with patient's foot, including arch, base layer minimum of 3/16 inch material of shore a 35 durometer (or higher), includes arch filler and other shaping material, custom fabricated, each terminated december 31, 2018.
injection, lacosamide, 1 mg
humidifier, durable for supplemental humidification during ippb treatment or oxygen delivery
risk-adjusted functional status change residual score for the hip impairment successfully calculated and the score was less than zero (< 0)
injection, anifrolumab-fnia, 1 mg
non-pvc (polyvinyl chloride) intravenous administration set, for use with drugs that are not stable in pvc e.g., paclitaxel
family assessment by licensed behavioral health professional for state defined purposes
positioning wheelchair back cushion, planar back with lateral supports, width less than 22 inches, any height, including any type mounting hardware
synthetic resorbable wound dressing, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing
all quality actions for the applicable measures in the dementia measures group have been performed for this patient terminated december 31, 2016.
5% dextrose and 0.45% normal saline, 1000 ml
upper extremity addition, excursion amplifier, pulley type
power wheelchair accessory, group 34 non-sealed lead acid battery, each
two or more benzodiazepine prescriptions ordered for patients who had a diagnosis of seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, or severe generalized anxiety disorder on or between january 1 of the year prior to the measurement period and the ipsd for benzodiazepines
routine ophthalmological examination including refraction; new patient
lso, full corset
clinical decision support mechanism infinx, as defined by the medicare appropriate use criteria program
injection, casimersen, 10 mg
gradient pressure aid (gauntlet), ready made
hospice services given to patient any time during the measurement period
foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing
fluid circulating cold pad with pump, any type
assistive listening device, personal fm/dm receiver, not otherwise specified
crutch, underarm, articulating, spring assisted, each
progressive lens, per lens
influenza immunization was not administered, reason not given
astigmatism correcting function of intraocular lens
nursing assessment / evaluation
physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care
wheelchair accessory, power seating system, recline only, with mechanical shear reduction
noncovered procedure(s) using either no anesthesia or local anesthesia only, in a medicare qualifying clinical trial, per day
addition to lower extremity, pelvic and thoracic control, gluteal pad, each
wheelchair accessory, cylinder tank carrier, each
noc for parenteral supplies
genetic testing for amyotrophic lateral sclerosis (als)
primary lung carcinoma resection report does not document pt category, pn category and for non-small cell lung cancer, histologic type (e.g., squamous cell carcinoma, adenocarcinoma)
parenteral nutrition solution compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, hepatic, hepatamine-premix
injection, dicyclomine hcl, up to 20 mg
injection, copanlisib, 1 mg terminated december 31, 2018.
screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening
manual wheelchair accessory, headrest extension, each
oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-refractory/androgen-independent (e.g., rising psa on anti-androgen therapy or post-orchiectomy); clinical metastases (for use in a medicare-approved demonstration project)
patients with clinical indications for imaging of the head: new onset headache in pediatric patients with disabilities for which headache is a concern as inferred from behavior
vertebral axial decompression, per session
death, permanent nursing home resident or receiving hospice or palliative care any time during the measurement period terminated december 31, 2015.
pediatrics mips specialty set
elevating footrests, articulating (telescoping), each
injection, triamcinolone hexacetonide, per 5 mg
injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg
carepatch, per square centimeter terminated september 30, 2021.
documentation of medical reason(s) for not performing ldl-c test (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) terminated december 31, 2014.
medication assisted treatment, buprenorphine (injectable); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)
one high-risk medication ordered terminated december 31, 2020.
granisetron hydrochloride, 1 mg (for circumstances falling under the medicare statute, use q0166)
power wheelchair accessory, non-expandable controller, including all related electronics and mounting hardware, replacement only
injection, luspatercept-aamt, 0.25 mg
fully-reclining wheelchair, detachable arms, desk or full length, swing away detachable elevating legrests
hemi-wheelchair detachable arms desk or full length, swing away detachable footrests
injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg
cardiac stress imaging test performed on patient for any reason including those who did not have low risk surgery or test that was performed more than 30 days preceding low risk surgery
face-to-face behavioral counseling for obesity, 15 minutes
two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 22-24 under the mdpp expanded model (em). an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 22-24
special wheelchair seat depth and/or width, by construction
iv t-pa not initiated within three hours (<= 180 minutes) of time last known well, reason not given
transcatheter occlusion or embolization for tumor destruction, percutaneous, any method, using yttrium-90 microspheres
comparative genomic hybridization (cgh) microarray testing for developmental delay, autism spectrum disorder and/or intellectual disability
new technology intraocular lens category 4 as defined in federal register notice
all potassium hydroxide (koh) preparations
chemodenervation of abductor muscle(s) of vocal cord
foot, insert, removable, molded to patient model, longitudinal arch support, each
injection, atezolizumab, 10 mg terminated december 31, 2017.
addition to lower extremity, hip disarticulation, flexible inner socket, external frame
no screening performed, partial screening performed or positive screen without recommendations and reason is not given or otherwise specified
pathology report includes the pt category and a statement on thickness and ulceration and for pt1, mitotic rate
bifocal add over 3.25d
prosthetic sock, multiple ply, below knee, each
facility service(s) for the onsite acute care treatment of a nursing facility resident with fluid or electrolyte disorder. (may only be billed once per day per beneficiary). this service is for a demonstration project
addition to lower extremity, pelvic control, plastic, molded to patient model, reciprocating hip joint and cables
risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0) terminated december 31, 2020.
nutrition classes, non-physician provider, per session
injection, ibalizumab-uiyk, 10 mg
addition to lower extremity, torsion control, straight knee joint, each joint
permeaderm c, per square centimeter
patients who did not abstain from smoking prior to anesthesia on the day of surgery or procedure
injection, tildrakizumab, 1 mg
no deep sternal wound infection/mediastinitis terminated december 31, 2020.
oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)
ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery
injection, omadacycline, 1 mg terminated september 30, 2019.
developed postoperative renal failure or required dialysis
documentation of system reason(s) for not prescribing beta-blocker therapy (eg, other reasons attributable to the health care system)
vestibular rehabilitation program, non-physician provider, per diem
albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
hospital bed, variable height, hi-lo, without side rails, with mattress
cast supplies, short arm splint, pediatric (0-10 years), plaster
contraceptive supply, condom, female, each
radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 20 mev or greater
autograft suspension, including cell processing and application, and all system components
patients without cardiac tamponade and/or pericardiocentesis occurring within 30 days
brachytherapy source, cesium-131 chloride solution, per millicurie
objective measurement of adherence to positive airway pressure therapy, documented
injection, anifrolumab-fnia, 1 mg terminated march 31, 2022.
iv hanger, each
injection, pralidoxime chloride, up to 1 gm
probe/needle, cryoablation
cast supplies, short arm splint, adult (11 years +), fiberglass
injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
foot, plastic, silicone or equal, heel stabilizer, prefabricated, off-the-shelf, each
external urethral clamp or compression device (not to be used for catheter clamp), each
injection, spectinomycin dihydrochloride, up to 2 gm
vascular surgery mips specialty set
wheelchair accessory, elevating leg rest, complete assembly, each
hydrocollator unit, includes pads
fda approved oral anticoagulant is prescribed
no documentation of a chlamydia screening test with proper follow-up
functional electrical stimulator, transcutaneous stimulation of nerve and/or muscle groups, any type, complete system, not otherwise specified
hospice services used by patient any time during the measurement period
blood pressure cuff only
spherocylinder, single vision, plus or minus 7.25 to plus or minus 12.00d sphere, .25 to 2.25d cylinder, per lens
lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
leg pain measured by the visual analog scale (vas) at three months (6 - 20 weeks) postoperatively was greater than 3.0 and leg pain measured by the visual analog scale (vas) within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated less than an improvement of 5.0 points
footwear evaluation performed and documented
patients who utilize hospice services any time during the measurement period
pathology report does not include the pt category, thickness, ulceration and mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors
pneumatic compressor, segmental home model with calibrated gradient pressure
rectal catheter for use with the manual pump-operated enema system, replacement only
replacement pad for infrared heating pad system, each
patients 66-80 years of age and had at least one claim/encounter for frailty during the measurement period and a dispensed dementia medication terminated december 31, 2020.
injection, eravacycline, 1 mg
skin substitute, not otherwise specified
ostomy pouch, urinary, for use on faceplate, plastic, each
dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
operative report identifies the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant terminated december 31, 2020.
permeaderm glove, each
oncology; disease status; prostate cancer, limited to adenocarcinoma; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)
patients who were in hospice at any time during the performance period terminated december 31, 2021.
oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease initially established as t3-4 and/or n1-3, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
intake activities, including initial medical examination that is a complete, fully documented physical evaluation and initial assessment by a program physician or a primary care physician, or an authorized healthcare professional under the supervision of a program physician qualified personnel that includes preparation of a treatment plan that includes the patient's short-term goals and the tasks the patient must perform to complete the short-term goals; the patient's requirements for education, vocational rehabilitation, and employment; and the medical, psycho- social, economic, legal, or other supportive services that a patient needs, conducted by qualified personnel (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure
demonstration, prior to initiation of home inr monitoring, for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria, under the direction of a physician; includes: face-to-face demonstration of use and care of the inr monitor, obtaining at least one blood sample, provision of instructions for reporting home inr test results, and documentation of patient's ability to perform testing and report results
hearing aid, analog, binaural, itc
lumbar-sacral orthosis, sagittal control, with rigid posterior panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
tlso, triplanar control, two piece rigid plastic shell with interface liner, multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, lateral strength is enhanced by overlapping plastic, restricts gross trunk motion in the sagittal, coronal, and transverse planes, includes a carved plaster or cad-cam model, custom fabricated
medical food nutritionally complete, administered orally, providing 100% of nutritional intake
hemostats, each
hallus-valgus night dynamic splint, prefabricated, off-the-shelf
power wheelchair accessory, caster wheel excludes tire, any size, replacement only, each
prenatal vitamins, 30-day supply
injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
stimulated intrauterine insemination (iui), case rate
oncology; disease status; ovarian cancer, limited to epithelial cancer; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)
hepatitis b virus (hbv) status not assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy, reason not given
standard hemi (low seat) wheelchair
in-line cartridge containing digestive enzyme(s) for enteral feeding, each
motor speech functional limitation, current status at therapy episode outset and at reporting intervals terminated december 31, 2019.
coma stimulation per diem
clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program
urinary suspensory with leg bag, with or without tube, each
all quality actions for the applicable measures in the multiple chronic conditions measures group have been performed for this patient terminated december 31, 2016.
injection, perphenazine, up to 5 mg
addition to spinal orthosis, not otherwise specified
aerosol mask, used with dme nebulizer
surgical trays
behavioral health counseling and therapy, per 15 minutes
sitz type bath or equipment, portable, used with or without commode
temozolomide, oral, 5 mg
injection, benztropine mesylate, per 1 mg
office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of greater than 56 mg esketamine nasal self-administration, includes 2 hours post-administration observation
addition to lower extremity, symes type, medial opening socket
technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries
segmental pneumatic appliance for use with pneumatic compressor, trunk
day care services, adult; per diem
injection, diphenhydramine hcl, up to 50 mg
injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg
scleral lens, liquid bandage device, per lens
functional status measured by the oswestry disability index (odi version 2.1a) at three months (6 - 20 weeks) postoperatively was greater than 22 and functional status measured by the odi version 2.1a within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated an improvement of less than 30 points
all quality actions for the applicable measures in the ischemic vascular disease (ivd) measures group have been performed for this patient terminated december 31, 2014.
hearing aid, digital, binaural, itc
non-segmental pneumatic appliance for use with pneumatic compressor, full arm
home infusion therapy, insertion of midline venous catheter, nursing services only (no supplies or catheter included)
addition to lower extremity, foot plate, molded to patient model, stirrup attachment
amphetamine or methamphetamine terminated december 31, 2015.
strontium sr-89 chloride, therapeutic, per millicurie
left ventricular ejection fraction (lvef) >= 40% or documentation as normal or mildly depressed left ventricular systolic function
screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician
wheelchair component or accessory, not otherwise specified
powered bone marrow biopsy needle
index date phq-score greater than 9 documented during the twelve month denominator identification period terminated december 31, 2016.
tracheal suction catheter, any type other than closed system, each
ostomy pouch, urinary; with barrier attached, with faucet-type tap with valve (1 piece), each
addition, endoskeletal knee-shin system, single axis, fluid swing and stance phase control
high frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each
initial or subsequent psychiatric collaborative care management, first 30 minutes in a month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional
behavioral health prevention education service (delivery of services with target population to affect knowledge, attitude and/or behavior)
addition, exoskeletal knee-shin system, single axis, pneumatic/hydra pneumatic swing phase control
ostomy pouch, urinary, with extended wear barrier attached, with faucet-type tap with valve (1 piece), each
wheelchair accessory, calf rest/pad, replacement only, each
dilated macular exam was not performed, reason not otherwise specified
cast supplies, long leg cast, pediatric (0-10 years), fiberglass
foot, arch support, removable, premolded, metatarsal, each
blood pressure has a systolic value of =140 and a diastolic value of = 90 or systolic value < 140 and diastolic value = 90 or systolic value = 140 and diastolic value < 90
supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)
elective delivery (without medical indication) by cesarean birth or induction of labor not performed (<39 weeks of gestation)
documentation that neoplasm detected is only diagnosed as traditional serrated adenoma, sessile serrated polyp, or sessile serrated adenoma terminated december 31, 2020.
esrd demo basic bundle level i
ldl-c not performed, reason not given terminated december 31, 2014.
all quality actions for the applicable measures in the optimizing patient exposure to ionizing radiation measures group have been performed for this patient terminated december 31, 2016.
injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial
methotrexate; oral, 2.5 mg
knee disarticulation (or through knee), molded socket, external knee joints, shin, sach foot
non-emergency transportation; mileage, per mile
male external catheter with integral collection chamber, any type, each
leuprolide acetate (for depot suspension), 7.5 mg
ostomy absorbent material (sheet/pad/crystal packet) for use in ostomy pouch to thicken liquid stomal output, each
treated water (deionized, distilled, or reverse osmosis) for peritoneal dialysis, per gallon
whole blood or red blood cells, leukocytes reduced, frozen, deglycerol, washed, each unit
beta-blocker therapy not prescribed, reason not given
addition to lower extremity orthosis, knee control, condylar pad
home visit, phototherapy services (e.g., bili-lite), including equipment rental, nursing services, blood draw, supplies, and other services, per diem
thoracic, rib belt, custom fabricated
i intend to report the rheumatoid arthritis (ra) measures group terminated december 31, 2016.
injection, diazoxide, up to 300 mg
intrauterine copper contraceptive
filter, disposable, used with positive airway pressure device
documented reason for not assessing hepatitis b virus (hbv) status (e.g., patient not initiating anti-tnf therapy, patient declined) prior to initiating anti-tnf therapy
platelets, irradiated, each unit
artificial pancreas device system (e.g., low glucose suspend (lgs) feature) including continuous glucose monitor, blood glucose device, insulin pump and computer algorithm that communicates with all of the devices
shock absorber for power wheelchair, each
acid concentrate, solution, for hemodialysis, per gallon
telehealth consultation, critical care, initial , physicians typically spend 60 minutes communicating with the patient and providers via telehealth
patient receiving maintenance hemodialysis for greater than or equal to 90 days without a catheter as the mode of vascular access terminated december 31, 2020.
foot, arch support, removable, premolded, longitudinal, each
procenta, per 200 mg
injection, bumetanide, 0.5 mg
cord blood-derived stem-cell transplantation, allogeneic
satisfaction with care achieved within 90 days following cataract surgery
other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals terminated december 31, 2019.
knee ankle foot orthosis, double upright, free ankle, solid stirrup, thigh and calf bands/cuffs (double bar 'ak' orthosis), custom fabricated
autologous platelet rich plasma (prp) for diabetic chronic wounds/ulcers, using an fda-cleared device (includes administration, dressings, phlebotomy, centrifugation, and all other preparatory procedures, per treatment)
application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)
hearing aid, digital, monaural, itc
dicom format image data availability not documented in final report due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) terminated december 31, 2015.
tlso, sagittal-coronal control, one piece rigid plastic shell, with overlapping reinforced anterior, with multiple straps and closures, posterior extends from sacrococcygeal junction and terminates at or before the t-9 vertebra, anterior extends from symphysis pubis to xiphoid, anterior opening, restricts gross trunk motion in sagittal and coronal planes, prefabricated, includes fitting and adjustment
most recent hemoglobin a1c (hba1c) level 7.0 to 9.0% terminated december 31, 2020.
patients who are transferred from one institution to another with a known diagnosis of cva for endovascular stroke treatment
optimizing chronic disease management mips value pathways
methadone terminated december 31, 2015.
fixed, adjustable height armrest, pair
low dose ct scan (ldct) for lung cancer screening terminated december 31, 2020.
injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) terminated december 31, 2014.
arthroereisis, subtalar
static or dynamic ankle foot orthosis, including soft interface material, adjustable for fit, for positioning, may be used for minimal ambulation, prefabricated, off-the-shelf
documentation of active injection drug use
patient offered assistance with end of life issues during the measurement period
functional outcomes assessment using a standardized tool is documented within the previous 30 days and care plan, based on identified deficiencies on the date of the functional outcome assessment, is documented
residential care, not otherwise specified (nos), waiver; per month
remote assessment of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related service provided within the previous 7 days nor leading to a service or procedure within the next 24 hours or soonest available appointment
accessory for speech generating device, mounting system
lithium ion battery charger, replacement only
preadmission screening and resident review (pasrr) level i identification screening, per screen
face tent
injection, cosyntropin, 0.25 mg
restorigin, per square centimeter
non-contact wound warming wound cover for use with the non-contact wound warming device and warming card
habilitation, residential, waiver; 15 minutes
ankle orthosis, supramalleolar with straps, with or without interface/pads, custom fabricated
cushion for use on nasal mask interface, replacement only, each
saquinavir, 200 mg
injection, belinostat, 10 mg terminated december 31, 2015.
axolotl ambient or axolotl cryo, 0.1 mg
oxygen accessory, flow regulator capable of positive inspiratory pressure
syringe with needle, sterile 3 cc, each
gauze, impregnated, other than water, normal saline, or zinc paste, sterile, any width, per linear yard
injection, phenylephrine hcl, up to 1 ml
miroderm, per square centimeter
patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer or hospital admission upon discharge from the facility
intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring
assay of imipramine terminated december 31, 2015.
stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy
injection, cosyntropin, not otherwise specified, 0.25 mg terminated december 31, 2018.
pneumocystis jiroveci pneumonia prophlaxis prescribed terminated december 31, 2014.
chlorambucil, oral, 2 mg
specialty trifocal (by report)
autogenous av fistula received terminated december 31, 2015.
hearing aid, digital, binaural, cic
home therapy; enteral nutrition; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem
ostomy skin barrier, non-pectin based, paste, per ounce
graft, vascular
for diabetics only, multiple density insert, direct formed, molded to foot after external heat source of 230 degrees fahrenheit or higher, total contact with patient's foot, including arch, base layer minimum of 1/4 inch material of shore a 35 durometer or 3/16 inch material of shore a 40 durometer (or higher), prefabricated, each
intravenous injection, bebtelovimab, includes injection and post administration monitoring
clinical decision support mechanism applied pathways, as defined by the medicare appropriate use criteria program terminated march 31, 2020.
shoulder sling or vest design, abduction restrainer, with or without swathe control, prefabricated, includes fitting and adjustment
positioning cushion/pillow/wedge, any shape or size, includes all components and accessories
lumbar orthosis, sagittal control, with rigid posterior panel(s), posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
prosthetic shrinker, above knee, each
multipositional patient support system, with integrated lift, patient accessible controls
amantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project) terminated december 31, 2019.
wig, any type, each
occupational therapy services requiring the skills of a qualified occupational therapist, furnished as a component of a partial hospitalization treatment program, per session (45 minutes or more)
injection, digoxin immune fab (ovine), per vial
home therapy; hematopoietic hormone injection therapy (e.g., erythropoietin, g-csf, gm-csf); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
truss, double with standard pads
home infusion therapy, enzyme replacement intravenous therapy; (e.g., imiglucerase); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
patients with 90 day mrs score of 0 to 2
attendant care services; per 15 minutes
electronic wrist rotator, otto bock or equal terminated december 31, 2014.
cervical traction device, with inflatable air bladder(s)
any ldl-c laboratory test result >= 190 mg/dl
self-help/peer services, per 15 minutes
cardiokymography
services performed by a doula birth worker, per 15 minutes
physician documentation of face-to-face visit for durable medical equipment determination performed by nurse practitioner, physician assistant or clinical nurse specialist
instillation, ciprofloxacin otic suspension, 6 mg terminated december 31, 2016.
advanced brain imaging (cta, ct, mra or mri) was not ordered terminated december 31, 2018.
lambswool sheepskin pad, any size
radioelements for brachytherapy, any type, each
injectable bulking agent for vocal cord medialization, 0.1 ml, includes shipping and necessary supplies
gastro-enterology mips specialty set
lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
complete cycle, zygote intrafallopian transfer (zift), case rate
patient had only urgent care visits during the performance period
primary non-small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type following iaslc guidance or classified as nsclc-nos with an explanation
contact lens, scleral, gas permeable, per lens (for contact lens modification, see 92325)
osteotomy, periacetabular, with internal fixation
home transfusion of blood product(s); administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (blood products, drugs, and nursing visits coded separately), per diem
pneumatic compression device, high pressure, rapid inflation/deflation cycle, for arterial insufficiency (unilateral or bilateral system)
ankle foot orthosis, fracture orthosis, tibial fracture orthosis, semi-rigid, prefabricated, includes fitting and adjustment
ankle foot orthosis, plastic with ankle joint, custom fabricated
professional services for the administration of intravenous chemotherapy or other intravenous highly complex drug or biological infusion for each infusion drug administration calendar day in the individual's home, each 15 minutes
injection, pyridoxine hcl, 100 mg
injection, ferric carboxymaltose, 1mg terminated december 31, 2014.
infusion, normal saline solution , 1000 cc
front caster assembly, complete, with semi-pneumatic tire, replacement only, each
power wheelchair accessory, nonstandard seat frame depth, 22-25 inches
ras (kras and nras) gene mutation testing not performed before initiation of anti-egfr moab
cast supplies, short leg splint, pediatric (0-10 years), plaster
residual limb support system for wheelchair, any type
helmet, protective, soft, custom fabricated, includes all components and accessories
power wheelchair component, actuator, replacement only
injection, meperidine hydrochloride, per 100 mg
injection, anistreplase, per 30 units
bcg live intravesical instillation, 1 mg
injection, pegylated interferon alfa-2a, 180 mcg per ml
hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg terminated december 31, 2016.
urgent care mips specialty set
blood pressure recorded during inpatient stays, emergency room visits, urgent care visits, and patient self-reported bp's (home and health fair bp results)
hip knee ankle foot orthosis, torsion control, unilateral torsion cable, ball bearing hip joint, pelvic band/ belt, custom fabricated
injection, ferric pyrophosphate citrate powder, 0.1 mg of iron
long-acting inhaled bronchodilator not prescribed, reason not otherwise specified
injection, protamine sulfate, per 10 mg
insulin, rapid onset, 5 units
power wheelchair, group 2 standard, seat elevator, sling/solid seat/back, patient weight capacity up to and including 300 pounds
addition to lower extremity, below knee, wood socket
dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
lutetium lu 177, dotatate, therapeutic, 1 millicurie
foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each
oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)
patient taking tamsulosin hydrochloride terminated december 31, 2020.
upper extremity addition, quick disconnect lamination collar with coupling piece, otto bock or equal
ankle foot orthosis, fracture orthosis, tibial fracture cast orthosis, custom fabricated
platelets, hla-matched leukocytes reduced, apheresis/pheresis, each unit
documentation of reason(s) for not documenting a preoperative assessment (e.g., patient with a gynecologic or other pelvic malignancy noted at the time of surgery) terminated december 31, 2020.
static progressive stretch wrist device, flexion and/or extension, with or without range of motion adjustment, includes all components and accessories
documentation of reason(s) for not performing minimally invasive biopsy to diagnose breast cancer preoperatively (e.g., lesion too close to skin, implant, chest wall, etc., lesion could not be adequately visualized for needle biopsy, patient condition prevents needle biopsy [weight, breast thickness, etc.], duct excision without imaging abnormality, prophylactic mastectomy, reduction mammoplasty, excisional biopsy performed by another physician)
hearing screening
lithium ion battery, rechargeable, for non-prosthetic use, replacement
comprehensive management and care coordination for advanced illness, per calendar month
injection, insulin, per 5 units
patient /caregiver dyad has been referred to appropriate resources and connection to those resources is confirmed
injection, estrogen conjugated, per 25 mg
power wheelchair, group 2 standard, multiple power option, captains chair, patient weight capacity up to and including 300 pounds
deionizer water purification system, for hemodialysis
all quality actions for the applicable measures in the hepatitis c measures group have been performed for this patient terminated december 31, 2016.
all quality actions for the applicable measures in the back pain measures group have been performed for this patient terminated december 31, 2014.
sacroiliac orthosis, provides pelvic-sacral support, with rigid or semi-rigid panels placed over the sacrum and abdomen, reduces motion about the sacroiliac joint, includes straps, closures, may include pendulous abdomen design, custom fabricated
alkaline battery for use with cochlear implant device, any size, replacement, each
cast supplies, hip spica (one or both legs), adult (11 years +), plaster
genetic counseling, under physician supervision, each 15 minutes
clinical decision support mechanism aim specialty health, as defined by the medicare appropriate use criteria program
addition, endoskeletal system, hip disarticulation, ultra-light material (titanium, carbon fiber or equal)
upper limb orthosis, not otherwise specified
limited (30 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)
all inclusive payment for services related to highly coordinated and integrated opioid use disorder (oud) treatment services furnished for the demonstration project
alcohol and/or drug services; acute detoxification (hospital inpatient)
injection, aripiprazole, intramuscular, 0.25 mg
xwrap, per square centimeter
manual wheelchair accessory, power add-on to convert manual wheelchair to motorized wheelchair, joystick control
dynamic adjustable ankle extension/flexion device, includes soft interface material
levonorgestrel (contraceptive) implant system, including implants and supplies
patient receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days terminated december 31, 2014.
driver for use with pneumatic ventricular assist device, replacement only
insertion tray with drainage bag with indwelling catheter, foley type, three-way, for continuous irrigation
take-home supply of nasal naloxone; 2-pack of 4mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure
repair or modification of maxillofacial prosthesis, labor component, 15 minute increments, provided by a non-physician
immediate post surgical or early fitting, application of initial rigid dressing including fitting alignment and suspension of components, and one cast change, shoulder disarticulation or interscapular thoracic
incontinence product, protective underpad, reusable, bed size, each
lumbar orthosis, flexible, provides lumbar support, posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include pendulous abdomen design, shoulder straps, stays, prefabricated, off-the-shelf
continuous noninvasive glucose monitoring device, purchase (for physician interpretation of data, use cpt code)
power wheelchair, pediatric size, not otherwise specified
blood tubing, arterial and venous combined, for hemodialysis, each
cervical-thoracic-lumbar-sacral orthosis (ctlso) (milwaukee), inclusive of furnishing initial orthosis, including model
patient was in hospice or receiving palliative care at any time during the performance period
novafix dl, per square centimeter
patient-months where there are more than one medicare capitated payment (mcp) provider listed for the month
comprehensive (60 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)
floweramniopatch, per square centimeter
elbow orthosis, rigid, without joints, includes soft interface material, prefabricated, off-the-shelf
lumbar-sacral orthosis, sagittal-coronal control, with rigid posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
surgical dressing holder, reusable, each
injection, factor xiii a-subunit, (recombinant), per iu
blood component or product not otherwise classified
collagen based wound filler, gel/paste, per gram of collagen
injection, ceftazidime, per 500 mg
dynamic adjustable toe extension/flexion device, includes soft interface material
injection, bamlanivimab-xxxx, 700 mg terminated april 16, 2021.
youth sized disposable incontinence product, protective underwear/pull-on, each
injection, ifosfamide, 1 gram
cast supplies, long leg cast, adult (11 years +), fiberglass
unplanned return to the operating room for a surgical procedure, for complications of the principal operative procedure, within 30 days of the principal operative procedure
counseling for diet and physical activity performed terminated december 31, 2014.
shoulder orthosis, figure of eight design abduction restrainer, prefabricated, off-the-shelf
addition to lower extremity orthosis, knee control, full kneecap
clinical decision support mechanism evicore, as defined by the medicare appropriate use criteria program
screening for depression documented as positive, follow-up plan not documented, reason not given
proposed adopting best practices and promoting patient safety within emergency medicine mips value pathways
ostomy pouch, closed; for use on barrier with locking flange (2 piece), each
addition to lower extremity prosthesis, below knee, suspension/sealing sleeve, with or without valve, any material, each
documented reason for not screening or recommending a follow-up for high blood pressure
addition, exoskeletal knee-shin system, single axis, fluid swing phase control
tracheostomy supply, not otherwise classified
amnioexcel, amnioexcel plus or biodexcel, per square centimeter
ctlso, anterior-posterior-lateral-control, molded to patient model, with interface material, (minerva type)
blood glucose monitor with integrated lancing/blood sample
patient not discharged to home by post-operative day #2 following cea
injection, buprenorphine hydrochloride, 0.1 mg
patient unable to complete the lepf prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available
cyclophosphamide; oral, 25 mg
addition to lower extremity, socket insert, symes, (kemblo, pelite, aliplast, plastazote or equal)
addition to ctlso, scoliosis orthosis, cover for upright, each
orthopedic footwear, ladies shoe, depth inlay, each
catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)
injection, immune globulin (vivaglobin), 100 mg
addition, endoskeletal system, polycentric hip joint, pneumatic or hydraulic control, rotation control, with or without flexion and/or extension control
injection, buprenorphine extended-release (sublocade), greater than 100 mg
addition, endoskeletal system, below knee, ultra-light material (titanium, carbon fiber or equal)
home injectable therapy; growth hormone, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
injection, tenecteplase, 1 mg
walker, heavy duty, wheeled, rigid or folding, any type
low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml
knee orthosis, elastic with joints, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
manual wheelchair accessory, propulsion wheel excludes tire, any size, replacement only, each
cast supplies, long leg cast, pediatric (0-10 years), plaster
injection, enfortumab vedotin-ejfv, 0.25 mg
derm-maxx, per square centimeter
ankle foot orthosis, fracture orthosis, tibial fracture orthosis, rigid, prefabricated, includes fitting and adjustment
autologous cultured chondrocytes, implant
injection, vinorelbine tartrate, 10 mg
hand orthosis, metacarpal fracture orthosis, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
injection, chlordiazepoxide hcl, up to 100 mg
manual wheelchair accessory, caster fork, any size, replacement only, each
ostomy pouch, closed, with barrier attached, with built-in convexity (1 piece), each
professional services for the administration of anti-infective, pain management, chelation, pulmonary hypertension, inotropic, or other intravenous infusion drug or biological (excluding chemotherapy or other highly complex drug or biological) for each infusion drug administration calendar day in the individual's home, each 15 minutes
qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 21 or more minutes terminated december 31, 2020.
sphere, trifocal, plano to plus or minus 4.00d, per lens
aspirin prescribed at discharge terminated december 31, 2016.
below elbow, external power, self-suspended inner socket, removable forearm shell, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device
emergency hand pump for use with electric or electric/pneumatic ventricular assist device, replacement only
gauze, impregnated, hydrogel, for direct wound contact, sterile, pad size greater than 16 sq. in., but less than or equal to 48 sq. in., each dressing
patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision
injection, asparaginase, recombinant, (rylaze), 0.1 mg
received instruction from the anesthesiologist or proxy prior to the day of surgery to abstain from smoking on the day of surgery
injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
injection, interferon beta-1a, 30 mcg
accessory, arm trough, with or without hand support, each
binaural, in the ear
blood pump for hemodialysis, replacement
integra flowable wound matrix, injectable, 1 cc
power source and control electronics unit for oral device/appliance for neuromuscular electrical stimulation of the tongue muscle for the reduction of snoring and obstructive sleep apnea, controlled by phone application
addition to knee lock with integrated release mechanism (bail, cable, or equal), any material, each joint
upper extremity addition, silicone gel insert or equal, each
injection, enfuvirtide, 1 mg
office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; each additional 30 minutes beyond the first 120 minutes (list separately in addition to code for primary procedure)
alcohol and/or other drug treatment program, per diem
ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency)
dicom format image data available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study not documented in final report, reason not given terminated december 31, 2020.
daclizumab, parenteral, 25 mg
patients who received cervical cytology or an hpv test
sphere, trifocal, plus or minus 4.12 to plus or minus 7.00d, per lens
cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
partial foot, shoe insert with longitudinal arch, toe filler
personal care item, nos, each
injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u. terminated june 30, 2019.
qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 11-20 minutes terminated december 31, 2020.
<50% of total number of a patient's outpatient ra encounters assessed
miscellaneous dialysis supplies, not otherwise specified
injection, dexamethasone, intravitreal implant, 0.1 mg
peroneal straps, prefabricated, off-the-shelf, pair
buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine
wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf
cranial remolding orthosis, pediatric, rigid, with soft interface material, custom fabricated, includes fitting and adjustment(s)
wheelchair accessory, power seatng system, recline only, with power shear reduction
ajcc stage at breast cancer diagnosis = ii or iii
remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 60 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology
non-emergency transportation; patient attendant/escort
tb screening not performed or results not interpreted, reason not given
knee orthosis, adjustable knee joints (unicentric or polycentric), positional orthosis, rigid support, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
pharmacologic therapy for osteoporosis was not prescribed, reason not given
injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u.
addition to tlso, (low profile), rib gusset (elastic), each
ostomy pouch, drainable, with barrier attached, with filter (1 piece), each
replacement, socket, below knee, molded to patient model
injection, minocycline hydrochloride, 1 mg
insertion tray without drainage bag with indwelling catheter, foley type, two-way, all silicone
red blood cells, frozen/deglycerolized/washed, leukocytes reduced, irradiated, each unit
discharge/discontinuation of the episode of care documented in the medical record terminated december 31, 2020.
cervical, semi-rigid, adjustable (plastic collar)
most recent ldl-c under control, results documented and reviewed terminated december 31, 2014.
injection, clofarabine, 1 mg
home infusion therapy, implanted pump pain management infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
dsm-ivtm criteria for major depressive disorder documented at the initial evaluation
shoulder disarticulation, passive restoration (shoulder cap only)
raised toilet seat
power wheelchair accessory, tube for pneumatic caster tire, any size, replacement only, each
integra matrix, per square centimeter
interphalangeal finger joint replacement, 2 or more pieces, metal (e.g., stainless steel or cobalt chrome), ceramic-like material (e.g., pyrocarbon) for surgical implantation, any size
telehealth originating site facility fee
spherocylinder, bifocal, plano to plus or minus 4.00d sphere, 4.25 to 6.00d cylinder, per lens
gradient pressure aid (sleeve and glove combination), ready made
injection, copanlisib, 1 mg
documentation of patient reason(s) for not performing a dilated macular examination
risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment not measured because the patient did not complete the general orthopedic fs prom at initial evaluation and/or near discharge, reason not given terminated december 31, 2020.
injection, hyoscyamine sulfate, up to 0.25 mg
oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease initially established as t4, any n, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
eye pad, sterile, each
patient receiving an anti-tnf agent
patient received anti-egfr monoclonal antibody therapy
platelets, leukocytes reduced, each unit
injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg
home infusion therapy, hydration therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use with hydration therapy codes s9374-s9377 using daily volume scales)
injection, heparin sodium, per 1000 units
patient has a history of active drainage from the ear within the previous 90 days
injection, ceftazidime and avibactam, 0.5 g/0.125 g
tracheostomy care kit for established tracheostomy
medication assisted treatment, buprenorphine (implant insertion and removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)
injection, iron dextran, 50 mg
hemi-facial prosthesis, provided by a non-physician
open treatment of posterior pelvic bone fracture and/or dislocation, for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, includes internal fixation, when performed (includes ilium, sacroiliac joint and/or sacrum)
with maintenance hemodialysis (in-center and home hd) for the complete reporting month
ostomy belt, each
hydrogel dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing
power operated vehicle, not otherwise classified
parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements and vitamins, including preparation, any strength, over 100 grams of protein - premix
air bubble detector for hemodialysis, each, replacement
injection, cabotegravir and rilpivirine, 2mg/3mg
wrist disarticulation, molded socket with expandable interface, flexible elbow hinges, triceps pad
ongoing care not indicated, patient seen only 1-2 visits (e.g., home program only, referred to another provider or facility, consultation only terminated december 31, 2020.
injection, aprepitant, 1 mg terminated december 31, 2018.
injection, somatrem, 1 mg
hand finger orthosis, without joints, may include soft interface, straps, prefabricated, off-the-shelf
ocular device, intraoperative, detached retina
transmitter cable for use with cochlear implant device or auditory osseointegrated device, replacement
supported employment, per 15 minutes
palliative care services provided to patient any time during the measurement period
catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping
scale, each
interface for cough stimulating device, includes all components, replacement only
other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting terminated december 31, 2019.
non-emergency transportation: ancillary: meals-escort
woundfix, biowound, woundfix plus, biowound plus, woundfix xplus or biowound xplus, per square centimeter
below elbow, molded double wall split socket, step-up hinges, half cuff
technetium tc-99m exametazime, diagnostic, per study dose, up to 25 millicuries
electric hook, switch or myoelectric controlled, adult
oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)
treatment planning and care coordination management for cancer, established patient with a change of regimen
infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)
patient received screening for hcv infection within the 12 month reporting period
large volume nebulizer, disposable, prefilled, used with aerosol compressor
laparotomy for islet cell transplant, includes portal vein catheterization and infusion
injection, brexanolone, 1 mg
humidifier, durable for extensive supplemental humidification during ippb treatments or oxygen delivery
injection, carmustine, 100 mg
the start of an episode of care documented in the medical record
addition, endoskeletal system, above knee, ultra-light material (titanium, carbon fiber or equal)
spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere, 4.25 to 6.00d cylinder, per lens
dialysate solution, any concentration of dextrose, fluid volume greater than 3999 cc but less than or equal to 4999 cc, for peritoneal dialysis
factor ix (antihemophilic factor, purified, non-recombinant) per i.u.
injection, elosulfase alfa, 1mg terminated december 31, 2014.
tlso, triplanar control, modular segmented spinal system, two rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the xiphoid, soft liner, restricts gross trunk motion in the sagittal, coronal, and transverse planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment
dialysis access system (implantable)
placement and removal (if performed) of applicator into breast for intraoperative radiation therapy, add-on to primary breast procedure
prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; each additional 30 minutes (list separately in addition to code g0513 for additional 30 minutes of preventive service)
patient received an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period terminated december 31, 2020.
mitomycin pyelocalyceal instillation, 1 mg
addition to lower extremity, above knee, pelvic control belt, light
patients with a diagnosis of lumbar idiopathic or congenital scoliosis
injection, propofol, 10 mg
injection, teniposide, 50 mg
factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified
oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t4, any n, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
foot, arch support, removable, premolded, longitudinal/ metatarsal, each
addition to endoskeletal knee-shin system, fluid stance extension, dampening feature, with or without adjustability
platelets, pheresis, irradiated, each unit
cervical, collar, semi-rigid, thermoplastic foam, two piece with thoracic extension, prefabricated, off-the-shelf
attention functional limitation, discharge status at discharge from therapy or to end reporting terminated december 31, 2019.
patient discharge to home no later than post-operative day #7
hearing aid, cros, behind the ear terminated december 31, 2018.
knee orthosis, double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
ostomy pouch, drainable, for use on faceplate, rubber, each
crisis intervention service, per 15 minutes
foot, adjustable shoe-styled positioning device
addition to lower extremity, non-molded lacer, for custom fabricated orthosis only
personalized, anterior and lateral interbody cage (implantable)
clinician documented reason patient was not able to complete 7 day follow-up from acute inpatient setting discharge (i.e patient death prior to follow-up visit, patient non-compliance for visit follow-up)
tubing for breast pump, replacement
limited (30 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)
injection, hyaluronidase, recombinant, 1 usp unit
oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; post r1 or r2 resection (with or without neoadjuvant therapy) with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)
catheter, pacing, transesophageal
two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 16-18 under the mdpp expanded model (em). an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 16-18
oncology; primary focus of visit; surveillance for disease recurrence for patient who has completed definitive cancer-directed therapy and currently lacks evidence of recurrent disease; cancer directed therapy might be considered in the future (for use in a medicare-approved demonstration project)
repair/modification of augmentative communicative system or device (excludes adaptive hearing aid)
personal care services, per diem, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant)
clinician treating major depressive disorder did not communicate to clinician treating comorbid condition for specified patient reason (e.g., patient is unable to communicate the diagnosis of a comorbid condition; the patient is unwilling to communicate the diagnosis of a comorbid condition; or the patient is unaware of the comorbid condition, or any other specified patient reason) terminated december 31, 2020.
injection, tetanus immune globulin, human, up to 250 units
iodine i-125 sodium iothalamate, diagnostic, per study dose, up to 10 microcuries
addition to lower extremity, below knee, air, fluid, gel or equal, cushion socket
breathing circuits
addition, endoskeletal system, above knee, knee disarticulation or hip disarticulation, manual lock
breast reconstruction with gluteal artery perforator (gap) flap, including harvesting of the flap, microvascular transfer, closure of donor site and shaping the flap into a breast, unilateral
kerecis omega3, per square centimeter
upper extremity addition, quick disconnect hook adapter, otto bock or equal
injection, bevacizumab, 10 mg
injection, adrenalin, epinephrine, 0.1 mg
addition to lower extremity, knee disarticulation, expandable wall socket
manual wheelchair accessory, insert for pneumatic propulsion tire (removable), any type, any size, each
rh-immunoglobulin (rhogam) not ordered for reasons documented by clinician (e.g., patient had prior documented receipt of rhogam within 12 weeks, patient refusal) terminated december 31, 2020.
addition to lower extremity, test socket, above knee
patient not discharged to home by post-operative day #2 following evar
injection, triamcinolone acetonide, suprachoroidal (xipere), 1 mg terminated june 30, 2022.
ostomy ring, each
platelets, pheresis, each unit
patient not offered assistance with end of life issues during the measurement period
power wheelchair accessory, hand or chin control interface, mini-proportional remote joystick, proportional, including fixed mounting hardware
outpatient, ed, or observation visits that result in an inpatient admission
ankle, symes, molded socket, sach foot
oral thermometer, reusable, any type, each
injection, paclitaxel protein-bound particles, 1 mg
safety enclosure frame/canopy for use with hospital bed, any type
screening for depression is documented as negative, a follow-up plan is not required
certified nurse midwife mips specialty set
injection, medroxyprogesterone acetate, 1 mg
hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg
injection, epoetin beta, 1 microgram, (for esrd on dialysis) terminated december 31, 2014.
capecitabine, oral, 500 mg
ostomy pouch, drainable, with barrier attached, with built-in convexity (1 piece), each
ostomy pouch, closed, with barrier attached, with filter (1 piece), each
power wheelchair accessory, pneumatic drive wheel tire, any size, replacement only, each
patients received both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart, with the first occurrence after the age of 60 before or during the measurement period terminated december 31, 2020.
percutaneous transluminal coronary atherectomy, with drug-eluting intracoronary stent, with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure)
variable asphericity lens, single vision, full field, glass or plastic, per lens
clinician documented that patient with a diagnosis of major depression was not an eligible candidate for antidepressant medication treatment or patient did not have a diagnosis of major depression terminated december 31, 2014.
red blood cells, each unit
patient had more than one emergency department visit in the last 30 days of life terminated december 31, 2020.
specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source
screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter
back pain was measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively terminated december 31, 2019.
leg pain measured by the visual analog scale (vas) at three months (6 - 20 weeks) postoperatively was less than or equal to 3.0 or leg pain measured by the visual analog scale (vas) within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated an improvement of 5.0 points or greater
oral interface used with respiratory suction pump, each
microporous collagen implantable tube (neuragen nerve guide), per centimeter length
patient did not sustain ureter injury at the time of surgery nor discovered subsequently up to 30 days post-surgery
technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries
trapeze bar, free standing, complete with grab bar
bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
shoulder elbow wrist hand orthosis, shoulder cap design, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment
microporous collagen implantable slit tube (neurawrap nerve protector), per centimeter length
children who are taking antibiotics in the 30 days prior to the date of the encounter during which the diagnosis was established terminated december 31, 2020.
injection, morphine sulfate (preservative-free sterile solution), per 10 mg terminated december 31, 2014.
oncology; disease status; limited to small cell and combined small cell/non-small cell; extent of disease initially established as limited with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
mapcp demonstration - physician incentive pool
hearing aid, contralateral routing system, binaural, bte/bte
upper extremity addition, locking elbow, forearm counterbalance
upper extremity addition, frame type socket, below elbow or wrist disarticulation
walker, folding (pickup), adjustable or fixed height
history of preoperative posterior capsule rupture terminated december 31, 2020.
warming card for use with the non contact wound warming device and non contact wound warming wound cover
adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five terminated december 31, 2020.
apis, per square centimeter
home injectable therapy, not otherwise classified, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
interspinous process distraction device (implantable)
screening papanicolaou smear, cervical or vaginal, up to three smears, requiring interpretation by physician
preparatory, wrist disarticulation or below elbow, single wall plastic socket, friction wrist, flexible elbow hinges, figure of eight harness, humeral cuff, bowden cable control, usmc or equal pylon, no cover, molded to patient model
injection, hydroxyprogesterone caproate, (makena), 10 mg terminated december 31, 2017.
addition, endoskeletal knee-shin system, polycentric, hydraulic swing phase control, mechanical stance phase lock
xenon xe-133 gas, diagnostic, per 10 millicuries
alcohol and/or other drug testing: collection and handling only, specimens other than blood
injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg
addition, endoskeletal system, high activity knee control frame
artacent ac, per square centimeter
surgical tissue localization and excision device (implantable)
two or more antipsychotic prescriptions ordered for patients who had a diagnosis of schizophrenia, schizoaffective disorder, or bipolar disorder on or between january 1 of the year prior to the measurement period and the index prescription start date (ipsd) for antipsychotics
trimming of dystrophic nails, any number
patients with clinical indications for imaging of the head: temporal headaches in patients over 55 years of age
combination oral/nasal mask, used with continuous positive airway pressure device, each
currently a tobacco non-user
patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminotomy
alcohol and/or substance abuse services, family/couple counseling
patient did not receive adjuvant treatment course including both chemotherapy and her2-targeted therapy
radiation treatment delivery, single treatment area,single port or parallel opposed ports, simple blocks or no blocks: 11-19 mev
screening performed and positive and provision of recommendations
transfer of an orthosis from one shoe to another, caliper plate, existing
5% dextrose with potassium chloride, 1000 ml
all quality actions for the applicable measures in the parkinson's disease measures group have been performed for this patient terminated december 31, 2016.
bcg (intravesical) per instillation terminated june 30, 2019.
semi-implantable middle ear hearing prosthesis
injection, oxytetracycline hcl, up to 50 mg
functional status measurement with score was obtained utilizing the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively terminated december 31, 2019.
cyclosporin, parenteral, 250 mg
cymetra, injectable, 1 cc
ostomy skin barrier, pectin-based, paste, per ounce
ongoing support to maintain employment, per 15 minutes
tlso, triplanar control, modular segmented spinal system, three rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the sternal notch, soft liner, restricts gross trunk motion in the sagittal, coronal, and transverse planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment
integra bilayer matrix wound dressing (bmwd), per square centimeter
lumbar-sacral orthosis, flexible, provides lumbo-sacral support, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include stays, shoulder straps, pendulous abdomen design, custom fabricated
elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given
limited (30 minutes) care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)
injection, abobotulinumtoxina, 5 units
injection, butorphanol tartrate, 1 mg
adhesive bandage, first-aid type, any size, each
injection, factor viii, fc fusion protein, (recombinant), per i.u. terminated march 31, 2015.
at least two orders for high-risk medications from the same drug class not ordered
wheelchair accessory, dynamic positioning hardware for back
postural drainage board
power operated vehicle, group 2 very heavy duty, patient weight capacity 451 to 600 pounds
addition to upper extremity prosthesis, below elbow/above elbow, custom fabricated socket insert for congenital or atypical traumatic amputee, silicone gel, elastomeric or equal, for use with or without locking mechanism, initial only (for other than initial, use code l6694 or l6695)
lithium ion battery for use with cochlear implant or auditory osseointegrated device speech processor, ear level, replacement, each
nasal septal prosthesis, provided by a non-physician
disease management program; per diem
left ventricular ejection fraction (lvef) < 40% or documentation of moderate or severe lvsd
left ventricular ejection fraction (lvef) <40% or documentation of moderately or severely depressed left ventricular systolic function
portable gaseous oxygen system, rental; home compressor used to fill portable oxygen cylinders; includes portable containers, regulator, flowmeter, humidifier, cannula or mask, and tubing
repair or nonroutine service for oxygen equipment requiring the skill of a technician, labor component, per 15 minutes
lens, index greater than or equal to 1.66 plastic or greater than or equal to 1.80 glass, excludes polycarbonate, per lens
pediatric patient with minor blunt head trauma classified as low risk according to the pecarn prediction rules
ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
injection, cefiderocol, 10 mg
patient screened for tobacco use and identified as a tobacco non-user
addition to lower extremity fracture orthosis, drop lock knee joint
patient had at least two hpv vaccines (with at least 146 days between the two) or three hpv vaccines on or between the patient's 9th and 13th birthdays
patient programmer, neurostimulator
hearing aid, bicros, behind the ear terminated december 31, 2018.
biopsy results reviewed, communicated, tracked and documented
monitor/display module for use with electric ventricular assist device, replacement only
injection, ceftolozane 50 mg and tazobactam 25 mg terminated december 31, 2015.
brief communication technology-based service, e.g. virtual check-in, by a qualified health care professional who cannot report evaluation and management services, provided to an established patient, not originating from a related service provided within the previous 7 days nor leading to a service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of clinical discussion
indium in-111 oxyquinoline, diagnostic, per 0.5 millicurie
total kt/v less than 1.7 per week (total clearance of urea [kt] / volume [v]) terminated december 31, 2015.
injection, interferon, alfa-2b, recombinant, 1 million units
back, contoured, for pediatric size wheelchair including fixed attaching hardware
cd4+ cell count or cd4+ cell percentage results documented terminated december 31, 2014.
probe, percutaneous lumbar discectomy
injection, eptinezumab-jjmr, 1 mg
culture, bacterial, urine; quantitative, sensitivity study
hospice care provided in inpatient hospital
oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-responsive; clinical metastases or m1 at diagnosis (for use in a medicare-approved demonstration project)
wrist hand orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment
ankle foot orthosis, double upright free plantar dorsiflexion, solid stirrup, calf band/cuff (double bar 'bk' orthosis), custom fabricated
asthma not well-controlled based on the act, c-act, acq, or ataq score, or specified asthma control tool not used, reason not given
injection, pentamidine isethionate, 300 mg
interscapular thoracic, molded socket, shoulder bulkhead, humeral section, internal locking elbow, forearm
puraply am, per square centimeter
home infusion therapy, all supplies necessary for catheter repair
speech generating device, digitized speech, using pre-recorded messages, greater than 20 minutes but less than or equal to 40 minutes recording time
crisis intervention, waiver; per diem
low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml
arthroscopy, shoulder, surgical; with implantation of subacromial spacer (e.g., balloon), includes debridement (e.g., limited or extensive), subacromial decompression, acromioplasty, and biceps tenodesis when performed
drainage extension line, sterile, for dialysis, each
injection, ferric carboxymaltose, 1 mg terminated june 30, 2014.
dialysate solution, any concentration of dextrose, fluid volume greater than 1999 cc but less than or equal to 2999 cc, for peritoneal dialysis
intervention for presence of leak of endoluminal contents through an anastomosis not required
adult sized disposable incontinence product, protective underwear/pull-on, small size, each
no documentation of signed an opioid treatment agreement at least once during opioid therapy terminated december 31, 2021.
power wheelchair accessory, foam drive wheel tire, any size, replacement only, each
power pack base for use with electric/pneumatic ventricular assist device, replacement only
injection, verteporfin, 0.1 mg
cervical, semi-rigid, wire frame occipital/mandibular support, prefabricated, off-the-shelf
orthopedic footwear, ladies shoe, oxford, each
tubular dressing with or without elastic, any width, per linear yard
influenza immunization administered or previously received
removal of non-biodegradable drug delivery implants, 4 or more (services for subdermal implants)
power wheelchair accessory, hand control interface, remote joystick, nonproportional, including all related electronics, mechanical stop switch, and fixed mounting hardware
dispensing fee, monaural hearing aid, any type
anticoagulation clinic, inclusive of all services except laboratory tests, per session
injection, avelumab, 10 mg
final reports for imaging studies with follow-up imaging recommended, or final reports that do not include a specific recommendation of no follow-up
knee ankle foot orthosis, full plastic, single upright, with or without free motion knee, with or without free motion ankle, custom fabricated
colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous
occupational therapy, in the home, per diem
addition to lower extremity orthosis, suspension sleeve
polarization, any lens material, per lens
tubing with integrated heating element for use with positive airway pressure device
i intend to report the cardiovascular prevention measures group terminated december 31, 2016.
oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage ii (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
positioning wheelchair back cushion, posterior-lateral, width less than 22 inches, any height, including any type mounting hardware
patient had prior adverse reaction caused by zoster vaccine or its components any time during or before the measurement period terminated december 31, 2020.
patients with moderate or severe mitral stenosis
patient age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period
documentation of reason(s) for not screening for uterine malignancy (e.g., prior hysterectomy) terminated december 31, 2016.
injection, pembrolizumab, 1 mg
joint device (implantable)
spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, 4.25 to 6.00d cylinder, per lens
genetic testing for niemann-pick disease
drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed
conforming bandage, non-elastic, knitted/woven, sterile, width greater than or equal to five inches, per yard
food thickener, administered orally, per ounce
non-pneumatic sequential compression garment, half leg
hip orthosis, abduction control of hip joint, postoperative hip abduction type, custom fabricated
meals for clinical trial participant and one caregiver/companion
documentation of medical reason(s) for not prescribing oral aspirin or other antithrombotic therapy (e.g., patient documented to be low risk or patient with terminal illness or treatment of hypertension with standard treatment goals is not clinically appropriate, or for whom risk of aspirin or other antithrombotic therapy exceeds potential benefits such as for individuals whose blood pressure is poorly controlled) terminated december 31, 2014.
crisis intervention mental health services, per hour
injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg
fda-approved anticoagulant not prescribed, reason not given
most recent bp is less than or equal to 140/90 mm hg
pain assessment documented as positive, follow-up plan not documented, documentation the patient is not eligible at the time of the encounter terminated december 31, 2020.
heel, new leather, standard
youth sized disposable incontinence product, brief/diaper, each
knee ankle foot orthosis, double upright, free ankle, solid stirrup, thigh and calf bands/cuffs, (double bar 'ak' orthosis), without knee joint, custom fabricated
hydrocolloid dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing
remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: a problem focused history; a problem focused examination; and straightforward medical decision making, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are self limited or minor. typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology
above knee, molded socket, single axis constant friction knee, shin, sach foot
ankle foot orthosis, single upright with static or adjustable stop (phelps or perlstein type), custom fabricated
level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)
injection, pegademase bovine, 25 iu
cervical or vaginal cancer screening; pelvic and clinical breast examination
patient achieved an improvement in visual acuity, from their preoperative level, within 90 days of surgery
radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 20 mev or greater
hygienic item or device, disposable or non-disposable, any type, each
full sole and heel wedge, between sole
patients with a positive hepatitis c antibody test terminated december 31, 2014.
upper extremity addition, shoulder lock mechanism, external powered actuator
elbow wrist hand finger orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment
theraskin, per square centimeter
genetic testing for detection of mutations in the presenilin - 1 gene terminated december 31, 2014.
generator, neurostimulator (implantable), with rechargeable battery and charging system
diskectomy, anterior, with decompression of spinal cord and/or nerve root(s), including osteophytectomy; lumbar, each additional interspace (list separately in addition to code for primary procedure)
injection, filgrastim (g-csf), excludes biosimilars, 1 microgram
knee ankle foot orthosis, single upright, free knee, free ankle, solid stirrup, thigh and calf bands/cuffs (single bar 'ak' orthosis), custom fabricated
afo, rigid anterior tibial section, total carbon fiber or equal material, prefabricated, includes fitting and adjustment
oncology; primary focus of visit; treatment decision-making after disease is staged or restaged, discussion of treatment options, supervising/coordinating active cancer directed therapy or managing consequences of cancer directed therapy (for use in a medicare-approved demonstration project)
low density lipoprotein (ldl) apheresis using heparin-induced extracorporeal ldl precipitation
i intend to report the parkinson's disease measures group terminated december 31, 2016.
patient referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation
patient did not achieve flat retinas six months post surgery terminated december 31, 2015.
addition to lower extremity, suction suspension, above knee or knee disarticulation socket
tracheo-esophageal voice prosthesis, inserted by a licensed health care provider, any type
supports brokerage, self-directed, waiver; per 15 minutes
dermal substitute, native, non-denatured collagen, neonatal bovine origin (surgimend collagen matrix), per 0.5 square centimeters
iodine i-125 serum albumin, diagnostic, per 5 microcuries
intraoperative cystoscopy performed to evaluate for lower tract injury
replacement battery for external infusion pump owned by patient, lithium, 3.6 volt, each
zidovudine, oral, 100 mg
injection, nusinersen, 0.1 mg terminated december 31, 2017.
speech generating software program, for personal computer or personal digital assistant
patient has mitral stenosis or prosthetic heart valves or patient has transient or reversible cause of af (e.g., pneumonia, hyperthyroidism, pregnancy, cardiac surgery)
lumbar-sacral orthosis, flexible, provides lumbo-sacral support, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf
integrated keratoprosthesis
albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose
home therapy, hemodialysis; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing services coded separately), per diem
oncology; practice guidelines; patient's condition not addressed by available guidelines (for use in a medicare-approved demonstration project)
amputee wheelchair, fixed full length arms, swing away detachable footrest
standing frame/table system, one position (e.g., upright, supine or prone stander), any size including pediatric, with or without wheels
injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
zanamivir, inhalation powder, administered through inhaler, per 10 mg (for use in a medicare-approved demonstration project) terminated december 31, 2019.
below elbow, molded double wall split socket, stump activated locking hinge, half cuff
compounded drug, not otherwise classified
samarium sm-153 lexidronam, therapeutic, per treatment dose, up to 150 millicuries
cast supplies, hip spica (one or both legs), adult (11 years +), fiberglass
services performed by other counselor in the hospice setting, each 15 minutes
replacement strap, any orthosis, includes all components, any length, any type
i intend to report the asthma measures group terminated december 31, 2016.
pain screened as moderate to severe terminated december 31, 2019.
replace soft interface material, foot drop splint
imaging coil, magnetic resonance (insertable)
alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 48 sq. in., each dressing
manual wheelchair accessory, tube for pneumatic caster tire, any size, each
wrist hand finger orthosis, without joint(s), prefabricated, off-the-shelf, any type
injection, ergonovine maleate, up to 0.2 mg
budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram
intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each
patients with clinical indications for imaging of the head: new onset headache in pre-school children or younger (<6 years of age)
injection, chlorothiazide sodium, per 500 mg
left ventricular ejection fraction (lvef) not performed or documented
alcohol and/or drug services; acute detoxification (residential addiction program inpatient)
bath tub wall rail, each
auricular prosthesis, provided by a non-physician
clinical follow-up and mrs score not assessed at 90 days following endovascular stroke intervention
injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg
gradient pressure aid (glove), custom made, heavy weight
application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)
advanced brain imaging (cta, ct, mra or mri) was ordered terminated december 31, 2018.
documentation of medical reason(s) for not performing a dilated macular examination
power operated vehicle, group 2 heavy duty, patient weight capacity 301 to 450 pounds
power wheelchair, group 3 heavy duty, single power option, sling/solid seat/back, patient weight 301 to 450 pounds
occluder lens, per lens
equestrian/hippotherapy, per session
injection, oritavancin, 10 mg terminated december 31, 2015.
injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg
services provided as part of a phase i clinical trial
two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 10-12 under the mdpp expanded model (em). a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary did not achieve at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 10-12
ground mileage, per statute mile
reguard, for topical use only, per square centimeter
urinary drainage bag, leg or abdomen, vinyl, with or without tube, with straps, each
carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml
national committee for quality assurance - level 3 medical home
magnetic resonance angiography with contrast, upper extremity
injection, emicizumab-kxwh, 0.5 mg
methylprednisolone oral, per 4 mg
cranial electrotherapy stimulation (ces) system, any type
addition, exoskeletal knee-shin system, single axis, friction swing and stance phase control (safety knee)
infusion pump, implantable, non-programmable (includes all components, e.g., pump, catheter, connectors, etc.)
hyaluronan or derivative, euflexxa, for intra-articular injection, per dose
within the past 2 years, central dual-energy x-ray absorptiometry (dxa) ordered and documented, review of systems and medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed terminated december 31, 2019.
absorptive wound dressing for use with suction pump, home model, portable, pad size more than 16 square inches but less than or equal to 48 square inches
risk-adjusted functional status change residual score for the shoulder impairment not measured because the patient did not complete the shoulder fs prom at initial evaluation and/or near discharge, reason not given
pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant
i intend to report the acute otitis externa (aoe) measures group terminated december 31, 2016.
addition to ctlso or scoliosis orthosis, kyphosis pad
patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminectomy
spirometry test results demonstrate fev1 >= 60% fev1/fvc >= 70%, predicted or patient does not have copd symptoms terminated december 31, 2021.
gauze, non-impregnated, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing
coordinated care fee, scheduled team conference
sacral nerve stimulation test lead, each
wheelchair accessory, wheelchair seat or back cushion, does not meet specific code criteria or no written coding verification from dme pdac
miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks"
prosthesis, urinary sphincter (implantable)
hospice routine home care; per diem
hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not given terminated december 31, 2016.
patient or care partner decline assessment
documentation of cha2ds2-vasc risk score of 0 or 1 for men; or 0, 1, or 2 for women
powered air flotation bed (low air loss therapy)
allergy/immunology mips specialty set
calcitrol, 0.25 microgram
reclining back, addition to pediatric size wheelchair
other physical or occupational therapy primary functional limitation, discharge status, at discharge from therapy or to end reporting terminated december 31, 2019.
intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency
patient had cancer, acute fracture or infection related to the lumbar spine or patient had neuromuscular, idiopathic or congenital lumbar scoliosis
power wheelchair accessory, hand control interface, multiple mechanical switches, nonproportional, including all related electronics, mechanical stop switch, and fixed mounting hardware
cardiac stress imaging test performed on symptomatic or higher than low chd risk patient or for any reason other than initial detection and risk assessment
injection, inebilizumab-cdon, 1 mg
power wheelchair, group 4 standard, sling/solid seat/back, patient weight capacity up to and including 300 pounds
injection, alglucosidase alfa, (lumizyme), 10 mg
injection, immune globulin (cutaquig), 100 mg
hospital bed, pediatric, electric or semi-electric, 360 degree side enclosures, top of headboard, footboard and side rails up to 24 inches above the spring, includes mattress
emergency response system; installation and testing
microprocessor control unit for use with electric ventricular assist device, replacement only
patient did not receive brief counseling if identified as an unhealthy alcohol user, reason not given
hospital bed, heavy duty, extra wide, with weight capacity greater than 350 pounds, but less than or equal to 600 pounds, with any type side rails, with mattress
surgical site infection
addition to knee joint, ratchet lock for active and progressive knee extension, each joint
injection, brexanolone, 1mg terminated september 30, 2020.
helmet, protective, hard, custom fabricated, includes all components and accessories
infusion pump system, implantable, programmable (includes all components, e.g., pump, catheter, connectors, etc.)
endoscopic submucosal dissection (esd), including endoscopy or colonoscopy, mucosal closure, when performed
advancing care for heart disease mips value pathways
cephalin floculation, blood
orthopedic shoe addition, sole, full
butorphanol tartrate, nasal spray, 25 mg
drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter terminated december 31, 2015.
injection, oritavancin (orbactiv), 10 mg
gloves, non-sterile, per 100
alcohol and/or drug abuse halfway house services, per diem
breast prosthesis, not otherwise specified
disease activity not assessed, reason not given
vitrectomy, mechanical, pars plana approach, with subretinal injection of pharmacologic/biologic agent
injection, epoetin beta, 1 microgram, (for non esrd use)
prescription drug, oral, non chemotherapeutic, nos
upper extremity addition, test socket, shoulder disarticulation or interscapular thoracic
patients greater than or equal to 86 years of age who received a colonoscopy for an assessment of signs/symptoms of gi tract illness, and/or because the patient meets high risk criteria, and/or to follow-up on previously diagnosed advanced lesions
risk-adjusted functional status change residual score for the low back impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)
take-home supply of buprenorphine (oral); up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure
all quality actions for the applicable measures in the perioperative care measures group have been performed for this patient terminated december 31, 2014.
in vitro fertilization; including but not limited to identification and incubation of mature oocytes, fertilization with sperm, incubation of embryo(s), and subsequent visualization for determination of development
albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
most recent diastolic blood pressure >= 90 mmhg
buprenorphine implant, 74.2 mg
tracheostomy cleaning brush, each
injection, zidovudine, 10 mg
woundex, bioskin, per square centimeter
hearing aid, analog, monaural, cic (completely in the ear canal)
all quality actions for the applicable measures in the coronary artery bypass graft (cabg) measures group have been performed for this patient terminated december 31, 2016.
exercise classes, non-physician provider, per session
knee orthosis (ko), single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf terminated december 31, 2016.
transportation of portable x-ray equipment and personnel to home or nursing home, per trip to facility or location, more than one patient seen
addition to lower extremity orthosis, rocker bottom for total contact ankle foot orthosis, for custom fabricated orthosis only
injection, daratumumab 10 mg and hyaluronidase-fihj terminated december 31, 2020.
injection, trastuzumab, 10 mg and hyaluronidase-oysk
blood tubing, arterial or venous, for hemodialysis, each
implantation of magnetic component of semi-implantable hearing device on ossicles in middle ear
patient did not receive at least one well-child visit with a pcp during the performance period
spacer, bag or reservoir, with or without mask, for use with metered dose inhaler
family training and counseling for child development, per 15 minutes
implantable breast prosthesis, silicone or equal
dispensing new spectacle lenses for patient supplied frame
below knee, molded socket, shin, sach foot, endoskeletal system
amnioarmor, per square centimeter
segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each
documentation of medical reason(s) for not providing safety concerns screen or for not providing recommendations, orders or referrals for positive screen (e.g., patient in palliative care, other medical reason) terminated december 31, 2020.
pet imaging whole body; melanoma for non-covered indications
pulmonary rehabilitation, including exercise (includes monitoring), one hour, per session, up to two sessions per day terminated december 31, 2021.
case management, per month
iodine i-131 sodium iodide capsule(s), diagnostic, per millicurie
dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
amnioband or guardian, per square centimeter
documentation of medical reason(s) for not screening for unhealthy alcohol use (e.g., limited life expectancy, other medical reasons)
pediatric sized disposable incontinence product, protective underwear/pull-on, large size, each
specialty absorptive dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing
documentation of medical reason(s) for prescribing or dispensing antibiotic (e.g., intestinal infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, acute pharyngitis, acute tonsillitis, chronic sinusitis, infection of the pharynx/larynx/tonsils/adenoids, prostatitis, cellulitis/ mastoiditis/bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia, gonococcal infections/venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis/uti, acne, hiv disease/asymptomatic hiv, cystic fibrosis, disorders of the immune system, malignancy neoplasms, chronic bronchitis, emphysema, bronchiectasis, extrinsic allergic alveolitis, chronic airway obstruction, chronic obstructive asthma, pneumoconiosis and other lung disease due to external agents, other diseases of the respiratory system, and tuberculosis
home health respiratory therapy, initial evaluation
partial hand, thumb remaining
injection, hexaminolevulinate hydrochloride, 100 mg, per study dose terminated december 31, 2018.
ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)
replace leather cuff kafo, proximal thigh
injection, evinacumab-dgnb, 5 mg terminated september 30, 2021.
lomustine, oral, 10 mg
sphere, single vision, plano to plus or minus 4.00, per lens
alcohol and/or drug screening; laboratory analysis of specimens for presence of alcohol and/or drugs
electric hand, switch or myoelectric, controlled, pediatric
intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session
alloskin ac, per square centimeter
gradient pressure aid (sleeve), custom made, medium weight
monitor control cable for use with electric/pneumatic ventricular assist device, replacement only
injection, crizanlizumab-tmca, 5 mg
replacement battery for external infusion pump owned by patient, silver oxide, 3 volt, each
injection, peginesatide, 0.1 mg (for esrd on dialysis)
self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to five inches, per yard
myringotomy, laser-assisted
ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, with built-in convexity, larger than 4 x 4 inches, each
shoulder elbow wrist hand orthosis, shoulder cap design, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment
percussor, electric or pneumatic, home model
injection, naloxone hydrochloride, per 1 mg
polishing/resurfacing of ocular prosthesis
novosorb synpath dermal matrix, per square centimeter
addition, exoskeletal knee-shin system, single axis, pneumatic swing, friction stance phase control
documented medical reasons for not performing intraoperative cystoscopy (e.g., urethral pathology precluding cystoscopy, any patient who has a congenital or acquired absence of the urethra) or in the case of patient death
injection, azithromycin, 500 mg
non-emergency transportation: wheelchair van
pacemaker monitor, self-contained, (checks battery depletion, includes audible and visible check systems)
high osmolar contrast material, 200-249 mg/ml iodine concentration, per ml
injection, testosterone enanthate, up to 200 mg terminated december 31, 2014.
injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg
prosthetic sock, multiple ply, upper limb, each
cast supplies, long arm cast, pediatric (0-10 years), fiberglass
lightweight wheelchair, fixed full length arms, swing away detachable footrest
nutrition/dietician mips specialty set
oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)
injection, dyphylline, up to 500 mg
hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source
hip knee ankle foot orthosis, torsion control, bilateral rotation straps, pelvic band/belt, custom fabricated
injection, cabazitaxel, 1 mg
patients with a catheter that have limited life expectancy
acetate concentrate solution, for hemodialysis, per gallon
budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg
all quality actions for the applicable measures in the chronic obstructive pulmonary disease (copd) measures group have been performed for this patient terminated december 31, 2016.
patients who have received or are receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 90 or greater consecutive days or a single prescription equating to 900 mg prednisone or greater for all fills terminated december 31, 2020.
clinician determines patient does not require referral
axillary crutch extension
injection, acyclovir, 5 mg
enteral nutrition infusion pump - without alarm terminated december 31, 2016.
injection, bimatoprost, intracameral implant, 1 microgram
cardiac stress imaging test primarily performed on low-risk surgery patient for preoperative evaluation within 30 days preceding this surgery
general surgery mips specialty set
ras (kras and nras) gene mutation testing performed before initiation of anti-egfr moab
patients aged 40 to 75 years at the beginning of the measurement period with type 1 or type 2 diabetes and with an ldl-c result of 70-189 mg/dl recorded as the highest fasting or direct laboratory test result in the measurement year or during the two years prior to the beginning of the measurement period
suction pump, home model, portable, for use on wounds
injection, meloxicam, 1 mg
injection abciximab, 10 mg
all lower extremity prostheses, multi-axial rotation unit ('mcp' or equal)
behavioral health prevention information dissemination service (one-way direct or non-direct contact with service audiences to affect knowledge and attitude)
documentation of order for first or second generation cephalosporin for antimicrobial prophylaxis
foot, insert, removable, molded to patient model, longitudinal/ metatarsal support, each
insertion or replacement of a permanent pacing cardioverter-defibrillator system with transvenous lead(s), single or dual chamber with insertion of pacing electrode, cardiac venous system, for left ventricular pacing
absence of signs of melanoma (tenderness, jaundice, localized neurologic signs such as weakness, or any other sign suggesting systemic spread) or absence of symptoms of melanoma (cough, dyspnea, pain, paresthesia, or any other symptom suggesting the possibility of systemic spread of melanoma)
terminal device, hook, mechanical, voluntary closing, any material, any size, lined or unlined, pediatric
injection, aducanumab-avwa, 2 mg
fracture frame, attachments for complex cervical traction
orthopedic shoe, hightop with supinator or pronator, junior
immediate post surgical or early fitting, application of initial rigid dressing, including fitting alignment and suspension of components, and one cast change, wrist disarticulation or below elbow
pacemaker, single chamber, non rate-responsive (implantable)
extensive (75 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)
gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing
surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure)
clinical decision support mechanism healthhelp, as defined by the medicare appropriate use criteria program
injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg
power operated vehicle, group 1 very heavy duty, patient weight capacity 451 to 600 pounds
spherocylinder, trifocal, plano to plus or minus 4.00d sphere, 4.25 to 6.00 cylinder, per lens
insulin delivery device, reusable pen; 3 ml size
hyaluronan or derivative, triluron, for intra-articular injection, 1 mg
manual wheelchair accessory, foam propulsion tire, any size, each
patient admitted to hospice terminated december 31, 2020.
chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion
injection, dexamethasone sodium phosphate, 1 mg
hearing aid, digitally programmable analog, monaural, cic
safety concerns screening not provided, reason not otherwise specified
addition to lower extremity, thigh-weight bearing, lacer, non-molded
injection, streptozocin, 1 gram
comprehensive environmental lead investigation, not including laboratory analysis, per dwelling
emergency stat laboratory charge for patient who is homebound or residing in a nursing facility
injection, baclofen, 50 mcg for intrathecal trial
alcohol and/or drug training service (for staff and personnel not employed by providers)
comprehensive (60 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)
brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source
osteogenesis stimulator, electrical, non-invasive, spinal applications
patient had one tetanus, diphtheria toxoids and acellular pertussis vaccine (tdap) on or between the patient's 10th and 13th birthdays
documentation of patient survival and absence of stroke following cea terminated december 31, 2020.
comprehensive community support services, per 15 minutes
clinician documented that patient was not an eligible candidate for angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy (eg, allergy, intolerance, pregnancy, renal failure due to ace inhibitor, diseases of the aortic or mitral valve, other medical reasons) or (eg, patient declined, other patient reasons) or (eg, lack of drug availability, other reasons attributable to the health care system)
pressure alarm for hemodialysis, each, replacement
home infusion therapy, total parenteral nutrition (tpn); more than two liters but no more than three liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem
clinician documented that patient had medical reason for not performing lower extremity neurological exam
documentation of patient reason(s) for patient not receiving counseling for diet and physical activity (e.g., patient is not willing to discuss diet or exercise interventions to help control blood pressure, or the patient said he/she refused to make these changes) terminated december 31, 2014.
prosthesis, breast (implantable)
addition to lower extremity, pelvic control, band and belt, unilateral
ankle foot orthosis, multiligamentous ankle support, prefabricated, off-the-shelf
cast supplies, long arm cast, adult (11 years +), plaster
home infusion therapy, routine service of infusion device (e.g., pump maintenance)
storage of previously frozen embryos
administration of influenza virus vaccine
community psychiatric supportive treatment, face-to-face, per 15 minutes
patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase terminated december 31, 2014.
oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t3b-t4, any n; any t, n1 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
documentation of advanced stage dementia and caregiver knowledge is limited
behavioral health outreach service (planned approach to reach a targeted population)
routine ophthalmological examination including refraction; established patient
cardiac stress imaging test performed primarily for any other reason than monitoring of asymptomatic patient who had pci within 2 years (e.g., symptomatic patient, patient greater than 2 years since pci, initial evaluation, etc)
comprehensive multidisciplinary evaluation
contraceptive supply, hormone containing vaginal ring, each terminated september 30, 2021.
no return to the operating room for a surgical procedure, for complications of the principal operative procedure, within 30 days of the principal operative procedure
upper extremity addition, removable insert, each
patients receiving palliative care during the measurement period
clinician documented that patient was not an eligible candidate for autogenous av fistula terminated december 31, 2015.
insertion of implants into the soft palate; minimum of three implants
addition to knee joint, lift loop for drop lock ring
prosthetic shrinker, upper limb, each
addition to halo procedure, replacement liner/interface material
methadone, oral, 5 mg
patient age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the measurement period
preparatory, above knee - knee disarticulation, ischial level socket, non-alignable system, pylon, no cover, sach foot, prefabricated adjustable open end socket
patient discontinued from hemodialysis or peritoneal dialysis terminated december 31, 2020.
corrugated tubing, non-disposable, used with large volume nebulizer, 10 feet terminated december 31, 2015.
manual wheelchair accessory, foam filled caster tire, any size, each
ambulance response and treatment, no transport
continuous passive motion exercise device for use other than knee
no documentation of pain assessment, reason not given terminated december 31, 2020.
addition to lower extremity, below knee/above knee, custom fabricated from existing mold or prefabricated, socket insert, silicone gel, elastomeric or equal, not for use with locking mechanism
injection, propranolol hcl, up to 1 mg
power wheelchair, group 5 pediatric, multiple power option, sling/solid seat/back, patient weight capacity up to and including 125 pounds
breast prosthesis, mastectomy form
tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic disease modifying anti-rheumatic drug therapy
flurazepam terminated december 31, 2015.
bridge payment: a one-time payment for the first medicare diabetes prevention program (mdpp) core session, core maintenance session, or ongoing maintenance session furnished by an mdpp supplier to an mdpp beneficiary during months 1-24 of the mdpp expanded model (em) who has previously received mdpp services from a different mdpp supplier under the mdpp expanded model. a supplier may only receive one bridge payment per mdpp beneficiary
addition, endoskeletal system, above knee or hip disarticulation, knee extension assist
ustekinumab, for intravenous injection, 1 mg terminated december 31, 2017.
immunization counseling by a physician or other qualified health care professional for covid-19, ages under 21, 16-30 mins time (this code is used for the medicaid early and periodic screening, diagnostic, and treatment benefit (epsdt)
elevating legrest, upper hanger bracket, replacement only, each
vaporizer, room type
transparent film, sterile, more than 48 sq. in., each dressing
injection, atropine sulfate, 0.01 mg
hydrogel dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing
smoking and tobacco cessation counseling visit for the asymptomatic patient; intensive, greater than 10 minutes terminated september 30, 2016.
in vitro fertilization procedure cancelled after aspiration, case rate
lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panels, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, custom fabricated
orthopedic shoe, hightop with supinator or pronator, child
dispensing fee, contralateral routing system, binaural
skin protection and positioning wheelchair seat cushion, width 22 inches or greater, any depth
day habilitation, waiver; per 15 minutes
microphone for use with cochlear implant device, replacement
oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease initially established as t1-t2 and n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
trans-abdominal or trans-vaginal ultrasound not performed, reason not given
brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion
pneumococcal conjugate vaccine, polyvalent, intramuscular, for children from five years to nine years of age who have not previously received the vaccine terminated december 31, 2015.
hemodialysis treatment performed exactly three times per week for > 90 days terminated december 31, 2015.
home infusion therapy, hydration therapy; more than three liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies (drugs and nursing visits coded separately), per diem
enterostomal therapy by a registered nurse certified in enterostomal therapy, per diem
ct scan of the paranasal sinuses not ordered at the time of diagnosis or received within 28 days after date of diagnosis terminated december 31, 2021.
home management of preeclampsia, includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing services coded separately); per diem (do not use this code with any home infusion per diem code)
infusion, normal saline solution, 250 cc
medical indication for delivery by cesarean birth or induction of labor (<39 weeks of gestation) [documentation of reason(s) for elective delivery (e.g., hemorrhage and placental complications, hypertension, preeclampsia and eclampsia, rupture of membranes (premature or prolonged), maternal conditions complicating pregnancy/delivery, fetal conditions complicating pregnancy/delivery, late pregnancy, prior uterine surgery, or participation in clinical trial)]
injection, testosterone enanthate and estradiol valerate, up to 1 cc terminated december 31, 2014.
injection, infliximab-abda, biosimilar, (renflexis), 10 mg
injection, romidepsin, non-lyophilized (e.g. liquid), 1mg terminated september 30, 2021.
her-2/neu negative or undocumented/unknown terminated december 31, 2020.
gauze, impregnated, water or normal saline, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing
medication assisted treatment, buprenorphine (implant removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)
injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
primatrix, per square centimeter
physician visit at member's home, outside of a capitation arrangement
oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)
nasal/sinus endoscopy, cryoablation nasal tissue(s) and/or nerve(s), unilateral or bilateral
i intend to report the diabetes mellitus (dm) measures group terminated december 31, 2016.
patient received chemotherapy in the last 14 days of life
shoulder elbow wrist hand orthosis, abduction positioning (airplane design), thoracic component and support bar, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment
order for first or second generation cephalosporin for antimicrobial prophylaxis was not documented, reason not given
neuromuscular stimulator for scoliosis
skin protection and positioning wheelchair seat cushion, width less than 22 inches, any depth
injection, cefoperazone sodium, 1 gram
breast adjuvant chemotherapy administered terminated december 31, 2020.
elbow orthosis (eo), with adjustable position locking joint(s), prefabricated, item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
reduction of ocular prosthesis
patient unable to complete the neck fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility, and an adequate proxy is not available
foot rest, for use with commode chair, each
addition, exoskeletal knee-shin system, polycentric, friction swing and stance phase control
skin barrier, wipes or swabs, each
injection, temozolomide, 1 mg
single vision prescription lens (safety, athletic, or sunglass), per lens
trimethobenzamide hydrochloride, 250 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
the number of adult patient-months in the denominator who were on maintenance hemodialysis using a catheter continuously for three months or longer under the care of the same practitioner or group partner as of the last hemodialysis session of the reporting month
depression screening not documented, reason not given
assistive listening device, personal fm/dm transmitter assistive listening device
lens, intraocular (new technology)
spkt/v less than 1.2 (single-pool clearance of urea [kt] / volume [v]), reason not given terminated december 31, 2015.
single lens spectacle mounted low vision aids
receiver (monitor); external, for use with interstitial continuous glucose monitoring system
dynamic adjustable wrist extension / flexion device, includes soft interface material
injection, secretin, synthetic, human, 1 microgram
adhesive, liquid or equal, any type, per oz
cygnus matrix, per square centimeter
multi-positional patient transfer system, with integrated seat, operated by care giver, patient weight capacity up to and including 300 lbs
footrest, lower extension tube, replacement only, each
documentation that the patient is on a statin medication or has documentation of a valid contraindication or exception to statin medications; contraindications/exceptions that can be defined by diagnosis codes include pregnancy during the measurement period, active liver disease, rhabdomyolysis, end stage renal disease on dialysis and heart failure; provider documented contraindications/exceptions include breastfeeding during the measurement period, woman of child-bearing age not actively taking birth control, allergy to statin, drug interaction (hiv protease inhibitors, nefazodone, cyclosporine, gemfibrozil, and danazol) and intolerance (with supporting documentation of trying a statin at least once within the last 5 years or diagnosis codes for myostitis or toxic myopathy related to drugs)
revita, per square centimeter
osteogenesis stimulator, electrical, surgically implanted
manual pump-operated enema system, includes balloon, catheter and all accessories, reusable, any type
wrist hand finger orthosis, without joint(s), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
fracture frame, free standing, includes weights
home infusion therapy, chelation therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg terminated june 30, 2018.
systemic antimicrobials not prescribed
injection, meperidine and promethazine hcl, up to 50 mg
upper extremity prosthesis addition, flexion/extension wrist with or without friction, for use with external powered terminal device
cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), plaster
clinician documented that prostate cancer patient is not an eligible candidate for adjuvant hormonal therapy; low or intermediate risk of recurrence or risk of recurrence not determined terminated december 31, 2014.
foot, shoe molded to patient model, plastazote (or similar), custom fabricated, each
upper extremity addition, frame type socket, interscapular-thoracic
supply allowance for adjunctive continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service
injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg terminated december 31, 2018.
follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth
mattress, innerspring
shoulder elbow wrist hand finger orthosis, shoulder cap design, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment
transport chair, pediatric size
everolimus, oral, 0.25 mg
ostomy deodorant for use in ostomy pouch, solid, per tablet
documentation of patient reason(s) for not being able to assess (e.g., patient refuses endoscopic and/or radiologic assessment) terminated december 31, 2014.
documentation of a chlamydia screening test with proper follow-up
alcohol and/or drug intervention service (planned facilitation)
injection, hydrocortisone sodium succinate, up to 100 mg
oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t1-t2c and gleason 2-7 and psa < or equal to 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals terminated december 31, 2019.
factor viii (antihemophilic factor (porcine)), per i.u.
arthroscopy, knee, surgical for harvesting of cartilage (chondrocyte cells)
home care training, non-family; per 15 minutes
ankle, symes, metal frame, molded leather socket, articulated ankle/foot
parenteral nutrition solution; amino acid, 5.5% through 7%, (500 ml = 1 unit) - home mix
morcellator
injection, faricimab-svoa, 0.1 mg
special back height for wheelchair
endoscope, retrograde imaging/illumination colonoscope device (implantable)
respite care, in the home, per diem
progenamatrix, per square centimeter
referral to a physician for an otologic evaluation performed
no neuropsychiatric symptoms terminated december 31, 2016.
hospital bed, heavy duty, extra wide, with weight capacity greater than 350 pounds, but less than or equal to 600 pounds, with any type side rails, without mattress
injection, paricalcitol, 1 mcg
positioning wheelchair back cushion, planar back with lateral supports, width 22 inches or greater, any height, including any type mounting hardware
patient died at any time during the 24-month measurement period
chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490, g2058 in the same calendar month as 99487, 99489, 99491)). terminated december 31, 2020.
prescribed anticoagulant medication during the performance period, history of gi bleeding, history of intracranial bleeding, bleeding disorder and specific provider documented reasons: allergy to aspirin or anti-platelets, use of non-steroidal anti-inflammatory agents, drug-drug interaction, uncontrolled hypertension > 180/110 mmhg or gastroesophageal reflux disease
cast supplies, short leg cast, adult (11 years +), fiberglass
injection, isavuconazonium, 1 mg
injection, promethazine hcl, up to 50 mg
5% dextrose/water (500 ml = 1 unit)
infusion, normal saline solution, sterile (500 ml = 1 unit)
replacement batteries, medically necessary, transcutaneous electrical stimulator, owned by patient
injection, levoleucovorin, 1 mg terminated december 31, 2019.
injection, oxaliplatin, 0.5 mg
injection, alatrofloxacin mesylate, 100 mg
risk-adjusted functional status change residual score for the knee impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate terminated december 31, 2019.
risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate terminated december 31, 2019.
injection, penicillin g procaine, aqueous, up to 600,000 units
pneumatic full leg splint, prefabricated, off-the-shelf
electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care
injection, iv, urokinase, 250,000 i.u. vial
artificial larynx replacement battery / accessory, any type
exemestane, 25 mg
drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter terminated december 31, 2015.
customized item (list in addition to code for basic item)
pain assessment documented as positive using a standardized tool, follow-up plan not documented, reason not given terminated december 31, 2020.
injection, fomivirsen sodium, intraocular, 1.65 mg
etonogestrel (contraceptive) implant system, including implant and supplies
remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved cms innovation center demonstration project, which requires at least 2 of the following 3 key components: a problem focused history; a problem focused examination; straightforward medical decision making, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are self limited or minor. typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology
resuscitation bag (for use by patient on artificial respiration during power failure or other catastrophic event)
no documentation of an elder maltreatment screen, reason not given
alcohol and/or drug prevention environmental service (broad range of external activities geared toward modifying systems in order to mainstream prevention through policy and law)
clinical decision support mechanism evidencecare imagingcare, as defined by the medicare appropriate use criteria program
contact lens, hydrophilic, spherical, photochromic additive, per lens
ostomy pouch, urinary; with barrier attached (1 piece), each
screening for depression not completed, documented patient or medical reason
immunization counseling by a physician or other qualified health care professional for covid-19, ages under 21, 5-15 mins time (this code is used for the medicaid early and periodic screening, diagnostic, and treatment benefit (epsdt)
endocrinology mips specialty set
electronic elbow, microprocessor sequential control of elbow and terminal device
wheelchair accessory, shoulder harness/straps or chest strap, including any type mounting hardware
injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mg terminated june 30, 2020.
power adapter for pneumatic ventricular assist device, replacement only, vehicle type
injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu
terminal device, sport/recreational/work attachment, any material, any size
injection, furosemide, up to 20 mg
injection, histrelin acetate, 10 micrograms
final reports for ct, cta, mri or mra of the chest or neck with follow-up imaging not recommended
lumbar-sacral orthosis, sagittal-coronal control, lumbar flexion, rigid posterior frame/panel(s), lateral articulating design to flex the lumbar spine, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, anterior panel, pendulous abdomen design, prefabricated, includes fitting and adjustment
injection, infliximab-axxq, biosimilar, (avsola), 10 mg
injection, difelikefalin, 0.1 microgram, (for esrd on dialysis)
surgical supply; miscellaneous
power wheelchair accessory, drive wheel excludes tire, any size, replacement only, each
injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg
documentation of medical reason(s) for not providing tobacco cessation intervention on the date of the encounter or within the previous 12 months if identified as a tobacco user (e.g., limited life expectancy, other medical reason)
injection, pamidronate disodium, per 30 mg
percutaneous arteriovenous fistula creation (avf), direct, any site, by tissue approximation using thermal resistance energy, and secondary procedures to redirect blood flow (e.g., transluminal balloon angioplasty, coil embolization) when performed, and includes all imaging and radiologic guidance, supervision and interpretation, when performed
dialysate solution, any concentration of dextrose, fluid volume greater than 2999 cc but less than or equal to 3999 cc, for peritoneal dialysis
injection, meloxicam, 1 mg terminated september 30, 2020.
patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period
documentation of patient reason(s) for not prescribing ace inhibitor or arb or arni therapy (e.g., patient declined, other patient reasons)
ileoscopy, through stoma; with transendoscopic stent placement (includes predilation) terminated december 31, 2015.
spherocylinder, trifocal, plano to plus or minus 4.00d sphere, over 6.00d cylinder, per lens
brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
manual wheelchair accessory, lever-activated, wheel drive, pair
injection, argatroban, 1 mg (for esrd on dialysis)
technetium tc-99m tetrofosmin, diagnostic, per study dose
emergency response system; service fee, per month (excludes installation and testing)
all lower extremity prosthesis, multi-axial ankle, dynamic response foot, one piece system
chest wrap
hospital bed, pediatric, manual, 360 degree side enclosures, top of headboard, footboard and side rails up to 24 inches above the spring, includes mattress
bronchoscopy, rigid or flexible, transbronchial ablation of lesion(s) by microwave energy, including fluoroscopic guidance, when performed, with computed tomography acquisition(s) and 3-d rendering, computer-assisted, image-guided navigation, and endobronchial ultrasound (ebus) guided transtracheal and/or transbronchial sampling (eg, aspiration[s]/biopsy[ies]) and all mediastinal and/or hilar lymph node stations or structures and therapeutic intervention(s)
halo procedure, cervical halo incorporated into jacket vest
addition to lower extremity, pelvic control, hip joint, heavy duty, each
heavy duty wheelchair, fixed full length arms, swing away detachable elevating legrests
documentation that the patient is on daily aspirin or anti-platelet or has documentation of a valid contraindication or exception to aspirin/anti-platelet; contraindications/exceptions include anti-coagulant use, allergy to aspirin or anti-platelets, history of gastrointestinal bleed and bleeding disorder; additionally, the following exceptions documented by the physician as a reason for not taking daily aspirin or anti-platelet are acceptable (use of non-steroidal anti-inflammatory agents, documented risk for drug interaction, uncontrolled hypertension defined as >180 systolic or >110 diastolic or gastroesophageal reflux)
compression burn garment, facial hood, custom fabricated
no documentation of blood pressure measurement, reason not given terminated december 31, 2014.
gradient pressure aid (glove), custom made, medium weight
addition to lower extremity orthosis, knee control, knee cap, medial or lateral pull, for use with custom fabricated orthosis only
therapeutic procedures to increase strength or endurance of respiratory muscles, face to face, one on one, each 15 minutes (includes monitoring)
hip disarticulation, tilt table type; molded socket, locking hip joint, single axis constant friction knee, shin, sach foot
home therapy, irrigation therapy (e.g., sterile irrigation of an organ or anatomical cavity); including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
rh-immunoglobulin (rhogam) ordered terminated december 31, 2020.
transportation costs to and from trial location and local transportation costs (e.g., fares for taxicab or bus) for clinical trial participant and one caregiver/companion
injection, ecallantide, 1 mg
addition to lower extremity, test socket, hemipelvectomy
nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap
injection, colistimethate sodium, up to 150 mg
documentation that patient is a current non-tobacco user
pcp prophylaxis was not prescribed within 3 months oflow cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%, reason not given terminated december 31, 2014.
cam release assembly, footrest or legrest, replacement only, each
haberman feeder for cleft lip/palate
pump for alternating pressure pad, for replacement only
technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries
intraoperative near-infrared fluorescence imaging of major extra-hepatic bile duct(s) (e.g., cystic duct, common bile duct and common hepatic duct) with intravenous administration of indocyanine green (icg) (list separately in addition to code for primary procedure)
lifestyle modification program for management of coronary artery disease, including all supportive services; fourth quarter / stage
technetium tc-99m succimer, diagnostic, per study dose, up to 10 millicuries
omeza collagen matrix, per 100 mg
patients with needle localization specimens which are not amenable to intraoperative imaging such as mri needle wire localization, or targets which are tentatively identified on mammogram or ultrasound which do not contain a biopsy marker but which can be verified on intraoperative inspection or pathology (e.g., needle biopsy site where the biopsy marker is remote from the actual biopsy site) terminated december 31, 2020.
als mileage (per mile)
the start of an episode of care documented in the medical record terminated december 31, 2020.
power wheelchair accessory, battery charger, single mode, for use with only one battery type, sealed or non-sealed, each
wheelchair, pediatric size, tilt-in-space, folding, adjustable, with seating system
collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)
biologic immune response modifier prescribed
below elbow, molded socket, flexible elbow hinge, triceps pad
injection, foscarnet sodium, per 1000 mg
pediatric patient had a head ct for trauma ordered by someone other than an emergency care provider or was ordered for a reason other than trauma
pt category (primary tumor), pn category (regional lymph nodes), and histologic grade were documented in pathology report
back pain as measured by the visual analog scale (vas) at one year (9 to 15 months) postoperatively was less than or equal to 3.0 or back pain measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated a change of 5.0 points or greater
compression burn garment, glove to elbow, custom fabricated
hydrogel dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing
final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)
injection, fomepizole, 15 mg
addition to upper extremity prosthesis, shoulder disarticulation/interscapular thoracic, acrylic material
oral medication administration, direct observation
moderate compression bandage, elastic, knitted/woven, load resistance of 1.25 to 1.34 foot pounds at 50% maximum stretch, width greater than or equal to three inches and less than five inches, per yard
accessory for speech generating device, not otherwise classified
als specialized service disposable supplies; esophageal intubation
home infusion therapy, infusion therapy, not otherwise classified; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
disposable endoscope sheath, each
gait trainer, pediatric size, posterior support, includes all accessories and components
patients who use hospice services any time during the measurement period terminated december 31, 2020.
mandibular orthopedic repositioning device, each terminated june 30, 2015.
tlso flexible, provides trunk support, extends from sacrococcygeal junction to above t-9 vertebra, restricts gross trunk motion in the sagittal plane, produces intracavitary pressure to reduce load on the intervertebral disks with rigid stays or panel(s), includes shoulder straps and closures, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
disease management program, follow-up/reassessment
remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a problem focused history; a problem focused examination; and straightforward medical decision making, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are self limited or minor. typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology
ustekinumab, for intravenous injection, 1 mg terminated june 30, 2017.
peritoneal dialysis clamps, each
anastrozole, oral, 1 mg
heavy duty wheelchair, fixed full length arms, swing away detachable footrest
intent for potential removal at time of placement
lipid panel results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c) terminated december 31, 2014.
incontinence garment, any type, (e.g., brief, diaper), each
injection, eteplirsen, 10 mg
charger and base station for intraurethral activation device, replacement only terminated march 31, 2021.
adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five. either phq-9 or phq-9m score was not assessed or is greater than or equal to five terminated december 31, 2020.
frozen in vitro fertilization cycle, case rate
leg strap; latex, replacement only, per set
annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes
ambulance service, conventional air service, nonemergency transport, one way (rotary wing)
dynamic adjustable elbow extension/flexion device, includes soft interface material
injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
non-pneumatic compression controller with sequential calibrated gradient pressure
application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)
knee orthosis, swedish type, prefabricated, off-the-shelf
colorectal cancer screening; alternative to g0105, screening colonoscopy, barium enema.
clinician documented reason patient was not able to complete 30 day follow-up from acute inpatient setting discharge (e.g., patient death prior to follow-up visit, patient non-compliant for visit follow-up)
introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away
injection, methocarbamol, up to 10 ml
upper extremity addition, standard control cable, extra
patients with no clinical indications for imaging of the head terminated december 31, 2021.
antibiotic regimen prescribed within 10 days after onset of symptoms
direct (face-to-face with patient) skilled nursing services of a registered nurse provided in a comprehensive outpatient rehabilitation facility, each 10 minutes beyond the first 5 minutes
injection, cerliponase alfa, 1 mg terminated december 31, 2018.
palliative care services given to patient any time during the measurement period
lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, prefabricated, off-the-shelf
physician supervision of a patient under a medicare-approved hospice (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patient status, review of laboratory and other studies, communication (including telephone calls) with other health care professionals involved in the patient's care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month, 30 minutes or more
patient with an initial phq-9 score greater than nine who did not achieve remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score greater than or equal to five
power wheelchair, group 4 standard, single power option, captains chair, patient weight capacity up to and including 300 pounds
specimen site is other than anatomic location of primary tumor
hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg
levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg
replacement measuring scales for jaw motion rehabilitation system, pkg. of 200
patient survey score improved from baseline following treatment
revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy and atherectomy, includes angioplasty within the same vessel (s), when performed
manual wheelchair accessory, wheel braking system and lock, complete, each
reconstruction, computed tomographic angiography of aorta for surgical planning for vascular surgery
orthopedic footwear, ladies shoe, hightop, depth inlay, each
injection, isavuconazonium sulfate, 1 mg terminated december 31, 2015.
foot, molded shoe plastazote (or similar) custom fitted, each
cast supplies, long arm splint, adult (11 years +), fiberglass
replacement battery for external infusion pump owned by patient, alkaline, 1.5 volt, each
services for high intensity clinical services associated with the initial engagement and outreach of beneficiaries assigned to the sip component of the pcf model (do not bill with chronic care management codes)
wheelchair accessory, power standing system, any type
immediate post surgical or early fitting, application of rigid dressing only
injection, factor viii fc fusion protein (recombinant), per iu
no risk factors or one moderate risk factor for thromboembolism
coordinated care fee, risk adjusted maintenance, level 3
addition to lower extremity fracture orthosis, quadrilateral brim
injection, ondansetron hydrochloride, per 1 mg
injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
home therapy; peritoneal dialysis, administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
ostomy skin barrier, with flange (solid, flexible, or accordion), extended wear, with built-in convexity, 4 x 4 inches or smaller, each
injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg
telescopic and other compound lens system, including distance vision telescopic, near vision telescopes and compound microscopic lens system
power wheelchair, group 2 extra heavy duty, single power option, sling/solid seat/back, patient weight capacity 601 pounds or more
lift, elevation, heel and sole, cork, per inch
hearing aid or assistive listening device/supplies/accessories, not otherwise specified
minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using two arterial grafts and single venous graft
magnetic resonance angiography without contrast followed by with contrast, abdomen
urinal; male, jug-type, any material
hospital bed, fixed height, with any type side rails, without mattress
documentation that the patient is not on a statin medication
dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
ostomy vent, any type, each
formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms
hospital bed, variable height, hi-lo, with any type side rails, with mattress
serum creatinine test not performed, reason not given terminated december 31, 2014.
injection, lepirudin, 50 mg
terminal device, hook, mechanical, voluntary opening, any material, any size, lined or unlined, pediatric
non-randomized, non-blinded procedure for nyha class ii, iii, iv heart failure; transcatheter implantation of interatrial shunt, including right and left heart catheterization, transeptal puncture, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study
documentation of system reason(s) for not prescribing an fda-approved anticoagulation due to patient being currently enrolled in a clinical trial related to af/atrial flutter treatment
indwelling catheter; foley type, three way for continuous irrigation, each
addition, endoskeletal knee-shin system, single axis, manual lock, ultra-light material
tracheoesophageal puncture dilator, replacement only, each
intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session
most recent ldl-c >= 100 mg/dl terminated december 31, 2014.
iodine i-125, sodium iodide solution, therapeutic, per millicurie
beta-blocker therapy prescribed
miscellaneous supply or accessory for use with an external ventricular assist device
esketamine, nasal spray, 1 mg
injection, patisiran, 0.1 mg
injection, vinblastine sulfate, 1 mg
adjustable angle footplate, each
addition to lower extremity, below knee, cuff suspension
complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count)
water pressure mattress
most recent blood pressure not under control, results documented and reviewed terminated december 31, 2014.
comprehensive (60 minutes) care management home care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)
addition to lower extremity prosthesis, endoskeletal, knee disarticulation, above knee, hip disarticulation, positional rotation unit, any type
surgical procedure performed within 30 days following cataract surgery for major complications (e.g., retained nuclear fragments, endophthalmitis, dislocated or wrong power iol, retinal detachment, or wound dehiscence) terminated december 31, 2020.
induced abortion, 32 weeks or greater
family medicine mips specialty set
foot, arch support, non-removable attached to shoe, longitudinal, each
influenza immunization ordered or recommended (to be given at alternate location or alternate provider); vaccine not available at time of visit terminated december 31, 2014.
colonoscopy, flexible, proximal to splenic flexure; with transendoscopic stent placement (includes predilation) terminated december 31, 2015.
injection, methylnaltrexone, 0.1 mg
intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment
death did not occur during the index acute care hospitalization terminated december 31, 2020.
power wheelchair, group 2 standard, single power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds
hyaluronan or derivative, visco-3, for intra-articular injection, per dose terminated march 31, 2021.
insertion tray with drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.)
documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., biopsy taken for other purposes in a patient with a history of non-small cell lung cancer or other documented medical reasons)
wheelchair accessory, seat lift mechanism
addition to upper extremity prosthesis, glove for terminal device, any material, custom fabricated
housing and integrated adhesive, for use in a tracheostoma heat and moisture exchange system and/or with a tracheostoma valve, each
face-to-face educational services related to the care of chronic kidney disease; individual, per session, per one hour
follow-up recommendations documented according to recommended guidelines for incidentally detected pulmonary nodules (e.g., follow-up ct imaging studies needed or that no follow-up is needed) based at a minimum on nodule size and patient risk factors
ultrasonic guidance for placement of radiation therapy fields
knee orthosis, elastic with joints, prefabricated, off-the-shelf
trans-abdominal or trans-vaginal ultrasound not performed for reasons documented by clinician (e.g., patient has visited the ed multiple times within 72 hours, patient has a documented intrauterine pregnancy [iup])
plan of care to address moderate to severe pain documented on or before the date of the second visit with a clinician terminated december 31, 2019.
light compression bandage, elastic, knitted/woven, width greater than or equal to five inches, per yard
screening cytopathology smears, cervical or vaginal, performed by automated system under physician supervision
lubricant, individual sterile packet, each
absorptive wound dressing for use with suction pump, home model, portable, pad size greater than 48 square inches
hearing aid, digitally programmable analog, binaural, itc
ultrasound guidance for multifetal pregnancy reduction(s), technical component (only to be used when the physician doing the reduction procedure does not perform the ultrasound, guidance is included in the cpt code for multifetal pregnancy reduction - 59866)
not otherwise classified, single vision lens
injection, amivantamab-vmjw, 2 mg
primary lung carcinoma resection report documents pt category, pn category and for non-small cell lung cancer, histologic type (e.g., squamous cell carcinoma, adenocarcinoma and not nsclc-nos)
documentation of patients with diabetes who have a most recent fasting or direct ldl- c laboratory test result < 70 mg/dl and are not taking statin therapy terminated december 31, 2021.
injection, gallium nitrate, 1 mg
iv alteplase not initiated within three hours (<= 180 minutes) of time last known well for reasons documented by clinician (e.g. patient enrolled in clinical trial for stroke, patient admitted for elective carotid intervention, patient received tenecteplase (tnk))
standard wheelchair
documentation of medical reason(s) that follow-up imaging is indicated (e.g., patient has lymphadenopathy, signs of metastasis or an active diagnosis or history of cancer, and other medical reason(s))
injection, tisotumab vedotin-tftv, 1 mg
elbow wrist hand orthosis, rigid, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment
dacarbazine, 100 mg
tubing (oxygen), per foot
patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic initiated on time
indium in-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 millicuries
imaging needed as part of a clinical trial; or other clinician ordered the study
finger orthosis, proximal interphalangeal (pip)/distal interphalangeal (dip), without joint/spring, extension/flexion (e.g., static or ring type), may include soft interface material, prefabricated, off-the-shelf
injection, blinatumomab, 1 mcg terminated december 31, 2015.
administration of medication, other than oral and/or injectable, by a health care agency/professional, per visit
glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
disposable external urethral clamp or compression device, with pad and/or pouch, each
filter, nondisposable, used with aerosol compressor or ultrasonic generator
patient received combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively
financial management, self-directed, waiver; per diem
hearing aid, digital, binaural, ite
knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf
dialyzer (artificial kidneys), all types, all sizes, for hemodialysis, each
warfarin responsiveness testing by genetic technique using any method, any number of specimen(s)
ongoing care not indicated, patient discharged after only 1-2 visits due to specific medical events, documented in the medical record that make the treatment episode impossible such as the patient becomes hospitalized or scheduled for surgery for surgery or hospitalized terminated december 31, 2020.
cochlear implant, external controller component, replacement
dermavest and plurivest, per square centimeter
pet imaging, full and partial-ring pet scanners only, for initial diagnosis of breast cancer and/or surgical planning for breast cancer (e.g., initial staging of axillary lymph nodes)
magnetic resonance imaging with contrast, breast; bilateral
electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report
ostomy pouch, closed; with barrier attached (1 piece), each
electromagnetic therapy, to one or more areas for chronic stage iii and stage iv pressure ulcers, arterial ulcers, diabetic ulcers and venous stasis ulcers not demonstrating measurable signs of healing after 30 days of conventional care as part of a therapy plan of care
injection, alteplase recombinant, 1 mg
infectious disease mips specialty set
injection, triamcinolone diacetate, per 5 mg
fresh frozen plasma, donor retested, each unit
enteral formula, for pediatrics, used to replace fluids and electrolytes (e.g., clear liquids), 500 ml = 1 unit
hospital bed, fixed height, with any type side rails, with mattress
patient was not admitted to the icu in the last 30 days of life
adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five; either phq-9 or phq-9m score was not assessed or is greater than or equal to five terminated december 31, 2020.
colorectal cancer screening; flexible sigmoidoscopy
non-thermal pulsed high frequency radiowaves, high peak power electromagnetic energy treatment device
disposable cycler set used with cycler dialysis machine, each
upper extremity addition, shoulder joint, multipositional locking, flexion, adjustable abduction friction control, for use with body powered or external powered system
moderate (45 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)
technetium tc-99m depreotide, diagnostic, per study dose, up to 35 millicuries
parenteral nutrition solution; carbohydrates (dextrose), greater than 50% (500 ml = 1 unit) - home mix
linear accelerator based stereotactic radiosurgery, complete course of therapy in one session terminated december 31, 2014.
documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family not completed
lift, elevation, inside shoe, tapered, up to one-half inch
5% dextrose in lactated ringers infusion, up to 1000 cc
ambulance service, neonatal transport, base rate, emergency transport, one way
remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires at least 2 of the following 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 40 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology
tracheostomy tube collar/holder, each
intermittent urinary catheter, with insertion supplies
power wheelchair accessory, lithium-based battery, each
treatment planning and care coordination management for cancer, initial treatment
heel, thomas with wedge
replace non-molded thigh lacer, for custom fabricated orthosis only
injection, cytomegalovirus immune globulin intravenous (human), per vial
prenatal care, at-risk enhanced service package (includes h1001-h1004)
patient not admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision
dry pressure pad for mattress, standard mattress length and width
prosthetic sock, single ply, fitting, below knee, each
ambulance service, conventional air service, nonemergency transport, one way (fixed wing)
clinical follow-up and mrs score assessed at 90 days following endovascular stroke intervention
wearable artificial kidney, each
isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
disposable catheter tips for peritoneal dialysis, per 10
whirlpool, non-portable (built-in type)
injection, orphenadrine citrate, up to 60 mg
injection, argatroban, per 5 mg terminated december 31, 2016.
implantable neurostimulator radiofrequency receiver
lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg
private duty / independent nursing service(s) - licensed, up to 15 minutes
cesarean birth classes, non-physician provider, per session
professional services for the administration of subcutaneous immunotherapy or other subcutaneous infusion drug or biological for each infusion drug administration calendar day in the individual's home, each 15 minutes
air pressure mattress
transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, without spectral or color doppler echocardiography
injection, calaspargase pegol-mknl, 10 units
oxygen accessory, battery charger for portable concentrator, any type, replacement only, each
isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
upper extremity addition to prosthesis, electric locking feature, only for use with manually powered elbow
multi-positional patient transfer system, extra-wide, with integrated seat, operated by caregiver, patient weight capacity greater than 300 lbs
clinical decision support mechanism persivia clinical decision support, as defined by the medicare appropriate use criteria program
integra dermal regeneration template (drt) or integra omnigraft dermal regeneration matrix, per square centimeter
air pressure elevator for heel
skin protection and positioning wheelchair seat cushion, adjustable, width less than 22 inches, any depth
paranasal sinus ultrasound
extracorporeal shockwave lithotripsy for gall stones (if performed with ercp, use 43265)
gravity assisted traction device, any type
delivery or service to high risk areas requiring escort or extra protection, per visit
documentation stating the patient has had a diagnosis of depression or has had a diagnosis of bipolar disorder
stent, non-coated/non-covered, without delivery system
radiofrequency transmitter (external) for use with implantable sacral root neurostimulator receiver for bowel and bladder management, replacement
non-standard size or width
all quality actions for the applicable measures in the cardiovascular prevention measures group have bee performed for this patient terminated december 31, 2014.
elbow orthosis, double upright with forearm/arm cuffs, free motion, custom fabricated
power wheelchair accessory, caster fork, any size, replacement only, each
cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel
injection, rolapitant, 0.5 mg terminated december 31, 2018.
amniotic membrane for surgical reconstruction, per procedure
patient documented to have received a burn prior to discharge
suicide risk assessed at the initial evaluation terminated december 31, 2014.
sirolimus, oral, 1 mg
immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure) terminated december 31, 2014.
documentation of system reason(s) for not prescribing ace inhibitor or arb or arni therapy (e.g., other system reasons)
prostate cancer screening; prostate specific antigen test (psa)
power wheelchair, group 3 heavy duty, captains chair, patient weight capacity 301 to 450 pounds
injection, ibuprofen, 100 mg
respiratory assist device, bi-level pressure capability, with backup rate feature, used with invasive interface, e.g., tracheostomy tube (intermittent assist device with continuous positive airway pressure device)
power wheelchair, group 4 standard, multiple power option, captains chair, patient weight capacity up to and including 300 pounds
patients 66 - 80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period
door to puncture time of greater than 2 hours for reasons documented by clinician (e.g., patients who are transferred from one institution to another with a known diagnosis of cva for endovascular stroke treatment; hospitalized patients with newly diagnosed cva considered for endovascular stroke treatment) terminated december 31, 2016.
communication board, non-electronic augmentative or alternative communication device
manual wheelchair accessory, anti-rollback device, each
risk-adjusted functional status change residual score for the knee impairment successfully calculated and the score was less than zero (< 0)
injection, cyclophosphamide, (auromedics), 10 mg terminated march 31, 2022.
power wheelchair, group 1 standard, captains chair, patient weight capacity up to and including 300 pounds
patient unable to complete the elbow/wrist/hand fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available
services performed by care coordinator in the hospice setting, each 15 minutes
power wheelchair, group 3 very heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 451 to 600 pounds
scratch resistant coating, per lens
post-partum screenings, evaluations and education not performed
improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration performed for ed admitted patients
injection, mogamulizumab-kpkc, 1 mg
foot, adductus positioning device, adjustable
patient had at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits
blinded procedure for new york heart association (nyha) class ii or iii heart failure, or canadian cardiovascular society (ccs) class iii or iv chronic refractory angina; transcatheter intramyocardial transplantation of autologous bone marrow cells (e.g., mononuclear) or placebo control, autologous bone marrow harvesting and preparation for transplantation, left heart catheterization including ventriculography, all laboratory services, and all imaging with or without guidance (e.g., transthoracic echocardiography, ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study
enteral formula, for pediatrics, nutritionally complete calorically dense (equal to or greater than 0.7 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit
innovamatrix fs, per square centimeter
non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation
injection, dalbavancin, 10 mg terminated december 31, 2015.
receiver (monitor), dedicated, for use with therapeutic glucose continuous monitor system
replacement cover for wheelchair seat cushion or back cushion, each
patient is not eligible for the referral for otologic evaluation measure (e.g., patients who are already under the care of a physician for acute or chronic dizziness)
heavy duty shock absorber for heavy duty or extra heavy duty power wheelchair, each
hiv-1 antibody testing of oral mucosal transudate
swallowing functional limitation, current status at therapy episode outset and at reporting intervals terminated december 31, 2019.
percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; single vessel
trauma response team associated with hospital critical care service
home infusion therapy, antibiotic, antiviral, or antifungal therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code with home infusion codes for hourly dosing schedules s9497-s9504)
injection, acetazolamide sodium, up to 500 mg
ambulance (als or bls) oxygen and oxygen supplies, life sustaining situation
minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using single arterial and venous graft(s), single venous graft
mlg-complete, per square centimeter
home infusion therapy, diuretic intravenous therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
i intend to report the diabetic retinopathy measures group terminated december 31, 2016.
crutch forearm, includes crutches of various materials, adjustable or fixed, each, with tip and handgrips
upper extremity addition, flexion/extension wrist unit, with or without friction
medical conference by a physician with interdisciplinary team of health professionals or representatives of community agencies to coordinate activities of patient care (patient is present); approximately 30 minutes
fluorodopa f-18, diagnostic, per millicurie
emergency power source for use with electric ventricular assist device, replacement only
injection, ferric derisomaltose, 10 mg
shoulder orthosis, acromio/clavicular (canvas and webbing type), prefabricated, off-the-shelf
documentation that administration of prophylactic parenteral antibiotics was initiated within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required), as ordered terminated december 31, 2014.
knee orthosis, locking knee joint(s), positional orthosis, prefabricated, includes fitting and adjustment
calibrated microcapillary tube, each
mental health services, not otherwise specified
generator, neurostimulator (implantable), non-rechargeable
mdpp session reported as a line-item on a claim for a payable mdpp expanded model (em) hcpcs code for a session furnished by the billing supplier under the mdpp expanded model and counting toward achievement of the attendance performance goal for the payable mdpp expanded model hcpcs code (this code is for reporting purposes only)
screening for depression is documented as being positive and a follow-up plan is documented
tub stool or bench
patient had one or less emergency department visits in the last 30 days of life terminated december 31, 2020.
orthopedic shoe, hightop with supinator or pronator, infant
tacrolimus, extended release, (astagraf xl), oral, 0.1 mg
swingaway, detachable footrests, replacement only, each
balance lens, per lens
cast supplies, long leg splint, pediatric (0-10 years), fiberglass
initial or subsequent psychiatric collaborative care management, each additional 30 minutes in a calendar month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional (list separately in addition to code for primary procedure); (use g0504 in conjunction with g0502, g0503) terminated december 31, 2017.
in-line cartridge containing digestive enzyme(s) for enteral feeding, each terminated december 31, 2018.
oncology; practice guidelines; management adheres to guidelines (for use in a medicare-approved demonstration project)
injection, ketorolac tromethamine, per 15 mg
androgen deprivation therapy prescribed/administered in combination with external beam radiotherapy to the prostate
two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 7-9 under the mdpp expanded model (em). a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.the beneficiary achieved at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 7-9
adenoma(s) or other neoplasm detected during screening colonoscopy terminated december 31, 2014.
oncology; disease status; pancreatic cancer, limited to adenocarcinoma as predominant cell type; post r0 resection without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
puraply, and puraply antimicrobial, any type, per square centimeter terminated december 31, 2016.
documented history of renal failure or baseline serum creatinine >= 4.0 mg/dl; renal transplant recipients are not considered to have preoperative renal failure, unless, since transplantation the cr has been or is 4.0 or higher
oversize lens, per lens
oncology; disease status; limited to multiple myeloma, systemic disease; stage ii or higher (for use in a medicare-approved demonstration project)
injection, droperidol, up to 5 mg
patient required a return to the operating room within 90 days of surgery
ear mold/insert, disposable, any type
patient enrolled in hospice
platelets, pheresis, leukocytes reduced, each unit
alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program)
injection, bortezomib (velcade), 0.1 mg
power wheelchair accessory, breath tube kit for sip and puff interface
red blood cells, irradiated, each unit
upper extremity addition, harness, (e.g., figure of eight type), single cable design
addition to lower extremity, above knee, pelvic control, sleeve suspension, neoprene or equal, each
battery/power pack charger for use with electric or electric/pneumatic ventricular assist device, replacement only
amniorepair or altiply, per square centimeter
other motorized/power wheelchair base
knee disarticulation (or through knee), molded socket, bent knee configuration, external knee joints, shin, sach foot
manual wheelchair accessory, solid seat insert
sorbent cartridges, for hemodialysis, per 10
floweramnioflo, 0.1 cc
i intend to report the heart failure (hf) measures group terminated december 31, 2016.
levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg terminated december 31, 2017.
cinacalcet, oral, 1 mg, (for esrd on dialysis)
addition to lower extremity orthosis, extension, per extension, per bar (for lineal adjustment for growth)
upper extremity addition, spring assisted rotational wrist unit with latch release
telephone calls by a registered nurse to a disease management program member for monitoring purposes; per month
injection, patisiran, 0.1 mg terminated september 30, 2019.
documentation of patient stroke following cas terminated december 31, 2020.
documentation of patient without one or more complications within 90 days terminated december 31, 2021.
direct skilled nursing services of a licensed practical nurse (lpn) in the home health or hospice setting, each 15 minutes
endoskeletal ankle foot system, microprocessor controlled feature, dorsiflexion and/or plantar flexion control, includes power source
technetium tc-99m teboroxime, diagnostic, per study dose
hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment terminated december 31, 2016.
addition to lower extremity, pelvic control, metal frame, reciprocating hip joint and cables
wheelchair; specially sized or constructed, (indicate brand name, model number, if any) and justification
injection, glatiramer acetate, 20 mg
oral interface used with positive airway pressure device, each
injection, trabectedin, 0.1 mg
minimally invasive biopsy method attempted but not diagnostic of breast cancer (e.g., high risk lesion of breast such as atypical ductal hyperplasia, lobular neoplasia, atypical lobular hyperplasia, lobular carcinoma in situ, atypical columnar hyperplasia, flat epithelial atypia, radial scar, complex sclerosing lesion, papillary lesion, or any lesion with spindle cells)
magnetic resonance imaging without contrast, breast; unilateral terminated december 31, 2018.
prosthesis, penile, inflatable
battery for pneumatic ventricular assist device, replacement only, each
injection, telavancin, 10 mg
image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatment
lodging costs (e.g., hotel charges) for clinical trial participant and one caregiver/companion
for diabetics only, fitting (including follow-up), custom preparation and supply of off-the-shelf depth-inlay shoe manufactured to accommodate multi-density insert(s), per shoe
power module for use with electric or electric/pneumatic ventricular assist device, replacement only
documentation of medical reason(s) for not performing serum creatinine test (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) terminated december 31, 2014.
miscellaneous dme supply, accessory, and/or service component of another hcpcs code
cast supplies, long arm splint, pediatric (0-10 years), fiberglass
laundry service, external, professional; per order
hearing aid, digitally programmable, analog, monaural, itc
gauze, non-impregnated, non-sterile, pad size more than 48 sq. in., without adhesive border, each dressing
patient alive 3 months post procedure
patient approved by a qualified transplant program and scheduled to receive a living donor kidney transplant terminated december 31, 2020.
tlso, triplanar control, modular segmented spinal system, four rigid plastic shells, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to the sternal notch, soft liner, restricts gross trunk motion in sagittal, coronal, and transverse planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment
replacement, socket, above knee/knee disarticulation, including attachment plate, molded to patient model
addition to lower extremity, below knee, waist belt, padded and lined
pathology mips specialty set
hospital observation service, per hour
addition, endoskeletal knee-shin system, single axis, friction swing and stance phase control (safety knee)
addition to lower extremity orthosis, drop lock retainer, each
injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iu
neoxflo or clarixflo, 1 mg
supplies for external insulin infusion pump, syringe type cartridge, sterile, each
injection, cidofovir, 375 mg
lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie
caster pin lock, each
cd4+ cell count or percentage not documented as performed, reason not given terminated december 31, 2014.
limited (30 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)
gauze, non-impregnated, non-sterile, pad size 16 sq. in. or less, without adhesive border, each dressing
at least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) not achieved within the 30 minutes immediately before or the 15 minutes immediately after anesthesia end time, reason not given
most recent hemoglobin (hgb) level >= 10 g/dl terminated december 31, 2020.
oxygen accessory, dc power adapter for portable concentrator, any type, replacement only, each
injection, lanreotide, (cipla), 1 mg
connective tissue, non-human (includes synthetic)
manual wheelchair accessory, foam caster tire, any size, each
leg pain was not measured by the visual analog scale (vas) at three months (6 - 20 weeks) postoperatively
injection, factor x, (human), 1 i.u.
factor ix (antihemophilic factor, recombinant), rixubis, per i.u. terminated december 31, 2014.
revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy, and transluminal stent placement(s), includes angioplasty within the same vessel(s), when performed
documentation of medical or patient reason(s) for not discussing treatment options; medical reasons: patient is not a candidate for treatment due to advanced physical or mental health comorbidity (including active substance use); currently receiving antiviral treatment; successful antiviral treatment (with sustained virologic response) prior to reporting period; other documented medical reasons; patient reasons: patient unable or unwilling to participate in the discussion or other patient reasons terminated december 31, 2021.
addition, exoskeletal knee-shin system, single axis, fluid swing and stance phase control
oncology; practice guidelines; management differs from guidelines because the patient, after being offered treatment consistent with guidelines, has opted for alternative treatment or management, including no treatment (for use in a medicare-approved demonstration project)
tubing used with positive airway pressure device
colorectal cancer screening; barium enema
introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser
cognition and functional assessment using standardized instruments with development of recorded care plan for the patient with cognitive impairment, history obtained from patient and/or caregiver, in office or other outpatient setting or home or domiciliary or rest home terminated december 31, 2017.
therapeutic camping, overnight, waiver; each session
oncology; disease status; ovarian cancer, limited to epithelial cancer; evidence of disease progression, or recurrence, and/or platinum resistance (for use in a medicare-approved demonstration project)
cast supplies, for unlisted types and materials of casts
tlso, flexible, provides trunk support, extends from sacrococcygeal junction to above t-9 vertebra, restricts gross trunk motion in the sagittal plane, produces intracavitary pressure to reduce load on the intervertebral disks with rigid stays or panel(s), includes shoulder straps and closures, prefabricated, off-the-shelf
pet imaging, any site, not otherwise specified
addition to lower extremity, below knee/above knee, custom fabricated socket insert for congenital or atypical traumatic amputee, silicone gel, elastomeric or equal, for use with or without locking mechanism, initial only (for other than initial, use code l5673 or l5679)
injection, ocrelizumab, 1 mg
orthotic side bar disconnect device, per bar
spherocylinder, single vision, sphere over plus or minus 12.00d, per lens
addition to tlso, (low profile), milwaukee type superstructure
hydrocolloid dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing
due to system reasons search not conducted for dicom format images for prior patient ct imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure, authorized, media-free, shared archive (e.g., non-affiliated external healthcare facilities or entities does not have archival abilities through a shared archival system)
brachytherapy source, non-stranded, not otherwise specified, per source
functional outcome assessment documented, care plan not documented, documentation the patient is not eligible for a care plan at the time of the encounter
injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml
on date of encounter, patient is not able to participate in assessment or screening, including non-verbal patients, delirious, severely aphasic, severely developmentally delayed, severe visual or hearing impairment and for those patients, no knowledgeable informant available
patient has documentation of ventricular shunt, brain tumor, or coagulopathy
injection, progesterone, per 50 mg
i intend to report the coronary artery bypass graft (cabg) measures group terminated december 31, 2016.
hyaluronan or derivative, monovisc, for intra-articular injection, per dose
padding for compression bandage, roll
injection, penicillin g potassium, up to 600,000 units
discharge/discontinuation of the episode of care documented in the medical record
conforming bandage, non-elastic, knitted/woven, sterile, width less than three inches, per yard
hearing aid, digitally programmable, binaural, ite
all quality actions for the applicable measures in the total knee replacement measures group have been performed for this patient terminated december 31, 2016.
power wheelchair, group 3 very heavy duty, sling/solid seat/back, patient weight capacity 451 to 600 pounds
water, distilled, used with large volume nebulizer, 1000 ml
all quality actions for the applicable measures in the sinusitis measures group have been performed for this patient terminated december 31, 2016.
intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency, subsequent repeat doses
tlso, flexible, provides trunk support, upper thoracic region, produces intracavitary pressure to reduce load on the intervertebral disks with rigid stays or panel(s), includes shoulder straps and closures, prefabricated, off-the-shelf
bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason
injection, eculizumab, 10 mg
wheelchair, pediatric size, tilt-in-space, rigid, adjustable, with seating system
home care training to home care client, per 15 minutes
diabetes outpatient self-management training services, individual, per 30 minutes
medical conference by a physician with interdisciplinary team of health professionals or representatives of community agencies to coordinate activities of patient care (patient is present); approximately 60 minutes
power wheelchair accessory, foam filled drive wheel tire, any size, replacement only, each
hospice or home health care provided in assisted living facility
documentation of patient reason(s) for not prescribing an oral anticoagulant that is fda approved for the prevention of thromboembolism (e.g., patient preference for not receiving anticoagulation)
functional outcome assessment using a standardized tool is documented; no functional deficiencies identified, care plan not required
dialysate concentrate, powder, additive for peritoneal dialysis, per packet
addition, endoskeletal system, hip disarticulation, mechanical hip extension assist
cast supplies, short arm splint, adult (11 years +), plaster
medical foods for non-inborn errors of metabolism
radiopharmaceutical, therapeutic, not otherwise classified
injection, piperacillin sodium, 500 mg
follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules, reason not given
oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; chronic phase not in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)
patient presented with a minor blunt head trauma and had a head ct ordered for trauma by an emergency care provider
gradient pressure aid (sleeve), ready made
assistive listening device, alerting, any type
nicotine terminated december 31, 2015.
tlso, full corset
power wheelchair accessory, solid (rubber/plastic) caster tire with integrated wheel, any size, replacement only, each
injection, iron-based magnetic resonance contrast agent, per ml
injection, procainamide hcl, up to 1 gm
services provided as part of a phase ii clinical trial
bifocal seg width over 28 mm
injection, zoledronic acid, 1 mg
urine protein test result documented and reviewed terminated december 31, 2014.
replacement battery, alkaline (other than j cell), for use with medically necessary home blood glucose monitor owned by patient, each
transfer of an orthosis from one shoe to another, solid stirrup, existing
collagen dressing, sterile, size more than 48 sq. in., each
flortaucipir f 18 injection, diagnostic, 1 millicurie
injection, plicamycin, 2.5 mg
gefitinib, oral, 250 mg
home infusion therapy, intermittent (less than twenty-four hours) pain management infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
manual wheelchair accessory, wheel lock assembly, complete, replacement only, each
spherocylinder, trifocal, plus or minus 7.25 to plus or minus 12.00d sphere, 2.25 to 4.00d cylinder, per lens
diabetes screening test performed terminated december 31, 2014.
preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no cover, sach foot, thermoplastic or equal, direct formed
wheelchair accessory, headrest, cushioned, any type, including fixed mounting hardware, each
injection, crizanlizumab-tmca, 1 mg terminated june 30, 2020.
plasma (single donor), pathogen reduced, frozen, each unit
water chamber for humidifier, used with positive airway pressure device, replacement, each
power wheelchair, group 1 standard, portable, captains chair, patient weight capacity up to and including 300 pounds
disposable underpads, all sizes
radiopharmaceutical, diagnostic, for beta-amyloid positron emission tomography (pet) imaging, per study dose, not otherwise specified terminated december 31, 2017.
patient discharge to home no later than post-operative day #7 terminated december 31, 2020.
transfer device, any type, each
patient is not ambulatory, bed ridden, immobile, confined to chair, wheelchair bound, dependent on helper pushing wheelchair, independent in wheelchair or minimal help in wheelchair
wrist hand orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment
home infusion therapy, catheter care / maintenance, simple (single lumen), includes administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment, (drugs and nursing visits coded separately), per diem
catheter, pressure-generating, one-way valve, intermittently occlusive
injection, fluphenazine decanoate, up to 25 mg
negative pressure wound therapy, (e.g. vacuum assisted drainage collection) using a mechanically-powered device, not durable medical equipment, including provision of cartridge and dressing(s), topical application(s), wound assessment, and instructions for ongoing care, per session; total wounds(s) surface area less than or equal to 50 square centimeters terminated december 31, 2014.
total number of emergency department visits and inpatient hospitalizations less than two in the past 12 months
parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, 10 to 51 grams of protein - premix
fluciclovine f-18, diagnostic, 1 millicurie
patients who have a diagnosis of rhabdomyolysis at any time during the measurement period
gradient compression stocking, thigh length, 40-50 mmhg, each
power wheelchair accessory, sip and puff interface, nonproportional, including all related electronics, mechanical stop switch, and manual swingaway mounting hardware
ankle, symes, molded to patient model, socket without solid ankle cushion heel (sach) foot, replacement only
magnetic resonance imaging (mri), low-field
injection, levorphanol tartrate, up to 2 mg
non-pneumatic sequential compression garment, full leg
application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area
addition to lower extremity, pelvic control, hip joint, clevis type, or thrust bearing, free, each
prescribed or dispensed antibiotic on or within 3 days after the episode date
amniobind, per square centimeter
terminal device, passive hand/mitt, any material, any size
post-coital direct, qualitative examinations of vaginal or cervical mucous
hearing aid, digital, monaural, ite
respiratory assist device, bi-level pressure capability, with back-up rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)
female patients unable to bear children
angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) or angiotensin receptor-neprilysin inhibitor (arni) therapy was not prescribed, reason not given
upper extremity addition, shoulder lock mechanism, body powered actuator
melphalan; oral, 2 mg
positioning wheelchair back cushion, posterior-lateral, width 22 inches or greater, any height, including any type mounting hardware
follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history, (2) a physical examination that includes: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear, and (3) patient education
coupling gel or paste, for use with ultrasound device, per oz
most recent blood pressure has a systolic measurement of >= 140 mmhg and/or a diastolic measurement of >= 90 mmhg
injection, casirivimab and imdevimab, 600 mg
direct skilled nursing services of a licensed nurse (lpn or rn) in the home health or hospice setting, each 15 minutes terminated february 29, 2016.
injection, adalimumab, 20 mg
wide heavy duty wheel chair, detachable arms (desk or full length), swing away detachable elevating leg rests
sperm procurement and cryopreservation services; subsequent visit
large volume nebulizer, disposable, unfilled, used with aerosol compressor
power wheelchair accessory, nonstandard seat frame width, 24-27 inches
imaging study not named according to standardized nomenclature, reason not given
injection, crotalidae polyvalent immune fab (ovine), up to 1 gram
injection, voriconazole, 10 mg
dme delivery, set up, and/or dispensing service component of another hcpcs code
portable oxygen contents, gaseous, 1 month's supply = 1 unit
pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3 for medical reason (i.e., patient's cd4+ cell count above threshold within 3 months after cd4+ cell count below threshold, indicating that the patient's cd4+ levels are within an acceptable range and the patient does not require pcp prophylaxis) terminated december 31, 2016.
administration of hepatitis b vaccine
knee orthosis, double upright with adjustable joint, with inflatable air support chamber(s), prefabricated, off-the-shelf
patient treated with a beta-lactam antibiotic as definitive therapy terminated december 31, 2020.
ostomy pouch, closed; for use on barrier with locking flange, with filter (2 piece), each
sterile water, saline and/or dextrose, diluent/flush, 10 ml
oral device/appliance used to reduce upper airway collapsibility, adjustable or non-adjustable, prefabricated, includes fitting and adjustment
lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg
ammonia test strips, for dialysis, per 50
cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10 years), fiberglass
unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility
wrist hand finger orthosis, external powered, electric, custom fabricated
injection, perflexane lipid microspheres, per ml
home therapy; enteral nutrition via bolus; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem
paramedic intercept, hospital-based als service (non-voluntary), non-transport
injection, ferric pyrophosphate citrate solution (triferic avnu), 0.1 mg of iron
comprehensive (60 mins) home care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility.)
tendon, porous matrix of cross-linked collagen and glycosaminoglycan matrix (tenoglide tendon protector sheet), per square centimeter
trastuzumab not administered within 12 months of diagnosis terminated december 31, 2020.
transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, real time with image documentation (2d) (with or without m-mode recording); including probe placement, image acquisition, interpretation and report
injection, necitumumab, 1 mg terminated december 31, 2016.
ultraviolet light therapy system, includes bulbs/lamps, timer and eye protection; treatment area 2 square feet or less
orthopedic shoe addition, convert instep to velcro closure
hepatitis b vaccine injection administered or previously received and is receiving a first course of anti-tnf therapy terminated december 31, 2015.
battery, other than lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only
skilled services of a registered nurse (rn) for the observation and assessment of the patient's condition, each 15 minutes (the change in the patient's condition requires skilled nursing personnel to identify and evaluate the patient's need for possible modification of treatment in the home health or hospice setting)
prescription digital cognitive and/or behavioral therapy, fda cleared, per course of treatment
wheelchair accessory, power seating system, recline only, without shear reduction
venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission, reason not given terminated december 31, 2014.
extension line with easy lock connectors, used with dialysis
skin barrier; solid, 4 x 4 or equivalent; each
oncology; primary focus of visit; other, unspecified service not otherwise listed (for use in a medicare-approved demonstration project)
injection, tagraxofusp-erzs, 10 micrograms
ossicula implant
functional status was not measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively
documentation caregiver is trained and certified in dementia care
sling or seat, patient lift, canvas or nylon
home care training, family; per session
history and physical (outpatient or office) related to surgical procedure (list separately in addition to code for appropriate evaluation and management service)
patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 180 day (6 month) continuation treatment phase terminated december 31, 2014.
immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service for ages under 21, 16-30 mins time (this code is used for medicaid billing purposes)
medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs
injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu
positioning wheelchair seat cushion, width less than 22 inches, any depth
services performed by qualified pharmacist in the hospice setting, each 15 minutes
diabetic management program, follow-up visit to non-md provider
dialysate solution, any concentration of dextrose, fluid volume greater than 4999 cc but less than or equal to 5999 cc, for peritoneal dialysis
shoulder elbow wrist hand finger orthosis, abduction positioning (airplane design), thoracic component and support bar, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment
manual wheelchair accessory, foam filled propulsion tire, any size, each
patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month) following only one surgery terminated december 31, 2015.
control unit for electronic bowel irrigation/evacuation system
antibiotic regimen prescribed
alcohol and/or substance abuse services, treatment plan development and/or modification
injection, dactinomycin, 0.5 mg
parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements and vitamins, including preparation, any strength, 74 to 100 grams of protein - premix
injection, human fibrinogen concentrate, not otherwise specified, 1 mg
beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
amputee wheelchair, detachable arms (desk or full length) without footrests or legrest
alloskin, per square centimeter
wheelchair, pediatric size, rigid, adjustable, with seating system
safety eyeglass frames
documentation of medical reason for not including pt category, pn category and histologic type [for patient with appropriate exclusion criteria (e.g., metastatic disease, benign tumors, malignant tumors other than carcinomas, inadequate surgical specimens)]
i intend to report the oncology measures group terminated december 31, 2016.
services performed by volunteer in the hospice setting, each 15 minutes
injection, ocriplasmin, 0.125 mg
injection, collagenase, clostridium histolyticum, 0.01 mg
cervical, collar, molded to patient model
knee orthosis, modification of supracondylar prosthetic socket, custom fabricated (sk)
injection, perflutren lipid microspheres, per ml
wheelchair accessory, ventilator tray, fixed
lens, index 1.54 to 1.65 plastic or 1.60 to 1.79 glass, excludes polycarbonate, per lens
formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
safety concerns screen provided and negative
injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg
hand finger orthosis (hfo), flexion glove with elastic finger control, prefabricated, off-the-shelf
surgical procedure not performed within 30 days following cataract surgery for major complications (e.g., retained nuclear fragments, endophthalmitis, dislocated or wrong power iol, retinal detachment, or wound dehiscence) terminated december 31, 2020.
above knee, for proximal femoral focal deficiency, constant friction knee, shin, sach foot
global fee urgent care centers
telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth
custom motorized/power wheelchair base
catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes)
cervical cap for contraceptive use
legg perthes orthosis, trilateral, (tachdijan type), custom fabricated
clinical decision support mechanism logicnets, as defined by the medicare appropriate use criteria program
documentation of medical reason(s) for patient not receiving counseling for diet and physical activity (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) terminated december 31, 2014.
electronic elbow, microprocessor simultaneous control of elbow and terminal device
ostomy pouch, urinary; without barrier attached (1 piece), each
gradient compression wrap, non-elastic, below knee, 30-50 mm hg, each
patient prescribed or dispensed antibiotic
power module patient cable for use with electric or electric/pneumatic ventricular assist device, replacement only
custom shaped protective cover, knee disarticulation
gel sheet for dermal or epidermal application, (e.g., silicone, hydrogel, other), each
parenteral nutrition solution, not otherwise specified, 10 grams lipids
diagnostic mammography, including computer-aided detection (cad) when performed; bilateral terminated december 31, 2017.
levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg
rimantadine hydrochloride, oral, brand, per 100 mg (for use in a medicare-approved demonstration project) terminated december 31, 2019.
insulin, intermediate acting (nph or lente); 5 units
spoken language comprehension functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting terminated december 31, 2019.
perianal fecal collection pouch with adhesive, each
percutaneous transluminal coronary atherectomy, with drug eluting intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch
metatarsal bar wedge, rocker
tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams
chromic phosphate p-32 suspension, therapeutic, per millicurie
magnetic resonance angiography without contrast, chest (excluding myocardium)
dexamethasone, oral, 0.25 mg
emergency power source for use with electric/pneumatic ventricular assist device, replacement only
dialysate solution, any concentration of dextrose, fluid volume greater than 249 cc, but less than or equal to 999 cc, for peritoneal dialysis
addition to lower extremity, test socket, symes
injection, ibutilide fumarate, 1 mg
plasma, high titer covid-19 convalescent, each unit
cocaine hydrochloride nasal solution for topical administration, 1 mg
cast supplies, hip spica (one or both legs), pediatric (0-10 years), plaster
amputee wheelchair, detachable arms (desk or full length) swing away detachable footrests
transcyte, per square centimeter
mattress, foam rubber
patient was not referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not given
injection, cetirizine hydrochloride, 0.5 mg
injection, gold sodium thiomalate, up to 50 mg
oncology; disease status; prostate cancer, limited to adenocarcinoma; after initial treatment with rising psa or failure of psa decline (for use in a medicare-approved demonstration project)
transtracheal oxygen catheter, each
oral device/appliance used to reduce upper airway collapsibility, adjustable or non-adjustable, custom fabricated, includes fitting and adjustment
infusion set for external insulin pump, needle type
documented medical reasons for not reporting ureter injury (e.g., gynecologic or other pelvic malignancy documented, concurrent surgery involving bladder pathology, injury that occurs during a urinary incontinence procedure, patient death from non-medical causes not related to surgery, patient died during procedure without evidence of ureter injury)
injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u.
mucoprotein, blood (seromucoid) (medical necessity procedure)
hydrogel dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing
brief (20 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)
injection, streptokinase, per 250,000 iu
injection, daratumumab, 10 mg terminated december 31, 2016.
attention functional limitation, current status at therapy episode outset and at reporting intervals terminated december 31, 2019.
injection, aprotonin, 10,000 kiu
injection, milrinone lactate, 5 mg
one ct scan or no ct scan of the paranasal sinuses ordered within 90 days after the date of diagnosis
injection, gamma globulin, intramuscular, 1 cc
injection, famotidine, 20 mg
venous thromboembolism (vte) prophylaxis not administered the day of or the day after hospital admission for documented reasons (eg, patient is ambulatory, patient expired during inpatient stay, patient already on warfarin or another anticoagulant, other medical reason(s) or eg, patient left against medical advice, other patient reason(s)) terminated december 31, 2014.
screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician
epiandrosterone terminated december 31, 2015.
tracheal suction catheter, closed system, each
high strength lightweight wheelchair, detachable arms desk or full length, swing away detachable elevating leg rests
isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires at least 2 of the following 3 key components: an expanded problem focused history; an expanded problem focused examination; medical decision making of low complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of low to moderate severity. typically, 15 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology
hospital bed, variable height, hi-lo, without side rails, without mattress
adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five terminated december 31, 2020.
injection, meropenem and vaborbactam, 10mg/10mg (20mg)
guide wire
injection, gadofosveset trisodium, 1 ml
sentinel lymph node biopsy procedure not performed, reason not given
levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
prosthetic sock, single ply, fitting, above knee, each
supplies for maintenance of insulin infusion catheter, per week
wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, reclining
i intend to report the chronic obstructive pulmonary disease (copd) measures group terminated december 31, 2016.
injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu
pcp prophylaxis was not prescribed at time of diagnosis of hiv, reason not given terminated december 31, 2014.
homemaker service, nos; per 15 minutes
technetium tc-99m bicisate, diagnostic, per study dose, up to 25 millicuries
patients between 50 and 85 years of age who received a screening colonoscopy during the performance period
injection, nalbuphine hydrochloride, per 10 mg
addition to lower extremity, below knee/above knee, custom fabricated from existing mold or prefabricated, socket insert, silicone gel, elastomeric or equal, for use with locking mechanism
prostate cancer screening; digital rectal examination
gallium ga-68, dotatate, diagnostic, 0.1 millicurie
new technology intraocular lens category 5 as defined in federal register notice
additive for enteral formula (e.g., fiber)
patients with clinical indications for imaging of the head: positional headaches
diagnostic radiology mips specialty set
cleaning device used with tracheoesophageal voice prosthesis, pipet, brush, or equal, replacement only, each
all lower extremity prostheses, energy storing foot (seattle carbon copy ii or equal)
mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting terminated december 31, 2019.
glaucoma screening for high risk patient furnished under the direct supervision of an optometrist or ophthalmologist
over-bed table
patient is using palliative care services any time during the measurement period
patients that do not have the filter removed, documented re-assessment for the appropriateness of filter removal, or documentation of at least two attempts to reach the patient to arrange a clinical re-assessment for the appropriateness of filter removal within 3 months of placement
above knee, molded socket, open end, sach foot, endoskeletal system, single axis knee
heat lamp, without stand (table model), includes bulb, or infrared element
implantable access catheter, (e.g., venous, arterial, epidural subarachnoid, or peritoneal, etc.) external access
knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated, includes fitting and adjustment
atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
documentation of medical reason(s) for not including pt category, thickness, ulceration and mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors (e.g., negative skin biopsies, insufficient tissue, or other documented medical reasons)
injection, crotalidae immune f(ab')2 (equine), 120 mg
alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention, 5-14 minutes
indium in-111 satumomab pendetide, diagnostic, per study dose, up to 6 millicuries
tisagenlecleucel, up to 250 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion terminated december 31, 2018.
documentation of viral load equal to or greater than 200 copies/ml or viral load not performed
hip orthosis, abduction control of hip joints, flexible, (frejka cover only), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
transmitter; external, for use with interstitial continuous glucose monitoring system
i intend to report the hepatitis c measures group terminated december 31, 2016.
all quality actions for the applicable measures in the rheumatoid arthritis (ra) measures group have been performed for this patient terminated december 31, 2016.
adjuvant chemotherapy referred, prescribed or previously received for ajcc stage iii, colon cancer terminated december 31, 2016.
monitored anesthesia care (mac)
indium in-111 pentetreotide, diagnostic, per study dose, up to 6 millicuries
reverse osmosis water purification system, for hemodialysis
mobility cart for pneumatic ventricular assist device, replacement only
leg strap; foam or fabric, replacement only, per set
injection, digoxin, up to 0.5 mg
preparatory, above knee - knee disarticulation ischial level socket, non-alignable system, pylon no cover, sach foot, laminated socket, molded to model
injection, sterile cefuroxime sodium, per 750 mg
patient documented not to have experienced a hospital transfer or hospital admission upon discharge from asc
ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, without built-in convexity, larger than 4 x 4 inches, each
iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms
hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg
patients with pregnancy during adjuvant treatment course
addition to lower extremity, reinforced solid stirrup (scott-craig type)
holster for use with electric or electric/pneumatic ventricular assist device, replacement only
addition to terminal device, modifier wrist unit
amnion bio or axobiomembrane, per square centimeter
focused ultrasound ablation/therapeutic intervention, other than uterine leiomyomata, with magnetic resonance (mr) guidance
external breast prosthesis garment, with mastectomy form, post mastectomy
power wheelchair accessory, 22nf non-sealed lead acid battery, each
hospice care provided in inpatient hospice facility
patient was not prescribed at least a 135 day treatment within the 180-day measurement interval with beta-blockers post-discharge for ami terminated december 31, 2020.
knee orthosis, rigid, without joint(s), includes soft interface material, prefabricated, off-the-shelf
clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program
assistive listening device, transmitter microphone, any type
clinical decision support mechanism sage health management solutions, as defined by the medicare appropriate use criteria program terminated march 31, 2022.
bed side rails, full length
injection, phenylephrine and ketorolac, 4 ml vial terminated september 30, 2019.
replacement socket, below elbow/wrist disarticulation, molded to patient model, for use with or without external power
physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care
epifix or epicord, per square centimeter terminated december 31, 2018.
follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules due to medical reasons (e.g., patients with known malignant disease, patients with unexplained fever, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) terminated december 31, 2015.
low frequency ultrasonic diathermy treatment device for home use, includes all components and accessories
manual wheelchair accessory, nonstandard seat frame width, 24-27 inches
patient documented as tobacco user and received tobacco cessation intervention (must include at least one of the following: advice given to quit smoking or tobacco use, counseling on the benefits of quitting smoking or tobacco use, assistance with or referral to external smoking or tobacco cessation support programs, or current enrollment in smoking or tobacco use cessation program) if identified as a tobacco user
patient not evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient not interviewed at least once during opioid therapy terminated december 31, 2021.
power wheelchair, group 2 standard, seat elevator, captains chair, patient weight capacity up to and including 300 pounds
whole blood, leukocytes reduced, irradiated, each unit
therapeutic procedures to improve respiratory function or increase strength or endurance of respiratory muscles, two or more individuals (includes monitoring)
surgigraft, per square centimeter
ascent, 0.5 mg
ldl value < 100 terminated december 31, 2014.
ankle foot orthosis, walking boot type, varus/valgus correction, rocker bottom, anterior tibial shell, soft interface, custom arch support, plastic or other material, includes straps and closures, custom fabricated
gradient pressure exterior wrap
manual wheelchair accessory, tube for pneumatic propulsion tire, any size, each
preparation with instillation of fecal microbiota by any method, including assessment of donor specimen
artacent wound, per square centimeter
cranial cervical orthosis, torticollis type, with or without joint, with or without soft interface material, prefabricated, includes fitting and adjustment
home infusion therapy, antibiotic, antiviral, or antifungal; once every 4 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
colonoscopy through stoma; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique terminated december 31, 2015.
sunglasses frames
vincristine sulfate, 1 mg
upper extremity addition, shoulder universal joint, each
adjuvant chemotherapy not prescribed or previously received, for documented reasons (e.g., medical co-morbidities, diagnosis date more than 5 years prior to the current visit date, patient's diagnosis date is within 120 days of the end of the 12 month reporting period, patient's cancer has metastasized, medical contraindication/allergy, poor performance status, other medical reasons, patient refusal, other patient reasons, patient is currently enrolled in a clinical trial that precludes prescription of chemotherapy, other system reasons) terminated december 31, 2016.
transcarpal/metacarpal or partial hand disarticulation prosthesis, external power, self-suspended, inner socket with removable forearm section, electrodes and cables, two batteries, charger, myoelectric control of terminal device, excludes terminal device(s)
induced abortion, 25 to 28 weeks
injection, cytarabine, 100 mg
static progressive stretch forearm pronation / supination device, with or without range of motion adjustment, includes all components and accessories
ostomy pouch, closed; for use on faceplate, each
enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit
injection, sulfamethoxazole and trimethoprim, 10 ml
most recent hemoglobin level <= 12.0 g/dl terminated december 31, 2014.
minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using arterial graft(s), two coronary arterial grafts
ostomy supply; miscellaneous
patients using hospice services any time during the measurement period
factor viii (antihemophilic factor, human) per i.u.
wheelchair accessory, manual fully reclining back, (recline greater than 80 degrees), each
upper extremity addition, harness, triple control, simultaneous operation of terminal device and elbow
adult sized disposable incontinence product, protective underwear/pull-on, large size, each
sphere, single vision, plus or minus 4.12 to plus or minus 7.00d, per lens
children who were not screened for risk of developmental, behavioral and social delays using a standardized tool with interpretation and report terminated december 31, 2020.
catheter, extravascular tissue ablation, any modality (insertable)
addition to lower extremity, pelvic control, pelvic sling
spherocylinder, single vision, plus or minus 4.25 to plus or minus 7.00 sphere, .12 to 2.00d cylinder, per lens
adult sized disposable incontinence product, brief/diaper, extra large, each
injection, interferon, gamma 1-b, 3 million units
prednisone, immediate release or delayed release, oral, 1 mg
injection, romidepsin, lyophilized, 0.1 mg
documentation of patient reason(s) for not receiving annual screening for hcv infection (e.g., patient declined, other patient reasons)
helicoll, per square centimeter
oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; extent of disease unknown, staging in progress, not listed (for use in a medicare-approved demonstration project)
triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service)
sole wedge, outside sole
oxygen and water vapor enriching system with heated delivery
replace trilateral socket brim
injection, glucarpidase, 10 units
extensive (75 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)
non-medical family planning education, per session
injection, daptomycin, 1 mg
spherocylinder, bifocal, plus or minus 7.25 to plus or minus 12.00d sphere, 2.25 to 4.00d cylinder, per lens
lumbar sacral orthosis, sagittal-coronal control, lumbar flexion, rigid posterior frame/panels, lateral articulating design to flex the lumbar spine, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, anterior panel, pendulous abdomen design, custom fabricated
injection, etelcalcetide, 0.1 mg
cast supplies, shoulder cast, adult (11 years +), plaster
injection, triptorelin pamoate, 3.75 mg
cast supplies, long arm splint, pediatric (0-10 years), plaster
patients who have ever had a fasting or direct laboratory result of ldl-c = 190 mg/dl
rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given terminated december 31, 2016.
hemostatic agent, gastrointestinal, topical
lead, pacemaker, transvenous vdd single pass
injection, emicizumab-kxwh, 0.5 mg terminated december 31, 2018.
crisis intervention mental health services, per diem
alcohol and/or drug prevention problem identification and referral service (e.g., student assistance and employee assistance programs), does not include assessment
patient screened for tobacco use and identified as a tobacco user
iris supported intraocular lens
patient did not have at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits
foster care, child, non-therapeutic, per diem
documentation of medical reason(s) for not naming ct studies according to a standardized nomenclature provided (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) terminated december 31, 2015.
replacement garment for use with automated external defibrillator, each
non-emergency transportation: ancillary: lodging-recipient
polycyte, for topical use only, per 0.5 cc
patient alive as of the last day of the measurement year
injection, durvalumab, 10 mg terminated december 31, 2018.
outpatient intravenous insulin treatment (oivit) either pulsatile or continuous, by any means, guided by the results of measurements for: respiratory quotient; and/or, urine urea nitrogen (uun); and/or, arterial, venous or capillary glucose; and/or potassium concentration
individual who did not fill at least two prescriptions for any antipsychotic medication or did not have a pdc of 0.8 or greater terminated december 31, 2015.
power wheelchair, group 3 extra heavy duty, captains chair, patient weight capacity 601 pounds or more
injectable bulking agent, collagen implant, urinary tract, 2.5 ml syringe, includes shipping and necessary supplies
prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; first 30 minutes (list separately in addition to code for preventive service)
power wheelchair accessory, tube for pneumatic drive wheel tire, any size, replacement only, each
final reports for imaging studies stating no follow-up imaging is recommended
goserelin acetate implant, per 3.6 mg
negative pressure wound therapy electrical pump, stationary or portable
documentation of system reason(s) for not prescribing a long-acting inhaled bronchodilator
injection, hydromorphone hydrochloride, 250 mg (loading dose for infusion pump)
foot drop splint, recumbent positioning device, prefabricated, off-the-shelf
shoulder disarticulation, external power, molded inner socket, removable shoulder shell, shoulder bulkhead, humeral section, mechanical elbow, forearm, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device
low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
replacement battery for patient-owned ear pulse generator, each
auditory osseointegrated device, includes all internal and external components
i intend to report the hiv/aids measures group terminated december 31, 2016.
risk-adjusted functional status change residual score for the lower leg, foot or ankle impairment successfully calculated and the score was less than zero (< 0)
nasal pillows for combination oral/nasal mask, replacement only, pair
photodocumentation of two or more cecal landmarks to establish a complete examination
infusion, plasma protein fraction (human), 5%, 250 ml
blood leak detector for hemodialysis, each, replacement
remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment
permanent implantable contraceptive intratubal occlusion device(s) and delivery system
external recharging system for battery (external) for use with implantable neurostimulator, replacement only
medical home program, comprehensive care coordination and planning, initial plan
intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat doses
injection, palifermin, 50 micrograms
injection, testosterone undecanoate, 1 mg
injection, bebtelovimab, 175 mg
dermal injection procedure(s) for facial lipodystrophy syndrome (lds) and provision of radiesse or sculptra dermal filler, including all items and supplies terminated december 31, 2016.
cast supplies, long arm cast, pediatric (0-10 years), plaster
addition to lower extremity, socket insert, above knee (kemblo, pelite, aliplast, plastazote or equal)
behavioral health; long-term care residential (non-acute care in a residential treatment program where stay is typically longer than 30 days), with room and board, per diem
i intend to report the cardiovascular prevention measures group terminated december 31, 2014.
implantable neurostimulator electrode, each
mental health clubhouse services, per 15 minutes
urinary catheter anchoring device, leg strap, each
surgical stockings below knee length, each
coordinated care fee, physician coordinated care oversight services
all endoskeletal lower extremity prostheses, dynamic prosthetic pylon
ostomy pouch, urinary, with extended wear barrier attached, with built-in convexity (1 piece), each
ethchlorvynol terminated december 31, 2015.
injection, casirivimab and imdevimab, 2400 mg
patient did not achieve a pdc of at least 75% for their asthma controller medication
knee orthosis (ko), double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf
ambulance service, conventional air services, transport, one way (fixed wing)
provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count
assisted living, waiver; per month
battery, heavy duty; replacement for patient owned ventilator
documentation of patient reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient refusal)
addition to lower extremity, below knee, back check (extension control)
dexamethasone, lacrimal ophthalmic insert, 0.1 mg
injection, methylprednisolone acetate, 40 mg
orthopedic footwear, additional charge for split size
power adapter for use with electric or electric/pneumatic ventricular assist device, vehicle type
sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion
pediatric sized disposable incontinence product, protective underwear/pull-on, small/medium size, each
hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg
services performed by a qualified occupational therapist assistant in the home health or hospice setting, each 15 minutes
habilitation, supported employment, waiver; per diem
addition to lower extremity, below knee, waist belt, webbing
speech language pathology mips specialty set
lower extremity orthoses, not otherwise specified
injection, gadobutrol, 0.1 ml
irrigation syringe, bulb or piston, each
activated carbon filter for hemodialysis, each
other speech language pathology functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting terminated december 31, 2019.
her-2/neu positive
injection, clindamycin phosphate, 300 mg
injection, belatacept, 1 mg
helmet, protective, hard, prefabricated, includes all components and accessories
colorectal cancer screening; colonoscopy on individual at high risk
patients on peritoneal dialysis for any portion of the reporting month
clinician documented that patient is not an eligible candidate for genotype testing; patient not receiving antiviral treatment for hepatitis c during the measurement period (e.g. genotype test done prior to the reporting period, patient declines, patient not a candidate for antiviral treatment) terminated december 31, 2016.
implantable/insertable device, not otherwise classified
tacrolimus, extended release, (envarsus xr), oral, 0.25 mg
patient not discharged to home by post-operative day #7 terminated december 31, 2020.
oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage ia-b (grade 2-3); or stage ic (all grades); or stage ii; without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
addition, endoskeletal system, hip disarticulation, flexible protective outer surface covering system
injection, bleomycin sulfate, 15 units
injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg
services performed by chaplain in the hospice setting, each 15 minutes
application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area
implantable neurostimulator, pulse generator, any type
manual wheelchair accessory, pneumatic caster tire, any size, each
screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with manual screening and rescreening by cytotechnologist under physician supervision
conformity evaluation
tracheostomy shower protector, each
transcatheter intraoperative blood vessel microinfusion(s) (e.g., intraluminal, vascular wall and/or perivascular) therapy, any vessel, including radiological supervision and interpretation, when performed
iv pole
replacement, handgrip, cane, crutch, or walker, each
flowerderm, per square centimeter
home infusion therapy, catheter care / maintenance, not otherwise classified; includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
upper extremity addition, frame type socket, shoulder disarticulation
stent, non-coronary, temporary, with delivery system
administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit
benzodiazepines terminated december 31, 2015.
technetium tc-99m tilmanocept, diagnostic, up to 0.5 millicuries
addition to lower extremity, endoskeletal system, above knee - knee disarticulation, 4 bar linkage, with friction swing phase control
power wheelchair, group 2 heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds
speech generating device, synthesized speech, permitting multiple methods of message formulation and multiple methods of device access
screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed terminated december 31, 2017.
mental/behavioral health mips specialty set
hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg
addition to upper extremity prosthesis, above elbow disarticulation, acrylic material
power wheelchair, group 2 standard, portable, captains chair, patient weight capacity up to and including 300 pounds
cystourethroscopy, with insertion of transprostatic implant; 4 or more implants
injection, fondaparinux sodium, 0.5 mg
indwelling intraurethral drainage device with valve, patient inserted, replacement only, each terminated march 31, 2021.
counseling and discussion regarding advance directives or end of life care planning and decisions, with patient and/or surrogate (list separately in addition to code for appropriate evaluation and management service)
perphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
battery cables; replacement for patient-owned ventilator
addition to lower extremity, socket insert, multi-durometer, below knee
dermal substitute, native, non-denatured collagen, fetal bovine origin (surgimend collagen matrix), per 0.5 square centimeters
magnetic resonance angiography without contrast, spinal canal and contents
history of or active diagnosis of familial hypercholesterolemia
catheter, hemodialysis/peritoneal, short-term
coordinated care fee, risk adjusted high, initial
all quality actions for the applicable measures in the sleep apnea measures group have been performed for this patient terminated december 31, 2016.
face mask interface, replacement for full face mask, each
injection, nivolumab, 1 mg terminated december 31, 2015.
brachytherapy source, non-stranded, yttrium-90, per source
manual wheelchair accessory, for pediatric size wheelchair, dynamic seating frame, allows coordinated movement of multiple positioning features
high compression bandage, elastic, knitted/woven, load resistance greater than or equal to 1.35 foot pounds at 50% maximum stretch, width greater than or equal to three inches and less than five inches, per yard
adults who have not had at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days
metal-on-metal total hip resurfacing, including acetabular and femoral components
federally qualified health center (fqhc) visit, new patient; a medically-necessary, face-to-face encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit
adult sized disposable incontinence product, brief/diaper, small, each
portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing
male vacuum erection system
refill kit for implantable infusion pump
ostomy pouch, drainable, with faceplate attached, plastic, each
assisted oocyte fertilization, case rate
power wheelchair, group 3 standard, single power option, captains chair, patient weight capacity up to and including 300 pounds
documentation of screening for uterine malignancy or those that had an ultrasound and/or endometrial sampling of any kind
clinic visit/encounter, all-inclusive
destruction of localized lesion of choroid (for example, choroidal neovascularization); photocoagulation, feeder vessel technique (one or more sessions)
walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
injection, phentolamine mesylate, up to 5 mg
oncology; practice guidelines; management differs from guidelines for reason(s) associated with patient comorbid illness or performance status not factored into guidelines (for use in a medicare-approved demonstration project)
i intend to report the multiple chronic conditions measures group terminated december 31, 2016.
injection, cefoxitin sodium, 1 gm
documentation of medical reason(s) for most recent blood pressure not being under control (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) terminated december 31, 2014.
clinical decision support mechanism test appropriate, as defined by the medicare appropriate use criteria program terminated december 31, 2020.
dynamic adjustable knee extension / flexion device, includes soft interface material
drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed
injection, rolapitant, 0.5 mg
ostomy skin barrier, liquid (spray, brush, etc.), per oz
infusion, albumin (human), 25%, 50 ml
home infusion therapy, repair of infusion device (e.g., pump repair)
irrigation solution for treatment of bladder calculi, for example renacidin, per 500 ml
dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation, reason not otherwise specified
shingrix vaccine not documented as administered, reason not given terminated december 31, 2020.
spherocylinder, single vision, plus or minus 7.25 to plus or minus 12.00d sphere, 2.25d to 4.00d cylinder, per lens
injection, epoetin beta, 1 microgram, (for esrd on dialysis)
heavy duty shock absorber for heavy duty or extra heavy duty manual wheelchair, each
manual wheelchair accessory, nonstandard seat frame, width greater than or equal to 20 inches and less than 24 inches
documentation of medical reason(s) for not including the histological type or nsclc-nos classification with an explanation (e.g. specimen insufficient or non-diagnostic, specimen does not contain cancer, or other documented medical reasons)
walker, folding, wheeled, adjustable or fixed height
injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specified
transfer of an orthosis from one shoe to another, caliper plate, new
cast supplies, hip spica (one or both legs), pediatric (0-10 years), fiberglass
injection, rituximab and hyaluronidase, 10 mg terminated december 31, 2018.
adults who are deliberately phased out of medication assisted treatment (mat) prior to 180 days of continuous treatment
non-emergency transportation and air travel (private or commercial) intra or inter state
power wheelchair accessory, head control or extremity control interface, electronic, proportional, including all related electronics and fixed mounting hardware
magnetic resonance imaging without contrast, breast; bilateral terminated december 31, 2018.
matrion, per square centimeter
seven standard field stereoscopic photos with interpretation by an ophthalmologist or optometrist documented and reviewed terminated december 31, 2020.
dose optimization by area under the curve (auc) analysis, for infusional 5-fluorouracil
ostomy pouch, urinary, with extended wear barrier attached (1 piece), each
injection, factor viii fc fusion protein (recombinant), per iu terminated december 31, 2015.
remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires at least 2 of the following 3 key components: a detailed history; a detailed examination; medical decision making of moderate complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 25 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology
technetium tc-99m fanolesomab, diagnostic, per study dose, up to 25 millicuries
power wheelchair, group 2 extra heavy duty, sling/solid seat/back, patient weight capacity 601 pounds or more
neurology mips specialty set
external recharging system for battery (internal) for use with implantable neurostimulator, replacement only
wrist disarticulation, external power, self-suspended inner socket, removable forearm shell, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device
disease management program; initial assessment and initiation of the program
tracheostomy/laryngectomy tube plug/stop, each
prenatal care, at risk enhanced service; care coordination
injection, idarubicin hydrochloride, 5 mg
injection, methyldopate hcl, up to 250 mg
implantable neurostimulator pulse generator, single array, non-rechargeable, includes extension
ostomy pouch, urinary, with extended wear barrier attached, with built-in convexity, with faucet-type tap with valve (1 piece), each
transport chair, adult size, heavy duty, patient weight capacity greater than 300 pounds
gait trainer, pediatric size, anterior support, includes all accessories and components
non-covered item or service
federally qualified health center (fqhc) visit, ippe or awv; a fqhc visit that includes an initial preventive physical examination (ippe) or annual wellness visit (awv) and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving an ippe or awv
injection, interferon beta-1a, 1 mcg for intramuscular use
behavioral health day treatment, per hour
injection, amphotericin b cholesteryl sulfate complex, 10 mg
nasal prosthesis, provided by a non-physician
pneumococcal vaccination not administered prior to discharge, reason not specified
injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)
patient not eligible due to active diagnosis of hypertension
adult sized disposable incontinence product, protective underwear/pull-on, above extra large, each
interscapular-thoracic, external power, molded inner socket, removable shoulder shell, shoulder bulkhead, humeral section, mechanical elbow, forearm, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device
retinal tamponade device, silicone oil
induced abortion, 29 to 31 weeks
infusion, albumin (human), 5%, 50 ml
sensor; invasive (e.g., subcutaneous), disposable, for use with interstitial continuous glucose monitoring system, one unit = 1 day supply
gradient compression stocking, below knee, 30-40 mmhg, each
documentation of medical reason(s) for not receiving one-time screening for hcv infection (e.g., decompensated cirrhosis indicating advanced disease [ie, ascites, esophageal variceal bleeding, hepatic encephalopathy], hepatocellular carcinoma, waitlist for organ transplant, limited life expectancy, other medical reasons)
hemophilia clotting factor, not otherwise classified
pelvic belt/harness/boot
injection, neostigmine methylsulfate, up to 0.5 mg
injection, mecasermin, 1 mg
extremity belt/harness
improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration not performed for ed admitted patients
injection, follitropin beta, 75 iu
enteral formula, nutritionally complete, for special metabolic needs for inherited disease of metabolism, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit
nasogastric tubing with stylet
injection, ticarcillin disodium and clavulanate potassium, 3.1 grams
assistive listening device, for use with cochlear implant
magnetic resonance angiography with contrast, abdomen
immediate post surgical or early fitting, application of initial rigid dressing, including fitting, alignment and suspension, below knee, each additional cast change and realignment
injection, gatifloxacin, 10 mg terminated december 31, 2016.
blood, split unit
hospice home care provided in a hospice facility
final reports for ct, cta, mri or mra of the chest or neck with follow-up imaging recommended
home infusion therapy, chemotherapy infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code with s9330 or s9331)
upper extremity addition, test socket, wrist disarticulation or below elbow
non-emergency transportation, per mile - vehicle provided by individual (family member, self, neighbor) with vested interest
patients prescribed opiates for longer than six weeks terminated december 31, 2021.
compression bandage, roll
addition to lower extremity orthosis, tibial length sock, fracture or equal, each
self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to three inches and less than five inches, per yard
cystourethroscopy, with insertion of temporary prostatic implant/stent with fixation/anchor and incisional struts
ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in convexity, each
injection, triamcinolone acetonide (xipere), 1 mg
trifocal add over 3.25d
lung biopsy plug with delivery system
addition to tlso, (low profile), anterior thoracic extension
shoulder orthosis, shoulder joint design, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment
infusion, d5w, 1000 cc
seat, planar, for pediatric size wheelchair including fixed attaching hardware
adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5. either phq-9 or phq-9m score was not assessed or is greater than or equal to 5
power wheelchair, group 2 very heavy duty, single power option, sling/solid seat/back, patient weight capacity 451 to 600 pounds
segmental gradient pressure pneumatic appliance, half leg
low dose rate (ldr) prostate brachytherapy services, composite rate
patient received one-time screening for hcv infection
patient does not have a history of active drainage from the ear within the previous 90 days
transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; including probe placement, image acquisition, interpretation and report
technetium tc-99m sestamibi, diagnostic, per study dose
most recent ldl-c not under control, results documented and reviewed terminated december 31, 2014.
weight management classes, non-physician provider, per session
portable oxygen contents, liquid, 1 month's supply = 1 unit
wheelchair accessory, lateral trunk or hip support, any type, including fixed mounting hardware, each
static progressive stretch shoulder device, with or without range of motion adjustment, includes all components and accessories
lower extremity prosthesis, not otherwise specified
transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; follow-up or limited study
acetaminophen terminated december 31, 2015.
gradient compression stocking, thigh length, 18-30 mmhg, each
patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy
speech therapy, re-evaluation
alcohol and/or drug services; sub-acute detoxification (hospital inpatient)
injection, paliperidone palmitate extended release, 1 mg
one-time screening for hcv infection not received within 12-month reporting period and no documentation of prior screening for hcv infection, reason not given
clinician diagnosed breast cancer preoperatively by a minimally invasive biopsy method
tape, non-waterproof, per 18 square inches
dolasetron mesylate, oral 50 mg (for circumstances falling under the medicare statute, use q0180)
initiation of medication for the treatment of opioid use disorder in the emergency department setting, including assessment, referral to ongoing care, and arranging access to supportive services (list separately in addition to code for primary procedure)
injection, rituximab-abbs, biosimilar, (truxima), 10 mg
tacrolimus, immediate release, oral, 1 mg
splint, prefabricated, elbow
most recent systolic blood pressure < 140 mmhg
injection, ipilimumab, 1 mg
documented reason in the medical records for why the statin therapy was not prescribed (i.e., lower extremity bypass was for a patient with non-artherosclerotic disease)
sign language or oral interpretive services, per 15 minutes
assessment of adequacy of volume management not documented, reason not given
anoscopy; with directed submucosal injection(s), any substance terminated december 31, 2014.
sexual offender treatment service, per diem
knee orthosis, without knee joint, rigid, custom fabricated
patients who abstained from smoking prior to anesthesia on the day of surgery or procedure
addition, endoskeletal, knee-shin system, stance flexion feature, adjustable
patient had history of at least one of the following contraindications any time during or before the measurement period: anaphylaxis due to tdap vaccine, anaphylaxis due to td vaccine or its components; encephalopathy due to tdap or td vaccination (post tetanus vaccination encephalitis, post diphtheria vaccination encephalitis or post pertussis vaccination encephalitis.) terminated december 31, 2020.
injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg
prosthetic sheath, above knee, each
provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the home and reporting of test results to physician; testing not occurring more frequently than once a week; testing materials, billing units of service include 4 tests
parenting classes, non-physician provider, per session
documentation of medical reason(s) for not on a daily aspirin or other antiplatelet (e.g., history of gastrointestinal bleed, intra-cranial bleed, idiopathic thrombocytopenic purpura (itp), gastric bypass or documentation of active anticoagulant use during the measurement period)
tracheostomy mask, each
volume control ventilator, without pressure support mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube) terminated december 31, 2015.
hepatitis c quantitative rna testing not performed between 4-12 weeks after the initiation of antiviral treatment for documented reason(s) (e.g., patients whose treatment was discontinued during the testing period prior to testing, other medical reasons, patient declined, other patient reasons) terminated december 31, 2016.
assistive listening device, personal fm/dm system, binaural, (2 receivers, transmitter, microphone), any type
isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
prolotherapy
addition to lower extremity, abduction bar-straight
external upper limb tremor stimulator of the peripheral nerves of the wrist
orthotic and prosthetic supply, accessory, and/or service component of another hcpcs "l" code
injection, sacituzumab govitecan-hziy, 2.5 mg
injection, c-1 esterase inhibitor (human), berinert, 10 units
bone marrow or blood-derived stem cells (peripheral or umbilical), allogeneic or autologous, harvesting, transplantation, and related complications; including: pheresis and cell preparation/storage; marrow ablative therapy; drugs, supplies, hospitalization with outpatient follow-up; medical/surgical, diagnostic, emergency, and rehabilitative services; and the number of days of pre-and post-transplant care in the global definition
ostomy skin barrier, with flange (solid, flexible or accordion), with built-in convexity, any size, each
oncology; disease status; non-hodgkin's lymphoma, any cellular classification; diagnostic evaluation, stage not determined, evaluation of possible relapse or non-response to therapy, or not listed (for use in a medicare-approved demonstration project)
injection, diazepam, up to 5 mg
powered pressure reducing mattress overlay/pad, alternating, with pump, includes heavy duty
processing, preserving and transporting corneal tissue
injection, cangrelor, 1 mg
bmi not documented due to medical reason or patient refusal of height or weight measurement
spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere, 2.12 to 4.00d cylinder, per lens
neuromuscular stimulator, electronic shock unit
patient received follow-up within 7 days after discharge
isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram
tracheostoma valve, including diaphragm, each
services by a journal-listed christian science practitioner for the purpose of healing, per diem
ankle foot orthosis, posterior solid ankle, plastic, custom fabricated
injection, levetiracetam, 10 mg
risk-adjusted functional status change residual score for the low back impairment not measured because the patient did not complete the low back fs prom at initial evaluation and/or near discharge, reason not given
gauze, impregnated, hydrogel, for direct wound contact, sterile, pad size 16 sq. in. or less, each dressing
neurosurgical mips specialty set
antiemetic drug, rectal/suppository, not otherwise specified
high osmolar contrast material, 300-349 mg/ml iodine concentration, per ml
home infusion therapy, anti-tumor necrosis factor intravenous therapy; (e.g., infliximab); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
statin not prescribed at discharge terminated december 31, 2016.
power wheelchair, group 3 standard, multiple power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds
complex lymphedema therapy, each 15 minutes
addition to ctlso or scoliosis orthosis, lumbar or lumbar rib pad
adhesive remover or solvent (for tape, cement or other adhesive), per ounce
static or dynamic ankle foot orthosis, including soft interface material, adjustable for fit, for positioning, may be used for minimal ambulation, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
patient documented to have experienced a fall within asc
injection, nelarabine, 50 mg
revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy and transluminal stent placement(s), and atherectomy, includes angioplasty within the same vessel (s), when performed
intervention for presence of leak of endoluminal contents through an anastomosis required
no unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery terminated december 31, 2020.
injection, meropenem, 100 mg
drug administered through a metered dose inhaler
legg perthes orthosis, (patten bottom type), custom fabricated
community transition, waiver; per service
permanent, long term, non-dissolvable lacrimal duct implant, each
addition to lower extremity, test socket, knee disarticulation
injection, ampicillin sodium/sulbactam sodium, per 1.5 gm
evaluation and treatment by an integrated, specialty team contracted to provide coordinated care to multiple or severely handicapped children, per encounter
5% dextrose/normal saline (500 ml = 1 unit)
intraoperative cystoscopy not performed to evaluate for lower tract injury
shoulder elbow wrist hand orthosis, abduction positioning (airplane design), thoracic component and support bar, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment
physical therapy/occupational therapy mips specialty set
unspecified oral dosage form, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for a iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
injection, clevidipine butyrate, 1 mg
mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals terminated december 31, 2019.
podiatry mips specialty set
cervical, flexible, non-adjustable, prefabricated, off-the-shelf (foam collar)
national committee for quality assurance - level 1 medical home
cast supplies, short leg splint, adult (11 years +), fiberglass
power wheelchair accessory, 12 to 24 amp hour sealed lead acid battery, each (e.g., gel cell, absorbed glassmat)
hydrocolloid dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing
functional status was measured by the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at three months (6 to 20 weeks) postoperatively terminated december 31, 2019.
eye glass case
injection, arsenic trioxide, 1 mg
carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals terminated december 31, 2019.
ultrasound b-scan and/or real time with image documentation; for abdominal aortic aneurysm (aaa) screening terminated december 31, 2016.
zinc air battery for use with cochlear implant device and auditory osseointegrated sound processors, replacement, each
injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u.
injection, hydroxyprogesterone caproate, 1 mg terminated december 31, 2017.
scleral application of tantalum ring(s) for localization of lesions for proton beam therapy
addition to lower extremity, socket insert, knee disarticulation (kemblo, pelite, aliplast, plastazote or equal)
vehicle modifications, waiver; per service
apnea hypopnea index (ahi) or respiratory disturbance index (rdi) not measured at the time of initial diagnosis, reason not given
injection, cerliponase alfa, 1 mg
hearing aid, monaural, body worn, air conduction
wheelchair accessory, power seating system, combination tilt and recline, without shear reduction
documentation of medical reason(s) for prescribing systemic antimicrobials
wheelchair accessory, power seating system, combination tilt and recline, with power shear reduction
addition to lower extremity orthosis, non-corrosive finish, per bar
all quality actions for the applicable measures in the oncology measures group have been performed for this patient terminated december 31, 2016.
traction equipment, overdoor, cervical
audiology mips specialty set
most recent hemoglobin (hgb) level > 12.0 g/dl terminated december 31, 2014.
rear wheel assembly, complete, with solid tire, spokes or molded, replacement only, each
mouth piece
hip orthosis, abduction control of hip joints, semi-flexible (von rosen type), custom fabricated
below knee, plastic socket, joints and thigh lacer, sach foot
foot, abduction rotation bar, including shoes
injection, rituximab, 100 mg terminated december 31, 2018.
injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg terminated june 30, 2022.
lightweight portable motorized/power wheelchair
incontinence supply, urethral insert, any type, each
non-invasive vagus nerve stimulator
dysphagia screening
donor services for in vitro fertilization (sperm or embryo), case rate
fluid flow or fluid gf, 1 cc
injection, ceftaroline fosamil, 10 mg
comprehensive geriatric assessment and treatment planning performed by assessment team
wound filler, gel/paste, per fluid ounce, not otherwise specified
all quality actions for the applicable measures in the cataract measures group have been performed for this patient terminated december 31, 2016.
drug test(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, tof, maldi, ldtd, desi, dart, ghpc, gc mass spectrometry), includes sample validation when performed, per date of service terminated december 31, 2016.
glasses, bone conduction
wheelchair accessory, addition to mobile arm support, supinator
hospice care provided in skilled nursing facility (snf)
injection, delafloxacin, 1 mg
development of cognitive skills to improve attention, memory, problem solving (includes compensatory training), direct (one-on-one) patient contact, each 15 minutes terminated december 31, 2019.
electron beam computed tomography (also known as ultrafast ct, cine ct)
statin prescribed at discharge terminated december 31, 2016.
home visit for wound care
injection, terbutaline sulfate, up to 1 mg
parenteral nutrition supply kit; home mix, per day
all lower extremity prosthesis, solid ankle cushion heel (sach) foot, replacement only
alcohol (ethanol); any specimen except breath terminated december 31, 2015.
injection, hemin, 1 mg
laparoscopy for islet cell transplant, includes portal vein catheterization and infusion
injection, testosterone cypionate, 1 mg
graftjacket, per square centimeter
addition to lower extremity, patten bottom
preventive medicine mips specialty set
screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision
clinician documented that patient was not an eligible candidate for antidepressant medication during the entire 12 week acute treatment phase measure terminated december 31, 2014.
injection, c-1 esterase inhibitor (human), (haegarda), 10 units
intensive outpatient psychiatric services, per diem
adults currently taking pharmacotherapy for oud
sphere, bifocal, plus or minus 7.12 to plus or minus 20.00d, per lens
addition to lower extremity, endoskeletal system, above knee, universal multiplex system, friction swing phase control
non-emergency transportation; stretcher van
catheter, ablation, non-cardiac, endovascular (implantable)
addition to lower extremity, below knee, flexible inner socket, external frame
hospice services utilized by patient any time during the measurement period
fluoroestradiol f18, diagnostic, 1 mci terminated december 31, 2020.
oscillatory positive expiratory pressure device, non-electric, any type, each
injection, ravulizumab-cwvz, 10 mg
catheter, electrophysiology, diagnostic, other than 3d mapping (20 or more electrodes)
patient is using hospice services any time during the measurement period
screening proctoscopy
foot, abduction rotation bar, without shoes
nursing care, in the home; by licensed practical nurse, per hour
heel, counter, leather reinforced
orthopedic shoe addition, sole, half
hearing aid, digital, binaural, bte
collagen matrix nerve wrap (neuromend collagen nerve wrap), per 0.5 centimeter length
buprenorphine, oral, 1 mg
water circulating heat pad with pump
documentation of patient discharged to home later than post-operative day 2 following cas
radiation exposure indices, or exposure time and number of fluorographic images in final report for procedures using fluoroscopy, documented
travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge
enteral formula, nutritionally complete with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit
power wheelchair accessory, harness for upgrade to expandable controller, including all fasteners, connectors and mounting hardware, each
unlisted procedure, intestine terminated december 31, 2015.
set-up portable x-ray equipment
oasis burn matrix, per square centimeter
social work visit, in the home, per diem
loxapine for inhalation, 1 mg
cochlear device, includes all internal and external components
functional status measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively was less than or equal to 22 or functional status measured by the odi version 2.1a within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of 30 points or greater
wellness assessment, performed by non-physician
transportation waiting time, air ambulance and non-emergency vehicle, one-half (1/2) hour increments
matristem burn matrix, per square centimeter terminated december 31, 2016.
noncovered ambulance mileage, per mile (e.g., for miles traveled beyond closest appropriate facility)
lithium ion battery, rechargeable, replacement
tlso, sagittal control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, restricts gross trunk motion in sagittal plane, produces intracavitary pressure to reduce load on intervertebral disks, prefabricated, off-the-shelf
nursing care, in the home, by registered nurse, per diem
transparent film, sterile, 16 sq. in. or less, each dressing
red blood cells, leukocytes reduced, cmv-negative, irradiated, each unit
speech generating device, digitized speech, using pre-recorded messages, less than or equal to 8 minutes recording time
albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme
spherocylinder, bifocal, plus or minus 7.25 to plus or minus 12.00d sphere, .25 to 2.25d cylinder, per lens
enteral formula, for pediatrics, nutritionally complete with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber and/or iron, administered through an enteral feeding tube, 100 calories = 1 unit
preparatory, hip disarticulation-hemipelvectomy, pylon, no cover, sach foot, laminated socket, molded to patient model
documentation of medical reason(s) for not on a statin (e.g., pregnancy, in vitro fertilization, clomiphene rx, esrd, cirrhosis, muscular pain and disease during the measurement period or prior year)
urine protein test was not performed, reason not given terminated december 31, 2014.
surfactor or nudyn, per 0.5 cc
auditory osseointegrated device abutment, any length, replacement only
injection, melphalan (evomela), 1 mg
risk-adjusted functional status change residual score for the elbow, wrist or hand impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)
traction frame, attached to footboard, pelvic traction
power wheelchair, group 2 heavy duty, single power option, captains chair, patient weight capacity 301 to 450 pounds
adults who have at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days
homemaker service, nos; per diem
injection, triamcinolone acetonide, preservative free, 1 mg
topical hyperbaric oxygen chamber, disposable
cervical, multiple post collar, occipital/mandibular supports, adjustable cervical bars (somi, guilford, taylor types)
skin substitute, fda cleared as a device, not otherwise specified
oncology; disease status; pancreatic cancer, limited to adenocarcinoma; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)
injection, phenobarbital sodium, up to 120 mg
partial hand, little and/or ring finger remaining
addition to ctlso or scoliosis orthosis, ring flange, plastic or leather, molded to patient model
all quality actions for the applicable measures in the general surgery measures group have been performed for this patient terminated december 31, 2016.
pacemaker, single chamber, rate-responsive (implantable)
fern test
cervical, multiple post collar, occipital/mandibular supports, adjustable cervical bars, and thoracic extension
power wheelchair component, drive wheel gear box, replacement only
psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi))
standard - weight frame motorized/power wheelchair
belt/vest/bag for use to carry external peripheral components of any type ventricular assist device, replacement only
no antiplatelet medication at discharge terminated december 31, 2014.
reaching/grabbing device, any type, any length, each
custom shaped protective cover, above knee
behavioral health; residential (hospital residential treatment program), without room and board, per diem
injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.)
replace quadrilateral socket brim, custom fitted
topotecan, oral, 0.25 mg
non-emergency transportation; stretcher van, mileage; per mile
injection, bivalirudin, 1 mg
introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away
oncology; practice guidelines; management differs from guidelines because the treating physician disagrees with guideline recommendations (for use in a medicare-approved demonstration project)
injection, biperiden lactate, per 5 mg
stationary liquid oxygen system, rental; includes container, contents, regulator, flowmeter, humidifier, nebulizer, cannula or mask, & tubing
most recent tobacco status is tobacco free
lead wires, (e.g., apnea monitor), per pair
hospital bed, total electric (head, foot and height adjustments), without side rails, with mattress
terminal device, multiple articulating digit, includes motor(s), initial issue or replacement
injection, dimercaprol, per 100 mg
history of receiving blood transfusions prior to 1992 terminated december 31, 2021.
artacent ac, 1 mg
yttrium y-90 ibritumomab tiuxetan, therapeutic, per treatment dose, up to 40 millicuries
promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
p2y inhibitor not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed) terminated december 31, 2016.
ultrasonic/electronic aerosol generator with small volume nebulizer
ippb machine, all types, with built-in nebulization; manual or automatic valves; internal or external power source
manual wheelchair accessory, power add-on to convert manual wheelchair to motorized wheelchair, tiller control
gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 48 sq. in., without adhesive border, each dressing
left ventricular ejection fraction (lvef) < 40% or documentation of severely or moderately depressed left ventricular systolic function terminated december 31, 2014.
advanced life support, level 2 (als 2)
addition to lower extremity, thigh/weight bearing, ischial containment/narrow m-l brim, custom fitted
patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 180 day (6 months) continuation treatment phase terminated december 31, 2014.
addition to lower extremity, pelvic control, hip joint, clevis or thrust bearing, lock, each
addition to lower extremity, symes type, posterior opening (canadian) socket
dermal filler injection(s) for the treatment of facial lipodystrophy syndrome (lds) (e.g., as a result of highly active antiretroviral therapy)
patient received at least one well-child visit with a pcp during the performance period
prosthetic sock, single ply, fitting, upper limb, each
gradient pressure aid (glove), ready made
spkt/v greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v]) terminated december 31, 2015.
home ventilator, any type, used with invasive interface, (e.g., tracheostomy tube)
dermagraft, per square centimeter
documentation of medical reason(s) for not receiving annual screening for hcv infection (e.g., decompensated cirrhosis indicating advanced disease [i.e., ascites, esophageal variceal bleeding, hepatic encephalopathy], hepatocellular carcinoma, waitlist for organ transplant, limited life expectancy, other medical reasons)
platelets, pheresis, pathogen-reduced, each unit
documentation of reason(s) for not prescribing positive airway pressure therapy (e.g., patient unable to tolerate, alternative therapies use, patient declined, financial, insurance coverage)
injection, trastuzumab, excludes biosimilar, 10 mg
spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, 2.12 to 4.00d cylinder, per lens
hearing aid, digitally programmable, binaural, bte
nebulizer, durable, glass or autoclavable plastic, bottle type, not used with oxygen
toilet rail, each
services performed by a qualified speech-language pathologist in the home health or hospice setting, each 15 minutes
halo procedure, cervical halo incorporated into milwaukee type orthosis
motor speech functional limitation, discharge status, at discharge from therapy or to end reporting terminated december 31, 2019.
remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: an expanded problem focused history; an expanded problem focused examination; straightforward medical decision making, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of low to moderate severity. typically, 20 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology
catheter, hemodialysis/peritoneal, long-term
ostomy pouch, urinary, with faceplate attached, rubber, each
5% dextrose/0.45% normal saline with potassium chloride and magnesium sulfate, 1500 ml
oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage iiia-iiib; and not t3, n1, m0; and er and pr negative; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
lodging, per diem, not otherwise classified
finger orthosis, proximal interphalangeal (pip)/distal interphalangeal (dip), non torsion joint/spring, extension/flexion, may include soft interface material, prefabricated, off-the-shelf
ostomy skin barrier, with flange (solid, flexible or accordion), without built-in convexity, 4 x 4 inches or smaller, each
alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes
blood pressure has a systolic value of < 140 and a diastolic value of < 90
exsufflation belt, includes all supplies and accessories
pail or pan for use with commode chair, replacement only
terminal device, hook, mechanical, voluntary closing, any material, any size, lined or unlined
hearing aid, digitally programmable analog, binaural, cic
upper extremity addition, shoulder flexion-abduction joint, each
dynamic adjustable forearm pronation/supination device, includes soft interface material
patient achieved a pdc of at least 75% for their asthma controller medication
replacement supplies and accessories for external upper limb tremor stimulator of the peripheral nerves of the wrist
assistive listening device, tdd
direct skilled nursing services of a registered nurse (rn) in the home health or hospice setting, each 15 minutes
dry pressure mattress
addition to lower extremity, thoracic control, paraspinal uprights
gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie
implantable neurostimulator pulse generator, single array, rechargeable, includes extension
copper cu-64, dotatate, diagnostic, 1 millicurie
satisfaction with care not achieved within 90 days following cataract surgery
metacarpophalangeal joint implant
injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
transurethral destruction of prostate tissue; by radiofrequency water vapor (steam) thermal therapy terminated december 31, 2018.
injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg
patient with minor blunt head trauma had an appropriate indication(s) for a head ct
injection, cefiderocol, 5 mg terminated september 30, 2021.
injection, mesna, 200 mg
compressor, air power source for equipment which is not self-contained or cylinder driven
parenteral nutrition solution compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, stress-branch chain amino acids-freamine-hbc-premix
replace molded thigh lacer, for custom fabricated orthosis only
home infusion therapy, all supplies (including catheter) necessary for a midline catheter insertion
compression burn garment, lower trunk including leg openings (panty), custom fabricated
injection, interferon beta-1a, 1 mcg for subcutaneous use
addition to lower extremity, dorsiflexion and plantar flexion assist/resist, each joint
electrocardiogram, routine ecg with 12 leads; interpretation and report only, performed as a screening for the initial preventive physical examination
insulin, most rapid onset (lispro or aspart); 5 units
pneumococcal vaccine administered on or after patient's 60th birthday and before the end of the measurement period
incontinence product, diaper/brief, reusable, any size, each
oseltamivir phosphate, oral, brand, per 75 mg (for use in a medicare-approved demonstration project) terminated december 31, 2019.
pathology report does not include the pt category and a statement on thickness and ulceration and for pt1, mitotic rate
no stroke following isolated cabg surgery terminated december 31, 2020.
injection, cefepime hydrochloride, 500 mg
terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
patient received hospice services any time during the measurement period
tint, photochromatic, per lens
addition to knee joint, drop lock, each
patient is undergoing palliative dialysis with a catheter terminated december 31, 2020.
injection, leuprolide acetate (for depot suspension), per 3.75 mg
oral aspirin or other antithrombotic therapy prescribed terminated december 31, 2014.
all quality actions for the applicable measures in the heart failure (hf) measures group have been performed for this patient terminated december 31, 2016.
no beta-blocker at discharge terminated december 31, 2014.
hydrocolloid dressing, wound filler, dry form, sterile, per gram
contact lens, hydrophilic, extended wear, per lens
gauze, impregnated, water or normal saline, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing
rotary wing air mileage, per statute mile
cellesta cord, per square centimeter
patient programmer (external) for use with implantable programmable neurostimulator pulse generator, replacement only
injection, gadoxetate disodium, 1 ml
injection, garamycin, gentamicin, up to 80 mg
injection, testosterone enanthate, 1 mg
injection, edetate calcium disodium, up to 1000 mg
addition to upper extremity orthosis, sock, fracture or equal, each
order for anti-platelet agents was not documented in the patient's record, reason not given
injection, trilaciclib, 1 mg terminated september 30, 2021.
diskectomy, anterior, with decompression of spinal cord and/or nerve root(s), including osteophytectomy; lumbar, single interspace
supplies for home delivery of infant
wound care set, for negative pressure wound therapy electrical pump, includes all supplies and accessories
external ambulatory infusion pump, insulin, dosage rate adjustment using therapeutic continuous glucose sensing
above elbow, molded double wall socket, internal locking elbow, forearm
continuous positive airway pressure (cpap) device
injection, sutimlimab-jome, 10 mg
injection, trimethobenzamide hcl, up to 200 mg
carrying, moving & handling objects functional limitation, discharge status, at discharge from therapy or to end reporting terminated december 31, 2019.
injection, iron sucrose, 1 mg
amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis for documented reason
documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care terminated december 31, 2020.
filter removed within 3 months of placement
stationary liquid oxygen system, purchase; includes use of reservoir, contents indicator, regulator, flowmeter, humidifier, nebulizer, cannula or mask, and tubing
power wheelchair, group 4 heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds
prednisone, oral, per 5 mg terminated december 31, 2015.
influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)
patient is not currently on a daily aspirin or other antiplatelet
most current ldl-c <100mg/dl terminated december 31, 2014.
patient pregnancy terminated december 31, 2020.
injection, protein c concentrate, intravenous, human, 10 iu
documentation of diagnosis of chronic kidney disease terminated december 31, 2014.
non-segmental pneumatic appliance for use with pneumatic compressor, half leg
wheelchair accessory, addition to mobile arm support, elevating proximal arm
other physical or occupational therapy subsequent functional limitation, current status, at therapy episode outset and at reporting intervals terminated december 31, 2019.
tobacco assessment or tobacco cessation intervention not performed, reason not given
ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record
patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period
traction stand, free standing, pelvic traction, (e.g., buck's)
patients with clinical indications for imaging of the head: head trauma
opiate(s), drug and metabolites, each procedure terminated december 31, 2015.
wrist hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, custom fabricated, includes fitting and adjustment
cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), fiberglass
gradient compression stocking, garter belt
spirometry test not performed or documented, reason not given terminated december 31, 2021.
patients who had the prophylactic antibiotic completely infused prior to the inflation of the proximal tourniquet terminated december 31, 2020.
high frequency chest wall oscillation system hose, replacement for use with patient owned equipment, each
azathioprine, parenteral, 100 mg
home health aide or certified nurse assistant, providing care in the home; per hour
power wheelchair, group 4 very heavy duty, single power option, sling/solid seat/back, patient weight 451 to 600 pounds
meals for individuals receiving alcohol and/or substance abuse services (when meals not included in the program)
patient has metastatic disease at diagnosis
replace high roll cuff
leg pain was measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively terminated december 31, 2019.
open treatment of anterior pelvic bone fracture and/or dislocation for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, includes internal fixation when performed (includes pubic symphysis and/or superior/inferior rami)
foot, insert, removable, molded to patient model, plastazote or equal, each
injection, regadenoson, 0.1 mg
pathologists/dermatopathologists providing a second opinion on a biopsy
automatic intermittent peritoneal dialysis system
cast supplies, short arm splint, pediatric (0-10 years), fiberglass
injection, siltuximab, 10 mg terminated december 31, 2015.
leuprolide acetate, per 1 mg
non-prescription drugs
acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
stationary oxygen contents, gaseous, 1 month's supply = 1 unit
etoposide; oral, 50 mg
bls routine disposable supplies
changing & maintaining body position functional limitation, discharge status, at discharge from therapy or to end reporting terminated december 31, 2019.
dermapure, per square centimeter
injection, metronidazole, 500 mg
bed side rails, half length
injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis)
incomplete cycle, treatment cancelled prior to stimulation, case rate
detachable, non-adjustable height armrest, replacement only, each
anterior chamber intraocular lens
upper extremity addition, lift assist for elbow
ostomy pouch, drainable, high output, for use on a barrier with flange (2 piece system), without filter, each
soft interface for helmet, replacement only
breast prosthesis, silicone or equal, without integral adhesive
dialysate solution, non-dextrose containing, 500 ml
clinical social work mips specialty set
supported housing, per month
functional status measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively was greater than 22 and functional status measured by the odi version 2.1a within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of less than 30 points
injection, topotecan, 0.1 mg
dialysis procedure with single evaluation by a physician or other qualified health care professional for acute kidney injury without esrd
unclassified drugs
coordinated care fee, home monitoring
phototherapeutic keratectomy (ptk)
event recorder, cardiac (implantable)
imaging of the head (ct or mri) was not obtained, reason not given
physician service required to establish and document the need for a power mobility device
habilitation, prevocational, waiver; per hour
carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting terminated december 31, 2019.
dynamic adjustable finger extension/flexion device, includes soft interface material
ankle foot orthosis, spiral, (institute of rehabilitative medicine type), plastic or other material, prefabricated, includes fitting and adjustment
tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose
addition to lower extremity, above knee or knee disarticulation, pelvic joint
suction pump, home model, portable or stationary, electric, any type, for use with external urine management system
injection, estradiol valerate, up to 10 mg
injection, amivantamab-vmjw, 10 mg terminated december 31, 2021.
injection, radiesse, 0.1 ml
betadine or iodine swabs/wipes, per box
radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: up to 5 mev
hospice care provided in inpatient psychiatric facility
battery charger, twelve volt, each
major amputation or open surgical bypass not required within 48 hours of the index endovascular lower extremity revascularization procedure terminated december 31, 2021.
upper extremity addition, nudge control elbow lock
nortriptyline terminated december 31, 2015.
orthopedic footwear, mens shoe, depth inlay, each
patient unable to complete the low back fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available
cardiac magnetic resonance imaging for morphology and function, quantification of segmental dysfunction; with stress imaging
powered pressure reducing underlay/pad, alternating, with pump, includes heavy duty
physician management of patient home care, hospice monthly case rate (per 30 days)
remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of moderate complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 45 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology
routine foot care by a physician of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include, the local care of superficial wounds (i.e. superficial to muscle and fascia) and at least the following if present: (1) local care of superficial wounds, (2) debridement of corns and calluses, and (3) trimming and debridement of nails
terminal device, hook or hand, heavy duty, mechanical, voluntary closing, any material, any size, lined or unlined
risk-adjusted functional status change residual score for the elbow, wrist or hand impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate terminated december 31, 2019.
injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg
ganciclovir, 4.5 mg, long-acting implant
injection, doxercalciferol, 1 mcg
addition to upper extremity prosthesis, above elbow disarticulation, ultralight material (titanium, carbon fiber or equal)
incidental thyroid nodule < 1.0 cm noted in report
blinded procedure for lumbar stenosis, percutaneous image-guided lumbar decompression (pild) or placebo-control, performed in an approved coverage with evidence development (ced) clinical trial
home infusion therapy, continuous or intermittent anti-emetic infusion therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and visits coded separately), per diem
hospice or home health care provided in place not otherwise specified (nos)
echosclerotherapy
bmi not documented and no reason is given
smoking cessation gum
platelets, leukocytes reduced, irradiated, each unit
hospital bed, semi-electric (head and foot adjustment), without side rails, without mattress
follow-up inpatient consultation, limited, physicians typically spend 15 minutes communicating with the patient via telehealth
hydrocolloid dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing
spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens
clinician treating major depressive disorder did not communicate to clinician treating comorbid condition, reason not given terminated december 31, 2020.
enlargement of ocular prosthesis
contact lens, hydrophilic, toric, or prism ballast, per lens
home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)
ambulance service, basic life support, non-emergency transport, (bls)
manual wheelchair accessory, solid (rubber/plastic) propulsion tire, any size, replacement only, each
rehabilitation services (occupational, physical or speech) ordered at or prior to discharge terminated december 31, 2014.
injection, ziconotide, 1 microgram
injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg terminated december 31, 2017.
waiver services; not otherwise specified (nos)
coordinated care fee, risk adjusted maintenance, level 4
documentation of patients with primary headache diagnosis and imaging other than ct or mri obtained
stent, coated/covered, without delivery system
training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more)
day care services, adult; per half day
heel wedge, sach
leuprolide acetate implant, 65 mg
lvf testing not performed prior to discharge or in the previous 12 months for a medical or patient documented reason terminated december 31, 2014.
serum creatinine test result documented and reviewed terminated december 31, 2014.
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r
addition to lower extremity, split flat caliper stirrups and plate attachment
patients who receive palliative care services any time during the intake period through the end of the measurement year
adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5
cystourethroscopy, with ureteroscopy and/or pyeloscopy, with lithotripsy, and ureteral catheterization for steerable vacuum aspiration of the kidney, collecting system, ureter, bladder, and urethra if applicable
documentation of medical reason(s) in the patient's record for not ordering anti-platelet agents
rheumatology mips specialty set
annual depression screening, 15 minutes
administration and supply of tositumomab, 450 mg terminated december 31, 2016.
wheelchair accessory, tray, each
lift, elevation, heel, per inch
repair device, urinary, incontinence, without sling graft
levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg
injection, denileukin diftitox, 300 micrograms
addition to lower extremity joint, knee or ankle, concentric adjustable torsion style mechanism for custom fabricated orthotics only, each
iodine i-123 sodium iodide, diagnostic, per 100 microcuries, up to 999 microcuries
gauze, non-impregnated, sterile, pad size more than 16 sq. in. less than or equal to 48 sq. in., without adhesive border, each dressing
beta-blocker therapy for lvef < 40% not prescribed for reasons documented by the clinician (e.g., low blood pressure, fluid overload, asthma, patients recently treated with an intravenous positive inotropic agent, allergy, intolerance, other medical reasons, patient declined, other patient reasons, or other reasons attributable to the healthcare system)
oncology/hematology mips specialty set
search not conducted prior to an imaging study being performed for prior patient ct studies completed at non-affiliated external healthcare facilities or entities within the past 12-months and are available through a secure, authorized, media-free, shared archive, reason not given
masters two step
oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease initially established as t1-t3, n0-n1 or nx (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
theragenesis, per square centimeter
wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, adjustable
reason for not administering trastuzumab documented (e.g. patient declined, patient died, patient transferred, contraindication or other clinical exclusion, neoadjuvant chemotherapy or radiation not complete) terminated december 31, 2020.
patients who died from cancer terminated december 31, 2020.
gallium ga-67 citrate, diagnostic, per millicurie
ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose terminated september 30, 2022.
documentation of medical reason for not screening for tb or interpreting results (i.e., patient positive for tb and documentation of past treatment; patient who has recently completed a course of anti-tb therapy)
additions to lower extremity, below knee, knee joints, single axis, pair
alcohol and/or drug services; sub-acute detoxification (residential addiction program inpatient)
transfer of an orthosis from one shoe to another, dennis browne splint (riveton), both shoes
terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
power wheelchair, group 2 standard, single power option, captains chair, patient weight capacity up to and including 300 pounds
fracture, frame, dual with cross bars, attached to bed, (e.g., balken, 4 poster)
patient did not require a return to the operating room within 90 days of surgery
>=50% of total number of a patient's outpatient ra encounters assessed
catheter, intraspinal
injection, phytonadione (vitamin k), per 1 mg
injection, ofloxacin, 400 mg
general use wheelchair seat cushion, width 22 inches or greater, any depth
patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period
miscellaneous supply or accessory for use with an implanted ventricular assist device
alloskin rt, per square centimeter
collagen dressing wound filler, sterile, per 6 inches
post-partum screenings, evaluations and education performed
clinician documented that patient was not an eligible candidate for screening terminated december 31, 2016.
home infusion therapy, continuous insulin infusion therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
hospice referral visit (advising patient and family of care options) performed by nurse, social worker, or other designated staff
documentation that patient is a current tobacco user
addition to ctlso or scoliosis orthosis, kyphosis pad, floating
immersion external heater for nebulizer
foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing
below elbow, external power, self-suspended inner socket, removable forearm shell, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device
specimen site other than anatomic location of esophagus
tlso, flexible, provides trunk support, upper thoracic region, produces intracavitary pressure to reduce load on the intervertebral disks with rigid stays or panel(s), includes shoulder straps and closures, custom fabricated
for diabetics only, direct formed, compression molded to patient's foot without external heat source, multiple-density insert(s) prefabricated, per shoe
wheelchair accessory, shoulder elbow, mobile arm support, monosuspension arm and hand support, overhead elbow forearm hand sling support, yoke type suspension support
i intend to report the back pain measures group terminated december 31, 2014.
adult sized disposable incontinence product, protective underwear/pull-on, extra large size, each
oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, used in conjunction with the power source and control electronics unit, controlled by phone application, 90-day supply
injection procedure for sacroiliac joint; arthrography
patient did not receive both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart, with the first occurrence after the age of 60 before or during measurement period; or have prior pneumococcal vaccine adverse reaction any time during or before the measurement period terminated december 31, 2020.
injection, ciprofloxacin for intravenous infusion, 200 mg
documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., a solitary fibrous tumor in a person with a history of non-small cell carcinoma or other documented medical reasons)
ajcc breast cancer stage i: t1 mic or t1a documented
ajcc melanoma cancer stage 0 through iic melanoma
pessary, non rubber, any type
lead, pacemaker, other than transvenous vdd single pass
ultralightweight wheelchair
platelets, pheresis, pathogen reduced or rapid bacterial tested, each unit terminated december 31, 2017.
insertion tray with drainage bag but without catheter
injection, pegfilgrastim, excludes biosimilar, 0.5 mg
no postoperative renal failure/dialysis not required
aprepitant, oral, 5 mg
bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
insertion tray without drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.)
injection, pegloticase, 1 mg
catheter, intradiscal
documentation of medical reason(s) for not prescribing a long-acting inhaled bronchodilator
ostomy clamp, any type, replacement only, each
vim, per square centimeter
pressure sensor system, includes all components (e.g., introducer, sensor), intramuscular (implantable), excludes mobile (wireless) software application
home blood glucose monitor
repair prosthetic device, labor component, per 15 minutes
injection, testosterone cypionate and estradiol cypionate, up to 1 ml terminated december 31, 2014.
amnioamp-mp, per square centimeter
esrd demo expanded bundle including venous access and related services
tlso, triplanar control, one piece rigid plastic shell with interface liner, multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, anterior or posterior opening, restricts gross trunk motion in sagittal, coronal, and transverse planes, includes a carved plaster or cad-cam model, custom fabricated
patient not screened for unhealthy alcohol use using a systematic screening method, reason not given
dilated macular or fundus exam not performed terminated december 31, 2020.
home injectable therapy, interferon, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
injection, degarelix, 1 mg
gauze, non-impregnated, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing
screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision
alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education
high strength lightweight wheelchair, detachable arms desk or full length, swing away detachable foot rests
hospital bed, semi-electric (head and foot adjustment), with any type side rails, without mattress
electric hook, switch or myoelectric controlled, pediatric
wheelchair accessory, power seating system, tilt only
injection, cefotetan disodium, 500 mg
hydroxyurea, oral, 500 mg
lobar lung transplantation
replace molded calf lacer, for custom fabricated orthosis only
wrist hand finger orthosis, dynamic flexor hinge, reciprocal wrist extension/ flexion, finger flexion/extension, wrist or finger driven, custom fabricated
dispensing fee, binaural
documentation that the patient declined therapy change or has documented contraindications (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi terminated december 31, 2016.
brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion
injection, lidocaine hcl for intravenous infusion, 10 mg
asthma education, non-physician provider, per session
factor ix (antihemophilic factor, recombinant), alprolix, per i.u. terminated december 31, 2014.
patient use of hospice services any time during the measurement period
idecabtagene vicleucel, up to 460 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
iodine i-131 tositumomab, diagnostic, per study dose terminated december 31, 2016.
external recharging system for battery for use with cochlear implant or auditory osseointegrated device, replacement only, each
documentation of at least two attempts to reach the patient to arrange a clinical re-assessment for the appropriateness of filter removal within 3 months of placement
pre-operative pulmonary surgery services for preparation for lvrs, complete course of services, to include a minimum of 16 days of services
immediate post surgical or early fitting, application of initial rigid dressing, incl. fitting, alignment and supension, 'ak' or knee disarticulation, each additional cast change and realignment
patient admitted to palliative care services
any patients who had no asthma controller medications dispensed during the measurement year
orthopedic shoe, oxford with supinator or pronator, infant
manual wheelchair accessory, hand rim with projections, any type, replacement only, each
power wheelchair, not otherwise classified
surgical boot, each, child
platelet rich plasma, each unit
hospital bed, fixed height, without side rails, without mattress
amputee wheelchair, fixed full length arms, without footrests or legrest
nonstandard lens (list this code in addition to the basic code for the lens)
power wheelchair, group 5 pediatric, single power option, sling/solid seat/back, patient weight capacity up to and including 125 pounds
injection, nandrolone decanoate, up to 50 mg
due to medical reasons, search not conducted for dicom format images for prior patient ct imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure, authorized, media-free, shared archive (e.g., ct studies performed for radiation treatment planning or image-guided radiation treatment delivery) terminated december 31, 2015.
amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis, reason not given
surgical boot, each, infant
respiratory suction pump, home model, portable or stationary, electric
cardiology mips specialty set
patient achieves refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit terminated december 31, 2015.
distal transcutaneous electrical nerve stimulator, stimulates peripheral nerves of the upper arm
injection, olanzapine, 2.5 mg
hip core decompression
hospice services for patient received any time during the measurement period
mirror coating, any type, solid, gradient or equal, any lens material, per lens
crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips
injection, risperidone (perseris), 0.5 mg terminated september 30, 2019.
footrest, complete assembly, replacement only, each
headgear used with positive airway pressure device
leg pain as measured by the visual analog scale (vas) at one year (9 to 15 months) postoperatively was less than or equal to 3.0 or leg pain measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of 5.0 points or greater
all quality actions for the applicable measures in the coronary artery disease (cad) measures group have been performed for this patient terminated december 31, 2016.
injection, methylprednisolone acetate, 80 mg
nicotine patches, legend
most recent ldl-c < 100 mg/dl terminated december 31, 2014.
injection, enoxaparin sodium, 10 mg
sexual offender treatment service, per 15 minutes
ankle foot orthosis, posterior, single bar, clasp attachment to shoe counter, prefabricated, includes fitting and adjustment
insulin syringes (100 syringes, any size)
injection, idursulfase, 1 mg
anti-lipid treatment contraindicated terminated december 31, 2014.
patient identified as a tobacco user received tobacco cessation intervention on the date of the encounter or within the previous 12 months (counseling and/or pharmacotherapy)
catheter, balloon dilatation, non-vascular
injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg
injection, gemcitabine hydrochloride (infugem), 200 mg terminated june 30, 2020.
breast prosthesis, mastectomy sleeve
injection, ranitidine hydrochloride, 25 mg
repair of nasal vestibular lateral wall stenosis with implant(s) terminated december 31, 2020.
annual wellness visit; includes a personalized prevention plan of service (pps), initial visit
power wheelchair, group 4 heavy duty, sling/solid seat/back, patient weight capacity 301 to 450 pounds
documentation of medical reason(s) for not ordering a first or second generation cephalosporin for antimicrobial prophylaxis (e.g., patients enrolled in clinical trials, patients with documented infection prior to surgical procedure of interest, patients who were receiving antibiotics more than 24 hours prior to surgery [except colon surgery patients taking oral prophylactic antibiotics], patients who were receiving antibiotics within 24 hours prior to arrival [except colon surgery patients taking oral prophylactic antibiotics], other medical reason(s))
home infusion therapy, immunotherapy, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service)
surface electromyography (emg)
injection, nafcillin sodium, 2 grams
application of a modality (requiring constant provider attendance) to one or more areas; low-level laser; each 15 minutes
additions to lower extremity, below knee, joint covers, pair
injection, pegylated interferon alfa-2b, 10 mcg
collagen meniscus implant procedure for filling meniscal defects (e.g., cmi, collagen scaffold, menaflex)
warfarin or another oral anticoagulant that is fda approved not prescribed, reason not given terminated december 31, 2017.
knee orthosis, double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, custom fabricated
leg pain was not measured by the visual analog scale (vas) at one year (9 to 15 months) postoperatively
power wheelchair accessory, electronic interface to operate speech generating device using power wheelchair control interface
addition, exoskeletal knee-shin system, single axis, variable friction swing phase control
gastrostomy/jejunostomy tube, standard, any material, any type, each
documentation stating the patient has received or is currently receiving palliative or hospice care
patients with a diagnosis of lumbar spine region fracture at the time of the procedure
no surgical site infection
segmental pneumatic appliance for use with pneumatic compressor, integrated, 2 full legs and trunk
filter for use in a tracheostoma heat and moisture exchange system, each
level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)
infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening
assessment for hearing aid
injection, vancomycin hcl, 500 mg
lenticular lens, per lens, bifocal
syringe with needle, sterile 5 cc or greater, each
stocking supporter grips, prefabricated, off-the-shelf, set of four (4)
patient has any emergency department encounter during the performance period with place of service indicator 23
segmental pneumatic appliance for use with pneumatic compressor, half leg
elbow disarticulation, external power, molded inner socket, removable humeral shell, outside locking hinges, forearm, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device
excised tissue evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesion terminated december 31, 2020.
piflufolastat f-18, diagnostic, 1 millicurie
eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications
patient not receiving a first course of anti-tnf therapy terminated december 31, 2015.
magnetic resonance imaging without contrast followed by with contrast, breast; bilateral
electrocardiogram, routine ecg with 12 leads; tracing only, without interpretation and report, performed as a screening for the initial preventive physical examination
percutaneous transcatheter placement of drug-eluting intracoronary stent(s), with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure)
ankle foot orthosis, plastic, rigid anterior tibial section (floor reaction), custom fabricated
respiratory assist device, bi-level pressure capability, without backup rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)
patient did not sustain bladder injury at the time of surgery nor discovered subsequently up to 30 days post-surgery
injection, busulfan, 1 mg
foot, insert, removable, molded to patient model, silicone gel, each
addition, endoskeletal knee/shin system, 4-bar linkage or multiaxial, pneumatic swing phase control
addition to lower extremity, varus/valgus correction, plastic modification, padded/lined
remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a detailed history; a detailed examination; medical decision making of low complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate severity. typically, 30 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology
injection, aminophyllin, up to 250 mg
normal blood pressure reading documented, follow-up not required
wheelchair accessory, back upholstery, replacement only, each
preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no cover, sach foot, plaster socket, molded to model
triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing
incontinence product, protective underpad, reusable, chair size, each
cardiac magnetic resonance imaging for morphology and function, quantification of segmental dysfunction; with strain imaging
alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes
negative pressure ventilator; portable or stationary terminated december 31, 2015.
injection, daunorubicin citrate, liposomal formulation, 10 mg
tlso, triplanar control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, extends from sacrococcygeal junction to scapula, lateral strength provided by pelvic, thoracic, and lateral frame pieces, rotational strength provided by subclavicular extensions, restricts gross trunk motion in sagittal, coronal, and transverse planes, provides intracavitary pressure to reduce load on the intervertebral disks, includes fitting and shaping the frame, prefabricated, includes fitting and adjustment
generator, neurostimulator (implantable), high frequency, with rechargeable battery and charging system
patients who are identified as having an intolerance or allergy to beta-blocker therapy terminated december 31, 2020.
omnicardiogram/cardiointegram
ldl value >= 100 terminated december 31, 2014.
cyclophosphamide, 100 mg
12-lead electrocardiogram (ecg) not performed, reason not given terminated december 31, 2014.
matristem wound matrix, per square centimeter terminated december 31, 2016.
functional status not performed, reason not otherwise specified
elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented
leg pain measured by the visual analog scale (vas) at one year (9 to 15 months) postoperatively was greater than 3.0 and leg pain measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated less than an improvement of 5.0 points
power wheelchair accessory, electronic connection between wheelchair controller and two or more power seating system motors, including all related electronics, indicator feature, mechanical function selection switch, and fixed mounting hardware
remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 60 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology
injection, amphotericin b, 50 mg
omegaven, 10 grams lipids
blood pressure measurement not performed or documented, reason not given
elbow wrist hand orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment
risk-adjusted functional status change residual score for the shoulder impairment successfully calculated and the score was less than zero (< 0)
the mdpp beneficiary achieved at least 5% weight loss (wl) from his/her baseline weight in months 1-12 of the mdpp services period under the mdpp expanded model (em). this is a one-time payment available when a beneficiary first achieves at least 5% weight loss from baseline as measured by an in-person weight measurement at a core session or core maintenance session
skin protection wheelchair seat cushion, adjustable, width less than 22 inches, any depth
hemoglobin level measurement not documented, reason not given terminated december 31, 2020.
als specialized service disposable supplies; defibrillation (to be used only in jurisdictions where defibrillation cannot be performed in bls ambulances)
battery charger, six volt, each
injection, gamma globulin, intramuscular, over 10 cc
ostomy accessory; convex insert
als specialized service disposable supplies; iv drug therapy
enteral formula, for pediatrics, nutritionally complete soy based with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber and/or iron, administered through an enteral feeding tube, 100 calories = 1 unit
nebulizer, with compressor and heater
utility services to support medical equipment and assistive technology/devices, waiver
patients 66 - 80 years of age with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period
diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)
technetium tc-99m pertechnetate, diagnostic, per millicurie
injection, risperidone, (perseris), 0.5 mg
shoulder elbow wrist hand finger orthosis, shoulder cap design, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment
moderate (45 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)
patient satisfaction survey was not completed by patient
preoperative assessment documented terminated december 31, 2020.
conforming bandage, non-elastic, knitted/woven, sterile, width greater than or equal to three inches and less than five inches, per yard
assessment of depression severity at the initial evaluation terminated december 31, 2014.
addition to lower extremity orthosis, femoral length sock, fracture or equal, each
medication reminder service, non-face-to-face; per month
injection, ramucirumab, 5 mg terminated december 31, 2015.
hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg
embolization endpoints are not documented separately for each embolized vessel or ovarian artery angiography or embolization not performed in the presence of variant uterine artery anatomy
peak expiratory flow rate (physician services)
ostomy pouch, urinary, with standard wear barrier attached, with built-in convexity (1 piece), each
continuous passive motion exercise device for use on knee only
day care services, center-based; services not included in program fee, per diem
influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)
prosthetic shrinker, below knee, each
patients with clinical indications for imaging of the head: occipital headache in children
needle-free injection device, each
radiation oncology mips specialty set
home infusion therapy, continuous (twenty-four hours or more) pain management infusion; administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
serum clotting time tube, for dialysis, per 50
home health respiratory therapy, nos, per diem
most recent bp is greater than 140/90 mm hg, or blood pressure not documented
unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery terminated december 31, 2020.
oncology; disease status; small cell lung cancer, limited to small cell and combined small cell/non-small; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)
closure device, vascular (implantable/insertable)
cast supplies, long leg splint, adult (11 years +), fiberglass
addition to lower extremity, below knee, fork strap
documentation of medical reason(s) for not performing diabetes screening test (e.g., patients with a diagnosis of diabetes, or with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) terminated december 31, 2014.
upper extremity additions, polycentric hinge, pair
ophthalmology mips specialty set
injection, plasminogen, human-tvmh, 1 mg terminated june 30, 2022.
implanted prosthetic device, payable only for inpatients who do not have inpatient coverage
combination, bilateral, lumbo-sacral, hip, femur orthosis providing adduction and internal rotation control, prefabricated, includes fitting and adjustment
pinworm examinations
documentation of medical reason(s) for not providing brief counseling if identified as an unhealthy alcohol user (e.g., limited life expectancy, other medical reasons)
electronic medication compliance management device, includes all components and accessories, not otherwise classified
oxygen and water vapor enriching system without heated delivery
myown skin, includes harvesting and preparation procedures, per square centimeter
documentation of patient with one or more complications or mortality within 30 days terminated december 31, 2021.
injection, lanreotide, 1 mg
outflare wedge
foot pressure off loading/supportive device, any type, each
patient was provided pallative care services any time during the measurement period
routine foot care; removal and/or trimming of corns, calluses and/or nails and preventive maintenance in specific medical conditions (e.g., diabetes), per visit
magnetic resonance angiography without contrast followed by with contrast, lower extremity
contact lens, pmma, spherical, per lens
shoulder orthosis, figure of eight design abduction restrainer, canvas and webbing, prefabricated, off-the-shelf
intensive, extended multidisciplinary services provided in a clinic setting to children with complex medical, physical, mental and psychosocial impairments, per diem
infusion pump, non-programmable, permanent (implantable)
home therapy; enteral nutrition via gravity; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem
procuren or other growth factor preparation to promote wound healing
no documentation of disease type, anatomic location, and activity, reason not given terminated december 31, 2014.
intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring terminated april 16, 2021.
plasma, pooled multiple donor, solvent/detergent treated, frozen, each unit
ankle orthosis, ankle gauntlet or similar, with or without joints, custom fabricated
tape, waterproof, per 18 square inches
skilled services of a licensed practical nurse (lpn) for the observation and assessment of the patient's condition, each 15 minutes (the change in the patient's condition requires skilled nursing personnel to identify and evaluate the patient's need for possible modification of treatment in the home health or hospice setting)
transplant related lodging, meals and transportation, per diem
replacement, soft interface material, static afo
transcutaneous electrical nerve stimulator for electrical stimulation of the trigeminal nerve
spherocylinder, single vision, plus or minus 4.25d to plus or minus 7.00d sphere, 2.12 to 4.00d cylinder, per lens
hemodialysis machine
emergency surgery
oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; clinical or pathologic m0, unresectable with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)
injection, casimersen, 10 mg terminated september 30, 2021.
electrode/transducer for use with electrical stimulation device used for cancer treatment, replacement only
diaphragm for contraceptive use
assistive listening device, personal fm/dm neck, loop induction receiver
enema tube, with or without adapter, any type, replacement only, each
upper extremity addition, teflon, or equal, cable lining
seat, contoured, for pediatric size wheelchair including fixed attaching hardware
statin medication prescribed at discharge
office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month
injection, hydrocortisone acetate, up to 25 mg
battery clips for use with electric or electric/pneumatic ventricular assist device, replacement only
assistive listening device, personal blue tooth fm/dm receiver
medicaid certified community behavioral health clinic services, per diem
non-segmental pneumatic appliance for use with pneumatic compressor, full leg
documentation of order for prophylactic parenteral antibiotic to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required) terminated december 31, 2014.
fistula cannulation set for hemodialysis, each
injection, givosiran, 0.5 mg terminated june 30, 2020.
cervical, flexible, thermoplastic collar, molded to patient
total kt/v greater than or equal to 1.7 per week (total clearance of urea [kt] / volume [v]) terminated december 31, 2015.
injection, tigecycline, 1 mg
addition to lower extremity, long tongue stirrup
afamelanotide implant, 1 mg
lipid profile results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c) terminated december 31, 2014.
ct studies performed reported to a radiation dose index registry that is capable of collecting at a minimum all necessary data elements terminated december 31, 2020.
addition to ctlso or scoliosis orthosis, ring flange, plastic or leather
symptomatic aaas that required urgent/emergent (non-elective) repair terminated december 31, 2020.
puraply xt, per square centimeter
mercaptopurine, oral, 50 mg
powered upper extremity range of motion assist device, elbow, wrist, hand with single or double upright(s), includes microprocessor, sensors, all components and accessories, custom fabricated
injection, aztreonam, 500 mg
power wheelchair, group 3 standard, sling/solid seat/back, patient weight capacity up to and including 300 pounds
thiethylperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
patient who had a diagnosis of bipolar disorder or personality disorder, death, permanent nursing home resident or receiving hospice or palliative care any time during the measurement or assessment period
suicide risk not assessed at the initial evaluation, reason not given terminated december 31, 2014.
cystic renal lesion that is simple appearing (bosniak i or ii) , or adrenal lesion less than or equal to 1.0 cm or adrenal lesion greater than 1.0 cm but less than or equal to 4.0 cm classified as likely benign by unenhanced ct or washout protocol ct, or mri with in- and opposed-phase sequences or other equivalent institutional imaging protocols
injection, bevacizumab, 0.25 mg
injection, deoxycholic acid, 1 mg
wheelchair accessory, lateral thigh or knee support, any type including fixed mounting hardware, each
this code is for the onsite acute care treatment of a nursing facility resident for a uti; may only be billed once per day per beneficiary
assistive listening device, personal fm/dm, direct audio input receiver
group psychotherapy other than of a multiple-family group, in a partial hospitalization setting, approximately 45 to 50 minutes
in hospice or using hospice services during the measurement period terminated december 31, 2020.
upper extremity additions, flexible metal hinge, pair
hand held low vision aids and other nonspectacle mounted aids
wheelchair accessory, manual semi-reclining back, (recline greater than 15 degrees, but less than 80 degrees), each
ostomy pouch, drainable; for use on barrier with locking flange (2 piece system), each
incontinence product, disposable underpad, large, each
leg strap, h style, each
deluxe frame
repair of prosthetic device, repair or replace minor parts
oncology; disease status; non-hodgkin's lymphoma, any cellular classification; relapsed/refractory (for use in a medicare-approved demonstration project)
ultraviolet multidirectional light therapy system in 6 foot cabinet, includes bulbs/lamps, timer and eye protection
administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable
connective tissue, human (includes fascia lata)
addition to lower extremity, offset knee joint, heavy duty, each joint
pharmacy dispensing fee for inhalation drug(s); per 90 days
amitriptyline terminated december 31, 2015.
alert or alarm device, not otherwise classified
assertive community treatment program, per diem
hair analysis (excluding arsenic)
oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage iii-iv; without evidence of progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
addition to upper extremity prosthesis, below elbow/above elbow, custom fabricated from existing mold or prefabricated, socket insert, silicone gel, elastomeric or equal, for use with locking mechanism
iv t-pa initiated within three hours (<= 180 minutes) of time last known well
surgical stockings above knee length, each
addition to lower extremity, pelvic control, band and belt, bilateral
replacement battery for external infusion pump owned by patient, lithium, 4.5 volt, each
nabilone, oral, 1 mg
cast supplies (e.g., plaster)
ajcc stage at breast cancer diagnosis = i (ia or ib) and t-stage at breast cancer diagnosis does not equal = t1, t1a, t1b
minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using arterial graft(s), single coronary arterial graft
chore services; per diem
geriatrics mips specialty set
power wheelchair accessory, hand or chin control interface, standard remote joystick (not including controller), proportional, including all related electronics and fixed mounting hardware, replacement only
documentation of medical reason(s) for not performing lipid profile (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate) terminated december 31, 2014.
injection, lorazepam, 2 mg
topical anesthetic, for dialysis, per gram
documentation that prophylactic antibiotics were given within 4 hours prior to surgical incision or intraoperatively terminated december 31, 2014.
spherocylinder, trifocal, plus or minus 7.25 to plus or minus 12.00d sphere, .25 to 2.25d cylinder, per lens
insert for indwelling tracheoesophageal prosthesis, with or without valve, replacement only, each
functional status measured by the oxford knee score (oks) at one year (9 to 15 months) postoperatively was less than 37 or the knee injury and osteoarthritis outcome score joint replacement (koos, jr.) was less than 71 postoperatively
wound filler, dry form, per gram, not otherwise specified
home infusion therapy, corticosteroid infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
other specified case management service not elsewhere classified
microcapillary tube sealant
attention functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting terminated december 31, 2019.
legg perthes orthosis, (newington type), custom fabricated
home infusion therapy, intermittent (less than twenty-four hours) chemotherapy infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
bath/shower chair, with or without wheels, any size
oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t2 or t3a gleason 8-10 or psa > 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
prenatal care, at-risk assessment
lead, pacemaker/cardioverter-defibrillator combination (implantable)
injection, levoleucovorin (khapzory), 0.5 mg
front caster assembly, complete, with pneumatic tire, replacement only, each
hyaluronan or derivative, durolane, for intra-articular injection, per dose terminated december 31, 2018.
specialized childcare, waiver; per 15 minutes
radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev
injection, amphotericin b lipid complex, 10 mg
injection, daratumumab, 10 mg and hyaluronidase-fihj
gravlee jet washer
cystourethroscopy, with ureteroscopy and/or pyeloscopy; with endoscopic laser treatment of ureteral calculi (includes ureteral catheterization)
ongoing care not indicated, patient self-discharged early and seen only 1-2 visits (e.g., financial or insurance reasons, transportation problems, or reason unknown) terminated december 31, 2020.
rolapitant, oral, 1 mg
functional neuromuscular stimulation, transcutaneous stimulation of sequential muscle groups of ambulation with computer control, used for walking by spinal cord injured, entire system, after completion of training program
spring-powered device for lancet, each
patient does not achieve final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery
injection, ofatumumab, 10 mg
injection, belantamab mafodontin-blmf, 0.5 mg terminated march 31, 2021.
addition to lower extremity, straight knee joint, heavy duty, each joint
ankle foot orthosis, spring wire, dorsiflexion assist calf band, custom fabricated
implantable intraspinal (epidural/intrathecal) catheter used with implantable infusion pump, replacement
patients with a diagnosis of lumbar spine region cancer at the time of the procedure
moderate or severe obstructive sleep apnea (apnea hypopnea index (ahi) or respiratory disturbance index (rdi) of 15 or greater)
injection, pantoprazole sodium, per vial
therapeutic lightbox, minimum 10,000 lux, table top model
sentinel lymph node biopsy procedure performed
medication assisted treatment, buprenorphine (implant insertion); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)
psychiatric symptoms not assessed, reason not otherwise specified terminated december 31, 2019.
addition to lower extremity, pre-tibial shell, molded to patient model
addition to lower extremity, below knee, thigh lacer, gluteal/ischial, molded
elder maltreatment screen not documented; documentation that patient is not eligible for the elder maltreatment screen at the time of the encounter
patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period terminated december 31, 2020.
documentation of medical reason(s) for most recent ldl-c not under control (e.g., patients with palliative goals for whom treatment of hypertension with standard treatment goals is not clinically appropriate) terminated december 31, 2014.
injection, benralizumab, 1 mg terminated december 31, 2018.
cyclosporine, oral, 25 mg
restraints, any type (body, chest, wrist or ankle)
addition to lower extremity orthosis, plating chrome or nickel, per bar
home infusion therapy, alpha-1-proteinase inhibitor (e.g., prolastin); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
contact lens, gas permeable, bifocal, per lens
addition to lower extremity fracture orthosis, waist belt
home glucose disposable monitor, includes test strips
xcellistem, 1 mg
injection, epoetin alfa, 100 units (for esrd on dialysis)
catheter, transluminal atherectomy, directional
injection, denosumab, 1 mg
power wheelchair accessory, specialty joystick handle for hand control interface, prefabricated
injection, doxorubicin hydrochloride, 10 mg
documentation of patient reason(s) for not referring to hospice care (e.g., patient declined, other patient reasons) terminated december 31, 2020.
injection, tolazoline hcl, up to 25 mg
foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing
intermittent limb compression device (includes all accessories), not otherwise specified
patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method and received brief counseling
documentation of medical reason(s) for an interval of less than 3 years since the last colonoscopy (e.g., last colonoscopy incomplete, last colonoscopy had inadequate prep, piecemeal removal of adenomas, last colonoscopy found greater than 10 adenomas, or patient at high risk for colon cancer [crohn's disease, ulcerative colitis, lower gastrointestinal bleeding, personal or family history of colon cancer, hereditary colorectal cancer syndromes])
iv tubing extension set
asthma well-controlled based on the act, c-act, acq, or ataq score and results documented
power wheelchair accessory, foam filled caster tire, any size, replacement only, each
normal, low and high calibrator solution / chips
ostomy pouch, drainable; for use on barrier with locking flange, with filter (2 piece system), each
clinical decision support mechanism radrite, as defined by the medicare appropriate use criteria program
documentation that prophylactic antibiotics were neither given within 4 hours prior to surgical incision nor intraoperatively terminated december 31, 2014.
drive belt for power wheelchair, replacement only
documentation of patient death following cea terminated december 31, 2020.
for diabetics only, fitting (including follow-up), custom preparation and supply of shoe molded from cast(s) of patient's foot (custom molded shoe), per shoe
chemotherapy administration by both infusion technique and other technique(s) (e.g., subcutaneous, intramuscular, push), per visit
injection, alemtuzumab, 1 mg
extensive (75 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)
blood (whole), for transfusion, per unit
external counterpulsation, per treatment session
polycarbonate bottle for use with breast pump, replacement
sleep apnea symptoms not assessed, reason not given
power wheelchair accessory, nonstandard seat frame width, 20-23 inches
alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing
ustekinumab, for subcutaneous injection, 1 mg
swallowing functional limitation, discharge status, at discharge from therapy or to end reporting terminated december 31, 2019.
patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the six months prior to the measurement period through december 31 of the measurement period
knee orthosis, single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, custom fabricated
gradient compression stocking, waist length, 40-50 mmhg, each
brief (20 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)
injection, teriparatide, 10 mcg
ankle foot orthosis, plastic or other material, custom fabricated
patient survey score did not improve from baseline following treatment
septal defect implant system, intracardiac
psychiatric health facility service, per diem
ear mold/insert, not disposable, any type
injection, elliotts' b solution, 1 ml
wheelchair accessory, ventilator tray, gimbaled
injection, cabotegravir and rilpivirine, 2mg/3mg terminated september 30, 2021.
left ventricular ejection fraction (lvef) < 40% or documentation of moderately or severely depressed left ventricular systolic function
ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient
high osmolar contrast material, 350-399 mg/ml iodine concentration, per ml
amniocyte plus, per 0.5 cc
injection, testosterone suspension, up to 50 mg terminated december 31, 2014.
documentation of patient reason(s) for not prescribing/administering androgen deprivation therapy in combination with external beam radiotherapy to the prostate
physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allowed practitioner development and/or revision of care plans
injection, protirelin, per 250 mcg
injection, casirivimab and imdevimab, 1200 mg
specialty bifocal (by report)
stent, non-coated/non-covered, with delivery system
ostomy pouch, drainable; without barrier attached (1 piece), each
injection, triamcinolone acetonide, not otherwise specified, 10 mg
photorefractive keratectomy (prk)
patient and/or care partner decline referral
back pain measured by the visual analog scale (vas) at three months (6 - 20 weeks) postoperatively was less than or equal to 3.0 or back pain measured by the visual analog scale (vas) within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated an improvement of 5.0 points or greater
skin sealants, protectants, moisturizers, ointments, any type, any size
foam dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing
cap for breast pump bottle, replacement
injection, chorionic gonadotropin, per 1,000 usp units
documentation of patient with one or more complications within 90 days terminated december 31, 2021.
edetate disodium, per 150 mg
chinstrap used with positive airway pressure device
injection, octreotide, depot form for intramuscular injection, 1 mg
removal of implantable interstitial glucose sensor with creation of subcutaneous pocket at different anatomic site and insertion of new 180 day implantable sensor, including system activation
parenteral nutrition supply kit; premix, per day
attendant care services; per diem
insulin, long acting; 5 units
adenoma(s) or other neoplasm not detected during screening colonoscopy terminated december 31, 2014.
orthopedic shoe addition, special extension to instep (leather with eyelets)
assessment of depression severity not documented, reason not given terminated december 31, 2014.
inj, sutimlimab-jome, 10 mg terminated september 30, 2022.
pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist
esophageal mucosal integrity testing by electrical impedance, transoral, includes esophagoscopy or esophagogastroduodenoscopy
patient was provided hospice services any time during the measurement period
patient is not on a statin therapy
no record of hbv results documented
indwelling catheter; specialty type, (e.g., coude, mushroom, wing, etc.), each
management of ovulation induction (interpretation of diagnostic tests and studies, non-face-to-face medical management of the patient), per cycle
telehealth transmission, per minute, professional services bill separately
splint, prefabricated, digit (specify digit by use of modifier)
leads (pneumatic/electrical) for use with any type electric/pneumatic ventricular assist device, replacement only
injection, tedizolid phosphate, 1 mg terminated december 31, 2015.
patients greater than or equal to 86 years of age who underwent a screening colonoscopy and did not have a history of colorectal cancer or other valid medical reason for the colonoscopy, including: iron deficiency anemia, lower gastrointestinal bleeding, crohn's disease (i.e., regional enteritis), familial adenomatous polyposis, lynch syndrome (i.e., hereditary non-polyposis colorectal cancer), inflammatory bowel disease, ulcerative colitis, abnormal finding of gastrointestinal tract, or changes in bowel habits
speech volume modulation system, any type, including all components and accessories
injection, thiamine hcl, 100 mg
injection, caffeine citrate, 5 mg
hearing aid, bicros, in the ear terminated december 31, 2018.
traction equipment, cervical, free-standing stand/frame, pneumatic, applying traction force to other than mandible
amniotext, per cc
therapeutic behavioral services, per 15 minutes
injection, moxetumomab pasudotox-tdfk, 0.01 mg
injection, colchicine, per 1 mg terminated december 31, 2016.
nasogastric tubing without stylet
holding chamber or spacer for use with an inhaler or nebulizer; without mask
medication assisted treatment, naltrexone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)
home infusion therapy, antibiotic, antiviral, or antifungal; once every 6 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
injection, dalteparin sodium, per 2500 iu
addition to upper extremity prosthesis, below elbow/above elbow, custom fabricated socket insert for other than congenital or atypical traumatic amputee, silicone gel, elastomeric or equal, for use with or without locking mechanism, initial only (for other than initial, use code l6694 or l6695)
injection, sermorelin acetate, 1 microgram
thoracic surgery mips specialty set
injection, epoprostenol, 0.5 mg
anti-egfr monoclonal antibody therapy
injection, tocilizumab, 1 mg
metatarsal joint implant
skin substitute, integra meshed bilayer wound matrix, per square centimeter
commode chair, mobile or stationary, with detachable arms
injection, caplacizumab-yhdp, 1 mg
manual wheelchair accessory, adapter for amputee, each
anti-reflective coating, per lens
port, indwelling (implantable)
injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u. terminated december 31, 2017.
federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit
elbow orthosis, elastic with metal joints, prefabricated, off-the-shelf
addition to lower extremity, below knee, thigh lacer, nonmolded
non-ophthalmic fluorescent vascular angiography
injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
patients 66-80 years of age and had at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period terminated december 31, 2020.
upper extremity addition, hook to hand, cable adapter
irrigation supply; sleeve, each terminated december 31, 2021.
a transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is used
orthopedic footwear, mens shoe, oxford, each
documentation of reason(s) for not documenting an assessment of sleep symptoms (e.g., patient didn't have initial daytime sleepiness, patient visited between initial testing and initiation of therapy)
injection, palonosetron hcl, 25 mcg
miscellaneous supply or accessory for use with any implanted ventricular assist device for which payment was not made under medicare part a
sperm procurement and cryopreservation services; initial visit
insertion of central venous catheter through central venous occlusion via inferior and superior approaches (e.g., inside-out technique), including imaging guidance
filter holder or filter cap, reusable, for use in a tracheostoma heat and moisture exchange system, each
ustekinumab, for intravenous injection, 1 mg
manual wheelchair accessory, one-arm drive attachment, each
wheelchair, pediatric size, folding, adjustable, with seating system
injection, levofloxacin, 250 mg
infusion, dextran 75, 500 ml
mental health partial hospitalization, treatment, less than 24 hours
lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose terminated september 30, 2021.
injection, brompheniramine maleate, per 10 mg
documentation of a medical reason(s) for not documenting, updating, or reviewing the patient's current medications list (e.g., patient is in an urgent or emergent medical situation)
injection, avelumab, 10 mg terminated december 31, 2017.
lead, cardioverter-defibrillator, endocardial single coil (implantable)
injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg
oxygen contents, liquid, 1 unit equals 1 pound
infusion pump, non-programmable, temporary (implantable)
high osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
lifestyle modification program for management of coronary artery disease, including all supportive services; second or third quarter / stage
risk-adjusted functional status change residual score for the neck impairment not measured because the patient did not complete the neck fs prom at initial evaluation and/or near discharge, reason not given
brake attachment for wheeled walker, replacement, each
addition to lower extremity prosthesis, endoskeletal knee-shin system, powered and programmable flexion/extension assist control, includes any type motor(s)
ankle foot orthosis, plastic or other material with ankle joint, prefabricated, includes fitting and adjustment
tretinoin, topical, 5 grams
catheter, transluminal angioplasty, laser
moderate (45 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)
wheelchair accessory, positioning belt/safety belt/pelvic strap, each
injection, morphine sulfate, 100mg terminated december 31, 2014.
ostomy pouch, drainable, for use on faceplate, plastic, each
initiated episode of rehabilitation therapy, medical, or chiropractic care for neck impairment
screening performed and negative
segmental pneumatic appliance for use with pneumatic compressor, full leg
prostate cancer antigen 3 (pca3) testing terminated december 31, 2015.
gallium ga-68, dotatoc, diagnostic, 0.01 mci
clinical decision support mechanism cranberry peak, as defined by the medicare appropriate use criteria program
inj, faricimab-svoa, 0.1 mg terminated september 30, 2022.
adult patients 18 years of age or older with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5
all lower extremity prosthesis, shank foot system with vertical loading pylon
elbow orthosis, double upright with forearm/arm cuffs, extension/ flexion assist, custom fabricated
addition to lower extremity, exoskeletal system, above knee-knee disarticulation, 4 bar linkage, with pneumatic swing phase control
catheter, transluminal intravascular lithotripsy, coronary
not medically necessary service (patient is aware that service not medically necessary)
magnetic resonance angiography without contrast followed by with contrast, pelvis
upper extremity fracture orthosis, wrist, prefabricated, includes fitting and adjustment
chiropractic medicine mips specialty set
prosthetic implant, not otherwise specified
manual wheelchair accessory, nonstandard seat frame depth, 20 to less than 22 inches
regulator
monitoring and storage of cryopreserved embryos, per 30 days
netupitant 300 mg and palonosetron 0.5 mg, oral
patients with a diagnosis of lumbar spine region infection at the time of the procedure
fasting lipid profile not performed, reason not given terminated december 31, 2016.
parenteral nutrition infusion pump, portable
general use wheelchair back cushion, width 22 inches or greater, any height, including any type mounting hardware
patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month) terminated december 31, 2015.
injection, panitumumab, 10 mg
unclassified drug or biological used for esrd on dialysis
power wheelchair accessory, solid (rubber/plastic) drive wheel tire, any size, replacement only, each
count of previous ct and cardiac nuclear medicine (myocardial perfusion) studies not documented in the 12-month period prior to the current study, reason not given
injection, methylprednisolone acetate, 20 mg
injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)
brief (20 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)
fracture frame, attached to bed, includes weights
influenza virus vaccine, split virus, for intramuscular use (agriflu)
injectable bulking agent, dextranomer/hyaluronic acid copolymer implant, urinary tract, 1 ml, includes shipping and necessary supplies
ankle foot orthosis, single upright free plantar dorsiflexion, solid stirrup, calf band/cuff (single bar 'bk' orthosis), custom fabricated
interphalangeal joint spacer, silicone or equal, each
instillation, bupivacaine and meloxicam, 1 mg/0.03 mg
generator, neurostimulator (implantable), non-rechargeable with carotid sinus baroreceptor stimulation lead(s)
respite care services, not in the home, per diem
injection, amifostine, 500 mg
i intend to report the sinusitis measures group terminated december 31, 2016.
injection, urofollitropin, 75 iu
enteral feeding supply kit; pump fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape
sigmoidoscopy, flexible; with transendoscopic stent placement (includes predilation) terminated december 31, 2015.
systemic antimicrobials prescribed
volume control ventilator, without pressure support mode, may include pressure control mode, used with non-invasive interface (e.g., mask) terminated december 31, 2015.
post-discharge pulmonary surgery services after lvrs, minimum of 6 days of services
patient was referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not specified)
documentation of patient reason(s) for not performing a 12-lead electrocardiogram (ecg) terminated december 31, 2014.
injection, brolucizumab-dbll, 1 mg
injection, cemiplimab-rwlc, 1 mg
prescription drug, oral, chemotherapeutic, nos
elbow disarticulation, molded socket with expandable interface, outside locking hinges, forearm
5% dextrose in lactated ringer's, 1000 ml terminated december 31, 2015.
addition to lower extremity, test socket, hip disarticulation
injection, sebelipase alfa, 1 mg
crutches, forearm, includes crutches of various materials, adjustable or fixed, pair, complete with tips and handgrips
flutamide, oral, 125 mg
disposable drug delivery system, flow rate of less than 50 ml per hour
injection, tbo-filgrastim, 1 microgram
prochlorperazine maleate, oral, 5 mg (for circumstances falling under the medicare statute, use q0164)
most recent systolic blood pressure >= 140 mmhg
services provided as part of a phase iii clinical trial
injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring
preparatory, above knee - knee disarticulation, ischial level socket, non-alignable system, pylon, no cover, sach foot, thermoplastic or equal, direct formed
cryopreserved embryo transfer, case rate
miscellaneous dme supply or accessory, not otherwise specified
contact lens, gas permeable, toric, prism ballast, per lens
lvf testing not documented as being performed prior to discharge or in the previous 12 months, reason not given terminated december 31, 2014.
cast supplies, short arm cast, pediatric (0-10 years), plaster
sodium fluoride f-18, diagnostic, per study dose, up to 30 millicuries
psoriasis assessment tool documented not meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi)) or psoriasis assessment tool not documented
clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer before or after neoadjuvant systemic therapy
injection, dostarlimab-gxly, 100 mg terminated december 31, 2021.
ostomy pouch, urinary; for use on barrier with flange (2 piece), each
injection, loncastuximab tesirine-lpyl, 0.1 mg terminated march 31, 2022.
addition to lower extremity, above knee, flexible inner socket, external frame
enteral formula, nutritionally incomplete/modular nutrients, includes specific nutrients, carbohydrates (e.g., glucose polymers), proteins/amino acids (e.g., glutamine, arginine), fat (e.g., medium chain triglycerides) or combination, administered through an enteral feeding tube, 100 calories = 1 unit
fresh frozen plasma between 8-24 hours of collection, each unit
preparatory, hip disarticulation-hemipelvectomy, pylon, no cover, sach foot, thermoplastic or equal, molded to patient model
mirragen advanced wound matrix, per square centimeter
topical oxygen delivery system, not otherwise specified, includes all supplies and accessories
ras (kras or nras) gene mutation
transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision
pathologists/dermatopathologists is the same clinician who performed the biopsy
documentation of medical reason(s) for not prescribing ace inhibitor or arb or arni therapy (e.g., hypotensive patients who are at immediate risk of cardiogenic shock, hospitalized patients who have experienced marked azotemia, allergy, intolerance, other medical reasons)
toe loop/holder, any type, each
functional status was measured by the oxford knee score (oks) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively terminated december 31, 2019.
beta-blocker therapy not prescribed
safety concerns screen provided and if positive then documented mitigation recommendations
repriza, per square centimeter
remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires at least 2 of the following 3 key components: a problem focused history; a problem focused examination; straightforward medical decision making, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are self limited or minor. typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology
high or very high risk of recurrence of prostate cancer
injection, cladribine, per 1 mg
documentation of medical reason(s) for not screening for unhealthy alcohol use using a systematic screening method (e.g., limited life expectancy, other medical reasons)
dilated retinal eye exam with interpretation by an ophthalmologist or optometrist documented and reviewed terminated december 31, 2020.
comprehensive medication services, per 15 minutes
diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen
pneumococcal vaccine was not administered on or after patient's 60th birthday and before the end of the measurement period, reason not otherwise specified
documentation of medical reason(s) for not offering assistance with end of life issues (e.g., patient in hospice care, patient in terminal phase) during the measurement period terminated december 31, 2017.
patients with a diagnosis or past history of total colectomy or colorectal cancer
garment, belt, sleeve or other covering, elastic or similar stretchable material, any type, each terminated december 31, 2016.
instillation, hexaminolevulinate hydrochloride, 100 mg
voice functional limitation, discharge status at discharge from therapy or to end reporting terminated december 31, 2019.
crutch attachment, walker, each
occult blood test strips, for dialysis, per 50
pneumocystis jiroveci pneumonia prophylaxis prescribed wthin 3 months of low cd4+ cell count below 200 cells/mm3 terminated december 31, 2016.
home care training, non-family; per session
office-based treatment for opioid use disorder, including development of the treatment plan, care coordination, individual therapy and group therapy and counseling; at least 70 minutes in the first calendar month
retrieval device, insertable (used to retrieve fractured medical devices)
injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg
injection, burosumab-twza 1 mg
risk-adjusted functional status change residual score for the low back impairment successfully calculated and the score was less than zero (< 0)
oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-2, n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
injection, vedolizumab, 1 mg terminated december 31, 2015.
spirometry test results demonstrate fev1/fvc < 70%, fev1 < 60% predicted and patient has copd symptoms (e.g., dyspnea, cough/sputum, wheezing)
diabetic management program, group session
oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)
no anti-lipid treatment at discharge terminated december 31, 2014.
global fee for extracorporeal shock wave lithotripsy treatment of kidney stone(s)
addition to lower extremity orthosis, removable soft interface, all components, replacement only, each
cervical thoracic lumbar sacral orthosis, immobilizer, infant size, prefabricated, includes fitting and adjustment
addition to lower extremity, thigh/weight bearing, quadri- lateral brim, custom fitted
hip orthosis, abduction control of hip joints, static, plastic, prefabricated, includes fitting and adjustment
gammagraft, per square centimeter
semi-reclining wheelchair, fixed full length arms, swing away detachable elevating leg rests
patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days
cogenex amniotic membrane, per square centimeter
memoderm, dermaspan, tranzgraft or integuply, per square centimeter
moisture exchanger, disposable, for use with invasive mechanical ventilation
spinal orthosis, not otherwise specified
all exoskeletal lower extremity prostheses, axial rotation unit
electronic positional obstructive sleep apnea treatment, with sensor, includes all components and accessories, any type
services performed by a qualified occupational therapist, in the home health setting, in the establishment or delivery of a safe and effective occupational therapy maintenance program, each 15 minutes
transesophageal doppler measurement of cardiac output (including probe placement, image acquisition, and interpretation per course of treatment) for monitoring purposes
alcohol and/or other drug abuse services, not otherwise specified
plasma, pooled multiple donor, pathogen reduced, frozen, each unit
cystourethroscopy, with insertion of transprostatic implant; 1 to 3 implants
hearing aid, disposable, any type, binaural
documentation of medical reason(s) for not on a daily aspirin or other antiplatelet (e.g. history of gastrointestinal bleed, intra-cranial bleed, blood disorders, idiopathic thrombocytopenic purpura (itp), gastric bypass or documentation of active anticoagulant use during the measurement period)
documentation of signed opioid treatment agreement at least once during opioid therapy terminated december 31, 2021.
injection, mitomycin, 5 mg
cast supplies, short arm cast, pediatric (0-10 years), fiberglass
documentation of end stage renal disease (esrd), dialysis, renal transplant before or during the measurement period or pregnancy during the measurement period
ldl-c result not present or not within 12 months prior terminated december 31, 2014.
power wheelchair accessory, foam caster tire, any size, replacement only, each
other speech language pathology functional limitation, current status at therapy episode outset and at reporting intervals terminated december 31, 2019.
injection, pegaptanib sodium, 0.3 mg
air pressure pad for mattress, standard mattress length and width
major amputation or open surgical bypass required within 48 hours of the index endovascular lower extremity revascularization procedure terminated december 31, 2021.
spherocylinder, bifocal, plano to plus or minus 4.00d sphere, over 6.00d cylinder, per lens
injection, bortezomib, not otherwise specified, 0.1 mg
microprocessor control feature, addition to upper limb prosthetic terminal device
therapeutic agent for urinary catheter irrigation
injection, fam-trastuzumab deruxtecan-nxki, 1 mg
pump for water circulating pad
capecitabine, oral, 150 mg
oncology; primary focus of visit; expectant management of patient with evidence of cancer for whom no cancer directed therapy is being administered or arranged at present; cancer directed therapy might be considered in the future (for use in a medicare-approved demonstration project)
magnetic resonance angiography with contrast, pelvis
monthly supplies for use of device coded at k1016
colonoscopy, flexible; proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique terminated december 31, 2015.
specialized supply, not otherwise specified, waiver
compression burn garment, upper trunk to waist including arm openings (vest), custom fabricated
habilitation, educational, waiver; per hour
tracheostomy/laryngectomy tube, stainless steel or equal (sterilizable and reusable), each
insertion or removal and replacement of intracardiac ischemia monitoring system including imaging supervision and interpretation and peri-operative interrogation and programming; complete system (includes device and electrode) terminated december 31, 2018.
comprehensive (60 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)
water softening system, for hemodialysis
injection, immune globulin (asceniv), 500 mg terminated march 31, 2021.
oncology; primary focus of visit; work-up, evaluation, or staging at the time of cancer diagnosis or recurrence (for use in a medicare-approved demonstration project)
addition to ctlso or scoliosis orthosis, lumbar bolster pad
injection, lumasiran, 0.5 mg
clinical decision support mechanism medcurrent, as defined by the medicare appropriate use criteria program
patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method
metatarsal bar wedge, between sole
repair of orthotic device, repair or replace minor parts
syringe with needle, sterile, 1 cc or less, each
antibiotic regimen prescribed within 10 days after onset of symptoms for documented medical reason
elbow orthosis, double upright with forearm/arm cuffs, adjustable position lock with active control, custom fabricated
appliance cleaner, incontinence and ostomy appliances, per 16 oz.
hyaluronan or derivative, orthovisc, for intra-articular injection, per dose
patient received follow-up within 30 days after discharge
injection, doripenem, 10 mg
seat height less than 17" or equal to or greater than 21" for a high strength, lightweight, or ultralightweight wheelchair
legg perthes orthosis, (toronto type), custom fabricated
walker, heavy duty, without wheels, rigid or folding, any type, each
ambulatory infusion pump, mechanical, reusable, for infusion less than 8 hours
venous pressure clamp, for hemodialysis, each
verification and documentation of sudden or rapidly progressive hearing loss
receipt and analysis of remote, asynchronous images for dermatologic and/or ophthalmologic evaluation, for use only in a medicare-approved cmmi model, 10-20 minutes
magnetic resonance imaging without contrast followed by with contrast, breast; unilateral
activation device for intraurethral drainage device with valve, replacement only, each terminated march 31, 2021.
orbital prosthesis, provided by a non-physician
injection, atezolizumab, 10 mg
genetic testing for retinoblastoma
infusion therapy, using other than chemotherapeutic drugs, per visit
stand/rack
injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
radiation treatment delivery, single treatment area,single port or parallel opposed ports, simple blocks or no blocks: 6-10 mev
bls mileage (per mile)
nicotine patches, non-legend
membrane graft or membrane wrap, per square centimeter
injection, mepivacaine hydrochloride, per 10 ml
final reports for imaging studies without an incidentally found lesion noted
heel or elbow protector, each
diabetes screening test not performed, reason not given terminated december 31, 2014.
power operated vehicle, group 1 standard, patient weight capacity up to and including 300 pounds
composite dressing, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing
annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
compact (portable) travel hemodialyzer system
elder maltreatment screen documented as positive, follow-up plan not documented, documentation the patient is not eligible for follow-up plan at the time of the encounter
wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment
rimantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project) terminated december 31, 2019.
injection, bupivicaine hydrochloride, 30 ml
clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program
injection, golimumab, 1 mg, for intravenous use
high strength lightweight wheelchair, fixed length arms, swing away detachable footrest
automatic external defibrillator, with integrated electrocardiogram analysis, garment type
patient underwent abdominal imaging with ultrasound, contrast enhanced ct or contrast mri for hcc
comprehensive (60 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)
iodine i-123 sodium iodide, diagnostic, per millicurie
radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; up to 5 mev
i intend to report the general surgery measures group terminated december 31, 2016.
injection, plazomicin, 5 mg
orthopedic footwear, mens shoe, hightop, depth inlay, each
lactation classes, non-physician provider, per session
permeaderm b, per square centimeter
blood glucose test strips, for dialysis, per 50
injection, tagraxofusp-erzs, 10 mcg terminated september 30, 2019.
orthopedic surgery mips specialty set
counseling for diet and physical activity not performed, reason not given terminated december 31, 2014.
prolonged postoperative intubation (> 24 hrs) required
documentation of medical reason(s) for not including a recommended interval and modality for follow-up or for no follow-up, and source of recommendations (e.g., patients with unexplained fever, immunocompromised patients who are at risk for infection)
pain assessment not documented as being performed, documentation the patient is not eligible for a pain assessment using a standardized tool at the time of the encounter terminated december 31, 2020.
specialized medical equipment, not otherwise specified, waiver
speech generating device, synthesized speech, requiring message formulation by spelling and access by physical contact with the device
addition to tlso, (low profile), anterior thoracic derotation pad
ostomy pouch, urinary; for use on barrier with locking flange (2 piece), each
endometrial sampling or hysteroscopy with biopsy and results not documented during the 12 months prior to the index date (exclusive of the index date) of the endometrial ablation
skin barrier; solid, 6 x 6 or equivalent, each
documentation of medical reason(s) for not providing brief counseling (e.g., limited life expectancy, other medical reasons)
behavioral health screening to determine eligibility for admission to treatment program
vena cava filter
harvesting of donor multivisceral organs, with preparation and maintenance of allografts; from cadaver donor
safety equipment, device or accessory, any type
one or more high risk factors for thromboembolism or more than one moderate risk factor for thromboembolism terminated december 31, 2017.
hydrocolloid dressing, wound filler, paste, sterile, per ounce
mitomycin pyelocalyceal instillation, 1 mg terminated december 31, 2020.
emergency response system; purchase only
spherocylinder, single vision, plus or minus 7.25 to plus or minus 12.00d sphere, 4.25 to 6.00d cylinder, per lens
padding bandage, non-elastic, non-woven/non-knitted, width greater than or equal to three inches and less than five inches, per yard
catheter, electrophysiology, diagnostic/ablation, other than 3d or vector mapping, cool-tip
pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) was not sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist
colorectal cancer screening; blood-based biomarker
injection, ropivacaine hydrochloride, 1 mg
leuprolide injectable, camcevi, 1 mg
injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u.
hospice inpatient respite care; per diem
needle, sterile, any size, each
patients not receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days terminated december 31, 2014.
extension drainage tubing, any type, any length, with connector/adaptor, for use with urinary leg bag or urostomy pouch, each
tracheostomy/laryngectomy tube, cuffed, polyvinylchloride (pvc), silicone or equal, each
documentation of a positive functional outcome assessment using a standardized tool; care plan not documented, reason not given
injection, ibandronate sodium, 1 mg
rectal thermometer, reusable, any type, each
shoulder orthosis, abduction positioning (airplane design), thoracic component and support bar, with or without nontorsion joint/turnbuckle, may include soft interface, straps, custom fabricated, includes fitting and adjustment
injection, laronidase, 0.1 mg
interscapular thoracic, molded socket, endoskeletal system, including soft prosthetic tissue shaping
paramedic intercept, non-hospital-based als service (non-voluntary), non-transport
pharmacy dispensing fee for inhalation drug(s); initial 30-day supply as a beneficiary
patients who were not prescribed/administered androgen deprivation therapy in combination with external beam radiotherapy to the prostate, reason not given
hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, prefabricated, off-the-shelf
below knee, molded socket, shin, sach foot
ostomy pouch, drainable, with extended wear barrier attached, (1 piece), each
wound closure utilizing tissue adhesive(s) only
addition to lower extremity fracture orthosis, limited motion knee joint
thymol turbidity, blood
influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)
splint
innovamatrix ac, per square centimeter
phoenix wound matrix, per square centimeter
non-disposable underpads, all sizes
screening papanicolaou smear, cervical or vaginal, up to three smears, by technician under physician supervision
brachytherapy source, non-stranded, cesium-131, per source
elder maltreatment screen documented as positive, follow-up plan not documented, reason not given
methsuximide terminated december 31, 2015.
right heart catheterization with implantation of wireless pressure sensor in the pulmonary artery, including any type of measurement, angiography, imaging supervision, interpretation, and report terminated december 31, 2018.
eye imaging validated to match diagnosis from seven standard field stereoscopic photos results documented and reviewed terminated december 31, 2020.
clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer terminated december 31, 2017.
leg pain was measured by the visual analog scale (vas) within three months preoperatively and at three months (6 to 20 weeks) postoperatively terminated december 31, 2019.
documentation of medical reason(s) for not administering pneumococcal vaccine (e.g., adverse reaction to vaccine)
risk-adjusted functional status change residual score for the lower leg, foot or ankle impairment successfully calculated and the score was equal to zero (0) or greater than zero ( > 0)
documentation of medical reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient allergic reaction, potential adverse drug reaction)
arthroscopy, shoulder, surgical; with thermally-induced capsulorrhaphy
cranial electrotherapy stimulation (ces) system supplies and accessories, per month
transplantation of multivisceral organs
oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t3, n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
patient with an initial phq-9 score greater than nine who was not assessed for remission at twelve months (+/- 30 days)
intragastric hypothermia using gastric freezing
non-implanted pelvic floor electrical stimulator, complete system
oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-4, n1-2, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
specialty absorptive dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing
injection, tafasitamab-cxix, 2 mg
patient sustained ureter injury at the time of surgery or discovered subsequently up to 30 days post-surgery
injection, granisetron, extended-release, 0.1 mg
physical medicine mips specialty set
injection, cefotaxime sodium, per gm
injection, epoetin alfa, (for non-esrd use), 1000 units
palliative care services used by patient any time during the measurement period
finger orthosis, without joints, may include soft interface, custom fabricated, includes fitting and adjustment
infusion supplies not used with external infusion pump, per cassette or bag (list drugs separately)
electronic elbow, adolescent, variety village or equal, myoelectronically controlled
collagen nerve cuff (neuromatrix), per 0.5 centimeter length
dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy
injection, talimogene laherparepvec, per 1 million plaque forming units
injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg
power wheelchair, group 4 very heavy duty, sling/solid seat/back, patient weight capacity 451 to 600 pounds
external recharging system for battery (internal) for use with implanted cardiac contractility modulation generator, replacement only
addition to tlso, (low profile), lateral trochanteric pad
injection, ganirelix acetate, 250 mcg
home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels
addition to lower extremity, dorsiflexion assist (plantar flexion resist), each joint
patient sustained bladder injury at the time of surgery or discovered subsequently up to 30 days post-surgery
counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making)
infusion, albumin (human), 5%, 250 ml
social work and psychological services, directly relating to and/or furthering the patient's rehabilitation goals, each 15 minutes, face-to-face; individual (services provided by a corf-qualified social worker or psychologist in a corf)
comprehensive community support services, per diem
ambulance service, basic life support, emergency transport (bls-emergency)
heavy duty wheelchair, fixed full length arms, elevating legrest
patients who are not evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g., history of dvt, pe, mi, arrhythmia and stroke, reason not given)
rolapitant, oral, 1 mg terminated december 31, 2016.
remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved coms innovation center demonstration project, which requires at least 2 of the following 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 40 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology
ajcc breast cancer stage i: t1b (tumor > 0.5 cm but <= 1 cm in greatest dimension) documented
hip orthosis, abduction control of hip joints, flexible, frejka type with cover, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an inidividual with expertise
methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram
shoulder orthosis, vest type abduction restrainer, canvas webbing type or equal, prefabricated, off-the-shelf
vacuum drainage bottle and tubing for use with implanted catheter terminated december 31, 2014.
dialysis/stress vitamin supplement, oral, 100 capsules
assisted living; waiver, per diem
modification to pediatric size wheelchair, width adjustment package (not to be dispensed with initial chair)
introducer/sheath, other than guiding, other than intracardiac electrophysiological, laser
infant safety (including cpr) classes, non-physician provider, per session
ostomy faceplate, each
general use wheelchair seat cushion, width less than 22 inches, any depth
high strength, lightweight wheelchair
variable concentration mask
level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)
technetium tc-99m disofenin, diagnostic, per study dose, up to 15 millicuries
injection, pentobarbital sodium, per 50 mg
hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
partial facial prosthesis, provided by a non-physician
addition to lower extremity, varus/valgus correction ('t') strap, padded/lined or malleolus pad
patients who were born in the years 1945 to 1965 terminated december 31, 2021.
hand finger orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment
assistive listening device, personal fm/dm adapter/boot coupling device for receiver, any type
alkaloids, urine, quantitative terminated december 31, 2015.
individual had a pdc of 0.8 or greater
injection, dopamine hcl, 40 mg
addition to lower extremity, round caliper and plate attachment
documentation of patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter for documented reasons (e.g., other medical reasons, patient declined arteriovenous fistula (avf)/arteriovenous graft (avg), other patient reasons) terminated december 31, 2020.
power wheelchair, group 4 standard, multiple power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds
women who had a bilateral mastectomy or who have a history of a bilateral mastectomy or for whom there is evidence of a right and a left unilateral mastectomy
patient starting antiviral treatmentfor hepatitis c during the measurement period terminated december 31, 2016.
adoptive immunotherapy i.e. development of specific anti-tumor reactivity (e.g., tumor-infiltrating lymphocyte therapy) per course of treatment
static progressive stretch knee device, extension and/or flexion, with or without range of motion adjustment, includes all components and accessories
hearing aid, bilateral, body worn
injectable bulking agent, synthetic implant, urinary tract, 1 ml syringe, includes shipping and necessary supplies
deluxe lens feature
injection, efgartigimod alfa-fcab, 2mg
documentation of viral load less than 200 copies/ml
four total medicare diabetes prevention program (mdpp) core sessions were attended by an mdpp beneficiary under the mdpp expanded model (em). a core session is an mdpp service that: (1) is furnished by an mdpp supplier during months 1 through 6 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for core sessions
first medicare diabetes prevention program (mdpp) core session was attended by an mdpp beneficiary under the mdpp expanded model (em). a core session is an mdpp service that: (1) is furnished by an mdpp supplier during months 1 through 6 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for core sessions
platforms for home blood glucose monitor, 50 per box
additions to lower extremity, total contact, above knee or knee disarticulation socket
replacement soft interface material, dynamic adjustable extension/flexion device
addition to lower limb prosthesis, vacuum pump, residual limb volume management and moisture evacuation system
alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing
congo red, blood
injection, leucovorin calcium, per 50 mg
lead, cardioverter-defibrillator, endocardial dual coil (implantable)
cytal, per square centimeter
percutaneous arteriovenous fistula creation (avf), direct, any site, using magnetic-guided arterial and venous catheters and radiofrequency energy, including flow-directing procedures (e.g., vascular coil embolization with radiologic supervision and interpretation, wen performed) and fistulogram(s), angiography, enography, and/or ultrasound, with radiologic supervision and interpretation, when performed
iodine i-131 sodium iodide solution, diagnostic, per millicurie
addition to lower extremity, lacer molded to patient model, for custom fabricated orthosis only
hearing aid, contralateral routing system, binaural, ite/bte
patients with clinical indications for imaging of the head: headache radiating to the neck
inversion/eversion correction device
addition to lower extremity, test socket, below knee
osteogenesis stimulator, electrical, non-invasive, other than spinal applications
xcellerate, per square centimeter
patient is not eligible for the referral for otologic evaluation for patients with a history of active drainage measure
injection, testosterone cypionate, up to 100 mg terminated december 31, 2014.
patient died including all deaths occurring during the hospitalization in which the operation was performed, even if after 30 days, and those deaths occurring after discharge from the hospital, but within 30 days of the procedure
capsaicin 8% patch, per square centimeter
clinician did not prescribe angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy, reason not given
injection, fulvestrant, 25 mg
cellesta flowable amnion (25 mg per cc); per 0.5 cc
hearing aid, monaural, behind the ear
antibiotic regimen not prescribed within 10 days after onset of symptoms
administration set, with small volume filtered pneumatic nebulizer
keramatrix or kerasorb, per square centimeter
crutch, underarm, other than wood, adjustable or fixed, with pad, tip, handgrip, with or without shock absorber, each
blood glucose test or reagent strips for home blood glucose monitor, per 50 strips
brief (20 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)
contraceptive intrauterine device (e.g., progestacert iud), including implants and supplies
oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive with current clinical, radiologic, or biochemical evidence of disease (for use in a medicare-approved demonstration project)
clinician documented that patient was not an eligible candidate for evaluation of footwear as patient is bilateral lower extremity amputee
addition to lower extremity, thigh/weight bearing, quadri- lateral brim, molded to patient model
preoperative assessment not documented, reason not given terminated december 31, 2020.
apnea hypopnea index (ahi) or respiratory disturbance index (rdi) measured at the time of initial diagnosis
dermacell, dermacell awm or dermacell awm porous, per square centimeter
fludarabine phosphate, oral, 10 mg
counseling, group, by chaplain services
injection, risperidone (risperdal consta), 0.5 mg
biodfence dryflex, per square centimeter
injection, remdesivir, 1 mg
discharge(s) for ami between july 1 of the year prior measurement period to june 30 of the measurement period terminated december 31, 2020.
injection, caspofungin acetate, 5 mg
ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
cobalt co-57 cyanocobalamin, oral, diagnostic, per study dose, up to 1 microcurie
injection, diclofenac sodium, 0.5 mg
injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg
cranial cervical orthosis, congenital torticollis type, with or without soft interface material, adjustable range of motion joint, custom fabricated
federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit
injection, tbo-filgrastim, 5 micrograms terminated december 31, 2015.
amnio-maxx or amnio-maxx lite, per square centimeter
home infusion therapy, tocolytic infusion therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
fixed wing air mileage, per statute mile
reason for not administering adjuvant treatment course including both chemotherapy and her2-targeted therapy (e.g. poor performance status (ecog 3-4; karnofsky =50), cardiac contraindications, insufficient renal function, insufficient hepatic function, other active or secondary cancer diagnoses, other medical contraindications, patients who died during initial treatment course or transferred during or after initial treatment course)
colonoscopy consultation performed prior to a screening colonoscopy procedure
mometasone furoate sinus implant, 370 micrograms terminated september 30, 2019.
surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method
sodium phosphate p-32, therapeutic, per millicurie
netupitant 300 mg and palonosetron 0.5 mg, oral terminated june 30, 2015.
alcohol and/or drug services; group counseling by a clinician
benesch boot, pair, junior
lancets, per box of 100
health-related quality of life not assessed with tool during at least two visits or quality of life score declined terminated december 31, 2021.
injection, galsulfase, 1 mg
injection, methylprednisolone sodium succinate, up to 40 mg
no. 2 footplates, except for elevating leg rest
injection, aripiprazole lauroxil, (aristada initio), 1 mg
cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
unlisted procedure for miscellaneous prosthetic services
addition to lower limb prosthesis, multiaxial ankle with swing phase active dorsiflexion feature
injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg
ambulance service, advanced life support, non-emergency transport, level 1 (als 1)
patients who had documentation of use of anticoagulant medications overlapping the measurement year
technetium tc-99m sodium gluceptate, diagnostic, per study dose, up to 25 millicurie
emergency medicine mips specialty set
hospice care provided in nursing long term care facility (ltc) or non-skilled nursing facility (nf)
intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider based to the hospital during the covid 19 public health emergency
conductive gel or paste, for use with electrical device (e.g., tens, nmes), per oz
home infusion therapy, hydration therapy; more than two liters but no more than three liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
synthetic sheepskin pad
grafix core and grafixpl core, per square centimeter
injection, mepolizumab, 1 mg
blood ketone test or reagent strip, each
insulin pump initiation, instruction in initial use of pump (pump not included)
bls specialized service disposable supplies; defibrillation (used by als ambulances and bls ambulances in jurisdictions where defibrillation is permitted in bls ambulances)
hearing aid, contralateral routing, monaural, glasses
levonorgestrel-releasing intrauterine contraceptive system, 52 mg terminated december 31, 2015.
urine test or reagent strips or tablets (100 tablets or strips)
brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source
functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies on the date of functional outcome assessment, is documented
patient did not receive at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively
injection, vincristine sulfate liposome, 1 mg
re-exploration required due to mediastinal bleeding with or without tamponade, graft occlusion, valve dysfunction or other cardiac reason
iodine i-131 sodium iodide solution, therapeutic, per millicurie
oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; accelerated phase not in hematologic cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)
statin therapy not prescribed at discharge, reason not given
manual wheelchair accessory, solid (rubber/plastic) caster tire with integrated wheel, any size, replacement only, each
oncology; disease status; limited to multiple myeloma, systemic disease; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)
oasis ultra tri-layer wound matrix, per square centimeter
risk-adjusted functional status change residual score for the lower leg, foot or ankle impairment not measured because the patient did not complete the lepf prom at initial evaluation and/or near discharge, reason not given
companion care, adult (e.g., iadl/adl); per 15 minutes
beta-blocker therapy prescribed or currently being taken
wheelchair accessory, bearings, any type, replacement only, each
comprehensive contact lens evaluation
magnetic resonance angiography with contrast, lower extremity
a finding of an incidental pulmonary nodule
power wheelchair, group 2 standard, captains chair, patient weight capacity up to and including 300 pounds
companion care, adult (e.g., iadl/adl); per diem
p2y inhibitor not prescribed at discharge terminated december 31, 2016.
injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u. terminated december 31, 2016.
take-home supply of nasal naloxone; 2-pack of 8mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure
most recent hemoglobin (hgb) level < 10 g/dl terminated december 31, 2020.
injection, factor ix (antihemophilic factor, recombinant), glycopegylated, rebinyn, 1 i.u. terminated december 31, 2018.
power wheelchair accessory, hand or chin control interface, compact remote joystick, proportional, including fixed mounting hardware
injection, mannitol, 25% in 50 ml
ostomy belt with peristomal hernia support
replacement pad for use with medically necessary alternating pressure pad owned by patient
novafix, per square cenitmeter
injection, sirolimus protein-bound particles, 1 mg
standard - weight frame motorized/power wheelchair with programmable control parameters for speed adjustment, tremor dampening, acceleration control and braking
conforming bandage, non-elastic, knitted/woven, non-sterile, width greater than or equal to 5 inches, per yard
infusion, dextran 40, 500 ml
assistive listening device, personal fm/dm system, monaural, (1 receiver, transmitter, microphone), any type
impression casting of a foot performed by a practitioner other than the manufacturer of the orthotic
injection, bendamustine hcl (belrapzo), 1 mg terminated june 30, 2019.
power wheelchair, group 2 heavy duty, captains chair, patient weight capacity 301 to 450 pounds
home infusion therapy, insertion of peripherally inserted central venous catheter (picc), nursing services only (no supplies or catheter included)
betadine or phisohex solution, per pint
blinded administration of convulsive therapy procedure, either electroconvulsive therapy (ect, current covered gold standard) or magnetic seizure therapy (mst, non-covered experimental therapy), performed in an approved ide-based clinical trial, per treatment session
injection, canakinumab, 1 mg
procarbazine hydrochloride, oral, 50 mg
injection, amikacin sulfate, 100 mg
this code is for onsite acute care treatment of a nursing facility resident with pneumonia; may only be billed once per day per beneficiary
injection, benralizumab, 1 mg
breast reconstruction of a single breast with "stacked" deep inferior epigastric perforator (diep) flap(s) and/or gluteal artery perforator (gap) flap(s), including harvesting of the flap(s), microvascular transfer, closure of donor site(s) and shaping the flap into a breast, unilateral
hearing aid, analog, binaural, cic
application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)
hospital bed, total electric (head, foot and height adjustments), with any type side rails, without mattress
infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2
modified solid food supplements for inborn errors of metabolism
injection, edaravone, 1 mg
shoulder elbow wrist hand orthosis, abduction positioning, erb's palsey design, prefabricated, includes fitting and adjustment
services performed by a doula birth worker, per diem
injection, decitabine, 1 mg
powered air overlay for mattress, standard mattress length and width
injection, antithrombin recombinant, 50 i.u.
interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results
home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 8 hours, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
single vitamin/mineral/trace element, oral, per dose, not otherwise specified
hearing aid, digitally programmable analog, monaural, bte (behind the ear)
palingen or palingen xplus, per square centimeter
patient lift, moveable from room to room with disassembly and reassembly, includes all components/accessories
addition, exoskeletal system, below knee, ultra-light material (titanium, carbon fiber or equal)
medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)
cast supplies, long leg cast, adult (11 years +), plaster
shoulder elbow wrist hand finger orthosis, abduction positioning (airplane design), thoracic component and support bar, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment
adjustment of gastric band diameter via subcutaneous port by injection or aspiration of saline
federally qualified health center (fqhc) visit, mental health, new patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit
choline c-11, diagnostic, per study dose up to 20 millicuries
busulfan; oral, 2 mg
hospital bed, extra heavy duty, extra wide, with weight capacity greater than 600 pounds, with any type side rails, without mattress
remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved cms innovation center demonstration project, which requires at least 2 of the following 3 key components: an expanded problem focused history; an expanded problem focused examination; medical decision making of low complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of low to moderate severity. typically, 15 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology
patient not receiving maintenance hemodialysis in an outpatient dialysis facility terminated december 31, 2014.
automatic grasp feature, addition to upper limb electric prosthetic terminal device
power wheelchair component, drive wheel motor, replacement only
puraply or puraply am, per square centimeter terminated december 31, 2018.
ostomy pouch, drainable, with extended wear barrier attached, with filter, (1 piece), each
alcohol and/or drug services; crisis intervention (outpatient)
suprathel, per square centimeter
power wheelchair, group 3 extra heavy duty, sling/solid seat/back, patient weight capacity 601 pounds or more
upper extremity addition, rotation wrist unit with cable lock
i intend to report the coronary artery disease (cad) measures group terminated december 31, 2016.
cellesta or cellesta duo, per square centimeter
injection, trimetrexate glucuronate, per 25 mg
custom breast prosthesis, post mastectomy, molded to patient model
neox 100 or clarix 100, per square centimeter
patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy terminated december 31, 2021.
count of previous ct (any type of ct) and cardiac nuclear medicine (myocardial perfusion) studies documented in the 12-month period prior to the current study
documentation of reason(s) sentinel lymph node biopsy not performed (e.g., reasons could include but not limited to; non-invasive cancer, incidental discovery of breast cancer on prophylactic mastectomy, incidental discovery of breast cancer on reduction mammoplasty, pre-operative biopsy proven lymph node (ln) metastases, inflammatory carcinoma, stage 3 locally advanced cancer, recurrent invasive breast cancer, clinically node positive after neoadjuvant systemic therapy, patient refusal after informed consent, patient with significant age, comorbidities, or limited life expectancy and favorable tumor; adjuvant systemic therapy unlikely to change)
transfer of care during an anesthetic or to the intensive care unit terminated december 31, 2016.
assistive listening device, television caption decoder
injection, centruroides immune f(ab)2, up to 120 milligrams
electronic elbow, adolescent, variety village or equal, switch controlled
monitor control cable for use with electric ventricular assist device, replacement only
headset/headpiece for use with cochlear implant device, replacement
high osmolar contrast material, 250-299 mg/ml iodine concentration, per ml
documentation of medical reason(s) for not currently being a statin therapy user or receiving an order (prescription) for statin therapy (e.g., patients with statin-associated muscle symptoms or an allergy to statin medication therapy, patients who are receiving palliative or hospice care, patients with active liver disease or hepatic disease or insufficiency, and patients with end stage renal disease [esrd])
ostomy irrigation supply; bag, each
cervical head harness/halter
nursing care, in the home; by registered nurse, per hour (use for general nursing care only, not to be used when cpt codes 99500-99602 can be used)
shoulder elbow wrist hand orthosis, abduction positioning, airplane design, prefabricated, includes fitting and adjustment
patient not screened for uterine malignancy, or those that have not had an ultrasound and/or endometrial sampling of any kind, reason not given
removal of sutures; by a physician other than the physician who originally closed the wound
canister, non-disposable, used with suction pump, each
alcohol and/or drug services; ambulatory detoxification
addition to lower extremity orthosis, soft interface for molded plastic, above knee section
injection, cilastatin sodium; imipenem, per 250 mg
alcohol and/or drug prevention process service, community-based (delivery of services to develop skills of impactors)
injection, levoleucovorin, not otherwise specified, 0.5 mg
tlso, triplanar control, modular segmented spinal system, two rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the sternal notch, soft liner, restricts gross trunk motion in the sagittal, coronal, and transverse planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise
all lower extremity prostheses, foot, flexible keel
imaging study named according to standardized nomenclature
screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory
power pack base for use with electric ventricular assist device, replacement only
injection, methadone hcl, up to 10 mg
angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed for reasons documented by the clinician (e.g., allergy, intolerance, pregnancy, renal failure due to ace inhibitor, diseases of the aortic or mitral valve, other medical reasons) or (e.g., patient declined, other patient reasons) or (e.g., lack of drug availability, other reasons attributable to the health care system)
pacemaker monitor, self contained, checks battery depletion and other pacemaker components, includes digital/visible check systems
radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev
injection, tebentafusp-tebn, 1 microgram
leg extensions for walker, per set of four (4)
non-emergency transportation: per mile - case worker or social worker
physician management of patient home care, standard monthly case rate (per 30 days)
telehealth consultation, critical care, subsequent, physicians typically spend 50 minutes communicating with the patient and providers via telehealth
capsaicin 8% patch, per 10 square centimeters terminated december 31, 2014.
assessment of home, physical and family environment, to determine suitability to meet patient's medical needs
tlso, sagittal-coronal control, modular segmented spinal system, two rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the xiphoid, soft liner, restricts gross trunk motion in the sagittal and coronal planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment
gallium ga-68 psma-11, diagnostic, (ucla), 1 millicurie
aspirin not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed) terminated december 31, 2016.
spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, .12 to 2.00d cylinder, per lens
surgical stockings thigh length, each
injection, linezolid, 200 mg
5% dextrose/0.45% normal saline with potassium chloride and magnesium sulfate, 1000 ml
sigmoidoscopy, flexible; with ablation of tumor(s), polyp(s), or other lesions(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique terminated december 31, 2015.
cast supplies, short arm cast, adult (11 years +), fiberglass
injection, ziprasidone mesylate, 10 mg
injection, octafluoropropane microspheres, per ml
dialysate solution, any concentration of dextrose, fluid volume greater than 5999 cc, for peritoneal dialysis
inj, tebentafusp-tebn, 1 mcg terminated september 30, 2022.
habilitation, prevocational, waiver; per 15 minutes
repair, urinary tract obstruction in the fetus, procedure performed in utero
addition to lower extremity, thigh/weight bearing, ischial containment/narrow m-l brim molded to patient model
intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring
wheelchair accessory, addition to power seating system, mechanically linked leg elevation system, including pushrod and leg rest, each
oxygen contents, gaseous, 1 unit equals 1 cubic foot
photodocumentation of less than two cecal landmarks (i.e., no cecal landmarks or only one cecal landmark) to establish a complete examination
multimodal pain management was used
home infusion therapy, total parenteral nutrition (tpn); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem (do not use with home infusion codes s9365-s9368 using daily volume scales)
donor lobectomy (lung) for transplantation, living donor
oximeter device for measuring blood oxygen levels non-invasively
injection, aripiprazole lauroxil, (aristada), 1 mg
catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)
smoking status and exposure to second hand smoke in the home not assessed, reason not given terminated december 31, 2014.
power wheelchair, group 3 heavy duty, sling/solid seat/back, patient weight capacity 301 to 450 pounds
compression burn garment, foot to knee length, custom fabricated
hemoglobin level measurement not documented, reason not given terminated december 31, 2014.
